
<html lang="en"     class="pb-page"  data-request-id="83cdd627-04fd-4d6b-97f3-440815b527ac"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2012.55.issue-22;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm3012239"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Potent and Selective Pyrazolopyrimidine Janus Kinase 2 Inhibitors" /></meta><meta name="dc.Creator" content="Emily J.  Hanan" /></meta><meta name="dc.Creator" content="Anne  van Abbema" /></meta><meta name="dc.Creator" content="Kathy  Barrett" /></meta><meta name="dc.Creator" content="Wade S.  Blair" /></meta><meta name="dc.Creator" content="Jeff  Blaney" /></meta><meta name="dc.Creator" content="Christine  Chang" /></meta><meta name="dc.Creator" content="Charles  Eigenbrot" /></meta><meta name="dc.Creator" content="Sean  Flynn" /></meta><meta name="dc.Creator" content="Paul  Gibbons" /></meta><meta name="dc.Creator" content="Christopher A.  Hurley" /></meta><meta name="dc.Creator" content="Jane R.  Kenny" /></meta><meta name="dc.Creator" content="Janusz  Kulagowski" /></meta><meta name="dc.Creator" content="Leslie  Lee" /></meta><meta name="dc.Creator" content="Steven R.  Magnuson" /></meta><meta name="dc.Creator" content="Claire  Morris" /></meta><meta name="dc.Creator" content="Jeremy  Murray" /></meta><meta name="dc.Creator" content="Richard M.  Pastor" /></meta><meta name="dc.Creator" content="Tom  Rawson" /></meta><meta name="dc.Creator" content="Michael  Siu" /></meta><meta name="dc.Creator" content="Mark  Ultsch" /></meta><meta name="dc.Creator" content="Aihe  Zhou" /></meta><meta name="dc.Creator" content="Deepak  Sampath" /></meta><meta name="dc.Creator" content="Joseph P.  Lyssikatos" /></meta><meta name="dc.Description" content="The discovery of somatic Jak2 mutations in patients with chronic myeloproliferative neoplasms has led to significant interest in discovering selective Jak2 inhibitors for use in treating these diso..." /></meta><meta name="Description" content="The discovery of somatic Jak2 mutations in patients with chronic myeloproliferative neoplasms has led to significant interest in discovering selective Jak2 inhibitors for use in treating these diso..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 24, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3012239" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3012239" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3012239" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3012239" /></link>
        
    
    

<title>Discovery of Potent and Selective Pyrazolopyrimidine Janus Kinase 2 Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3012239" /></meta><meta property="og:title" content="Discovery of Potent and Selective Pyrazolopyrimidine Janus Kinase 2 Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0021.jpeg" /></meta><meta property="og:description" content="The discovery of somatic Jak2 mutations in patients with chronic myeloproliferative neoplasms has led to significant interest in discovering selective Jak2 inhibitors for use in treating these disorders. A high-throughput screening effort identified the pyrazolo[1,5-a]pyrimidine scaffold as a potent inhibitor of Jak2. Optimization of lead compounds 7a–b and 8 in this chemical series for activity against Jak2, selectivity against other Jak family kinases, and good in vivo pharmacokinetic properties led to the discovery of 7j. In a SET2 xenograft model that is dependent on Jak2 for growth, 7j demonstrated a time-dependent knock-down of pSTAT5, a downstream target of Jak2." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="The discovery of somatic Jak2 mutations in patients with chronic myeloproliferative neoplasms has led to significant interest in discovering selective Jak2 inhibitors for use in treating these disorders. A high-throughput screening effort identified the pyrazolo[1,5-a]pyrimidine scaffold as a potent inhibitor of Jak2. Optimization of lead compounds 7a–b and 8 in this chemical series for activity against Jak2, selectivity against other Jak family kinases, and good in vivo pharmacokinetic properties led to the discovery of 7j. In a SET2 xenograft model that is dependent on Jak2 for growth, 7j demonstrated a time-dependent knock-down of pSTAT5, a downstream target of Jak2." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0021.jpeg" /></meta><meta name="twitter:title" content="Discovery of Potent and Selective Pyrazolopyrimidine Janus Kinase 2 Inhibitors" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3012239"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3012239">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3012239&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3012239&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3012239&amp;href=/doi/10.1021/jm3012239" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 10090-10107</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301205j" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm301226a" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Potent and Selective Pyrazolopyrimidine Janus Kinase 2 Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emily+J.++Hanan">Emily J. Hanan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne++van+Abbema">Anne van Abbema</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathy++Barrett">Kathy Barrett</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wade+S.++Blair">Wade S. Blair</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeff++Blaney">Jeff Blaney</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Chang">Christine Chang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles++Eigenbrot">Charles Eigenbrot</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sean++Flynn">Sean Flynn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊗</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Gibbons">Paul Gibbons</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+A.++Hurley">Christopher A. Hurley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊗</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jane+R.++Kenny">Jane R. Kenny</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Janusz++Kulagowski">Janusz Kulagowski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊗</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leslie++Lee">Leslie Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+R.++Magnuson">Steven R. Magnuson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claire++Morris">Claire Morris</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊗</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeremy++Murray">Jeremy Murray</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+M.++Pastor">Richard M. Pastor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tom++Rawson">Tom Rawson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Siu">Michael Siu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Ultsch">Mark Ultsch</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aihe++Zhou">Aihe Zhou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deepak++Sampath">Deepak Sampath</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+P.++Lyssikatos">Joseph P. Lyssikatos</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Departments of Discovery Chemistry, <sup>‡</sup>Biochemical and Cellular Pharmacology, <sup>§</sup>Structural Biology, <sup>∥</sup>Drug Metabolism and Pharmacokinetics, <sup>⊥</sup>Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">⊗</span> <span class="aff-text">Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div><div class="corresp-info"><strong>*</strong>Phone: 650-467-6671. E-mail: <a href="/cdn-cgi/l/email-protection#711d080202181a10051e025f1b1e021401193116141f145f121e1c"><span class="__cf_email__" data-cfemail="bad6c3c9c9d3d1dbced5c994d0d5c9dfcad2fadddfd4df94d9d5d7">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3012239&amp;href=/doi/10.1021%2Fjm3012239" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 10090–10107</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 12, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 August 2012</li><li><span class="item_label"><b>Published</b> online</span>24 October 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 November 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3012239" title="DOI URL">https://doi.org/10.1021/jm3012239</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10090%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DEmily%2BJ.%2BHanan%252C%2BAnne%2Bvan%2BAbbema%252C%2BKathy%2BBarrett%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D22%26contentID%3Djm3012239%26title%3DDiscovery%2Bof%2BPotent%2Band%2BSelective%2BPyrazolopyrimidine%2BJanus%2BKinase%2B2%2BInhibitors%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10107%26publicationDate%3DNovember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3012239"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4344</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">55</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3012239" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Potent and Selective Pyrazolopyrimidine Janus Kinase 2 Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Emily&quot;,&quot;last_name&quot;:&quot;J. Hanan&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;van Abbema&quot;},{&quot;first_name&quot;:&quot;Kathy&quot;,&quot;last_name&quot;:&quot;Barrett&quot;},{&quot;first_name&quot;:&quot;Wade&quot;,&quot;last_name&quot;:&quot;S. Blair&quot;},{&quot;first_name&quot;:&quot;Jeff&quot;,&quot;last_name&quot;:&quot;Blaney&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;Eigenbrot&quot;},{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;Flynn&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Gibbons&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;A. Hurley&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;R. Kenny&quot;},{&quot;first_name&quot;:&quot;Janusz&quot;,&quot;last_name&quot;:&quot;Kulagowski&quot;},{&quot;first_name&quot;:&quot;Leslie&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;R. Magnuson&quot;},{&quot;first_name&quot;:&quot;Claire&quot;,&quot;last_name&quot;:&quot;Morris&quot;},{&quot;first_name&quot;:&quot;Jeremy&quot;,&quot;last_name&quot;:&quot;Murray&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;M. Pastor&quot;},{&quot;first_name&quot;:&quot;Tom&quot;,&quot;last_name&quot;:&quot;Rawson&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Siu&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Ultsch&quot;},{&quot;first_name&quot;:&quot;Aihe&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Deepak&quot;,&quot;last_name&quot;:&quot;Sampath&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;P. Lyssikatos&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;10090-10107&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3012239&quot;},&quot;abstract&quot;:&quot;The discovery of somatic Jak2 mutations in patients with chronic myeloproliferative neoplasms has led to significant interest in discovering selective Jak2 inhibitors for use in treating these disorders. A high-throughput screening effort identified the pyrazolo[1,5-a]pyrimidine scaffold as a potent inhibitor of Jak2. Optimization of lead compounds 7a–b and 8 in this chemical series for activity against Jak2, selectivity against other Jak family kinases, and good in vivo pharmacokinetic properties led to the discovery of 7j. In a SET2 xenograft model that is dependent on Jak2 for growth, 7j demonstrated a time-dependent knock-down of pSTAT5, a downstream target of Jak2.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3012239&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3012239" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3012239&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3012239" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3012239&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3012239" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3012239&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3012239&amp;href=/doi/10.1021/jm3012239" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3012239" /></input><a href="/doi/pdf/10.1021/jm3012239" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3012239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3012239%26sid%3Dliteratum%253Aachs%26pmid%3D23061660%26genre%3Darticle%26aulast%3DHanan%26date%3D2012%26atitle%3DDiscovery%2Bof%2BPotent%2Band%2BSelective%2BPyrazolopyrimidine%2BJanus%2BKinase%2B2%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D22%26spage%3D10090%26epage%3D10107%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/22" title="Go to Volume 55, Issue 22"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jmcmar.2012.55.issue-22/production/jmcmar.2012.55.issue-22.largecover.jpg" alt="Go to Volume 55, Issue 22"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The discovery of somatic Jak2 mutations in patients with chronic myeloproliferative neoplasms has led to significant interest in discovering selective Jak2 inhibitors for use in treating these disorders. A high-throughput screening effort identified the pyrazolo[1,5-<i>a</i>]pyrimidine scaffold as a potent inhibitor of Jak2. Optimization of lead compounds <b>7a</b>–<b>b</b> and <b>8</b> in this chemical series for activity against Jak2, selectivity against other Jak family kinases, and good in vivo pharmacokinetic properties led to the discovery of <b>7j</b>. In a SET2 xenograft model that is dependent on Jak2 for growth, <b>7j</b> demonstrated a time-dependent knock-down of pSTAT5, a downstream target of Jak2.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>#</span> Author Present Address</h4><p class="last">Department of Cell Biology, Novartis, Emeryville, California.</p></div><div class="extra-info-sec articleNote"><h4><span>¶</span> Author Present Address</h4><p class="last">Department of Infectious Disease, MedImmune, Gaithersburg, Maryland.</p></div><div class="extra-info-sec articleNote withdrawn"><h4><span></span> Accession Codes</h4><p class="last">PDB ID for the <b>8</b>−Jak2 complex: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HGE">4HGE</a>.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58025" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58025" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The Janus kinase (Jak) family consists of four nonreceptor tyrosine kinases (Jak1, Jak2, Jak3, and Tyk2) that play important roles in hematopoiesis and immune response.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Upon activation through cytokine signaling, Jaks subsequently activate the downstream signal transducer and activator of transcription (STAT) family of transcription factors, which regulate target gene expression that govern cell proliferation and survival.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The identification of a single gain of function point mutation in the JH2 pseudokinase autoinhibitory domain of Jak2 (Jak2<sup>V617F</sup>), which renders the kinase constitutively active, has led to interest in Jak2 as a potential therapeutic target.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Philadelphia (Ph)-negative myeloproliferative disorders (MPDs) are a group of heterogeneous hematologic diseases resulting from deregulated proliferation of differentiated myeloid cells and include the disorders polycythemia vera (PV), essential thrombocytemia (ET), and primary myelofibrosis (PMF).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Gain of function mutations in Jak2 are frequently observed in these disorders; the Jak2 mutation has been identified in 77% of patients with PV, in 35% of patients with ET, and 43% of patients with PMF.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In preclinical cellular models of PV, Jak2<sup>V617F</sup> expression is necessary and sufficient to drive cytokine-independent activation of STAT1 or STAT5 and subsequently regulates cell proliferation and survival. Therefore, the identification of the Jak2<sup>V617F</sup> somatic mutation provides a strong and compelling rationale to develop a targeted therapy for Ph-negative MPDs.</div><div class="NLM_p">Indeed, a number of small molecule ATP-competitive Jak2 inhibitors are currently in clinical development for the treatment of MPDs, including TG101348,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> SB1518,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> AZD1480,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> LY2784544,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and CYT387<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). The recent FDA approval of ruxolitinib for the treatment of patients with intermediate or high-risk MF (including apMF, post-PV MF, and post-ET MF) has validated this target.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> As a pan-Jak inhibitor, ruxolitinib has equivalent activity against Jak1 and Jak2, with decreased activity against Jak3 and Tyk2.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> To potentially increase the safety index of a Jak2 inhibitor, it would be advantageous to identify a Jak2-selective inhibitor in light of the anticipated chronic dosing required for MPD treatment and the potential for immunosuppressive side effects related to inhibition of Jak1, Jak3, or Tyk2.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> While the degree of selectivity for Jak2 over Jak1, Jak3, and Tyk2 necessary for therapeutic benefit is unclear, a 10-fold window would provide a minimum degree of differentiation. We therefore initiated a program to identify potent inhibitors of Jak2 with at least 10-fold selectivity against all other Jak family members.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of Jak2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The pyrazolo[1,5-<i>a</i>]pyrimidine scaffold was identified through high-throughput screening to have inhibitory activity against Jak2, and after initial medicinal chemistry exploration, compounds <b>7a</b>–<b>b</b> and <b>8</b> were identified as lead compounds with good inhibitory activity against Jak2 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). These compounds are close to the desired 10× selectivity against Jak1, with even better selectivity against the other Jak family members Jak3 and Tyk2. With these compounds as a starting point, we undertook a lead-optimization program to address the liabilities of <b>7a</b> and <b>8</b> and to identify a Jak2 inhibitor with an in vitro and in vivo profile suitable for the effective oral treatment of MPDs. The in vitro parameters measured for inhibitors synthesized as part of this lead-optimization campaign are provided in Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, with in vivo pharmacokinetic parameters detailed in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. This work culminated in the discovery and evaluation of <b>7j</b> as a potent and selective orally active inhibitor of Jak2.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Early Lead Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0015.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">NH<sub>2</sub><br /></br><b>7a</b></th><th class="colsep0 rowsep0" align="center" char=".">NHCH<sub>3</sub><br /></br><b>7b</b></th><th class="colsep0 rowsep0" align="center" char=".">H<br /></br><b>8</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Jak2 <i>K</i><sub>i</sub> (nM)</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">11.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LE<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">0.46</td><td class="colsep0 rowsep0" align="char" char=".">0.43</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LELP<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Jak1/2<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">8.6</td><td class="colsep0 rowsep0" align="char" char=".">7.8</td><td class="colsep0 rowsep0" align="char" char=".">9.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Jak3/2<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">30.4</td><td class="colsep0 rowsep0" align="char" char=".">31.3</td><td class="colsep0 rowsep0" align="char" char=".">58.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tyk2/Jak2<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">32.4</td><td class="colsep0 rowsep0" align="char" char=".">24.4</td><td class="colsep0 rowsep0" align="char" char=".">24.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pSTAT5 IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">131</td><td class="colsep0 rowsep0" align="char" char=".">259</td><td class="colsep0 rowsep0" align="char" char=".">1100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP450 inhibition IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">>5</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">4.6 (3A4)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Ligand efficiency<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (LE) calculated as Δ<i>G</i> (in kcal/mol) divided by the number of heavy atoms.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">LELP<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> = cLogP<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a>/LE.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">fold biochemical selectivity for Jak2 over other Jak family kinase.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">pSTAT5 SET2 MSD format.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">CYP isoforms tested: 1A2, 2C9, 2C19, 2D6, 3A4; IC<sub>50</sub> is given for most potently inhibited isoform.</p></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07408" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07408" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The general synthetic procedure for 5-aminopyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamides <b>7a</b>–<b>k</b> is described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. 3-Amino-pyrazole and 1,3-dimethyluracil were heated together with sodium ethoxide in ethanol to produce the cyclized pyrazolo[1,5-<i>a</i>]pyrimidine intermediate compound <b>1</b>. After neutralization with acetic acid, iodination with <i>N</i>-iodosuccinimide provided <b>3</b>. Palladium-catalyzed carbonylation and subsequent saponification yielded intermediate <b>4</b>. Alternatively, <b>4</b> could be generated in a one-step condensation of 5-amino-1<i>H</i>-pyrazole-4-carboxylic acid with 1,3-dimethyluracil.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Bis-chlorination of <b>4</b> with POCl<sub>3</sub> generated the key intermediate <b>5</b>, which was derivatized sequentially through amide formation followed by an S<sub>N</sub>Ar reaction with ammonia or methylamine to yield compounds <b>7a</b>–<b>k</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Procedure for 5-Amino-pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) 21% EtONa, EtOH, 95%; (b) HOAc, H<sub>2</sub>O, 85%; (c) <i>N</i>-iodosuccinimide, DMF, 86%; (d) CO (1 atm), Pd(OAc)<sub>2</sub>, Et<sub>3</sub>N, MeOH; (e) 5% aq LiOH, 68% (2 steps); (f) POCl<sub>3</sub>, DIPEA, 87%; (g) H<sub>2</sub>NR, DIPEA, DCM, 52–92%; (h) NH<sub>3</sub>, iPrOH, DIPEA, μW 120 °C, 15 min, 9–80%; (i) H<sub>2</sub>NCH<sub>3</sub>, H<sub>2</sub>O, μW 100 °C, 15 min, 62%.</p></p></figure><div class="NLM_p">5-<i>H</i>-Pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamides <b>8</b>, <b>10a</b>–<b>c</b>, <b>12</b>, <b>13a</b>–<b>g</b>, and <b>14a</b>–<b>j</b> were prepared in one or two steps from pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxylic acid as described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Pyridine containing compounds <b>10a</b>–<b>c</b> were prepared as described in Schemes <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. 5-Bromo-2-methylpyridine was oxidized with mCPBA to generate the <i>N</i>-oxide <b>15</b>, which was nitrated to provide compound <b>16</b>. Pyridine-<i>N</i>-oxide <b>16</b> was then reduced with SnCl<sub>2</sub> to yield 5-bromo-2-methylpyridin-4-amine <b>17</b>. The acid chloride of pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxylic acid was generated using oxalyl chloride and then used to acylate each of 2-bromo-pyridin-3-amine, 3-bromo-pyridine-4-amine, or <b>17</b> to provide bromo-pyridines <b>9a</b>–<b>c</b>. Suzuki coupling with 3-chlorophenyl boronic acid yielded compounds <b>10a</b>–<b>c</b>.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Procedure for Compounds <b>8</b>–<b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) RNH<sub>2</sub>, HATU or PyAOP, DIPEA, DMAP, 20–90%; (b) (COCl)<sub>2</sub>, DCM; (c) 2-bromopyridin-3-amine or 3-bromopyridin-4-amine or <b>17</b>, Et<sub>3</sub>N, DCM, 21–56%; (d) 3-chlorophenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, H<sub>2</sub>O, μW, 120 °C, 42–59%; (e) 3-chlorophenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, diglyme, 100 °C, 7%; (f) R<sup>3</sup>-X, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 5–61%; (g) subsituted oxirane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 46%.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Aminopyridine <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) mCPBA, DCM, 99%; (b) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, 90%; (c) SnCl<sub>2</sub>, HCl, 56%.</p></p></figure><div class="NLM_p">Regioisomeric pyrazole compound <b>12</b> was prepared in two steps. Pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxylic acid was reacted with 4-bromo-1-methyl-1<i>H</i>-pyrazol-3-amine under standard HATU-mediated amide coupling conditions, followed by coupling with 3-chlorophenyl boronic acid under Suzuki conditions (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><div class="NLM_p">3-Aryl-4-aminopyrazole intermediates used for the synthesis of compounds <b>13</b> and <b>14</b> were prepared as described in Schemes <a class="ref internalNav" href="#sch4" aria-label="4">4</a>–<a class="ref internalNav" href="#sch6" aria-label="6">6</a>. In Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, various aryl-substituted α-bromoacetophenones were treated with potassium phthalimide or di-<i>tert</i>-butyl-iminodicarboxylate to generate α-amino-ketones <b>18a</b>–<b>d</b>. Treatment of these ketones with 1,1-dimethoxy-<i>N</i>,<i>N</i>-dimethylmethanamine (DMFDMA) at elevated temperatures provided intermediates <b>19a</b>–<b>d</b>, which were cyclized with either hydrazine or methylhydrazine to yield 1-<i>H</i>-4-aminopyrazoles or 1-methyl-1<i>H</i>-4-aminopyrazoles, respectively (<b>20a</b>–<b>e</b>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. 2-Bromo-1-phenylethanone-Based Synthesis of 1-Methyl-3-phenyl-1<i>H</i>-pyrazol-4-amines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) potassium phthalimide, 88%; (b) HN(Boc)<sub>2</sub>, NaH, 34–77%; (c) DMFDMA, 38–80%; (d) methylhydrazine, EtOH, 38–53%; (e) hydrazine, EtOH, 80%.</p></p></figure><div class="NLM_p">As an alternate preparation, as described in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>, acid chlorides or benzoic acids activated by CDI were treated with potassium ethyl malonate and MgCl<sub>2</sub> to provide β-keto-esters <b>21a</b>–<b>b</b>.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Reaction with DMFDMA gave <b>22a</b>–<b>b</b>. <b>22a</b> was cyclized with hydrazine to provide pyrazole <b>23</b>, which was alkylated with iodomethane to yield a regioisomeric mixture of pyrazoles <b>24a</b> and <b>25</b>. Carrying forward the regioisomeric mixture, saponification of the ester followed by Curtius rearrangement using Shioiri’s conditions<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> to the <i>tert</i>-butylcarbamate and finally acid catalyzed Boc-deprotection yielded amino-pyrazoles <b>26a</b> and <b>27</b>, which are easily separated via silica gel chromatography.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Intermediate <b>22b</b> was reacted with <i>N</i>-methylhydrazine to give the desired regiosiomer <b>24b</b> directly, which was carried forward in the same manner to provide aminopyrazole <b>26b</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0010.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Benzoic Acid Based Synthesis of 3-(5-Chloro-2-methylphenyl)-1-methyl-1<i>H</i>-pyrazol-4-amine<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) potassium ethyl malonate, CDI, MgCl<sub>2</sub>, THF, 50 °C; (b) potassium ethyl malonate, Et<sub>3</sub>N, MgCl<sub>2</sub>, CH<sub>3</sub>CN; (c) DMFDMA, 34–70% (2 steps); (d) hydrazine, EtOH, 70 °C, quant; (e) CH<sub>3</sub>I, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 40 °C, 81%; (f) methylhydrazine, AcOH, 45%; (g) NaOH, EtOH/H<sub>2</sub>O; (h) (PhO)<sub>2</sub>P(O)N<sub>3</sub>, Et<sub>3</sub>N, 1,4-dioxane, tBuOH; (i) HCl, 1,4-dioxane, 37–46% (3 steps).</p></p></figure><div class="NLM_p">The preferred construction of the 3-aryl-4-amino-pyrazole intermediate used for compound <b>14j</b> is described in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. The SEM-protected 4-nitropyrazole <b>28</b> was subjected to palladium-catalyzed direct arylation conditions<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> with 2-bromo-4-chloro-1-methoxybenzene. The biaryl product <b>29</b> was then reduced with iron in the presence of ammonium chloride to yield SEM-protected 4-aminopyrazole <b>30</b>. Intermediate <b>30</b> was carried forward as described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, with SEM deprotection effected with aqueous HCl in ethanol, to provide the final compound <b>14j</b>.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0011.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. 4-Nitropyrazole CH-arylation Synthesis of <b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) SEM-Cl, NaH, THF, 99%; (b) 2-bromo-4-chloro-1-methoxybenzene, Pd(OAc)<sub>2</sub>, (Ad)<sub>2</sub>BuP, K<sub>2</sub>CO<sub>3</sub>, tBuCO<sub>2</sub>H, DMF, 120 °C, 89%; (c) Fe, NH<sub>4</sub>Cl, EtOH, H<sub>2</sub>O, 70 °C, quant.</p></p></figure><div class="NLM_p">The regioisomeric aminoisoxazole intermediates used for the preparation of compounds <b>7e</b> and <b>7f</b> were synthesized as described in Schemes <a class="ref internalNav" href="#sch7" aria-label="7">7</a> and <a class="ref internalNav" href="#sch8" aria-label="8">8</a>. Acylation of 1-(3-chlorophenyl)ethanone provided β-keto-ester <b>31</b>, which was reacted with DMFDMA and then cyclized to the isoxazole <b>32</b> using hydroxylamine. Hydrolysis of the ester followed by Curtius rearrangement yielded Boc-protected amine <b>34</b>, which was deprotected with HCl to give 5-(3-chlorophenyl)isoxazol-4-amine <b>35</b>. Compound <b>35</b> was carried forward as described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> to yield compound <b>7e</b>. As shown in Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>, 3-chlorobenzaldehyde was condensed with hydroxylamine to give oxime <b>36</b>. Chlorination of <b>36</b> with <i>N</i>-chlorosuccinimide provided α-chlorobenzaldoxime <b>37</b>. After treatment with triethylamine, <b>37</b> underwent [3 + 2] dipolar cycloaddition with 3-pyrrolidin-1-yl-acrylic acid ethyl ester <b>38</b> via the in situ generated benzonitrile oxide to afford isoxazole <b>39</b>. Acid catalyzed hydrolysis of the ester followed by Curtius rearrangement to the <i>tert</i>-butylcarbamate <b>41</b> and subsequent Boc-deprotection yielded 3-(3-chlorophenyl)isoxazol-4-amine <b>42</b>, which was carried forward as described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> to provide compound <b>7f</b>.</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0012.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Aminoisoxazole <b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) diethyl carbonate, NaH, toluene, rt to reflux, 51%; (b) DMFDMA, DMF, reflux; (c) NH<sub>2</sub>OH-HCl, MeOH, reflux, 79% (2 steps); (d) HCl, AcOH, reflux; (e) SOCl<sub>2</sub>, reflux, NaN<sub>3</sub>, acetone, 0 °C to rt, tBuOH, 85 °C, 55% (2 steps); (f) 4 M HCl in 1,4-dioxane, 40 °C, quant.</p></p></figure><figure id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0013.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Aminoisoxazole <b>42</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) NH<sub>2</sub>OH-HCl, pyridine, EtOH, quant; (b) NCS, DMF, quant; (c) ethyl propiolate, toluene, 94%; (d) Et<sub>3</sub>N, Et<sub>2</sub>O, 57%; (e) HCl, AcOH, reflux, 99%; (f) (PhO)<sub>2</sub>P(O)N<sub>3</sub>, Et<sub>3</sub>N, tBuOH, 85 °C, 77%; (g) 4 M HCl in 1,4-dioxane, 97%.</p></p></figure><div class="NLM_p">The amino-thiazole intermediate used for compound <b>7g</b> was prepared as described in Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>. Heating commercially available α-amino-(3-chlorophenyl)acetonitrile hydrochloride in the presence of elemental sulfur and acetaldehyde directly yielded aminothiazole <b>43</b>. Compound <b>43</b> was carried forward as described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> to provide compound <b>7g</b>.</div><figure id="sch9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0014.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Aminothiazole <b>43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) powdered sulfur, EtOH, 0 °C; (b) acetaldehyde, Et<sub>3</sub>N, EtOH, 60 °C, 73% (2 steps).</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00337" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00337" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">An HTS campaign identified the pyrazolo[1,5-<i>a</i>]pyrimidine <b>7a</b> as a compelling lead molecule for our selective Jak2 inhibitor program. Compound <b>7a</b> is a low nanomolar inhibitor of Jak2 (<i>K</i><sub>i</sub> = 2.5 nM) with high ligand efficiency<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (LE = 0.46), low ligand-efficiency-dependent lipophilicity<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (LELP = 4.5), and has potent inhibitory activity (IC<sub>50</sub> = 131 nM) in a Jak2-driven SET2 cell-based assay as measured by the inhibition of pSTAT5, a downstream target of Jak2 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compound <b>7a</b> has low potential for reversible inhibition of the 5 major human CYP450 isoforms and good in vitro permeability. Compound <b>7a</b> has moderate selectivity (∼9–30×) against the other Jak family members and excellent selectivity across a panel of 177 kinases.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Some of the liabilities of compound <b>7a</b> include low microsomal stability across five species and poor thermodynamic aqueous solubility (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The pharmacokinetic profile of compound <b>7a</b> was determined for rats and mice<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> in order to determine how these apparent liabilities manifested in vivo (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div><div class="NLM_p">Compound <b>7a</b> has lower than expected plasma clearances in both mice and rats (3 and 6.8 mL/min/kg, respectively) because for both species microsomes predicted moderate/high clearance (Cl<sub>pred</sub> = 60 and 39 mL/min/kg, respectively). The very low <i>V</i><sub>d</sub> in both species (<i>V</i><sub>dss</sub> = 0.27 and 0.19 L/kg, respectively) and lower than predicted plasma clearances are consistent with high plasma protein binding in both species (98.7% and 99.6%, respectively). Unfortunately, compound <b>7a</b> has poor oral bioavailability in mice and rats (<i>F</i><sub>oral</sub> (%) = 8.6 and 1, respectively). The limited oral exposure may be a result of poor aqueous solubility because the compound has good permeability. Moreover, the first pass effect should be minimal because the plasma clearance is low (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div><div class="NLM_p">We surmised that the poor solubility of <b>7a</b> was due to high crystal packing forces as a consequence of the multiple aromatic rings<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (four) and multiple potential hydrogen bond donors (HBDs) and acceptors (HBAs). Poor aqueous solubility is also often associated with high lipophilicity; however, because the cLogP<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> of compound <b>7a</b> is in a reasonable range (2.1), lipophilicity may not be the key driver for the poor aqueous solubility. The rat pharmacokinetic profile of the 2-<i>des</i>-amino compound <b>8</b> and the 2-methylamino compound <b>7b</b> were obtained to probe the effect of removing HBDs on oral bioavailability (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The rat plasma clearance and <i>V</i><sub>d</sub> of compound <b>8</b> are low as was observed with compound <b>7a</b>; however, a much-improved oral exposure was observed (<i>F</i><sub>oral</sub> (%) = 44 vs 1). The improved oral exposure may be a result of the greater kinetic aqueous solubility of compound <b>8</b> vs <b>7a</b> because their thermodynamic solubilities, are comparable and both compounds have similar permeability in MDCK cells. Unfortunately, compound <b>8</b> is ∼10-fold less potent than compound <b>7a</b> against Jak2 in both the enzyme and cell assays. However, compound <b>7b</b>, in which the 2-NH<sub>2</sub> group is replaced with a 2-NHCH<sub>3</sub> group, was only 2-fold less potent in the Jak2 enzyme assay (<i>K</i><sub>i</sub> = 5.1 nM, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compound <b>7b</b> unfortunately has high clearance in rats, which is consistent with the ∼4× higher free fraction in rat plasma (1.7% vs 0.4%) and higher predicted clearance in rat microsomes (48 vs 39 mL/min/kg) as compared to compound <b>7a</b>. Interestingly, compound <b>7b</b> has a significantly higher oral bioavailability compared to compound <b>7a</b> (<i>F</i><sub>oral</sub> (%) = 30 vs 1, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) despite the higher plasma clearance. The improved oral exposure may be a result of the greater kinetic aqueous solubility of compound <b>7b</b>.</div><div class="NLM_p">An X-ray structure of <b>8</b> with Jak2 was solved (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), revealing a binding mode consistent with observed SAR. The N1-nitrogen of the pyrazolopyrimidine core makes a hydrogen bond with the backbone NH of Leu932. A possible weak nonclassical hydrogen-bond between the C–H moiety at C-7 of the pyrazolopyrimidine core and the backbone of carbonyl Glu930 is interesting; however, the distance of this putative hydrogen bond is a bit long (3.4 Å).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Both the amide carbonyl and the pyrazole N2-nitrogen of <b>8</b> form hydrogen bonds to waters, and the terminal phenyl ring of <b>8</b> occupies the hydrophobic sugar region of the ATP binding site.</div><figure id="fig2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0003.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Co-crystal structure (2.3 Å) of compound <b>8</b> in the active site of the Jak2 kinase domain with the P-loop removed to allow a better view of the key active site interactions. Dashed lines indicate close contacts between ligand and protein with distances labeled in Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While a high degree of sequence homology exists between Jak1 and Jak2, several differences are observed in amino acids at the periphery of the binding site. The residue Asp939 in Jak2, which is in close proximity to the pyrazole methyl substituent, is Glu966 in Jak1. Other residue differences with the potential to interact with bound ATP-competitive ligands are Jak2 Tyr931→Jak1 Phe958 and Jak2 Gln853→Jak1 Arg879.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> As these amino acids are somewhat removed from the space occupied by <b>8</b> and other compounds in this series, improvement of selectivity for Jak2 over Jak1 remained a challenging task, with the best potential for Jak1/Jak2 differentiation offered by positive interactions with Asp939.</div><div class="NLM_p">In addition to the poor solubility and poor metabolic stability in human liver microsomes, we were also concerned about two potential reactive metabolites<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> of the 3-methyl-<i>N</i>-arylpyrazole core of the lead series as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>. The <i>N</i>-linked pyrazole moiety could potentially be oxidized to the paraquinoneimine (pathway A). Furthermore, the electron-rich nature of the aryl ring of the <i>N</i>-arylpyrazole moiety may contribute to the poor microsomal stability. The other potential reactive metabolite is envisioned to form through a two-step process in which the methyl group is oxidized to the alcohol, which subsequently eliminates to give the potentially highly reactive pyrazoleiminium species (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, pathway B and C). Therefore, in parallel with the efforts exploring the SAR of compound <b>7a</b>, a significant effort was expended to explore replacements for the <i>N</i>-arylpyrazole group.</div><figure id="fig3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0004.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Potential reactive metabolites of the 3-methyl-<i>N</i>-aryl-methylpyrazole scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The pyridine and regioisomeric pyrazole core replacements that were prepared are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. 4-Pyridyl <b>10b</b> is marginally more active than 3-pyridyl <b>10a</b>. Not surprisingly, 4-pyridyl <b>10b</b> exhibited potent CYP3A4 inhibition (IC<sub>50</sub> = 0.2 μM), which is likely related to the heme-binding ability of a sterically unhindered pyridine nitrogen. Indeed, introducing a methyl substituent <i>ortho</i> to the pyridine nitrogen (compound <b>10c</b>) decreased CYP3A4 inhibition.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> 4-Pyridyl compounds, <b>10b</b> and <b>10c</b>, have Jak family enzyme potencies similar to compound <b>8</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pyrazole Replacement SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0016.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0017.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Fold biochemical selectivity for Jak2 over other Jak family kinase.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">pSTAT5 SET2 MSD format.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">CYP isoforms tested: 1A2, 2C9, 2C19, 2D6, 3A4; IC<sub>50</sub> is given for most potently inhibited isoform;</p></div><div class="footnote" id="t2fn4"><sup>Table d)</sup><p class="last">N.D.: not determined.</p></div></div><div></div></div><div class="NLM_p">Compound <b>13a</b> is the more potent of the regioisomeric pyrazoles (<b>12</b> and <b>13a</b>) that were prepared. The >30-fold decrease in the potency of <b>12</b> vs Jak2 as compared to <b>13a</b> may be ascribed to an increase in energy required to adopt a coplanar conformation between the amide and pyrazole groups due to lone pair repulsion between the <i>N</i>2 nitrogen of the pyrazole and one of the lone pairs of the amide oxygen. This is consistent with the binding mode for this scaffold observed in X-ray structures (e.g., Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Moreover, the pyrazole ring nitrogen of <b>13a</b> can form an H-bond to a water molecule consistently observed within the binding site, whereas regioisomer <b>12</b> is lacking a HBA at this position. Interestingly, <b>13a</b> is >2× more potent in both the Jak2 kinase and cell assays than <b>8</b> while maintaining moderate selectivity within the Jak family. The increase in potency may be due to an increase in the polarization of the C–H bonds of the <i>N</i>-methyl moiety of compound <b>13a</b> relative to the <i>C</i>-methyl group in compound <b>8</b>. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, a cocrystal structure of compound <b>8</b> with the Jak2 kinase domain indicated a potential charge-partial charge interaction (3.3 Å) of the carbonyl of Asp939 and the pyrazole methyl hydrogens. Presumably, this weak interaction could be enhanced with the increased polarization of the methyl protons in a pyrazole <i>N</i>-methyl group as compared to a <i>C</i>-linked methyl group. Although the methyl group of compound <b>8</b> is more acidic (calculated p<i>K</i><sub>a</sub><a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> 40 vs 43) due to resonance stabilization of the resulting anion into the pyrazole ring, the partial positive charge on the methyl protons are greater in compound <b>13a</b> due to greater polarization of the <i>N</i>-methyl bond. Compound <b>13a</b> has a similar rat plasma clearance to its regioisomer <b>8</b> (12.5 vs 13.3 mL/min/kg; Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Interestingly, <b>13a</b> has high oral bioavailability despite poor kinetic and thermodynamic solubilities (both ∼1 μM). A possible explanation for the observed equivalence in kinetic and thermodynamic solubilities is that compound <b>13a</b> precipitated as a crystalline form during the kinetic solubility study.</div><div class="NLM_p">To probe the putative pyrazole <i>N</i>-methyl effect further, <b>7c</b> was prepared in which the 5-<i>H</i> of the pyrazolopyrimidine ring was replaced with 5-NH<sub>2</sub> in an effort to improve Jak2 potency relative to <b>13a</b>. Gratifyingly, <b>7c</b> also has a >2-fold improvement in potencies in both in the Jak2 enzyme and cell assays as compared to its regioisomer <b>7a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Moreover, the selectivity against Jak1 is slightly increased. Unlike its regioisomer <b>7a</b>, the rat in vivo clearance of <b>7c</b> was well predicted by rat liver microsomes (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Although an improvement in oral bioavailability was observed with <b>7c</b> relative to <b>7a</b>, the oral bioavailability is still poor (7%). Assuming the observed plasma clearance is mainly hepatic-driven, the expected oral bioavailability is ∼60% (based on a hepatic extraction ratio of 0.40 and rat liver blood flow of 57 mL/min/kg) for a compound that is completely absorbed intact from the GI tract. As was observed with compound <b>7a</b>, compound <b>7c</b> has poor kinetic and thermodynamic aqueous solubility, which could explain the significantly lower than expected oral exposure (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div><div class="NLM_p">Two common strategies to improve stability toward CYP-mediated metabolism are to increase polarity and to remove and/or block metabolic hotspots such as <i>N</i>-methyl groups;<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> therefore, several compounds that lacked the <i>N</i>-methyl group were prepared. 1-<i>H</i>-Pyrazoles <b>7d</b> and <b>13b</b> have very similar Jak2 enzyme potencies relative to their corresponding <i>N</i>-methyl-1<i>H</i>-pyrazole analogs while preserving selectivity versus the other Jak family members (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Interestingly, compound <b>7d</b> is ∼7× less potent than <i>N</i>-methyl analog <b>7c</b> in the Jak2 cell assay. Unfortunately, removing the <i>N</i>-methyl moiety coupled with an increase in polarity did not lead to improved human liver microsome (HLM) stability. Because the pyrazole core may be the key metabolic liability in this series, two isomeric isoxazoles (<b>7e</b>–<b>f</b>) and a methylthiazole (<b>7g</b>) were prepared. All three compounds have a heteroatom (O or N) <i>ortho</i> to the phenyl ring with a potential to form an H-bond with an active site water molecule. Isoxazole <b>7f</b> has comparable Jak2 kinase potency and Jak family selectivity to compounds <b>7c</b>–<b>d</b>. Interestingly, isoxazole <b>7e</b> is less potent against all Jak family members than its regioisomer <b>7f</b>. This may be a result of the poor H-bond accepting character of oxygen atoms in heteroaromatic ring systems, whereas sp<sup>2</sup> nitrogens of heteroaromatics tend to be good H-bond acceptors.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> While the Jak2 activity of <b>7f</b> compared favorably with <b>13a</b>, it unfortunately potently inhibited CYP1A2 (IC<sub>50</sub> = 1.2 μM). Finally, because 2-<i>H</i> thiazoles are generally potent CYP inhibitors,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> we only prepared the 2-methyl-thiazole <b>7g</b> to mitigate this known risk. This particular regioisomeric thiazole was chosen because it was presumed that an attractive intramolecular thiocarbonyl interaction would stabilize the requisite coplanar geometry between the amide and five-membered heteroaryl required for potent Jak2 activity.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Compound <b>7g</b> was determined to be equipotent with compound <b>7c</b> in the Jak2 enzyme assay and slightly more selective vs the other Jak family members. It is, however, less potent in the Jak2 cell assay (<i>K</i><sub>i</sub> = 176 nM vs 60.4 nM). Moreover, compound <b>7g</b> is a moderate inhibitor of CYP3A4 (IC<sub>50</sub> = 6.7 μM), whereas compound <b>7c</b> is inactive against all 5 CYP isoforms tested.</div><div class="NLM_p">As part of our efforts to improve the aqueous solubility and metabolic stability of our lead series, various branched and hydrophilic substituents were prepared off the pyrazole nitrogen because this vector points toward bulk solvent (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). These substituents are also in the region of the Jak2 Asp939→Jak1 Glu966 amino acid difference with the potential to impact selectivity over Jak1. The isopropyl-substituted compound <b>14a</b> was designed to increase the percentage of sp<sup>3</sup> centers, which has been correlated in the literature with improved solubility.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Moreover, by replacing the <i>N</i>-methyl group with an <i>N</i>-isopropyl, it was hoped that the metabolic stability might improve. Gratifyingly, <b>14a</b> is indeed more soluble than <b>13a</b> (44 μM vs 1 μM kinetic aqueous solubility) and more stable in HLMs; however, <b>14a</b> has poor Jak2 potency and selectivity vs Jak1 is eroded. The traditional method to improve aqueous solubility is to add hydrophilic groups such as hydroxyls or groups that are charged at physiological pH. Furthermore, increasing polarity often leads to an increase in metabolic stability toward CYP-mediated metabolism. The introduction of a single hydroxyl functional group (<b>14b</b>, <b>14e</b>, and <b>14f</b>) improved kinetic solubility significantly vs <b>13a</b> although only the <i>tert</i>-butyl alcohol analog <b>14f</b> showed a significant improvement in HLM stability (CL<sub>pred</sub> = 7.8 vs 18 mL/min/kg). The greatest improvement in kinetic aqueous solubility was seen with the bis-hydroxy compounds <b>14c</b> and <b>14d</b>, both of which have measured kinetic aqueous solubilities >200 μM at pH 7.4. Moreover, both of these analogs are also more stable in HLMs than <b>13a</b>, although to a lesser extent than <b>14f</b>. Interestingly, the morpholino-containing compound <b>14g</b> has very poor kinetic aqueous solubility (<1 μM at pH = 7.4) and is highly unstable in HLMs. The poor solubility of <b>14g</b> may be due to the possibility that the morpholine group of <b>14g</b> is only partially protonated at pH = 7.4 (calculated p<i>K</i><sub>a</sub> = 7.06). Because all but one of these analogs are significantly less potent vs Jak2 than <b>13a</b>, coupled with the erosion of selectivity vs Jak1 with several of the compounds (<b>14a</b>, <b>14f</b> and <b>14g</b>), this subseries was not progressed further. Only the <i>N</i>-ethanol analog <b>14b</b> maintained good Jak2 potency and moderate selectivity vs Jak1; however, it has poor stability in HLMs. It is not clear as to why Jak2 activity dropped off significantly with most of these analogs given that these substituents seemingly point toward solvent. One possibility is that the side chain of the solvent-exposed Asp939 is less flexible than presumed, leading to steric clashes with groups larger than methyl substituted off the pyrazole.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pyrazole <i>N</i>-Substitutions</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0018.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0019.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Fold biochemical selectivity for Jak2 over other Jak family kinase.</p></div></div><div></div></div><div class="NLM_p">We then focused efforts on optimizing the substituents of the phenyl ring. Parallel work (not shown) on the regioisomeric <i>N</i>-arylpyrazole series exemplified by compound <b>7a</b> indicated that any substitution at the <i>para</i>-position of the <i>N</i>-aryl group significantly decreases inhibitory potencies for all Jak family members. This observation is consistent with the binding mode observed for <b>8</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information Figure S1">Supporting Information Figure S1</a>) with the <i>para</i>-position of the phenyl ring abutting the back of the pocket. The preferred substituents in the 3-position are methyl, chloro, and cyano. Groups larger than chloro are not well tolerated. The X-ray cocrystal structure of <b>8</b> with Jak2 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) suggests that there is hydrophobic space at both the top and bottom of the sugar-binding pocket within the ATP binding site. This led us to make directed bis-substitutions around the phenyl ring (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). <i>ortho</i>-Substitution was designed to enforce a high degree of twist between the phenyl and pyrazole rings, thereby lowering the ground-state energy of the active conformation adopted in cocrystal structures, as well as decreasing the flatness of the compounds, which could improve solubility. The 2,5-dimethylphenyl compound <b>14h</b> is slightly more potent than <b>13a</b>; however, the 2,5-dichlorophenyl analog <b>14i</b> is nearly 10-fold more active with a <i>K</i><sub>i</sub> of 0.4 nM. The <i>K</i><sub>i</sub> of the 2-methyl-5-chlorophenyl analog <b>13e</b> is in-between that of <b>14h</b> and <b>14i</b>, which is consistent with the SAR. The 2,6-dichlorophenyl analog <b>13g</b> is nearly 10-fold less active against Jak2 than the corresponding 2,5-dichlorophenyl analog <b>14i</b>, with similar drops in activity against the other Jak family members. Compounds <b>14h</b>–<b>j</b> and <b>13e</b> spanned a ∼3-fold range of activity in the Jak2 cell assay, with 2-chloro, 2-methyl, or 2-methoxy substituents resulting in similar activities. 2,5-Bis-substitution proved to be critical for optimal activity against Jak2 because the 2-monosubstituted analog <b>7h</b> and the 2,6-dichloro bis-substituted analog <b>13g</b> are 5–10× less potent than their respective 2,5-bis-substituted analogs <b>7i</b> and <b>14i</b>. Interestingly, only analogs <b>7i</b>–<b>k</b>, where R<sup>1</sup> = NH<sub>2</sub> in the 2,5-bis-substituted series are both highly potent vs Jak2 (<i>K</i><sub>i</sub> < 1nM) and also meet our selectivity requirements vs the other Jak family members (>10×).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Phenyl Bis-substitution SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0020.gif" alt="" id="fx8" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char=".">Jak2 <i>K</i><sub>i</sub><br /></br> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">Jak<br /></br>1/2<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">Jak<br /></br>3/2<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">Tyk2/Jak2<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">pSTAT5 IC<sub>50</sub><br /></br>(nM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">HLM, RLM Cl<sub>pred</sub><br /></br>(mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char=".">kinetic<br /></br>solubility<br /></br>pH 7.4 (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14h</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">17.0</td><td class="colsep0 rowsep0" align="char" char=".">12.0</td><td class="colsep0 rowsep0" align="char" char=".">64.2</td><td class="colsep0 rowsep0" align="left">14, 42</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14i</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char=".">12.6</td><td class="colsep0 rowsep0" align="char" char=".">14.2</td><td class="colsep0 rowsep0" align="char" char=".">42.3</td><td class="colsep0 rowsep0" align="left">12, 11</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">19.4</td><td class="colsep0 rowsep0" align="char" char=".">7.4</td><td class="colsep0 rowsep0" align="char" char=".">34.5</td><td class="colsep0 rowsep0" align="left">17, 38</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14j</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">22.4</td><td class="colsep0 rowsep0" align="left">13, 25</td><td class="colsep0 rowsep0" align="char" char=".">82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13g</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2,6-Cl</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">10.4</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">39.6</td><td class="colsep0 rowsep0" align="char" char=".">242</td><td class="colsep0 rowsep0" align="left">7, 11</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7h</b></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">14.6</td><td class="colsep0 rowsep0" align="char" char=".">68.6</td><td class="colsep0 rowsep0" align="left">11, 22</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7i</b></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">9.7</td><td class="colsep0 rowsep0" align="char" char=".">9.8</td><td class="colsep0 rowsep0" align="char" char=".">24.5</td><td class="colsep0 rowsep0" align="char" char=".">40.4</td><td class="colsep0 rowsep0" align="left">16, 36</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7j</b></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">14.8</td><td class="colsep0 rowsep0" align="char" char=".">9.7</td><td class="colsep0 rowsep0" align="char" char=".">43.7</td><td class="colsep0 rowsep0" align="char" char=".">7.4</td><td class="colsep0 rowsep0" align="left">14, 31</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7k</b></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="char" char=".">13.1</td><td class="colsep0 rowsep0" align="char" char=".">20.1</td><td class="colsep0 rowsep0" align="char" char=".">9.8</td><td class="colsep0 rowsep0" align="left">15, 21</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Fold biochemical selectivity for Jak2 over other Jak family kinase.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">pSTAT5 TF1+EPO MSD format.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></p></div></div></div><div class="NLM_p">On the basis of its Jak2 activity and selectivity, compound <b>7j</b> was dosed in rat pharmacokinetic studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Compound <b>7j</b> has good oral bioavailability (<i>F</i><sub>oral</sub> (%) = 63) despite poor kinetic and thermodynamic aqueous solubilities. The good oral exposure may be a result of the combination of low plasma clearance and high permeability. The low clearance was not unexpected given the predicted clearance based on rat microsomes coupled with high rat plasma protein binding. No reversible CYP inhibition was observed for the five major isoforms and only minimal time-dependent inhibition (TDI) of CYP3A4 (TDI IC<sub>50</sub> = 5.8 μM with a 38% shift in AUC).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Compound <b>7j</b> is very selective against a panel of 183 kinases; when tested at 0.01 μM (100× the Jak2 K<sub>i</sub>), <b>7j</b> inhibited only five kinases outside of the Jak family at >50%.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Physicochemical/Pharmacokinetic<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> Parameters</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>7a</b></th><th class="colsep0 rowsep0" align="center"><b>7b</b></th><th class="colsep0 rowsep0" align="center"><b>7c</b></th><th class="colsep0 rowsep0" align="center"><b>7j</b></th><th class="colsep0 rowsep0" align="center"><b>8</b></th><th class="colsep0 rowsep0" align="center"><b>13a</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">solubility, pH 6.5 (μM)</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left"><2.0</td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left"><2.0</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left"><2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kinetic solubility, pH 7.4 (μM)</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">121</td><td class="colsep0 rowsep0" align="left">44</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">%PPB (human, rat)</td><td class="colsep0 rowsep0" align="left">99.5, 99.6</td><td class="colsep0 rowsep0" align="left">98.4, 98.3</td><td class="colsep0 rowsep0" align="left">98.9, 99.7</td><td class="colsep0 rowsep0" align="left">98.5, 98.5</td><td class="colsep0 rowsep0" align="left">95.8, 99.3</td><td class="colsep0 rowsep0" align="left">99.4, 99.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDCK A-B 10E<sup>–6</sup> cm/sec (B-A/A-B)</td><td class="colsep0 rowsep0" align="left">8.4 (1.3)</td><td class="colsep0 rowsep0" align="left">15.1 (0.9)</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">10.5 (0.7)</td><td class="colsep0 rowsep0" align="left">10.5 (0.5)</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HLM<sub>CL</sub>, RLM<sub>CL</sub>(mL/min/kg)</td><td class="colsep0 rowsep0" align="left">15, 39</td><td class="colsep0 rowsep0" align="left">17, 48</td><td class="colsep0 rowsep0" align="left">15, 23</td><td class="colsep0 rowsep0" align="left">14, 31</td><td class="colsep0 rowsep0" align="left">18, 36</td><td class="colsep0 rowsep0" align="left">18, 36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>p</sub> (iv, mL/min/kg)</td><td class="colsep0 rowsep0" align="left">6.8</td><td class="colsep0 rowsep0" align="left">51.3</td><td class="colsep0 rowsep0" align="left">23.1</td><td class="colsep0 rowsep0" align="left">12.6</td><td class="colsep0 rowsep0" align="left">13.3</td><td class="colsep0 rowsep0" align="left">12.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Vd<sub>ss</sub> (iv, L/kg)</td><td class="colsep0 rowsep0" align="left">0.185</td><td class="colsep0 rowsep0" align="left">0.843</td><td class="colsep0 rowsep0" align="left">0.355</td><td class="colsep0 rowsep0" align="left">1.08</td><td class="colsep0 rowsep0" align="left">0.293</td><td class="colsep0 rowsep0" align="left">0.349</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (iv, hr)</td><td class="colsep0 rowsep0" align="left">0.38</td><td class="colsep0 rowsep0" align="left">0.24</td><td class="colsep0 rowsep0" align="left">0.22</td><td class="colsep0 rowsep0" align="left">1.20</td><td class="colsep0 rowsep0" align="left">0.36</td><td class="colsep0 rowsep0" align="left">0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i><sub>oral</sub> (%)</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">63</td><td class="colsep0 rowsep0" align="left">44</td><td class="colsep0 rowsep0" align="left">124</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Male Sprague–Dawley rats, 0.1–1 mg/kg iv (solution in 60% aqueous PEG 400); 5 mg/kg PO (suspension in 60% aqueous PEG 400).</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">ND = low recovery, permeability not calculated.</p></div></div></div><div class="NLM_p">The excellent oral exposure of <b>7j</b> in rats coupled with its potent Jak2 inhibition in cells prompted us to test whether it could knockdown Jak2-mediated phosphorylation of STAT5 in a SCID mouse SET2 xenograft model that is dependent on Jak2 for growth. At an oral dose of 100 mg/kg, 64% inhibition of pSTAT5 was observed at the 1 h time point, while the inhibition of pSTAT5 decreased as the plasma levels of <b>7j</b> decreased over time (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). A more in-depth discussion of the in vivo profile of <b>7j</b> has been published elsewhere including efficacy studies in preclinical PV and AML models.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><figure id="fig4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0005.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. PK/PD study of <b>7j</b> at an oral dose of 100 mg/kg in a SET2 xenograft model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88747" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88747" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, a series of highly potent and selective novel pyrazolo[1,5-<i>a</i>]pyrimidine-based Jak2 inhibitors has been discovered. Optimization of lead compounds <b>7a</b>–<b>b</b> and <b>8</b> for potency and pharmacokinetic properties led to the discovery of <b>7j</b>, a potent Jak2 inhibitor (<i>K</i><sub>i</sub> = 0.10 nM) with high LE (0.49) and low LELP (5.9). Compound <b>7j</b> displays an adequate combination of cell potency, oral exposure, and in vivo knock-down of pSTAT5 making it a reasonable tool for proof of principal Jak2-dependent efficacy studies. Preclinical efficacy studies of <b>7j</b> in PV and acute myeloid leukemia (AML) models have been disclosed elsewhere.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15475" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15475" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Methods</h3><div class="NLM_p">Unless otherwise noted, all solvents and reagents were obtained from commercial suppliers and used without further purification. Anhydrous solvents were obtained from EMD or Aldrich and used directly. All reactions involving air- or moisture-sensitive reagents were performed under a nitrogen atmosphere. Unless otherwise stated, operations were carried out at ambient temperature (in the range 18–25 °C). Microwave experiments were carried out using a Biotage Initiator 60, which uses a single-mode resonator and dynamic field tuning. Silica gel chromatography was performed using medium-pressure liquid chromatography on a CombiFlash Companion (Teledyne Isco) with RediSep normal-phase silica gel columns. All final compounds were purified to ≥95% as determined by an Agilent 1100 series HPLC using an Agilent ZORBAX SB-C18 30 mm × 2.1 mm column, eluting with a binary solvent system A and B using a gradient elusion [A, H<sub>2</sub>O with 0.05% trifluoroacetic acid (TFA); B, CH<sub>3</sub>CN with 0.05% TFA] with UV detection at 254 nm. <sup>1</sup>H NMR spectra were recorded on a Bruker 400 or 300 MHz NMR spectrometer using the deuterated solvent stated. Chemical shifts are reported in ppm from the solvent resonance. NMR data are reported as follows: chemical shift, multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; and br, broad peak), coupling constants, and number of protons. Mass spectral (MS) data was determined with a Sciex API150ex or Agilent 6140 spectrometer and ESI source.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Sodium Pyrazolo[1,5-<i>a</i>]pyrimidin-5-olate (<b>1</b>)</h4><div class="NLM_p last">A mechanically stirred mixture of 3-aminopyrazole (9.38 g, 113 mmol), 1,3-dimethyluracil (14.7 g, 105 mmol), and 21% sodium ethoxide in ethanol (170 mL) was heated to reflux for one h. The reaction mixture was cooled, filtered, and the collected solid washed with cold ethanol and vacuum-dried to yield 13.47 g (95%) of sodium pyrazolo[1,5-<i>a</i>]pyrimidin-5-olate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.0 (d, 1H), 7.43 (d, 1H), 5.65 (d, 1H), 5.37 (d, 1H). MS: <i>m</i>/<i>z</i> 136.0 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Pyrazolo[1,5-<i>a</i>]pyrimidin-5(4<i>H</i>)-one (<b>2</b>)</h4><div class="NLM_p last">To <b>1</b> (13.47 g, 85.74 mmol) was added 500 mL of acetic acid and 100 mL of water. The mixture was stirred at ambient temperature for 15 min and then evaporated to dryness under vacuum. The residue was suspended in 300 mL of 9:1 dichloromethane (DCM):methanol and vacuum filtered through silica gel to remove sodium acetate. The silica gel pad was washed with 700 mL of additional 9:1 DCM:methanol solution. The combined DCM:methanol solution was concentrated to dryness. The solid product was suspended in 1:1 hexane:DCM and filtered to yield 9.9 g (85%) of pyrazolo[1,5-<i>a</i>]pyrimidin-5(4<i>H</i>)-one. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.1 (br s, 1H), 8.47 (d, <i>J</i> = 7.9 Hz, 1H), 7.75 (d, <i>J</i> = 1.9 Hz, 1H), 5.94 (d, <i>J</i> = 7.5 Hz, 1H), 5.81 (d, <i>J</i> = 1.7 Hz, 1H). MS: <i>m</i>/<i>z</i> 136.0 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 3-Iodopyrazolo[1,5-<i>a</i>]pyrimidin-5(4<i>H</i>)-one (<b>3</b>)</h4><div class="NLM_p last">A mixture of <b>2</b> (1.0 g, 7.4 mmol) and <i>N</i>-iodosuccinimide (1.67 g, 7.42 mmol) was combined with 20 mL of DMF and warmed slightly until a heavy precipitate formed. The reaction mixture was stirred an additional 1 h at ambient temperature and then cooled on an ice–water bath and filtered. The collected solid was washed with 20 mL of DCM and air-dried to give 1.66 g (86%) of 3-iodopyrazolo[1,5-<i>a</i>]pyrimidin-5(4<i>H</i>)-one. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.1 (s, 1H), 8.5 (d, <i>J</i> = 7.6 Hz, 1H), 7.84 (s, 1H), 6.01 (d, <i>J</i> = 7.1 Hz, 1H). MS: <i>m</i>/<i>z</i> 262.2 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 5-Oxo-4,5-dihydropyrazolo[1,5-<i>a</i>]-pyrimidine-3-carboxylic Acid (<b>4</b>)</h4><div class="NLM_p">A mixture of <b>3</b> (1.5 g, 5.8 mmol), palladium(II) acetate (0.27 g, 1.2 mmol), triethylamine (2.3 mL, 17 mmol), and 75 mL of methanol was stirred, degassed with nitrogen twice under vacuum, and then blanketed with carbon monoxide under a balloon. The reaction mixture was heated to 55 °C for 5 h and then filtered through Celite and concentrated under vacuum. The residue was recrystallized from water and filtered to give 0.81 g (73%) of methyl 5-oxo-4,5-dihydropyrazolo[1,5-<i>a</i>]-pyrimidine-3-carboxylate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.0 (br s, 1H), 8.58 (d, <i>J</i> = 7.9 Hz, 1H), 8.19 (s, 1H), 6.19 (d, <i>J</i> = 7.9 Hz, 1H), 3.80 (s, 3H). A solution of methyl 5-oxo-4,5-dihydropyrazolo[1,5-<i>a</i>]-pyrimidine-3-carboxylate (0.75 g, 3.9 mmol), lithium hydroxide (0.466 g, 19.5 mmol), and 20 mL of water was stirred at ambient temperature for 3 h. Acetic acid (5 mL) was added to the reaction mixture, and the precipitated solid was collected by vacuum filtration to give 0.65 g (93%) of 5-oxo-4,5-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxylic acid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.54 (d, <i>J</i> = 9.2 Hz, 1H), 8.06 (s, 1H), 6.11 (d, <i>J</i> = 7.2 Hz, 1H).</div><div class="NLM_p last">As an alternative preparation, to a stirred solution of 5-amino-1<i>H</i>-pyrazole-4-carboxylic acid (10.0 g, 71.4 mmol) in ethanol (100 mL) was added sodium ethoxide (17.0 g, 245 mmol) followed by 1,3-dimethyluracil (11.0 g, 78.6 mmol). The reaction mixture was then stirred at reflux under an argon atmosphere overnight. The mixture was poured into ice–water and concentrated HCl added to adjust the pH to ∼3–4. The mixture was stirred for 2 h, and the resulting precipitate was collected via filtration and dried under vacuum to yield 10.0 g (58%) of 5-oxo-4,5-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxylic acid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.54 (d, <i>J</i> = 9.2 Hz, 1H), 8.06 (s, 1H), 6.11 (d, <i>J</i> = 7.2 Hz, 1H).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 5-Chloropyrazolo[1,5-<i>a</i>]pyrimidine-3-carbonyl Chloride (<b>5</b>)</h4><div class="NLM_p last">A mixture of <b>4</b> (0.371 g, 2.07 mmol), phosphorus oxychloride (20 mL), and DIPEA (1.2 mL, 6.9 mmol) was refluxed for 2 h. The reaction mixture was cooled and concentrated under reduced pressure. The residue was taken up in DCM and concentrated again 3 times. The residue was partitioned between water and DCM, and the DCM layer was dried with sodium sulfate, vacuum filtered through a bed of silica gel, and concentrated to give 390 mg (87%) of 5-chloropyrazolo[1,5-<i>a</i>]pyrimidine-3-carbonyl chloride as a yellow solid which was used immediately without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.72 (d, <i>J</i> = 7.2 Hz, 1H), 8.65 (s, 1H), 7.17 (d, <i>J</i> = 7.6 Hz, 1H).</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 5-Chloro-<i>N</i>-(1-(3-chlorophenyl)-3-methyl-1<i>H</i>-pyrazol-5-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide (<b>6a</b>)</h4><div class="NLM_p last">A solution of <b>5</b> (150 mg, 0.694 mmol), 1-(3-chlorophenyl)-3-methyl-1<i>H</i>-pyrazol-5-amine (140 mg, 0.674 mmol), DIPEA (0.18 mL, 1.0 mmol), and 15 mL of DCM was stirred at ambient temperature for 3 days. The reaction mixture was partitioned between DCM and water, and the DCM phase was dried over sodium sulfate and vacuum filtered through a pad of silica gel. The silica gel pad was washed with 95:5 DCM:methanol. The combined filtrates were concentrated to give 250 mg (93%, 74% purity by HPLC) of 5-chloro-<i>N</i>-(1-(3-chlorophenyl)-3-methyl-1<i>H</i>-pyrazol-5-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide which was used without further purification. MS: <i>m</i>/<i>z</i> 387.2 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 5-Amino-<i>N</i>-(1-(3-chlorophenyl)-3-methyl-1<i>H</i>-pyrazol-5-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide (<b>7a</b>)</h4><div class="NLM_p last">A mixture of 74% pure <b>6a</b> (55.0 mg, 1.05 mmol) and 3 mL of concentrated ammonium hydroxide was sealed and heated in a microwave reactor at 105 °C for 30 min. The reaction mixture was cooled, and the resulting precipitate was collected by filtration, rinsed with water, and dried under vacuum to yield 25.0 mg (48%) of 5-amino-<i>N</i>-(1-(3-chlorophenyl)-3-methyl-1<i>H</i>-pyrazol-5-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide, which was purified by reverse-phase HPLC and lyophilized. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.93 (s, 1H), 8.65 (d, <i>J</i> = 7.5 Hz, 1H), 8.19 (s, 1H), 7.69–7.64 (m, 1H), 7.59 (d, <i>J</i> = 8.0 Hz, 1H), 7.51 (t, <i>J</i> = 8.0 Hz, 1H), 7.43 (d, <i>J</i> = 8.0 Hz, 1H), 6.42–6.37 (m, 2H), 2.24 (s, 3H). MS: <i>m</i>/<i>z</i> 368.3 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-(1-(3-Chlorophenyl)-3-methyl-1<i>H</i>-pyrazol-5-yl)-5-(methylamino)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide (<b>7b</b>)</h4><div class="NLM_p last">A mixture of <b>6a</b> (172 mg, 0.444 mmol) and a 40 wt % solution of methylamine in water (3 mL, 4.44 mmol) was sealed and heated in a microwave reactor at 100 °C for 15 min. The reaction mixture was cooled, and the resulting precipitate was collected by filtration, rinsed with water, and dried under vacuum to yield 105.6 mg (62%) of <i>N</i>-(1-(3-chlorophenyl)-3-methyl-1<i>H</i>-pyrazol-5-yl)-5-(methylamino)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.93 (s, 1H), 8.55 (d, <i>J</i> = 7.6 Hz, 1H), 8.22 (s, 1H), 8.02 (d, <i>J</i> = 4.3 Hz, 1H), 7.64 (t, <i>J</i> = 1.8 Hz, 1H), 7.57–7.52 (m, 1H), 7.50 (t, <i>J</i> = 7.8 Hz, 1H), 7.47–7.42 (m, 1H), 6.46 (s, 1H), 6.33 (d, <i>J</i> = 7.6 Hz, 1H), 2.25–2.19 (m, 6H). MS: <i>m</i>/<i>z</i> 382.1 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 5-Amino-<i>N</i>-(3-(3-chlorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide (<b>7c</b>)</h4><div class="NLM_p last">Ammonia gas was bubbled through a stirring 0 °C suspension of <b>6b</b> (60 mg, 0.2 mmol) and ethanol (3 mL) for 20 min. The reaction vessel was capped and subjected to microwave irradiation at 120 °C for 90 min. After the reaction mixture was cooled to ambient temperature, the resulting precipitate was collected by filtration, rinsed with ethanol, and dried under vacuum to yield 47.5 mg (80%) of 5-amino-<i>N</i>-(3-(3-chlorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.57 (s, 1H), 8.66 (d, <i>J</i> = 7.6 Hz, 1H), 8.20 (s, 1H), 8.07 (s, 1H), 7.78–7.69 (m, 2H), 7.46 (t, <i>J</i> = 7.8 Hz, 1H), 7.39 (d, <i>J</i> = 8.0 Hz, 1H), 6.40 (d, <i>J</i> = 7.6 Hz, 1H), 3.90 (s, 3H). MS: <i>m</i>/<i>z</i> 368.1 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-(1-(3-Chlorophenyl)-3-methyl-1<i>H</i>-pyrazol-5-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide (<b>8</b>)</h4><div class="NLM_p last">To pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxylic acid (202 mg, 1.24 mmol) was added phosphoryl chloride (5.35 mL, 57.4 mmol) and then dropwise DIPEA (0.647 mL, 3.72 mmol). The reaction mixture was heated at reflux (130 °C) for 2.5 h. The solvents were then removed under reduced pressure, exchanging the solvent with DCM 4 times. The resulting residue was dissolved in DCM (20 mL), and 1-(3-chlorophenyl)-3-methyl-1<i>H</i>-pyrazol-5-amine (385.7 mg, 1.857 mmol) and DIPEA (0.431 mL, 2.48 mmol) were added. The reaction mixture was stirred at ambient temperature for 5 h and then partitioned between ethyl acetate and water. The organic portion was washed with water and brine, dried over magnesium sulfate, and concentrated. The crude product was purified by preparative reverse-phase HPLC and lyophilized to yield 151 mg (35%) of <i>N</i>-(1-(3-chlorophenyl)-3-methyl-1<i>H</i>-pyrazol-5-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.32 (s, 1H), 9.36 (dd, <i>J</i> = 7.0, 1.6 Hz, 1H), 8.71 (s, 1H), 8.66 (dd, <i>J</i> = 4.2, 1.6 Hz, 1H), 7.77–7.76 (m, 1H), 7.66–7.59 (m, 2H), 7.56–7.51 (m, 1H), 7.31 (dd, <i>J</i> = 7.0, 4.3 Hz, 1H), 6.58 (s, 1H), 2.25 (s, 3H). MS: <i>m</i>/<i>z</i> 353.1 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-(2-Bromopyridin-3-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide (<b>9a</b>)</h4><div class="NLM_p last">To a suspension of pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxylic acid (253.9 mg, 1.556 mmol) in DCM (10 mL) was added DMF (0.1 mL) followed by oxalyl chloride (2.0 M in DCM, 1.0 mL, 2.0 mmol). The reaction mixture was stirred at ambient temperature for 30 min, and then additional oxalyl chloride (0.8 mL, 1.6 mmol) was added. After a further 30 min, the reaction mixture was concentrated. The resulting residue was resuspended in DCM (10 mL), and 2-bromopyridin-3-amine (215.4 mg, 1.245 mmol) and triethylamine (0.8 mL, 6 mmol) were added. The reaction mixture was stirred at ambient temperature for 1.5 h and then concentrated onto silica gel. The crude product was purified via flash chromatography on silica gel (gradient elution: 20–80% ethyl acetate in DCM) to yield 151.3 mg (38%) of <i>N</i>-(2-bromopyridin-3-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide. MS: <i>m</i>/<i>z</i> 317.9 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-(2-(3-Chlorophenyl)pyridin-3-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide (<b>10a</b>)</h4><div class="NLM_p last">A mixture of <b>9a</b> (76.2 mg, 0.240 mmol), 3-chlorobenzeneboronic acid (100.2 mg, 0.6408 mmol), bis(triphenylphosphine)palladium(II) chloride (22.6 mg, 0.032 mmol), sodium carbonate (1.0 M aqueous solution, 1.0 mL, 1.0 mmol), and acetonitrile (3.0 mL) was subjected to microwave irradiation at 120 °C for 30 min. The reaction mixture was partitioned between ethyl acetate and water, and the organic layer was dried over magnesium sulfate, filtered, and concentrated. The crude product was purified by reverse phase HPLC and lyophilized to give 49.4 mg (59%) of <i>N</i>-(2-(3-chlorophenyl)pyridin-3-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.97 (s, 1H), 9.33 (dd, <i>J</i> = 7.0, 1.6 Hz, 1H), 8.82 (dd, <i>J</i> = 8.3, 1.4 Hz, 1H), 8.69 (s, 1H), 8.42 (dd, <i>J</i> = 4.6, 1.4 Hz, 1H), 8.39 (dd, <i>J</i> = 4.2, 1.6 Hz, 1H), 7.71–7.69 (m, 1H), 7.63–7.58 (m, 3H), 7.49 (dd, <i>J</i> = 8.4, 4.6 Hz, 1H), 7.27 (dd, <i>J</i> = 7.0, 4.2 Hz, 1H). MS: <i>m</i>/<i>z</i> 350.0 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-(4-Bromo-1-methyl-1<i>H</i>-pyrazol-3-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide (<b>11</b>)</h4><div class="NLM_p last">A mixture of pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxylic acid (165.5 mg, 1.014 mmol), 4-bromo-1-methyl-1<i>H</i>-pyrazol-3-amine (177.4 mg, 1.008 mmol), HATU (497.0 mg, 1.307 mmol), DIPEA (0.25 mL, 1.4 mmol), 4-dimethylaminopyridine (33.8 mg, 0.277 mmol), and 5 mL of DMF was heated at 50 °C for 4 days. The reaction mixture was partitioned between ethyl acetate and water, and the organic portion washed with brine, dried over magnesium sulfate, filtered, and concentrated. The crude product was purified by flash chromatography on silica gel (gradient elution: 20–80% ethyl acetate in 5% methanol:DCM) to yield 203.6 mg (63%) of <i>N</i>-(4-bromo-1-methyl-1<i>H</i>-pyrazol-3-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ: 9.17 (dd, <i>J</i> = 7.0, 1.6 Hz, 1H), 8.85 (dd, <i>J</i> = 4.2, 1.6 Hz, 1H), 8.68 (s, 1H), 7.76 (s, 1H), 7.28 (dd, <i>J</i> = 7.0, 4.2 Hz, 1H), 3.88 (s, 3H). MS: <i>m</i>/<i>z</i> 321.1 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-(1-Methyl-4-(3-chlorophenyl)-1<i>H</i>-pyrazol-3-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide (<b>12</b>)</h4><div class="NLM_p last">To a mixture of <b>11</b> (59.5 mg, 0.185 mmol) and 3-chlorobenzeneboronic acid (44.6 mg, 0.285 mmol) in diglyme (5.0 mL) was added sodium carbonate (2 M aqueous solution, 0.3 mL, 0.6 mmol) and tetrakis(triphenylphosphine)palladium(0) (19.5 mg, 0.0169 mmol). The reaction mixture was purged with nitrogen and then stirred at 100 °C for 24 h. The reaction mixture was partitioned between ethyl acetate and water and the organic portion washed with brine, dried over magnesium sulfate, filtered, and concentrated. The crude product was purified by reverse phase HPLC and lyophilized to yield 4.3 mg (7%) of <i>N</i>-(1-methyl-4-(3-chlorophenyl)-1<i>H</i>-pyrazol-3-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.70 (s, 1H), 9.38 (dd, <i>J</i> = 7.0, 1.6 Hz, 1H), 8.86 (dd, <i>J</i> = 4.2, 1.6 Hz, 1H), 8.68 (s, 1H), 8.16 (s, 1H), 7.56 (t, <i>J</i> = 1.8 Hz, 1H), 7.45 (d, <i>J</i> = 7.9 Hz, 1H), 7.35–7.34 (m, 1H), 7.32 (d, <i>J</i> = 7.7 Hz, 1H), 7.23 (d, <i>J</i> = 8.0 Hz, 1H), 3.86 (s, 3H). MS: <i>m</i>/<i>z</i> 353.0 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-(3-(3-Chlorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide (<b>13a</b>)</h4><div class="NLM_p last">A mixture of <b>20a</b> (400.0 mg, 1.926 mmol), pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxylic acid (342.9 mg, 2.102 mmol), 7-azabenzotriazol-1-yloxy-tris-(pyrrolidino)phosphonium hexafluorophosphate (PyAOP) (1.205 g, 2.324 mmol), DIPEA (0.80 mL, 4.6 mmol), and 4-dimethylaminopyridine (43.4 mg, 0.355 mmol) in 15.0 mL DMF was stirred at 50 °C for 15 h. The reaction mixture was partitioned between DCM and water and the aqueous layer extracted once more with DCM. The combined organic portions were dried over magnesium sulfate and concentrated onto silica gel. The crude product was separated by flash chromatography on silica gel (solvent gradient: 0–70% ethyl acetate (containing 2% methanol) in DCM). The resulting solid material was triturated with ethyl acetate, sonicated, and the solids were collected by filtration and dried under vacuum to yield 0.502 g (74%) of <i>N</i>-(3-(3-chlorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.00 (s, 1H), 9.38 (dd, <i>J</i> = 7.0, 1.6 Hz, 1H), 8.84 (dd, <i>J</i> = 4.2, 1.6 Hz, 1H), 8.70 (s, 1H), 8.33 (s, 1H), 7.84 (t, <i>J</i> = 1.8 Hz, 1H), 7.77 (dt, <i>J</i> = 7.8, 1.8 Hz, 1H), 7.57 (t, <i>J</i> = 7.9 Hz, 1H), 7.47 (d, <i>J</i> = 7.9 Hz, 1H), 7.34 (dd, <i>J</i> = 7.0, 4.2 Hz, 1H), 3.93 (s, 3H). MS: <i>m</i>/<i>z</i> 353.0 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-(3-(3-Chlorophenyl)-1-isopropyl-1<i>H</i>-pyrazol-4-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide (<b>14a</b>)</h4><div class="NLM_p last"><b>13b</b> (68.9 mg, 0.203 mmol) was dissolved in 4 mL of DMF. To this solution was added cesium carbonate (148 mg, 0.454 mmol) and isopropyl iodide (23.0 μL, 0.230 mmol). The reaction mixture was stirred at 50 °C for 2 h. The reaction mixture was then partitioned between ethyl acetate and water and the organic portion washed with brine, dried over magnesium sulfate, and concentrated. The crude product was purified by reverse phase HPLC and lyophilized to give 47.2 mg (61%) of <i>N</i>-(3-(3-chlorophenyl)-1-isopropyl-1<i>H</i>-pyrazol-4-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.99 (s, 1H), 9.38 (dd, <i>J</i> = 7.0, 1.6 Hz, 1H), 8.84 (dd, <i>J</i> = 4.2, 1.6 Hz, 1H), 8.70 (s, 1H), 8.36 (s, 1H), 7.85 (t, <i>J</i> = 1.8 Hz, 1H), 7.78 (td, <i>J</i> = 7.7, 1.4 Hz, 1H), 7.57 (t, <i>J</i> = 7.9 Hz, 1H), 7.50–7.44 (m, 1H), 7.34 (dd, <i>J</i> = 7.0, 4.2 Hz, 1H), 4.66–4.51 (m, 1H), 1.49 (d, <i>J</i> = 6.7 Hz, 6H). MS: <i>m</i>/<i>z</i> 381.1 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-(3-(3-Chlorophenyl)-1-(2-hydroxy-2-methylpropyl)-1<i>H</i>-pyrazol-4-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide (<b>14f</b>)</h4><div class="NLM_p last"><b>13b</b> (58.9 mg, 0.174 mmol) was dissolved in 5 mL of DMF. To this solution was added isobutylene oxide (0.5 mL, 6 mmol) and cesium carbonate (56.4 mg, 0.173 mmol). The reaction mixture was stirred at 50 °C for 7.5 h. The reaction mixture was then partitioned between ethyl acetate and water and the organic portion washed with brine, dried over magnesium sulfate, and concentrated. The crude product was purified by reverse phase HPLC and lyophilized to give 33.1 mg (46%) of <i>N</i>-(3-(3-chlorophenyl)-1-(2-hydroxy-2-methylpropyl)-1<i>H</i>-pyrazol-4-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamide. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.02 (s, 1H), 9.37 (dd, <i>J</i> = 7.0, 1.5 Hz, 1H), 8.84 (dd, <i>J</i> = 4.2, 1.6 Hz, 1H), 8.69 (s, 1H), 8.35 (s, 1H), 7.84 (t, <i>J</i> = 1.7 Hz, 1H), 7.77 (d, <i>J</i> = 7.8 Hz, 1H), 7.58 (t, <i>J</i> = 7.9 Hz, 1H), 7.48 (dd, <i>J</i> = 8.0, 1.0 Hz, 1H), 7.33 (dd, <i>J</i> = 7.0, 4.2 Hz, 1H), 4.73 (s, 1H), 4.09 (s, 2H), 1.13 (s, 6H). MS: <i>m</i>/<i>z</i> 411.1 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 5-Bromo-2-methylpyridine 1-oxide (<b>15</b>)</h4><div class="NLM_p last">A solution of 5-bromo-2-methylpyridine (2.0 g, 12 mmol) and <i>m</i>-chloroperoxybenzoic acid (70%, 2.89 g, 12.9 mmol) in 30 mL of chloroform was stirred at room temperature for 4 h. The reaction mixture was then partitioned between DCM and 2 M aqueous sodium carbonate. The aqueous layer was extracted once more with DCM, and the combined organic portions were dried over magnesium sulfate, filtered, and concentrated to yield 2.1575 g (99%) of 5-bromo-2-methylpyridine 1-oxide. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.57 (d, <i>J</i> = 1.4 Hz, 1H), 7.51 (dd, <i>J</i> = 8.4, 1.6 Hz, 1H), 7.44 (d, <i>J</i> = 8.4 Hz, 1H), 2.30 (s, 3H). MS: <i>m</i>/<i>z</i> 189.0 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 5-Bromo-2-methyl-4-nitropyridine 1-oxide (<b>16</b>)</h4><div class="NLM_p last"><b>15</b> (2.269 g, 12.07 mmol) was dissolved in sulfuric acid (4 mL, 80 mmol) and cooled in an ice–water bath. Fuming nitric acid (3 mL, 60 mmol) was added dropwise. After addition of the nitric acid was complete, the reaction mixture was first warmed to room temperature and then heated to 90 °C. After heating for 2 h, the reaction mixture was cooled in an ice–water bath and slowly adjusted to pH 10 with 2 M aqueous sodium carbonate. This mixture was extracted twice with DCM. The combined organic extracts were dried over magnesium sulfate, filtered, and concentrated to yield 2.54 g (90%) of 5-bromo-2-methyl-4-nitropyridine 1-oxide. MS: <i>m</i>/<i>z</i> 233.0 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 5-Bromo-2-methylpyridin-4-amine (<b>17</b>)</h4><div class="NLM_p last">To a solution of <b>16</b> (2.54 g, 10.9 mmol) in 10 mL of concentrated hydrochloric acid was added tin chloride dihydrate (9.96 g, 43.75 mmol). The reaction mixture was heated at 90 °C for 24 h, at which time additional tin chloride dihydrate (3.15 g, 13.84 mmol) and 5 mL of concentrated hydrochloric acid were added. The reaction mixture was held at 90 °C for an additional 24 h and then cooled to room temperature and adjusted to neutral pH with 2 M aqueous sodium carbonate. The resulting mixture was extracted three times with DCM, and the combined organic extracts dried over magnesium sulfate, filtered, and concentrated to yield 1.15 g (56%) of 5-bromo-2-methylpyridin-4-amine. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.07 (s, 1H), 6.51 (s, 1H), 6.13 (s, 2H), 2.22 (s, 3H). MS: <i>m</i>/<i>z</i> 187.2 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-(2-(3-Chlorophenyl)-2-oxoethylisoindoline-1,3-dione (<b>18a</b>)</h4><div class="NLM_p last">A mixture of 2-bromo-3′-chloroacetophenone (0.927 g, 3.97 mmol) and potassium phthalimide (0.813 g, 4.39 mmol) in 15 mL of DMF was stirred at 50 °C for 1 h. The solvent was removed under vacuum, and the resulting solids were triturated with ethyl acetate and filtered. The collected solids were dried under vacuum to give 2-(2-(3-chlorophenyl)-2-oxoethylisoindoline-1,3-dione, which was carried forward without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.13 (t, <i>J</i> = 1.9 Hz, 1H), 8.06 (d, <i>J</i> = 7.9 Hz, 1H), 8.00–7.90 (m, 4H), 7.85–7.80 (m, 1H), 7.65 (t, <i>J</i> = 7.9 Hz, 1H), 5.29 (s, 2H).</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Di-<i>tert</i>-butyl 2-(2,5-Dimethylphenyl)-2-oxoethyliminodicarbonate (<b>18b</b>)</h4><div class="NLM_p last">In an oven-dried flask, di-<i>tert</i>-butyl iminodicarboxylate (2.566 g, 11.81 mmol) was combined with sodium hydride (60 wt % in mineral oil, 0.59 g, 15 mmol) and 30 mL of DMF. The reaction mixture was stirred at ambient temperature for 1.5 h, and then 2-bromo-1-(2,5-dimethylphenyl)ethanone (2.432 g, 10.71 mmol) was added. The reaction was stirred at ambient temperature for an additional 1.5 h and then partitioned between ethyl acetate and water. The organic portion was washed with water and brine, dried over magnesium sulfate, and concentrated under vacuum. The crude product was purified by flash chromatography on silica gel (gradient elution: 0–40% ethyl acetate in heptanes) to obtain 3.008 g (77%) of di-<i>tert</i>-butyl 2-(2,5-dimethylphenyl)-2-oxoethyl-iminodicarbonate. MS: <i>m</i>/<i>z</i> 386.2 ([M + Na]<sup>+</sup>).</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-(3-(3-Chlorophenyl)-1-(dimethylamino)-3-oxoprop-1-en-2-yl)isoindoline-1,3-dione (<b>19a</b>)</h4><div class="NLM_p last">A stirred mixture of <b>18a</b> (782.2 mg, 2.610 mmol) and DMFDMA (1.5 mL, 11 mmol) was heated at 100 °C for 18 h. Excess DMFDMA was removed under vacuum. The crude product was purified by flash chromatography on silica gel (gradient elution: 50–100% ethyl acetate in heptanes) to yield 740 mg (80%) of 2-(3-(3-chlorophenyl)-1-(dimethylamino)-3-oxoprop-1-en-2-yl)isoindoline-1,3-dione. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 7.91 (dd, <i>J</i> = 5.4, 3.1 Hz, 2H), 7.76 (dd, <i>J</i> = 5.5, 3.1 Hz, 2H), 7.57 (s, 1H), 7.45 (d, <i>J</i> = 7.5 Hz, 1H), 7.42–7.35 (m, 2H), 7.31 (t, <i>J</i> = 7.8 Hz, 1H), 3.00 (s, 6H). MS: <i>m</i>/<i>z</i> 355.2 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 3-(3-Chlorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-amine (<b>20a</b>)</h4><div class="NLM_p last">To a solution of <b>19a</b> (2.30 g, 6.48 mmol) in 50 mL of ethanol was added <i>N</i>-methylhydrazine (1.4 mL, 26 mmol). The reaction mixture was stirred at 80 °C for 2 h and then concentrated onto silica gel. The crude mixture of regioisomers was separated and purified by flash chromatography on silica gel (gradient elution: 0–80% ethyl acetate in DCM) to yield 715.0 mg (53%) of 3-(3-chlorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-amine. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 7.78 (t, <i>J</i> = 1.8 Hz, 1H), 7.64 (dt, <i>J</i> = 7.7, 1.4 Hz, 1H), 7.33 (t, <i>J</i> = 7.8 Hz, 1H), 7.28–7.23 (m, 2H), 7.04 (s, 1H), 3.84 (s, 3H). MS: <i>m</i>/<i>z</i> 208.2 ([M + H]<sup>+</sup>). Also isolated was 274.6 mg (20%) of 5-(3-chlorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-amine. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 7.46–7.40 (m, 1H), 7.40–7.35 (m, 2H), 7.29–7.25 (m, 1H), 7.23 (s, 1H), 3.76 (s, 3H). MS: <i>m</i>/<i>z</i> 208.2 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Ethyl 3-(5-Chloro-2-methylphenyl)-3-oxopropanoate (<b>21a</b>)</h4><div class="NLM_p last">To a stirring solution of 5-chloro-2-methylbenzoic acid (4.8547 g, 28.458 mmol) in 30 mL of THF was added <i>N</i>,<i>N</i>-carbonyldiimidazole (4.8688 g, 30.027 mmol). Stirring was continued at ambient for 30 min to generate the acyl-imidazole. Separately, potassium ethyl malonate (11.612 g, 68.224 mmol) and MgCl<sub>2</sub> (3.2689 g, 34.333 mmol) were suspended in 50 mL of THF. To the magnesium chloride mixture was added the acyl-imidazole solution. The resulting reaction mixture was heated at 50 °C for 10 h. The reaction mixture was partitioned between ethyl acetate and water, and the organic portion dried over magnesium sulfate, filtered through a pad of Celite, and concentrated to provide 8.07 g of ethyl 3-(5-chloro-2-methoxyphenyl)-3-oxopropanoate, which was used without purification. MS: <i>m</i>/<i>z</i> 241.2 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Ethyl 3-(2,6-Dichlorophenyl)-3-oxopropanoate (<b>21b</b>)</h4><div class="NLM_p last">Potassium ethyl malonate (63.0 g, 370 mmol) was placed in a flask under nitrogen. Acetonitrile (1 L) was added, and the mixture was cooled to 10–15 °C. To the cooled solution was added triethylamine (55 mL, 0.39 mol) followed by MgCl<sub>2</sub> (42.8 g, 0.449 mol), and the mixture was then stirred at ambient temperature for 2.5 h. After cooling the reaction mixture to 0 °C, 2,6-dichlorobenzoyl chloride (37.7 g, 180 mmol) was added slowly over 25 min, followed by addition of more triethylamine (5 mL, 40 mmol). The reaction mixture was stirred at ambient temperature overnight. The solvent was removed under reduced pressure and the residue partitioned between toluene and 10% aqueous HCl. The organic layer was concentrated to provide a quantitative yield of ethyl 3-(2,6-dichlorophenyl)-3-oxopropanoate, which was carried forward without purification.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Ethyl 2-(5-Chloro-2-methylbenzoyl)-3-(dimethylamino)acrylate (<b>22a</b>)</h4><div class="NLM_p last">A stirred mixture of <b>21a</b> (28.458 mmol) and DMFDMA (10.0 mL, 75.3 mmol) was heated at 90 °C for 3 h. After evaporation of excess DMFDMA under reduced pressure, the crude product was purified by flash chromatography on silica gel (gradient elution: 0–80% ethyl acetate in DCM) to yield 2.87 g (34%) of ethyl 2-(5-chloro-2-methylbenzoyl)-3-(dimethylamino)acrylate. MS: <i>m</i>/<i>z</i> 296.3 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Ethyl 5-(5-Chloro-2-methylphenyl)-1<i>H</i>-pyrazole-4-carboxylate (<b>23</b>)</h4><div class="NLM_p last">A solution of <b>22a</b> (2.87 g, 9.70 mmol) and hydrazine (0.50 mL, 16.0 mmol) in 30 mL of ethanol was heated at 70 °C for 2 h. The crude reaction mixture was concentrated under vacuum to provide 2.57 g (100%) ethyl 5-(5-chloro-2-methoxyphenyl)-1<i>H</i>-pyrazole-4-carboxylate, which was used without further purification. MS: <i>m</i>/<i>z</i> 265.2 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Ethyl 3-(5-Chloro-2-methylphenyl)-1-methyl-1<i>H</i>-pyrazole-4-carboxylate (<b>24a</b>) and Ethyl 5-(5-Chloro-2-methylphenyl)-1-methyl-1<i>H</i>-pyrazole-4-carboxylate (<b>25</b>)</h4><div class="NLM_p last">To a solution of <b>23</b> (9.70 mmol) in 35 mL of DMF was added cesium carbonate (3.831 g, 11.76 mmol) and iodomethane (0.90 mL, 14 mmol). The reaction mixture was stirred at 40 °C for 7 h and was then partitioned between ethyl acetate and water. The organic portion was dried over magnesium sulfate and concentrated. The crude product was purified by flash chromatography on silica gel (gradient elution: 0–40% ethyl acetate in DCM) to yield 2.179 g (81%) of a 1:1 mixture of the regioisomeric products, ethyl 3-(5-chloro-2-methylphenyl)-1-methyl-1<i>H</i>-pyrazole-4-carboxylate, and ethyl 5-(5-chloro-2-methylphenyl)-1-methyl-1<i>H</i>-pyrazole-4-carboxylate. MS: <i>m</i>/<i>z</i> 279.2 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Ethyl 3-(2,6-Dichlorophenyl)-1-methyl-1<i>H</i>-pyrazole-4-carboxylate (<b>24b</b>)</h4><div class="NLM_p last">To a stirred solution of <b>22b</b> (12.6 g, 40 mmol) in acetic acid (100 mL) was added <i>N</i>-methyl-hydrazine (3.84 g, 83.4 mmol). The reaction mixture was stirred at ambient temperature for 3 days. The mixture was then concentrated under reduced pressure, and the residue was partitioned between ethyl acetate and water. The organic portion was dried over magnesium sulfate and concentrated under vacuum. The crude product was purified by flash chromatography on silica gel to yield 5.4 g (45%) of ethyl 3-(2,6-dichlorophenyl)-1-methyl-1<i>H</i>-pyrazole-4-carboxylate. MS: <i>m</i>/<i>z</i> 298.9 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 3-(5-Chloro-2-methylphenyl)-1-methyl-1<i>H</i>-pyrazol-4-amine (<b>26a</b>) and 5-(5-Chloro-2-methylphenyl)-1-methyl-1<i>H</i>-pyrazol-4-amine (<b>27</b>)</h4><div class="NLM_p last">To a solution of <b>24a</b> and <b>25</b> (1:1 mixture of regioisomers, 2.179 g, 7.818 mmol) in ethanol (10 mL) was added 1 M aqueous NaOH (18 mL, 18 mmol). The reaction mixture was heated at 50 °C for 20 h, and then the solvent was removed under reduced pressure. The resulting residue was adjusted to pH 2 with 1 M aqueous H<sub>3</sub>PO<sub>4</sub> and extracted with DCM (3 × 100 mL). The combined organic extracts were dried over magnesium sulfate, filtered, and concentrated under vacuum. The resulting material was dissolved in 1,4-dioxane (15 mL) and treated with triethylamine (2.20 mL, 15.8 mmol) and diphenylphosphonic azide (1.90 mL, 8.82 mmol). The mixture was stirred at ambient temperature for 1 h and then treated with <i>tert</i>-butyl alcohol (15 mL) and heated at 90 °C for 1 h. After being cooled to room temperature, the mixture was partitioned between ethyl acetate and water. The organic portion was dried over magnesium sulfate and concentrated. The crude product was purified by flash chromatography on silica gel (solvent gradient: 0–50% ethyl acetate in DCM) to yield a mixture of the title compounds as the <i>tert</i>-butyl-carbamates (1.637 g, 66%). To a solution of this material (1:1 mixture of regioisomers, 1.637 g, 5.088 mmol) in 10 mL of DCM was added hydrogen chloride (10.0 mL of a 4.0 M solution in 1,4-dioxane, 40 mmol). The reaction mixture was stirred at ambient temperature for 16 h and then evaporated to dryness. The solid residue was partitioned between DCM and a saturated aqueous solution of sodium bicarbonate. The aqueous portion was extracted once more with DCM, and the combined organic extracts were dried over magnesium sulfate, filtered, and concentrated under vacuum. The crude product was purified and regioisomers separated by flash chromatography on silica gel (gradient elution: 0–100% ethyl acetate in DCM) to yield 429.7 mg (38%) of 3-(5-chloro-2-methylphenyl)-1-methyl-1<i>H</i>-pyrazol-4-amine (<b>26a</b>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 7.35 (d, <i>J</i> = 1.8 Hz, 1H), 7.24–7.17 (m, 2H), 7.04 (s, 1H), 3.84 (s, 3H), 2.76 (s, 2H), 2.30 (s, 3H). MS, <i>m</i>/<i>z</i> 222.1 ([M + H]<sup>+</sup>). And 420.2 mg (37%) of 5-(5-chloro-2-methylphenyl)-1-methyl-1<i>H</i>-pyrazol-4-amine (<b>27</b>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 7.33 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 7.28 (s, 1H), 7.24–7.19 (m, 2H), 3.57 (s, 3H), 2.71 (s, 2H), 2.15 (s, 3H). MS: <i>m</i>/<i>z</i> 222.1 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 4-Nitro-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazole (<b>28</b>)</h4><div class="NLM_p last">In an oven-dried flask equipped with a stir bar, 4-nitro-1<i>H</i>-pyrazole (6.598 g, 58.35 mmol) was dissolved in 50 mL of THF. Sodium hydride (60 wt % dispersion in mineral oil, 4.827 g, 120.7 mmol) was added while cooling the reaction vessel with an ice–water bath, and the reaction was then stirred at ambient temperature for 10 min. [β-(Trimethylsilyl)ethoxy]methyl chloride (12.0 mL, 67.8 mmol) was then added, and the reaction stirred at ambient temperature for 1.5 h. The reaction mixture was quenched with 50 mL of water and extracted into ethyl acetate. The organic extract was dried over magnesium sulfate, filtered, and concentrated under vacuum. The resulting crude product was purified by flash chromatography on silica gel (gradient elution: 0–30% ethyl acetate in heptanes) to obtain 14.1368 g (99%) of 4-nitro-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazole. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.30 (s, 1H), 8.10 (s, 1H), 5.45 (s, 2H), 3.73–3.54 (m, 2H), 1.02–0.84 (m, 2H), −0.00 (s, 9H). MS: <i>m</i>/<i>z</i> 244.2 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 5-(5-Chloro-2-methoxyphenyl)-4-nitro-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazole (<b>29</b>)</h4><div class="NLM_p last">To a solution of <b>28</b> (4.259 g, 17.50 mmol) in 40 mL DMF was added 2-bromo-4-chloroanisole (3.35 mL, 24.6 mmol), palladium(II) acetate (197.2 mg, 0.8784 mmol), di(1-adamantyl)-<i>n</i>-butylphosphine (469.5 mg, 1.309 mmol), potassium carbonate (7.2763 g, 52.648 mmol), and trimethylacetic acid (0.4523 g, 4.428 mmol). While stirring at room temperature, nitrogen gas was bubbled through the reaction mixture for 10 min, and the reaction was then heated under a nitrogen balloon at 120 °C for 6 h. The reaction mixture was then cooled to room temperature, diluted into ethyl acetate, washed with water and brine, dried over magnesium sulfate, filtered, and concentrated under vacuum. The crude product was purified by flash chromatography on silica gel (gradient elution: 0–25% ethyl acetate in heptanes) to obtain 6.719 g (89%) of 3-(5-chloro-2-methoxyphenyl)-4-nitro-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazole. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.22 (s, 1H), 7.47 (dd, <i>J</i> = 8.9, 2.6 Hz, 1H), 7.36 (d, <i>J</i> = 2.5 Hz, 1H), 6.96 (d, <i>J</i> = 8.9 Hz, 1H), 5.34–5.20 (m, 2H), 3.76 (s, 3H), 3.69–3.46 (m, 2H), 0.96–0.79 (m, 2H), −0.02 (s, 9H). MS: <i>m</i>/<i>z</i> 384.2 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 5-(5-Chloro-2-methoxyphenyl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-amine (<b>30</b>)</h4><div class="NLM_p last">To a solution of <b>29</b> (5.97 g, 15.6 mmol) in 25 mL of ethanol was added water (50 mL), ammonium chloride (3.367 g, 62.94 mmol), and iron powder (4.367 g, 78.2 mmol). The reaction mixture was heated at 75 °C for 1.5 h. After being cooled to ambient temperature, the mixture was diluted with DCM and filtered through a Celite pad, rinsing with more DCM. The combined filtrate was added to 150 mL of saturated aqueous sodium bicarbonate and extracted twice with DCM. The combined organic extracts were dried over magnesium sulfate, filtered, and concentrated under vacuum to yield 5.50 g (100%) of 3-(5-chloro-2-methoxyphenyl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrazol-4-amine, which was carried forward without purification. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.44 (d, <i>J</i> = 2.6 Hz, 1H), 7.35 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 7.28 (s, 1H), 6.93 (d, <i>J</i> = 8.9 Hz, 1H), 5.24 (s, 2H), 3.82 (s, 3H), 3.52 (t, <i>J</i> = 8.2 Hz, 2H), 0.91–0.79 (m, 2H), −0.04 (s, 9H). MS: <i>m</i>/<i>z</i> 354.3 ([M + H]<sup>+</sup>).</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 3-(3-Chlorophenyl)-3-oxopropoinic Acid Ethyl Ester (<b>31</b>)</h4><div class="NLM_p last">Sodium hydride (60% in mineral oil, 1.03 g, 25.9 mmol) was added to a stirred solution of diethyl carbonate (3.9 mL, 32 mmol) in toluene (25 mL), under nitrogen. 3-Chloroacetophenone (0.84 mL, 6.5 mmol) in toluene (5 mL) was then added dropwise to the suspension over 30 min. The resulting mixture was heated to reflux for 16 h. After cooling, the reaction was carefully quenched with acetic acid (20 mL). Water (20 mL) was added and the mixture extracted into ethyl acetate (3×). The combined organic extracts were washed with saturated aqueous sodium bicarbonate solution, dried with anhydrous sodium sulfate, and concentrated under reduced pressure to yield a dark-orange oil, which was purified by Kugelrohr bulb to bulb distillation, at 150 °C, under vacuum, to yield 0.996 g of a colorless oil. Further purification by flash chromatography on silica gel (gradient elution: 0–15% ethyl acetate in cyclohexane) afforded 0.75 g (51%) of 3-(3-chlorophenyl)-3-oxopropoinic acid ethyl ester, 2:1 mixture of keto–enol tautomers, as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 12.56 (s, 1H), 7.93 (t, <i>J</i> = 1.9 Hz, 1H), 7.83 (ddd, <i>J</i> = 7.8, 1.7, 1.1 Hz, 1H), 7.77 (t, <i>J</i> = 1.9 Hz, 1H), 7.65 (dt, <i>J</i> = 7.7, 1.5 Hz, 1H), 7.58 (ddd, <i>J</i> = 8.0, 2.1, 1.1 Hz, 1H), 7.47–7.32 (m, 3H), 5.66 (s, 1H), 4.33–4.16 (m, 4H), 3.98 (s, 2H), 1.35 (t, <i>J</i> = 7.1 Hz, 3H), 1.27 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 5-(3-Chlorophenyl)-isoxazole-4-carboxylic Acid Ethyl Ester (<b>32</b>)</h4><div class="NLM_p last">DMF-DMA (1.5 mL, 11.6 mmol) was added to a solution of <b>31</b> (0.75 g, 3.3 mmol) in DMF (25 mL), under nitrogen. The mixture was heated to reflux for 5 h. After cooling, ethyl acetate and water were added and the layers separated. The organic extract was dried with anhydrous sodium sulfate and concentrated under reduced pressure to yield 0.79 g of a thick orange oil. The residue (0.595 g, ca. 2.11 mmol) was dissolved in methanol (5 mL) and treated with hydroxylamine hydrochloride (0.147 g, 2.11 mmol) at reflux for 1 h. After cooling, ethyl acetate and water were added and the layers separated. The aqueous phase was then extracted with ethyl acetate (2×). The combined organic extracts were dried with anhydrous sodium sulfate and concentrated under reduced pressure to yield an orange solid. Purification by flash chromatography on silica gel (gradient elution: 0–10% ethyl acetate in cyclohexane) afforded 422 mg (79%) of 5-(3-chlorophenyl)-isoxazole-4-carboxylic acid ethyl ester as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.65 (s, 1H), 8.18 (t, <i>J</i> = 1.9 Hz, 1H), 8.04 (dt, <i>J</i> = 7.7, 1.4 Hz, 1H), 7.53 (ddd, <i>J</i> = 8.1, 2.1, 1.2 Hz, 1H), 7.49–7.44 (m, 1H), 4.37 (q, <i>J</i> = 7.1 Hz, 2H), 1.39 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 5-(3-Chlorophenyl)-isoxazole-4-carboxylic Acid (<b>33</b>)</h4><div class="NLM_p last">A suspension of <b>32</b> (422 mg, 1.68 mmol) in 6 M aqueous HCl (10 mL) and acetic acid (6 mL) was heated to reflux for 5 h. After cooling, ethyl acetate was added to the suspension and the layers were separated. The aqueous layer was then extracted with ethyl acetate (2×). The organic extracts were combined, dried with anhydrous sodium sulfate, and concentrated under reduced pressure to yield 5-(3-chlorophenyl)-isoxazole-4-carboxylic acid as a white solid. This was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.70 (d, <i>J</i> = 2.3 Hz, 1H), 8.13 (d, <i>J</i> = 2.3 Hz, 1H), 8.02 (d, <i>J</i> = 7.9 Hz, 1H), 7.54 (m, 1H), 7.47 (td, <i>J</i> = 7.9, 2.3 Hz, 1H).</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> [5-(3-Chlorophenyl)-isoxazole-4-yl]-carbamic Acid <i>tert</i>-Butyl Ester (<b>34</b>)</h4><div class="NLM_p last">A solution of crude <b>33</b> (254 mg, 1.14 mmol) in thionyl chloride (3 mL) was heated to reflux for 3 h. After cooling, the mixture was concentrated under reduced pressure to yield an orange residue. The residue was dissolved in acetone (2 mL) and cooled to 0 °C (ice–water bath). Sodium azide (133 mg, 2.04 mmol) was added, and the resulting mixture was stirred for 1 h and then at ambient temperature for 1 h. Ethyl acetate was added and the layers separated. The organic extract was washed with water (2×) and brine (2×), dried with anhydrous sodium sulfate, and concentrated under reduced pressure to leave an orange solid. The residue was then treated with <i>tert</i>-butanol (8 mL) at reflux for 16 h. After cooling, the solvent was removed under vacuum and the residue purified by flash chromatography on silica gel (gradient elution: 0–20% ethyl acetate in cyclohexane) to afford 184 mg (55%) of [5-(3-chlorophenyl)-isoxazole-4-yl]-carbamic acid <i>tert</i>-butyl ester as an orange solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 7.70 (s, 1H), 7.59 (d, <i>J</i> = 6.9 Hz, 1H), 7.48–7.37 (m, 3H), 1.52 (s, 9H).</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 5-(3-Chlorophenyl)-isoxazole-4-ylamine Hydrochloride (<b>35</b>)</h4><div class="NLM_p last">First, 4 M HCl solution in 1,4-dioxane (1.5 mL, 6.0 mmol) was added to a stirred solution of <b>34</b> (184 mg, 0.624 mmol) in 1,4-dioxane (2 mL). Then the resulting mixture was heated to 40 °C for 20 h. After cooling, the mixture was concentrated under reduced pressure to give 147 mg (quant) of 5-(3-chlorophenyl)-isoxazole-4-ylamine hydrochloride as a yellow solid. This was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ: 8.61 (br, m, 1H), 7.85 (br, m, 1H), 7.75 (br, m, 1H), 7.62 (br, m, 2H).</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 3-Chlorobenzaldehyde Oxime (<b>36</b>)</h4><div class="NLM_p last">To a solution of 3-chlorobenzaldehyde (0.81 mL, 7.1 mmol) in EtOH (25 mL) was added hydroxylamine hydrochloride (0.54 g, 7.8 mmol), followed by pyridine (0.57 mL, 7.1 mmol). The resulting colorless mixture was stirred at ambient temperature for 5 h. Then 1 M aqueous HCl was added until pH reached 2, and then the mixture was extracted into DCM (3×). The organic layers were combined and dried with anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to yield 1.22 g (quant) of 3-chlorobenzaldehyde oxime as a white solid. This was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.11 (s, 1H), 7.59 (m, 1H), 7.45 (m, 1H), 7.36 (m, 1H), 7.32 (m, 1H).</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (<i>Z</i>)-3-Chloro-<i>N</i>-hydroxybenzene-1-carbonimidoyl Chloride (<b>37</b>)</h4><div class="NLM_p last">To a solution of <b>36</b> (436 mg, 2.80 mmol) in DMF (8 mL) was added <i>N</i>-chlorosuccinimide (307 mg, 2.30 mmol), and the resulting yellow mixture was stirred at ambient temperature for 1.5 h. The reaction was quenched with ice–water and extracted into diethyl ether (2×). The organic layers were combined, washed with water (4×), dried with anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to yield 480 mg (quant) of (<i>Z</i>)-3-chloro-<i>N</i>-hydroxybenzene-1-carbonimidoyl chloride as an orange solid. This was used in the next step without further purification. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.85 (m, 1H), 7.75 (ddd, <i>J</i> = 7.72, 1.75, 1.25 Hz, 1 H), 7.43 (ddd; <i>J</i> = 8.02, 2.06, 1.25 Hz, 1H), 7.36 (m, 1H).</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (<i>E</i>)-3-Pyrrolidin-1-ylacrylic Acid Ethyl Ester (<b>38</b>)</h4><div class="NLM_p last">To a solution of ethyl propiolate (2.9 mL, 29 mmol) in toluene (20 mL) was added dropwise a solution of pyrrolidine (2.4 mL, 29 mmol) in toluene (5 mL) over 10 min. The resulting orange mixture was stirred at ambient temperature for 16 h and concentrated under reduced pressure to leave a thick orange oil, which was purified by Kugelrohr distillation, at 140–150 °C, under vacuum, to afford 4.56 g (94%) of (<i>E</i>)-3-pyrrolidin-1-ylacrylic acid ethyl ester as pale-yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 7.65 (d, <i>J</i> = 12.9 Hz, 1H), 4.48 (d, <i>J</i> = 12.9 Hz, 1H), 4.13 (q, <i>J</i> = 7.1 Hz, 2H), 3.27 (s, 4H), 1.93 (s, 4H), 1.26 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 3-(3-Chlorophenyl)-isoxazole-4-carboxylic Acid Ethyl Ester (<b>39</b>)</h4><div class="NLM_p last">A mixture of <b>38</b> (0.427 g, 2.52 mmol) and triethylamine (0.413 mL, 2.96 mmol) in diethyl ether (5 mL), under nitrogen, was cooled using an ice bath. To this was added dropwise a solution of <b>37</b> (0.48 g, 2.5 mmol) in diethyl ether, over 25 min. A cream-colored solid precipitate formed, and the suspension was stirred at ambient temperature for 18 h. The mixture was partitioned between water and diethyl ether, and the aqueous layer was extracted with diethyl ether. The organic extracts were combined and dried with anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to give a viscous yellow oil. Purification by flash chromatography on silica gel (gradient elution: 0–20% ethyl acetate in cyclohexane) afforded 0.359 g (57%) of 3-(3-chlorophenyl)-isoxazole-4-carboxylic acid ethyl ester as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 9.02 (s, 1H), 7.81 (ddd, <i>J</i> = 2.1, 1.6, 0.5 Hz, 1H), 7.68 (ddd, <i>J</i> = 7.6, 1.6, 1.2 Hz, 1H), 7.48 (ddd, <i>J</i> = 8.1, 2.1, 1.2 Hz, 1H), 7.43–7.39 (m, 1H), 4.31 (q, <i>J</i> = 7.1 Hz, 2H), 1.32 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 3-(3-Chlorophenyl)-isoxazole-4-carboxylic Acid (<b>40</b>)</h4><div class="NLM_p last">A stirred solution of <b>39</b> (0.359 g, 1.43 mmol) in acetic acid (6 mL) was treated with 6 M aqueous HCl (10 mL) at reflux for 5.5 h. After cooling, ethyl acetate was added causing phase separation of the organic and aqueous layers. The resulting aqueous layer was extracted again with ethyl acetate. The combined organic extracts were dried with anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to yield 0.315 g (99%) of 3-(3-chlorophenyl)-isoxazole-4-carboxylic acid as a white solid. This was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 9.12 (m, 1H), 7.81 (m, 1H), 7.69 (d, <i>J</i> = 7.6 Hz, 1H), 7.49 (m, 1H), 7.43 (m, 1H).</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> [3-(3-Chlorophenyl)-isoxazol-4-yl]-carbamic Acid <i>tert</i>-Butyl Ester (<b>41</b>)</h4><div class="NLM_p last">A mixture of <b>40</b> (0.215 g, 0.962 mmol), diphenylphosphorylazide (0.21 mL, 0.96 mmol), and triethylamine (0.134 mL, 0.961 mmol) in <i>tert</i>-butanol was heated to reflux (85 °C) for 16 h. After cooling, ethyl acetate was added and the mixture successively washed with 1 M aqueous HCl (2×), saturated aqueous sodium bicarbonate (2×), and brine (2×). The organic layer was dried with anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to yield a cream-colored residue. Purification by flash chromatography on silica gel (gradient elution: 0–15% ethyl acetate in cyclohexane) afforded 217 mg (77%) of [3-(3-chlorophenyl)-isoxazol-4-yl]-carbamic acid <i>tert</i>-butyl ester as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.91 (s, 1H), 7.63 (m, 1H), 7.50 (m, 3H), 6.09 (s, 1H), 1.51 (s, 9H).</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 3-(3-Chlorophenyl)-isoxazol-4-ylamine Hydrochloride (<b>42</b>)</h4><div class="NLM_p last">A solution of <b>41</b> (0.217 g, 0.736 mmol) in 1,4-dioxane (2 mL) was treated with 4 M HCl solution in 1,4-dioxane (1.5 mL) at ambient temperature for 20 h. The mixture was concentrated under reduced pressure to yield 165 mg (97%) of 3-(3-chlorophenyl)-isoxazol-4-ylamine hydrochloride as a cream-colored solid. This was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ: 9.06 (s, 1H), 7.80 (td, <i>J</i> = 1.8, 0.5 Hz, 1H), 7.69 (dt, <i>J</i> = 7.2, 1.6 Hz, 1H), 7.63 (m, 1H), 7.59 (m, 1H).</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 4-(3-Chlorophenyl)-2-methylthiazol-5-ylamine (<b>43</b>)</h4><div class="NLM_p last">A mixture of α-amino-(3-chlorophenyl)acetonitrile hydrochloride (0.52 g, 2.6 mmol) and powdered sulfur (80 mg, 2.6 mmol) in ethanol (3 mL) was stirred in a sealed tube at 0 °C. Triethylamine (0.53 mL, 3.8 mmol) and a solution of acetaldehyde in ethanol (0.11 g, 2.6 mmol in 0.5 mL) were added sequentially. The resulting mixture was then heated to 60 °C for 2.5 h. After cooling, mixture was concentrated under reduced pressure, and the resulting residue was then dissolved in ethanol (2 mL) and treated with 1 M aqueous HCl (2 mL) at ambient temperature for 16 h. The pH was then adjusted to 12 (using saturated aqueous sodium carbonate solution) and the mixture extracted into DCM (3 × 10 mL). The combined organic extracts were dried with anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was purified using an Isolute SCX-2 cartridge (washing with DCM and eluting with 2 M NH<sub>3</sub> in methanol solution) to afford 0.42 g (73%) of 4-(3-chlorophenyl)-2-methylthiazol-5-ylamine as a pale-orange oil, which solidified on standing. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 7.75 (ddd, <i>J</i> = 2.1, 1.7, 0.4 Hz, 1H), 7.61 (ddd, <i>J</i> = 7.8, 1.7, 1.1 Hz, 1H), 7.33 (m, 1H), 7.23 (ddd, <i>J</i> = 8.0, 2.1, 1.1 Hz, 1H), 3.84 (s, 2 H), 2.58 (s, 3H). MS: <i>m</i>/<i>z</i> 224.9/226.9 ([M + H]<sup>+</sup>).</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Enzyme Assays</h3><div class="NLM_p last">The activity of the isolated Jak1, Jak2, Jak3, or Tyk2 kinase domain was measured by monitoring phosphorylation of a peptide derived from Jak3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, MA). To determine the inhibition constants (<i>K</i><sub>i</sub>), compounds were diluted serially in DMSO and added to 50 μL kinase reactions containing 1.5 nM purified Jak1 enzyme (or 0.2 nM purified Jak2 enzyme or 5 nM purified Jak3 enzyme or 1 nM purified Tyk2 enzyme), 100 mM Hepes pH 7.2, 0.015% Brij-35, 1.5 μM peptide substrate, 25 μM ATP, 10 mM MgCl<sub>2</sub>, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22 °C in 384-well polypropylene microtiter plates for 30 min and then stopped by addition of 25 μL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer’s specifications. <i>K</i><sub>i</sub> values were then determined using the Morrison tight binding model.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The activity of ruxolitinib was measured as follows, with data representing either three or four independent experiments and error described as the standard deviation: Jak1 <i>K</i><sub>i</sub> 0.09 nM (±0.01 nM), Jak2 <i>K</i><sub>i</sub> 0.24 nM (±0.04 nM), Jak3 <i>K</i><sub>i</sub> 3.22 nM (±0.27 nM), Tyk2 <i>K</i><sub>i</sub> 0.55 nM (±0.07 nM).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Cell Assays</h3><div class="NLM_p">The activities of compounds in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> were determined in cell-based assays that are designed to measure Jak2-dependent signaling. The activity of ruxolitinib was measured in both assay formats as follows, with data representing either two (SET2 format) or five (TF1+EPO format) independent experiments and error described as the standard deviation: pSTAT5 SET2 MSD IC<sub>50</sub> 1.84 nM (±1.70 nM), pSTAT5 SET2 MSD IC<sub>50</sub> 6.85 nM (±3.57 nM). </div><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> pSTAT5 SET2 MSD Format</h4><div class="NLM_p last">Compounds were serially diluted in DMSO and incubated with SET2 cells (German Collection of Microorganisms and Cell Cultures (DSMZ); Braunschweig, Germany), which express the JAK2<sup>V617F</sup> constitutively active mutant protein, in 96-well microtiter plates for 1 h at 37 °C in RPMI medium at a final cell density of 100000 cells per well and a final DMSO concentration of 0.57%. Compound-mediated effects on STAT5 phosphorylation were then measured in the lysates of incubated cells using the Meso Scale Discovery (MSD) technology (Gaithersburg, Maryland) according to the manufacturer’s protocol, and EC<sub>50</sub> values were determined.</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> pSTAT5 TF1+EPO MSD Format</h4><div class="NLM_p last">Compounds were serially diluted in DMSO and incubated with TF-1 cells (American Type Culture Collection, ATCC), Manassas, VA) in 384-well microtiter plates in OptiMEM medium without phenol red, 1% charcoal/dextran stripped FBS, 0.1 mM NEAA, 1 mM sodium pyruvate (Invitrogen Corp.; Carlsbad, CA) at a final cell density of 100000 cells per well and a final DMSO concentration of 0.2%. Human recombinant EPO (Invitrogen Corp., Carlsbad, CA) was then added at a final concentration of 10 units/mL to the microtiter plates containing the TF-1 cells and compound, and the plates were incubated for 30 min at 37 °C. Compound-mediated effects on STAT5 phosphorylation were then measured in the lysates of cells incubated in the presence of EPO, using the MSD technology (Gaithersburg, Maryland) according to the manufacturer’s protocol and IC50 values were determined.</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> In Vivo Pharmacodynamic Assay</h3><div class="NLM_p last">Twenty million SET2 cells containing 1:1 matrigel were inoculated subcutaneously in the right flank of female, 8–12-week-old, severe combined immunodeficient mice (SCID beige) obtained from Charles River (Hollister, CA). Treatment was initiated when mean tumor volume reached 250–300 mm<sup>3</sup>. For pharmacodynamic studies, mice were administered a single oral dose of compound in 0.5% methylceullulose/0.2% Tween-80 (MCT). At 1, 4, 8, and 24 h after dosing, mice were euthanized according to IACUC guidelines and tumor samples were harvested and snap frozen on dry ice or fixed in 10% neutral buffered formalin. Tris lysis buffer containing 150 mM NaCl, 20 mM Tris PH 7.5, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100 supplemented with phosphatase and protease inhibitors (Sigma), 1 mM NaF, and 1 mM PMSF was added to frozen tumor biopsies. Tumors were dissociated with a small pestle (Konte Glass Company, Vineland, NJ), sonicated briefly on ice, and centrifuged at maximum RPM for 20 min at 4 °C. Then 20 μg of protein from tumor lysates was used to determine phosphorylation status. Samples were assayed in duplicates per manufacturer’s protocol for pSTAT5/tSTAT5 (MSD). Plasma samples were obtained by centrifugation, and drug concentrations were determined using liquid chromatography with tandem mass spectrometric detection (LC/MS).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Kinetic Solubility</h3><div class="NLM_p last">Compounds were dissolved in DMSO to a concentration of 10 mM. These solutions were diluted into PBS buffer (pH 7.2, composed with NaCl, KCl, Na<sub>2</sub>HPO<sub>4</sub>, and KH<sub>2</sub>PO<sub>4</sub>) to a final compound concentration of 100 μM, DMSO concentration of 2%, at pH 7.4. The samples were shaken for 24 h at room temperature, followed by filtration. LC/CLND was used to determine compound concentration in the filtrate, with the concentration calculated by a caffeine calibration curve and the sample’s nitrogen content. An internal standard compound was spiked into each sample for accurate quantification.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Thermodynamic Solubility</h3><div class="NLM_p last">Compounds were dissolved in DMSO to a concentration of 10 mM, and these solutions were used to make serial dilutions to 2, 20, and 200 μM. A calibration curve for each compound was generated by LC/UV (254 nM) measurement. Solid compound (2 mg) was placed into Whatman UniPrep filter vials with 0.45 mL PBS buffer (pH 6.5). The vials were shaken for 24 h at room temperature and filtered. The samples were diluted 10× with PBS buffer and analyzed by LC/UV, and the solubility calculated by comparison with the calibration curves.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> In Vitro Microsome Metabolic Stability</h3><div class="NLM_p last">Experiments were carried out as described.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> MDCK Permeability</h3><div class="NLM_p last">Experiments were carried out as described.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> Crystallography</h3><div class="NLM_p last">Jak2 JH1 (kinase) domain was prepared, complexed with compound <b>8</b>, crystallized, and its molecular structure determined as described as previously described.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> See <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information Table S2">Supporting Information Table S2</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81"><a href="/doi/suppl/10.1021/jm3012239">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15510" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15510" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Mouse pharmacokinetic parameters for selected compounds, X-ray data collection and refinement details, cocrystal structure (2.3 Å) of compound <b>8</b> in the active site of the Jak2 kinase with protein surface displayed, and preparation and characterization of compounds <b>6b</b>–<b>j</b>, <b>7d</b>–<b>k</b>, <b>9b</b>–<b>c</b>, <b>10b</b>–<b>c</b>, <b>13b</b>–<b>g</b>, <b>14b</b>–<b>e</b>, <b>14g</b>–<b>j</b>, <b>18c</b>–<b>d</b>, <b>19b</b>–<b>d</b>, <b>20b</b>–<b>e</b>, <b>22b</b>, and <b>26b</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3012239/suppl_file/jm3012239_si_001.pdf">jm3012239_si_001.pdf (324.6 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm3012239" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38852" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38852" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph P. Lyssikatos</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7b1702080812101a0f1408551114081e0b133b1c1e151e55181416"><span class="__cf_email__" data-cfemail="ec80959f9f85878d98839fc286839f899c84ac8b898289c28f8381">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emily J. Hanan</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne van Abbema</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathy Barrett</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wade S. Blair</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeff Blaney</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Chang</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles Eigenbrot</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean Flynn</span> - <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Gibbons</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher A. Hurley</span> - <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane R. Kenny</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janusz Kulagowski</span> - <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leslie Lee</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven R. Magnuson</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claire Morris</span> - <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeremy Murray</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard M. Pastor</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tom Rawson</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Siu</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Ultsch</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aihe Zhou</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deepak Sampath</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Structural Biology, ∥Drug Metabolism
and Pharmacokinetics, ⊥Translational Oncology, Genentech, Inc. 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta,
8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="ack" id="ACK-d2572e4962-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73551" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73551" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Christopher Hamman, Michael Hayes, and Mengling Wong for assistance with compound purification, Baiwei Lin for conducting kinetic solubility experiments, Sashi Gopaul, Hoa Le, Emile Plise, Savita Ubhayakar, and Jacob Chen for conducting DMPK experiments, and Sarah Hymowitz and Ivan Bosanac for collecting diffraction data. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract no. DE-AC02-05CH11231.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i83" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i83"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i84" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i84"> Abbreviations Used</h2><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last">1,1′-carbonyldiimidazole</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMFDMA</td><td class="NLM_def"><p class="first last">1,1-dimethoxy-<i>N</i>,<i>N</i>-dimethylmethanamine</p></td></tr><tr><td class="NLM_term">ET</td><td class="NLM_def"><p class="first last">essential thrombocytemia</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">2-(1<i>H</i>-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyluronoium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HBA</td><td class="NLM_def"><p class="first last">hydrogen bond acceptor</p></td></tr><tr><td class="NLM_term">HBD</td><td class="NLM_def"><p class="first last">hydrogen bond donor</p></td></tr><tr><td class="NLM_term">Jak</td><td class="NLM_def"><p class="first last">Janus kinase</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">HOAc</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">mCPBA</td><td class="NLM_def"><p class="first last"><i>meta</i>-chloroperoxybenzoic acid</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney cells</p></td></tr><tr><td class="NLM_term">MF</td><td class="NLM_def"><p class="first last">myelofibrosis</p></td></tr><tr><td class="NLM_term">MPD</td><td class="NLM_def"><p class="first last">myeloproliferative disorder</p></td></tr><tr><td class="NLM_term">MSD</td><td class="NLM_def"><p class="first last">meso scale discovery</p></td></tr><tr><td class="NLM_term">NCS</td><td class="NLM_def"><p class="first last"><i>N</i>-chlorosuccinimide</p></td></tr><tr><td class="NLM_term">PK/PD</td><td class="NLM_def"><p class="first last">pharmacokinetic/pharmakodynamic</p></td></tr><tr><td class="NLM_term">PV</td><td class="NLM_def"><p class="first last">polycythemia vera</p></td></tr><tr><td class="NLM_term">PyAOP</td><td class="NLM_def"><p class="first last">7-azabenzotriazol-1-yloxy-tris-(pyrrolidino)phosphonium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">2-(trimethylsilyl)ethoxymethyl</p></td></tr><tr><td class="NLM_term">STAT</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription</p></td></tr><tr><td class="NLM_term">tBuOH</td><td class="NLM_def"><p class="first last"><i>tert</i>-butanol</p></td></tr><tr><td class="NLM_term">TDI</td><td class="NLM_def"><p class="first last">time-dependent inhibition</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i85">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23368" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23368" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 45 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Yamaoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saharinen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, V. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvennoinen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">The Janus kinases (Jaks)</span> <span class="citation_source-journal">Genome Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=253&author=K.+Yamaokaauthor=P.+Saharinenauthor=M.+Pesuauthor=V.+E.+Holtauthor=O.+Silvennoinenauthor=J.+J.+O%E2%80%99Shea&title=The+Janus+kinases+%28Jaks%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamaoka%26aufirst%3DK.%26aulast%3DSaharinen%26aufirst%3DP.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DHolt%26aufirst%3DV.%2BE.%26aulast%3DSilvennoinen%26aufirst%3DO.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520Janus%2520kinases%2520%2528Jaks%2529%26jtitle%3DGenome%2520Biol.%26date%3D2004%26volume%3D5%26spage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Aaronson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, C. M.</span><span> </span><span class="NLM_article-title">A road map for those who don’t know JAK-STAT</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">1653</span><span class="NLM_x">–</span> <span class="NLM_lpage">1655</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=1653-1655&author=D.+S.+Aaronsonauthor=C.+M.+Horvath&title=A+road+map+for+those+who+don%E2%80%99t+know+JAK-STAT"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAaronson%26aufirst%3DD.%2BS.%26aulast%3DHorvath%26aufirst%3DC.%2BM.%26atitle%3DA%2520road%2520map%2520for%2520those%2520who%2520don%25E2%2580%2599t%2520know%2520JAK-STAT%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D1653%26epage%3D1655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kisseleva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braunstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, C. W.</span><span> </span><span class="NLM_article-title">Signaling through the JAK/STAT pathway, recent advances and future challenges</span> <span class="citation_source-journal">Gene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2002&pages=1-24&author=T.+Kisselevaauthor=S.+Bhattacharyaauthor=J.+Braunsteinauthor=C.+W.+Schindler&title=Signaling+through+the+JAK%2FSTAT+pathway%2C+recent+advances+and+future+challenges"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKisseleva%26aufirst%3DT.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DBraunstein%26aufirst%3DJ.%26aulast%3DSchindler%26aufirst%3DC.%2BW.%26atitle%3DSignaling%2520through%2520the%2520JAK%252FSTAT%2520pathway%252C%2520recent%2520advances%2520and%2520future%2520challenges%26jtitle%3DGene%26date%3D2002%26volume%3D285%26spage%3D1%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, R. D.</span><span> </span><span class="NLM_article-title">Cytokine signaling in 2002: new surprises in the Jak/Stat pathway</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl</span><span class="NLM_x">) </span> <span class="NLM_fpage">S121</span><span class="NLM_x">–</span> <span class="NLM_lpage">S131</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=S121-S131&issue=Suppl&author=J.+J.+O%E2%80%99Sheaauthor=M.+Gadinaauthor=R.+D.+Schreiber&title=Cytokine+signaling+in+2002%3A+new+surprises+in+the+Jak%2FStat+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DGadina%26aufirst%3DM.%26aulast%3DSchreiber%26aufirst%3DR.%2BD.%26atitle%3DCytokine%2520signaling%2520in%25202002%253A%2520new%2520surprises%2520in%2520the%2520Jak%252FStat%2520pathway%26jtitle%3DCell%26date%3D2002%26volume%3D109%26issue%3DSuppl%26spage%3DS121%26epage%3DS131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Heinrich, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrmann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermanns, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller-Newen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaper, F.</span><span> </span><span class="NLM_article-title">Principles of interleukin (IL)-6-type cytokine signalling and its regulation</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2003&pages=1-20&author=P.+C.+Heinrichauthor=I.+Behrmannauthor=S.+Haanauthor=H.+M.+Hermannsauthor=G.+Muller-Newenauthor=F.+Schaper&title=Principles+of+interleukin+%28IL%29-6-type+cytokine+signalling+and+its+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DP.%2BC.%26aulast%3DBehrmann%26aufirst%3DI.%26aulast%3DHaan%26aufirst%3DS.%26aulast%3DHermanns%26aufirst%3DH.%2BM.%26aulast%3DMuller-Newen%26aufirst%3DG.%26aulast%3DSchaper%26aufirst%3DF.%26atitle%3DPrinciples%2520of%2520interleukin%2520%2528IL%2529-6-type%2520cytokine%2520signalling%2520and%2520its%2520regulation%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D374%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Baxter, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">East, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fourouclas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassiliou, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bench, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erber, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. R.</span><span> </span><span class="NLM_article-title">Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">1054</span><span class="NLM_x">–</span> <span class="NLM_lpage">1061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1016%2FS0140-6736%2805%2971142-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=15781101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFGrs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2005&pages=1054-1061&author=E.+J.+Baxterauthor=L.+M.+Scottauthor=P.+J.+Campbellauthor=C.+Eastauthor=N.+Fourouclasauthor=S.+Swantonauthor=G.+S.+Vassiliouauthor=A.+J.+Benchauthor=E.+M.+Boydauthor=N.+Curtinauthor=M.+A.+Scottauthor=W.+N.+Erberauthor=A.+R.+Green&title=Acquired+mutation+of+the+tyrosine+kinase+JAK2+in+human+myeloproliferative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders</span></div><div class="casAuthors">Baxter, E. Joanna; Scott, Linda M.; Campbell, Peter J.; East, Clare; Fourouclas, Nasios; Swanton, Soheila; Vassiliou, George S.; Bench, Anthony J.; Boyd, Elaine M.; Curtin, Natasha; Scott, Mike A.; Erber, Wendy N.; Green, Anthony R.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">9464</span>),
    <span class="NLM_cas:pages">1054-1061</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Background: Human myeloproliferative disorders form a range of clonal haematol. malignant diseases, the main members of which are polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis.  The mol. pathogenesis of these disorders is unknown, but tyrosine kinases have been implicated in several related disorders.  We investigated the role of the cytoplasmic tyrosine kinase JAK2 in patients with a myeloproliferative disorder.  Methods: We obtained DNA samples from patients with polycythemia vera, essential thrombocythemia, or idiopathic myelofibrosis.  The coding exons of JAK2 were bidirectionally sequenced from peripheral-blood granulocytes, T cells, or both.  Allele-specific PCR, mol. cytogenetic studies, microsatellite PCR, Affymetrix single nucleotide polymorphism array analyses, and colony assays were undertaken on subgroups of patients.  Findings: A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythemia vera, 29 (57%) of 51 with essential thrombocythemia, and eight (50%) of 16 with idiopathic myelofibrosis.  The mutation is acquired, is present in a variable proportion of granulocytes, alters a highly conserved valine present in the neg. regulatory JH2 domain, and is predicted to dysregulate kinase activity.  It was heterozygous in most patients, homozygous in a subset as a result of mitotic recombination, and arose in a multipotent progenitor capable of giving rise to erythroid and myeloid cells.  The mutation was present in all erythropoietin-independent erythroid colonies.  Interpretation: A single acquired mutation of JAK2 was noted in more than half of patients with a myeloproliferative disorder.  Its presence in all erythropoietin-independent erythroid colonies demonstrates a link with growth factor hypersensitivity, a key biol. feature of these disorders.  Relevance to practice: Identification of the Val617Phe JAK2 mutation lays the foundation for new approaches to the diagnosis, classification, and treatment of myeloproliferative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8cc-kg2leZrVg90H21EOLACvtfcHk0lh1OJotTIjiVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFGrs7g%253D&md5=3c9dc565a1986a47d12e4bccd8c8cc1a</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2971142-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252971142-9%26sid%3Dliteratum%253Aachs%26aulast%3DBaxter%26aufirst%3DE.%2BJ.%26aulast%3DScott%26aufirst%3DL.%2BM.%26aulast%3DCampbell%26aufirst%3DP.%2BJ.%26aulast%3DEast%26aufirst%3DC.%26aulast%3DFourouclas%26aufirst%3DN.%26aulast%3DSwanton%26aufirst%3DS.%26aulast%3DVassiliou%26aufirst%3DG.%2BS.%26aulast%3DBench%26aufirst%3DA.%2BJ.%26aulast%3DBoyd%26aufirst%3DE.%2BM.%26aulast%3DCurtin%26aufirst%3DN.%26aulast%3DScott%26aufirst%3DM.%2BA.%26aulast%3DErber%26aufirst%3DW.%2BN.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26atitle%3DAcquired%2520mutation%2520of%2520the%2520tyrosine%2520kinase%2520JAK2%2520in%2520human%2520myeloproliferative%2520disorders%26jtitle%3DLancet%26date%3D2005%26volume%3D365%26spage%3D1054%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">James, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Couedic, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staerk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delhommeau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacout, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raslova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennaceur-Griscelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villeval, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constantinescu, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadevall, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vainchenker, W.</span><span> </span><span class="NLM_article-title">A unique clonal JAK2 mutation leading to constitutive signaling causes polycythaemia vera</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=1144-1148&author=C.+Jamesauthor=V.+Ugoauthor=J.-P.+Le+Couedicauthor=J.+Staerkauthor=F.+Delhommeauauthor=C.+Lacoutauthor=L.+Garconauthor=H.+Raslovaauthor=R.+Bergerauthor=A.+Bennaceur-Griscelliauthor=J.+L.+Villevalauthor=S.+N.+Constantinescuauthor=N.+Casadevallauthor=W.+Vainchenker&title=A+unique+clonal+JAK2+mutation+leading+to+constitutive+signaling+causes+polycythaemia+vera"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DC.%26aulast%3DUgo%26aufirst%3DV.%26aulast%3DLe%2BCouedic%26aufirst%3DJ.-P.%26aulast%3DStaerk%26aufirst%3DJ.%26aulast%3DDelhommeau%26aufirst%3DF.%26aulast%3DLacout%26aufirst%3DC.%26aulast%3DGarcon%26aufirst%3DL.%26aulast%3DRaslova%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DBennaceur-Griscelli%26aufirst%3DA.%26aulast%3DVilleval%26aufirst%3DJ.%2BL.%26aulast%3DConstantinescu%26aufirst%3DS.%2BN.%26aulast%3DCasadevall%26aufirst%3DN.%26aulast%3DVainchenker%26aufirst%3DW.%26atitle%3DA%2520unique%2520clonal%2520JAK2%2520mutation%2520leading%2520to%2520constitutive%2520signaling%2520causes%2520polycythaemia%2520vera%26jtitle%3DNature%26date%3D2005%26volume%3D434%26spage%3D1144%26epage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kralovics, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passamonti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teo, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiedt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passweg, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tichelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazzola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skoda, R. C.</span><span> </span><span class="NLM_article-title">A gain-of-function mutation of JAK2 in myeloproliferative disorders</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">1779</span><span class="NLM_x">–</span> <span class="NLM_lpage">1790</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1056%2FNEJMoa051113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=15858187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsFyhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=1779-1790&author=R.+Kralovicsauthor=F.+Passamontiauthor=A.+S.+Buserauthor=S.-S.+Teoauthor=R.+Tiedtauthor=J.+R.+Passwegauthor=A.+Tichelliauthor=M.+Cazzolaauthor=R.+C.+Skoda&title=A+gain-of-function+mutation+of+JAK2+in+myeloproliferative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">A gain-of-function mutation of JAK2 in myeloproliferative disorders</span></div><div class="casAuthors">Kralovics, Robert; Passamonti, Francesco; Buser, Andreas S.; Teo, Soon-Siong; Tiedt, Ralph; Passweg, Jakob R.; Tichelli, Andre; Cazzola, Mario; Skoda, Radek C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1779-1790</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are clonal myeloproliferative disorders arising from a multi-potent progenitor.  The loss of heterozygosity (LOH) on the short arm of chromosome 9 (9pLOH) in myeloproliferative disorders suggests that 9p harbors a mutation that contributes to the cause of clonal expansion of hematopoietic cells in these diseases.  METHODS We performed microsatellite mapping of the 9pLOH region and DNA sequencing in 244 patients with myeloproliferative disorders (128 with polycythemia vera, 93 with essential thrombocythemia, and 23 with idiopathic myelofibrosis).  RESULTS Microsatellite mapping identified a 9pLOH region that included the Janus kinase 2 (JAK2) gene.  In patients with 9pLOH, JAK2 had a homozygous G→T transversion, causing phenylalanine to be substituted for valine at position 617 of JAK2 (V617F).  All 51 patients with 9pLOH had the V617F mutation.  Of 193 patients without 9pLOH, 66 were heterozygous for V617F and 127 did not have the mutation.  The frequency of V617F was 65 % among patients with polycythemia vera (83 of 128), 57 % among patients with idiopathic myelofibrosis (13 of 23), and 23 % among patients with essential thrombocythemia (21 of 93).  V617F is a somatic mutation present in hematopoietic cells.  Mitotic recombination probably causes both 9pLOH and the transition from heterozygosity to homozygosity for V617F.  Genetic evidence and in vitro functional studies indicate that V617F gives hematopoietic precursors proliferative and survival advantages.  Patients with the V617F mutation had a significantly longer duration of disease and a higher rate of complications (fibrosis, hemorrhage, and thrombosis) and treatment with cytoreductive therapy than patients with wild-type JAK2.  CONCLUSIONS A high proportion of patients with myeloproliferative disorders carry a dominant gain-of-function mutation of JAK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqTe7EsB_527Vg90H21EOLACvtfcHk0lhwYZmay39hhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsFyhsLw%253D&md5=5dd4bc090ded1c812b61923cad36e77e</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa051113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa051113%26sid%3Dliteratum%253Aachs%26aulast%3DKralovics%26aufirst%3DR.%26aulast%3DPassamonti%26aufirst%3DF.%26aulast%3DBuser%26aufirst%3DA.%2BS.%26aulast%3DTeo%26aufirst%3DS.-S.%26aulast%3DTiedt%26aufirst%3DR.%26aulast%3DPassweg%26aufirst%3DJ.%2BR.%26aulast%3DTichelli%26aufirst%3DA.%26aulast%3DCazzola%26aufirst%3DM.%26aulast%3DSkoda%26aufirst%3DR.%2BC.%26atitle%3DA%2520gain-of-function%2520mutation%2520of%2520JAK2%2520in%2520myeloproliferative%2520disorders%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D1779%26epage%3D1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadleigh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cools, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wlodarska, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelsperger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercher, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frohling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marynen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberghe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesa, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span> </span><span class="NLM_article-title">Activating mutation in the tyrosine kinase JAK2 in polycythemia vera essential thrombocythemia, and myeloid metaplasia with myelofibrosis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=387-397&author=R.+L.+Levineauthor=M.+Wadleighauthor=J.+Coolsauthor=B.+L.+Ebertauthor=G.+Wernigauthor=B.+J.+Huntlyauthor=T.+J.+Boggonauthor=I.+Wlodarskaauthor=J.+J.+Clarkauthor=S.+Mooreauthor=J.+Adelspergerauthor=S.+Kooauthor=J.+C.+Leeauthor=S.+Gabrielauthor=T.+Mercherauthor=A.+D%E2%80%99Andreaauthor=S.+Frohlingauthor=K.+Dohnerauthor=P.+Marynenauthor=P.+Vandenbergheauthor=R.+A.+Mesaauthor=A.+Tefferiauthor=J.+D.+Griffinauthor=M.+J.+Eckauthor=W.+R.+Sellersauthor=M.+Meyersonauthor=T.+R.+Golubauthor=S.+J.+Leeauthor=D.+G.+Gilliland&title=Activating+mutation+in+the+tyrosine+kinase+JAK2+in+polycythemia+vera+essential+thrombocythemia%2C+and+myeloid+metaplasia+with+myelofibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DWadleigh%26aufirst%3DM.%26aulast%3DCools%26aufirst%3DJ.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DWernig%26aufirst%3DG.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DWlodarska%26aufirst%3DI.%26aulast%3DClark%26aufirst%3DJ.%2BJ.%26aulast%3DMoore%26aufirst%3DS.%26aulast%3DAdelsperger%26aufirst%3DJ.%26aulast%3DKoo%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DMercher%26aufirst%3DT.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%26aulast%3DFrohling%26aufirst%3DS.%26aulast%3DDohner%26aufirst%3DK.%26aulast%3DMarynen%26aufirst%3DP.%26aulast%3DVandenberghe%26aufirst%3DP.%26aulast%3DMesa%26aufirst%3DR.%2BA.%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26atitle%3DActivating%2520mutation%2520in%2520the%2520tyrosine%2520kinase%2520JAK2%2520in%2520polycythemia%2520vera%2520essential%2520thrombocythemia%252C%2520and%2520myeloid%2520metaplasia%2520with%2520myelofibrosis%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D387%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krantz, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z. J.</span><span> </span><span class="NLM_article-title">Identification of an acquired JAK2 mutation in polycythemia vera</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">22788</span><span class="NLM_x">–</span> <span class="NLM_lpage">22792</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=22788-22792&author=R.+Zhaoauthor=S.+Xingauthor=Z.+Liauthor=X.+Fuauthor=Q.+Liauthor=S.+B.+Krantzauthor=Z.+J.+Zhao&title=Identification+of+an+acquired+JAK2+mutation+in+polycythemia+vera"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DXing%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DKrantz%26aufirst%3DS.%2BB.%26aulast%3DZhao%26aufirst%3DZ.%2BJ.%26atitle%3DIdentification%2520of%2520an%2520acquired%2520JAK2%2520mutation%2520in%2520polycythemia%2520vera%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D22788%26epage%3D22792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardanani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span> </span><span class="NLM_article-title">Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1038%2Fnrc2210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=17721432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFSjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=673-683&author=R.+L.+Levineauthor=A.+Pardananiauthor=A.+Tefferiauthor=D.+G.+Gilliland&title=Role+of+JAK2+in+the+pathogenesis+and+therapy+of+myeloproliferative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3fR"><div class="casContent"><span class="casTitleNuber">3f</span><div class="casTitle"><span class="NLM_cas:atitle">Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders</span></div><div class="casAuthors">Levine, Ross L.; Pardanani, Animesh; Tefferi, Ayalew; Gilliland, D. Gary</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">673-683</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The myeloproliferative disorders polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) are clonal disorders of multipotent hematopoietic progenitors.  The genetic cause of these diseases was not known until 2005, when several independent groups demonstrated that most patients with PV, ET and PMF acquire a single point mutation in the cytoplasmic tyrosine kinase JAK2 (JAK2V617F).  These discoveries have changed the landscape for diagnosis and classification of PV, ET and PMF, and show the ability of genomic technologies to identify new mol. targets in human malignancies with pathogenetic, diagnostic and therapeutic significance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ5nfhX3BsOrVg90H21EOLACvtfcHk0lhwYZmay39hhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFSjsbg%253D&md5=89429b6786f421d06163a48540c03dcb</span></div><a href="/servlet/linkout?suffix=cit3f&amp;dbid=16384&amp;doi=10.1038%2Fnrc2210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2210%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DPardanani%26aufirst%3DA.%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26atitle%3DRole%2520of%2520JAK2%2520in%2520the%2520pathogenesis%2520and%2520therapy%2520of%2520myeloproliferative%2520disorders%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D673%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Campbell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. R.</span><span> </span><span class="NLM_article-title">The Myeloproliferative Disorders</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">2452</span><span class="NLM_x">–</span> <span class="NLM_lpage">2466</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1056%2FNEJMra063728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=17151367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12nt7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=2452-2466&author=P.+J.+Campbellauthor=A.+R.+Green&title=The+Myeloproliferative+Disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The myeloproliferative disorders</span></div><div class="casAuthors">Campbell, Peter J.; Green, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2452-2466</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The three main Philadelphia chromosome-neg. myeloproliferative disorders - polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis - are the focus of this article.  The altered genetics and pathogenesis of myeloproliferative disorders are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBxI0YeB02JrVg90H21EOLACvtfcHk0lhpLXKsIXSD4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12nt7vN&md5=a3437f87672e934689348b7d0cf6935d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMra063728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra063728%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DP.%2BJ.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26atitle%3DThe%2520Myeloproliferative%2520Disorders%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D2452%26epage%3D2466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">James, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadevall, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constantinescu, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vainchenker, W.</span><span> </span><span class="NLM_article-title">A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospect</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">546</span><span class="NLM_x">–</span> <span class="NLM_lpage">554</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=546-554&author=C.+Jamesauthor=V.+Ugoauthor=N.+Casadevallauthor=S.+N.+Constantinescuauthor=W.+Vainchenker&title=A+JAK2+mutation+in+myeloproliferative+disorders%3A+pathogenesis+and+therapeutic+and+scientific+prospect"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DC.%26aulast%3DUgo%26aufirst%3DV.%26aulast%3DCasadevall%26aufirst%3DN.%26aulast%3DConstantinescu%26aufirst%3DS.%2BN.%26aulast%3DVainchenker%26aufirst%3DW.%26atitle%3DA%2520JAK2%2520mutation%2520in%2520myeloproliferative%2520disorders%253A%2520pathogenesis%2520and%2520therapeutic%2520and%2520scientific%2520prospect%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D546%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Wernig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharas, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okabe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullen, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doukas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noronha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span> </span><span class="NLM_article-title">Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1016%2Fj.ccr.2008.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=18394554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslSjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=311-320&author=G.+Wernigauthor=M.+G.+Kharasauthor=R.+Okabeauthor=S.+A.+Mooreauthor=D.+S.+Leemanauthor=D.+E.+Cullenauthor=M.+Gozoauthor=E.+P.+McDowellauthor=R.+L.+Levineauthor=J.+Doukasauthor=C.+C.+Makauthor=G.+Noronhaauthor=M.+Martinauthor=Y.+D.+Koauthor=B.+H.+Leeauthor=R.+M.+Sollauthor=A.+Tefferiauthor=J.+D.+Hoodauthor=D.+G.+Gilliland&title=Efficacy+of+TG101348%2C+a+selective+JAK2+inhibitor%2C+in+treatment+of+a+murine+model+of+JAK2V617F-induced+polycythemia+vera"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera</span></div><div class="casAuthors">Wernig, Gerlinde; Kharas, Michael G.; Okabe, Rachel; Moore, Sandra A.; Leeman, Dena S.; Cullen, Dana E.; Gozo, Maricel; McDowell, Elizabeth P.; Levine, Ross L.; Doukas, John; Mak, Chi Ching; Noronha, Glenn; Martin, Michael; Ko, Yon D.; Lee, Benjamin H.; Soll, Richard M.; Tefferi, Ayalew; Hood, John D.; Gilliland, D. Gary</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-320</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We report that TG101348, a selective small-mol. inhibitor of JAK2 with an in vitro IC50 of ∼3 nM, shows therapeutic efficacy in a murine model of myeloproliferative disease induced by the JAK2V617F mutation.  In treated animals, there was a statistically significant redn. in hematocrit and leukocyte count, a dose-dependent redn./elimination of extramedullary hematopoiesis, and, at least in some instances, evidence for attenuation of myelofibrosis.  There were no apparent toxicities and no effect on T cell no.  In vivo responses were correlated with surrogate endpoints, including redn./elimination of JAK2V617F disease burden assessed by quant. genomic PCR, suppression of endogenous erythroid colony formation, and in vivo inhibition of JAK-STAT signal transduction as assessed by flow cytometric measurement of phosphorylated Stat5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSJOc4cS_lO7Vg90H21EOLACvtfcHk0lhpLXKsIXSD4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslSjtrs%253D&md5=3dd923595cafebb6439dd67f026735be</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2008.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2008.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DWernig%26aufirst%3DG.%26aulast%3DKharas%26aufirst%3DM.%2BG.%26aulast%3DOkabe%26aufirst%3DR.%26aulast%3DMoore%26aufirst%3DS.%2BA.%26aulast%3DLeeman%26aufirst%3DD.%2BS.%26aulast%3DCullen%26aufirst%3DD.%2BE.%26aulast%3DGozo%26aufirst%3DM.%26aulast%3DMcDowell%26aufirst%3DE.%2BP.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DDoukas%26aufirst%3DJ.%26aulast%3DMak%26aufirst%3DC.%2BC.%26aulast%3DNoronha%26aufirst%3DG.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DKo%26aufirst%3DY.%2BD.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DHood%26aufirst%3DJ.%2BD.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26atitle%3DEfficacy%2520of%2520TG101348%252C%2520a%2520selective%2520JAK2%2520inhibitor%252C%2520in%2520treatment%2520of%2520a%2520murine%2520model%2520of%2520JAK2V617F-induced%2520polycythemia%2520vera%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D13%26spage%3D311%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Hart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotny-Diermayr, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentze, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amalini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">William, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaraman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethirajulu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. W.</span><span> </span><span class="NLM_article-title">SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1751</span><span class="NLM_x">–</span> <span class="NLM_lpage">1759</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1751-1759&author=S.+Hartauthor=K.+C.+Gohauthor=V.+Novotny-Diermayrauthor=C.+Y.+Huauthor=H.+Hentzeauthor=Y.+C.+Tanauthor=B.+Madanauthor=C.+Amaliniauthor=Y.+K.+Lohauthor=L.+C.+Ongauthor=A.+D.+Williamauthor=A.+Leeauthor=A.+Poulsenauthor=R.+Jayaramanauthor=K.+H.+Ongauthor=K.+Ethirajuluauthor=B.+W.+Dymockauthor=J.+W.+Wood&title=SB1518%2C+a+novel+macrocyclic+pyrimidine-based+JAK2+inhibitor+for+the+treatment+of+myeloid+and+lymphoid+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DS.%26aulast%3DGoh%26aufirst%3DK.%2BC.%26aulast%3DNovotny-Diermayr%26aufirst%3DV.%26aulast%3DHu%26aufirst%3DC.%2BY.%26aulast%3DHentze%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DY.%2BC.%26aulast%3DMadan%26aufirst%3DB.%26aulast%3DAmalini%26aufirst%3DC.%26aulast%3DLoh%26aufirst%3DY.%2BK.%26aulast%3DOng%26aufirst%3DL.%2BC.%26aulast%3DWilliam%26aufirst%3DA.%2BD.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DJayaraman%26aufirst%3DR.%26aulast%3DOng%26aufirst%3DK.%2BH.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DWood%26aufirst%3DJ.%2BW.%26atitle%3DSB1518%252C%2520a%2520novel%2520macrocyclic%2520pyrimidine-based%2520JAK2%2520inhibitor%2520for%2520the%2520treatment%2520of%2520myeloid%2520and%2520lymphoid%2520malignancies%26jtitle%3DLeukemia%26date%3D2011%26volume%3D25%26spage%3D1751%26epage%3D1759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ionnidis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alimzhanov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M.</span><span> </span><span class="NLM_article-title">Discovery of 5-Chloro-<i>N</i>2-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i>4-(5-methyl-1<i>H</i>-pyrazol-3-yl)-pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat Pathway</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=262-276&author=S.+Ionnidisauthor=M.+L.+Lambauthor=T.+Wangauthor=L.+Almeidaauthor=M.+H.+Blockauthor=A.+M.+Daviesauthor=B.+Pengauthor=M.+Suauthor=H.-J.+Zhangauthor=E.+Hoffmanauthor=C.+Rivardauthor=I.+Greenauthor=T.+Howardauthor=H.+Pollardauthor=J.+Readauthor=M.+Alimzhanovauthor=G.+Bebernitzauthor=K.+Bellauthor=M.+Yeauthor=D.+Huszarauthor=M.+Zinda&title=Discovery+of+5-Chloro-N2-%5B%281S%29-1-%285-fluoropyrimidin-2-yl%29ethyl%5D-N4-%285-methyl-1H-pyrazol-3-yl%29-pyrimidine-2%2C4-diamine+%28AZD1480%29+as+a+Novel+Inhibitor+of+the+Jak%2FStat+Pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIonnidis%26aufirst%3DS.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DBlock%26aufirst%3DM.%2BH.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.-J.%26aulast%3DHoffman%26aufirst%3DE.%26aulast%3DRivard%26aufirst%3DC.%26aulast%3DGreen%26aufirst%3DI.%26aulast%3DHoward%26aufirst%3DT.%26aulast%3DPollard%26aufirst%3DH.%26aulast%3DRead%26aufirst%3DJ.%26aulast%3DAlimzhanov%26aufirst%3DM.%26aulast%3DBebernitz%26aufirst%3DG.%26aulast%3DBell%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DHuszar%26aufirst%3DD.%26aulast%3DZinda%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25205-Chloro-N2-%255B%25281S%2529-1-%25285-fluoropyrimidin-2-yl%2529ethyl%255D-N4-%25285-methyl-1H-pyrazol-3-yl%2529-pyrimidine-2%252C4-diamine%2520%2528AZD1480%2529%2520as%2520a%2520Novel%2520Inhibitor%2520of%2520the%2520Jak%252FStat%2520Pathway%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D262%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Burkholder, T. P.; Clayton, J. R.; Ma, L.</span><span> </span><span class="NLM_article-title">Amino pyrazole compound</span>. U.S. Pat. Appl. Publ. US 20100152181 A1 20100617; CAN 153:97762, AN 2010:753991.201,<span class="NLM_x"> </span><span class="NLM_year">2010</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+P.+Burkholder&author=J.+R.+Clayton&author=L.+Ma&title=Amino+pyrazole+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurkholder%26aufirst%3DT.%2BP.%26atitle%3DAmino%2520pyrazole%2520compound%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Burns, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourke, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donohue, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrugia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feutrill, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joffe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nero, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikanyik, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Styles, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treutlein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilks, A. F.</span><span> </span><span class="NLM_article-title">Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5887</span><span class="NLM_x">–</span> <span class="NLM_lpage">5882</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5887-5882&author=C.+J.+Burnsauthor=D.+G.+Bourkeauthor=L.+Andrauauthor=X.+Buauthor=S.+A.+Charmanauthor=A.+C.+Donohueauthor=E.+Fantinoauthor=M.+Farrugiaauthor=J.+T.+Feutrillauthor=M.+Joffeauthor=M.+R.+Klingauthor=M.+Kurekauthor=T.+L.+Neroauthor=T.+Nguyenauthor=J.+T.+Palmerauthor=I.+Phillipsauthor=D.+M.+Shaklefordauthor=H.+Sikanyikauthor=M.+Stylesauthor=S.+Suauthor=H.+Treutleinauthor=J.+Zengauthor=A.+F.+Wilks&title=Phenylaminopyrimidines+as+inhibitors+of+Janus+kinases+%28JAKs%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26aulast%3DBourke%26aufirst%3DD.%2BG.%26aulast%3DAndrau%26aufirst%3DL.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DDonohue%26aufirst%3DA.%2BC.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DFarrugia%26aufirst%3DM.%26aulast%3DFeutrill%26aufirst%3DJ.%2BT.%26aulast%3DJoffe%26aufirst%3DM.%26aulast%3DKling%26aufirst%3DM.%2BR.%26aulast%3DKurek%26aufirst%3DM.%26aulast%3DNero%26aufirst%3DT.%2BL.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPhillips%26aufirst%3DI.%26aulast%3DShakleford%26aufirst%3DD.%2BM.%26aulast%3DSikanyik%26aufirst%3DH.%26aulast%3DStyles%26aufirst%3DM.%26aulast%3DSu%26aufirst%3DS.%26aulast%3DTreutlein%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26atitle%3DPhenylaminopyrimidines%2520as%2520inhibitors%2520of%2520Janus%2520kinases%2520%2528JAKs%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5887%26epage%3D5882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tyner, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bumm, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aichberger, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriaux, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, M. W.</span><span> </span><span class="NLM_article-title">CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">5232</span><span class="NLM_x">–</span> <span class="NLM_lpage">5240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=5232-5240&author=J.+W.+Tynerauthor=T.+G.+Bummauthor=J.+Deiningerauthor=L.+Woodauthor=K.+J.+Aichbergerauthor=M.+M.+Loriauxauthor=B.+J.+Drukerauthor=C.+J.+Burnsauthor=E.+Fantinoauthor=M.+W.+Deininger&title=CYT387%2C+a+novel+JAK2+inhibitor%2C+induces+hematologic+responses+and+normalizes+inflammatory+cytokines+in+murine+myeloproliferative+neoplasms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DBumm%26aufirst%3DT.%2BG.%26aulast%3DDeininger%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DL.%26aulast%3DAichberger%26aufirst%3DK.%2BJ.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DDeininger%26aufirst%3DM.%2BW.%26atitle%3DCYT387%252C%2520a%2520novel%2520JAK2%2520inhibitor%252C%2520induces%2520hematologic%2520responses%2520and%2520normalizes%2520inflammatory%2520cytokines%2520in%2520murine%2520myeloproliferative%2520neoplasms%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D5232%26epage%3D5240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Verstovsek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesa, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardanani, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Franco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrov, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson-Viitanen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span> </span><span class="NLM_article-title">Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1056%2FNEJMoa1002028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=20843246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOltrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1117-1127&author=S.+Verstovsekauthor=H.+Kantarjianauthor=R.+A.+Mesaauthor=A.+D.+Pardananiauthor=J.+Cortes-Francoauthor=D.+A.+Thomasauthor=Z.+Estrovauthor=J.+S.+Fridmanauthor=E.+C.+Bradleyauthor=S.+Erickson-Viitanenauthor=K.+Vaddiauthor=R.+Levyauthor=A.+Tefferi&title=Safety+and+efficacy+of+INCB018424%2C+a+JAK1+and+JAK2+inhibitor%2C+in+myelofibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis</span></div><div class="casAuthors">Verstovsek, Srdan; Kantarjian, Hagop; Mesa, Ruben A.; Pardanani, Animesh D.; Cortes-Franco, Jorge; Thomas, Deborah A.; Estrov, Zeev; Fridman, Jordan S.; Bradley, Edward C.; Erickson-Viitanen, Susan; Vaddi, Kris; Levy, Richard; Tefferi, Ayalew</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1117-1127</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Myelofibrosis is a Philadelphia chromosome-neg. myeloproliferative neoplasm assocd. with cytopenias, splenomegaly, poor quality of life, and shortened survival.  About half of patients with myelofibrosis carry a gain-of-function mutation in the Janus kinase 2 gene (JAK2 V617F) that contributes to the pathophysiol. of the disease.  INCB018424 is a potent and selective Janus kinase 1 (JAK1) and JAK2 inhibitor.  Methods: We conducted a phase 1-2 trial of INCB018424 in patients with JAK2 V617F-pos. or JAK2 V617F-neg. primary myelofibrosis, post-essential thrombocythemia myelofibrosis, or post-polycythemia vera myelofibrosis.  Results: A total of 153 patients received INCB018424 for a median duration of more than 14.7 mo.  The initial dose-escalation phase established 25 mg twice daily or 100 mg once daily as max. tolerated doses, on the basis of reversible thrombocytopenia.  A dose-dependent suppression of phosphorylated signal transducer and activator of transcription 3 (STAT3), a marker of JAK signaling, was demonstrated in patients with wild-type JAK2 and in patients with the JAK2 V617F mutation.  We studied addnl. doses and established that a 15-mg twice-daily starting dose, followed by individualized dose titrn., was the most effective and safest dosing regimen.  At this dose, 17 of 33 patients (52%) had a rapid objective response (>50% redn. of splenomegaly) lasting for 12 mo or more, and this therapy was assocd. with grade 3 or grade 4 adverse events (mainly myelosuppression) in less than 10% of patients.  Patients with debilitating symptoms, including wt. loss, fatigue, night sweats, and pruritus, had rapid improvement.  Clin. benefits were assocd. with a marked diminution of levels of circulating inflammatory cytokines that are commonly elevated in myelofibrosis.  Conclusions: INCB018424 was assocd. with marked and durable clin. benefits in patients with myelofibrosis for whom no approved therapies existed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUi05ApP1FLrVg90H21EOLACvtfcHk0lhJnGt5M9oZ-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOltrjJ&md5=ba6fe766323a10a1508c686fdb3720b1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1002028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1002028%26sid%3Dliteratum%253Aachs%26aulast%3DVerstovsek%26aufirst%3DS.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DMesa%26aufirst%3DR.%2BA.%26aulast%3DPardanani%26aufirst%3DA.%2BD.%26aulast%3DCortes-Franco%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DD.%2BA.%26aulast%3DEstrov%26aufirst%3DZ.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DBradley%26aufirst%3DE.%2BC.%26aulast%3DErickson-Viitanen%26aufirst%3DS.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DLevy%26aufirst%3DR.%26aulast%3DTefferi%26aufirst%3DA.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520INCB018424%252C%2520a%2520JAK1%2520and%2520JAK2%2520inhibitor%252C%2520in%2520myelofibrosis%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D1117%26epage%3D1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Quintas-Cardama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manshouri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caulder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waeltz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">3109</span><span class="NLM_x">–</span> <span class="NLM_lpage">3117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1182%2Fblood-2009-04-214957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=20130243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltlWqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=3109-3117&author=A.+Quintas-Cardamaauthor=K.+Vaddiauthor=P.+Liuauthor=T.+Manshouriauthor=J.+Liauthor=P.+A.+Scherleauthor=E.+Caulderauthor=X.+Wenauthor=Y.+Liauthor=P.+Waeltzauthor=M.+Ruparauthor=T.+Burnauthor=Y.+Loauthor=J.+Kelleyauthor=M.+Covingtonauthor=S.+Shepardauthor=J.+D.+Rodgersauthor=P.+Haleyauthor=J.+Kantarjianauthor=J.+S.+Fridmanauthor=S.+Verstovsek&title=Preclinical+characterization+of+the+selective+JAK1%2F2+inhibitor+INCB018424%3A+therapeutic+implications+for+the+treatment+of+myeloproliferative+neoplasms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms</span></div><div class="casAuthors">Quintas-Cardama, Alfonso; Vaddi, Kris; Liu, Phillip; Manshouri, Taghi; Li, Jun; Scherle, Peggy A.; Caulder, Eian; Wen, Xiaoming; Li, Yanlong; Waeltz, Paul; Rupar, Mark; Burn, Timothy; Lo, Yvonne; Kelley, Jennifer; Covington, Maryanne; Shepard, Stacey; Rodgers, James D.; Haley, Patrick; Kantarjian, Hagop; Fridman, Jordan S.; Verstovsek, Srdan</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3109-3117</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Constitutive JAK2 activation in hematopoietic cells by the JAK2V617F mutation recapitulates myeloproliferative neoplasm (MPN) phenotypes in mice, establishing JAK2 inhibition as a potential therapeutic strategy.  Although most polycythemia vera patients carry the JAK2V617F mutation, half of those with essential thrombocythemia or primary myelofibrosis do not, suggesting alternative mechanisms for constitutive JAK-STAT signaling in MPNs.  Most patients with primary myelofibrosis have elevated levels of JAK-dependent proinflammatory cytokines (eg, interleukin-6) consistent with our observation of JAK1 hyperactivation.  Accordingly, we evaluated the effectiveness of selective JAK1/2 inhibition in exptl. models relevant to MPNs and report on the effects of INCB018424, the first potent, selective, oral JAK1/JAK2 inhibitor to enter the clinic.  INCB018424 inhibited interleukin-6 signaling (50% inhibitory concn. [IC50] = 281nM), and proliferation of JAK2V617F+ Ba/F3 cells (IC50 = 127nM).  In primary cultures, INCB018424 preferentially suppressed erythroid progenitor colony formation from JAK2V617F+ polycythemia vera patients (IC50 = 67nM) vs. healthy donors (IC50 > 400nM).  In a mouse model of JAK2V617F+ MPN, oral INCB018424 markedly reduced splenomegaly and circulating levels of inflammatory cytokines, and preferentially eliminated neoplastic cells, resulting in significantly prolonged survival without myelosuppressive or immunosuppressive effects.  Preliminary clin. results support these preclin. data and establish INCB018424 as a promising oral agent for the treatment of MPNs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvKGz1l6Y-CbVg90H21EOLACvtfcHk0lhFI3VV5jTiJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltlWqsr8%253D&md5=cd52b7013d76ed00ca2df22444c45160</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-04-214957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-04-214957%26sid%3Dliteratum%253Aachs%26aulast%3DQuintas-Cardama%26aufirst%3DA.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DManshouri%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26aulast%3DCaulder%26aufirst%3DE.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWaeltz%26aufirst%3DP.%26aulast%3DRupar%26aufirst%3DM.%26aulast%3DBurn%26aufirst%3DT.%26aulast%3DLo%26aufirst%3DY.%26aulast%3DKelley%26aufirst%3DJ.%26aulast%3DCovington%26aufirst%3DM.%26aulast%3DShepard%26aufirst%3DS.%26aulast%3DRodgers%26aufirst%3DJ.%2BD.%26aulast%3DHaley%26aufirst%3DP.%26aulast%3DKantarjian%26aufirst%3DJ.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DPreclinical%2520characterization%2520of%2520the%2520selective%2520JAK1%252F2%2520inhibitor%2520INCB018424%253A%2520therapeutic%2520implications%2520for%2520the%2520treatment%2520of%2520myeloproliferative%2520neoplasms%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D3109%26epage%3D3117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Macchi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacco, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frattini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugazio, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candotti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vezzoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Notarangelo, L. D.</span><span> </span><span class="NLM_article-title">Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1038%2F377065a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=7659163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADyaK2MXnvFektb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=1995&pages=65-68&author=P.+Macchiauthor=A.+Villaauthor=S.+Gilianiauthor=M.+G.+Saccoauthor=A.+Frattiniauthor=F.+Portaauthor=A.+G.+Ugazioauthor=J.+A.+Johnstonauthor=F.+Candottiauthor=J.+J.+O%E2%80%99Sheaauthor=P.+Vezzoniauthor=L.+D.+Notarangelo&title=Mutations+of+Jak-3+gene+in+patients+with+autosomal+severe+combined+immune+deficiency+%28SCID%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)</span></div><div class="casAuthors">Macchi, Paolo; Villa, Anna; Giliani, Silvia; Sacco, Maria G.; Frattini, Annalisa; Porta, Fulvio; Ugazio, Alberto G.; Johnston, James A.; Candotti, Fabio; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">6544</span>),
    <span class="NLM_cas:pages">65-8</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Severe combined immune deficiency (SCID) represents a heterogeneous group of hereditary diseases.  Mutations in the common γ-chain (γc), which is part of several cytokine receptors including those for interleukin (IL)-2, IL-4, IL-7, IL-9 and IL-15, are responsible for X-linked SCID, which is usually assocd. with a lack of circulating T cells and the presence of B lymphocytes (T- B+ SCID).  The gene(s) responsible for autosomal recessive T- B+ SCID is still unknown.  The Jak-3 protein kinase has been found to assoc. with the γc-chain-contg. cytokine receptors.  Therefore Jak-3 or other STAT proteins with which it interacts are candidate genes for autosomal recessive T- B+ SCID.  Here the authors investigate two unrelated T- B+ SCID patients (both from consanguineous parents) who have homozygous mutations in the gene for Jak-3.  One patient carries a mutation (Tyr100→Cys) in a conserved tyrosine residue in the JH7 domain of Jak-3 which is absent in more than 150 investigated chromosomes.  The other patient carries a homozygous 151-base-pair deletion in the kinase-like domain, leading to a frameshift and premature termination.  Both mutations resulted in markedly reduced levels of Jak-3.  These findings show that abnormalities in the Jak/STAT signaling pathway can account for SCID in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJWFs-Wbegq7Vg90H21EOLACvtfcHk0lhFI3VV5jTiJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvFektb4%253D&md5=ac5a7064e6c3361c8906813770e1b6d9</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1038%2F377065a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F377065a0%26sid%3Dliteratum%253Aachs%26aulast%3DMacchi%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DA.%26aulast%3DGiliani%26aufirst%3DS.%26aulast%3DSacco%26aufirst%3DM.%2BG.%26aulast%3DFrattini%26aufirst%3DA.%26aulast%3DPorta%26aufirst%3DF.%26aulast%3DUgazio%26aufirst%3DA.%2BG.%26aulast%3DJohnston%26aufirst%3DJ.%2BA.%26aulast%3DCandotti%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DVezzoni%26aufirst%3DP.%26aulast%3DNotarangelo%26aufirst%3DL.%2BD.%26atitle%3DMutations%2520of%2520Jak-3%2520gene%2520in%2520patients%2520with%2520autosomal%2520severe%2520combined%2520immune%2520deficiency%2520%2528SCID%2529%26jtitle%3DNature%26date%3D1995%26volume%3D377%26spage%3D65%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Russell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tayebi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedy, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migone, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markert, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, W. J.</span><span> </span><span class="NLM_article-title">Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=797-800&author=S.+M.+Russellauthor=N.+Tayebiauthor=H.+Nakajimaauthor=M.+C.+Riedyauthor=J.+L.+Robertsauthor=M.+J.+Amanauthor=T.+S.+Migoneauthor=M.+Noguchiauthor=M.+L.+Markertauthor=R.+H.+Buckleyauthor=J.+J.+O%E2%80%99Sheaauthor=W.+J.+Leonard&title=Mutation+of+Jak3+in+a+patient+with+SCID%3A+essential+role+of+Jak3+in+lymphoid+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DS.%2BM.%26aulast%3DTayebi%26aufirst%3DN.%26aulast%3DNakajima%26aufirst%3DH.%26aulast%3DRiedy%26aufirst%3DM.%2BC.%26aulast%3DRoberts%26aufirst%3DJ.%2BL.%26aulast%3DAman%26aufirst%3DM.%2BJ.%26aulast%3DMigone%26aufirst%3DT.%2BS.%26aulast%3DNoguchi%26aufirst%3DM.%26aulast%3DMarkert%26aufirst%3DM.%2BL.%26aulast%3DBuckley%26aufirst%3DR.%2BH.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26atitle%3DMutation%2520of%2520Jak3%2520in%2520a%2520patient%2520with%2520SCID%253A%2520essential%2520role%2520of%2520Jak3%2520in%2520lymphoid%2520development%26jtitle%3DScience%26date%3D1995%26volume%3D270%26spage%3D797%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meraz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, R. D.</span><span> </span><span class="NLM_article-title">Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1998&pages=373-383&author=S.+J.+Rodigauthor=M.+A.+Merazauthor=J.+M.+Whiteauthor=P.+A.+Lampeauthor=J.+K.+Rileyauthor=C.+D.+Arthurauthor=K.+L.+Kingauthor=K.+C.+Sheehanauthor=L.+Yinauthor=D.+Pennicaauthor=E.+M.+Johnsonauthor=R.+D.+Schreiber&title=Disruption+of+the+Jak1+gene+demonstrates+obligatory+and+nonredundant+roles+of+the+Jaks+in+cytokine-induced+biologic+responses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DMeraz%26aufirst%3DM.%2BA.%26aulast%3DWhite%26aufirst%3DJ.%2BM.%26aulast%3DLampe%26aufirst%3DP.%2BA.%26aulast%3DRiley%26aufirst%3DJ.%2BK.%26aulast%3DArthur%26aufirst%3DC.%2BD.%26aulast%3DKing%26aufirst%3DK.%2BL.%26aulast%3DSheehan%26aufirst%3DK.%2BC.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DPennica%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DE.%2BM.%26aulast%3DSchreiber%26aufirst%3DR.%2BD.%26atitle%3DDisruption%2520of%2520the%2520Jak1%2520gene%2520demonstrates%2520obligatory%2520and%2520nonredundant%2520roles%2520of%2520the%2520Jaks%2520in%2520cytokine-induced%2520biologic%2520responses%26jtitle%3DCell%26date%3D1998%26volume%3D93%26spage%3D373%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="note"><p class="first last">The prescribing information for ruxolitinib (Jakafi) includes: “Active serious infections should have resolved before starting therapy with Jakafi. Physicians should carefully observe patients receiving Jakafi for signs and symptoms of infection and initiate appropriate treatment promptly.”</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eYIM_d7eTTLLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Keseru, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makara, G. M.</span><span> </span><span class="NLM_article-title">The influence of lead discovery strategies on the properties of drug candidates</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=203-212&author=G.+M.+Keseruauthor=G.+M.+Makara&title=The+influence+of+lead+discovery+strategies+on+the+properties+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DThe%2520influence%2520of%2520lead%2520discovery%2520strategies%2520on%2520the%2520properties%2520of%2520drug%2520candidates%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D203%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Cruciani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crivori, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Molecular fields in quantitative structure-permeation relationships: the VolSurf approach</span> <span class="citation_source-journal">J. Mol. Struct. (THEOCHEM)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">503</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2000&pages=17-30&author=G.+Crucianiauthor=P.+Crivoriauthor=P.-A.+Carruptauthor=B.+Testa&title=Molecular+fields+in+quantitative+structure-permeation+relationships%3A+the+VolSurf+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DCrivori%26aufirst%3DP.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DMolecular%2520fields%2520in%2520quantitative%2520structure-permeation%2520relationships%253A%2520the%2520VolSurf%2520approach%26jtitle%3DJ.%2520Mol.%2520Struct.%2520%2528THEOCHEM%2529%26date%3D2000%26volume%3D503%26spage%3D17%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Gavrin, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Provencher, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massefski, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huhn, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciszewski, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKew, J. C.</span><span> </span><span class="NLM_article-title">Synthesis of pyrazolo[1,5-alpha]pyrimidinone regioisomers</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1043</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo062120g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=1043-1046&author=L.+K.+Gavrinauthor=A.+Leeauthor=B.+A.+Provencherauthor=W.+W.+Massefskiauthor=S.+D.+Huhnauthor=G.+M.+Ciszewskiauthor=D.+C.+Coleauthor=J.+C.+McKew&title=Synthesis+of+pyrazolo%5B1%2C5-alpha%5Dpyrimidinone+regioisomers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjo062120g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo062120g%26sid%3Dliteratum%253Aachs%26aulast%3DGavrin%26aufirst%3DL.%2BK.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DProvencher%26aufirst%3DB.%2BA.%26aulast%3DMassefski%26aufirst%3DW.%2BW.%26aulast%3DHuhn%26aufirst%3DS.%2BD.%26aulast%3DCiszewski%26aufirst%3DG.%2BM.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DMcKew%26aufirst%3DJ.%2BC.%26atitle%3DSynthesis%2520of%2520pyrazolo%255B1%252C5-alpha%255Dpyrimidinone%2520regioisomers%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26spage%3D1043%26epage%3D1046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Miyaura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2457</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00039a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2457-2483&author=N.+Miyauraauthor=A.+Suzuki&title=Palladium-Catalyzed+Cross-Coupling+Reactions+of+Organoboron+Compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span></div><div class="casAuthors">Miyaura, Norio; Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2457-83</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with >250 refs. including title reactions and their mechanisms, prepn. of organoboron reagents, alkoxycarbonylation and dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwupBJT1UCbVg90H21EOLACvtfcHk0lgaGk12wDG6eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D&md5=d127b414a75161652876eebc3ed0c486</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcr00039a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00039a007%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DPalladium-Catalyzed%2520Cross-Coupling%2520Reactions%2520of%2520Organoboron%2520Compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26spage%3D2457%26epage%3D2483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcoxen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, J. R.</span><span> </span><span class="NLM_article-title">A convenient one-pot synthesis of 4-amino-3-arylpyrazoles from alpha-phthaloylaminoacetophenones</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">8229</span><span class="NLM_x">–</span> <span class="NLM_lpage">8232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=8229-8232&author=C.+Chenauthor=K.+Wilcoxenauthor=J.+R.+McCarthy&title=A+convenient+one-pot+synthesis+of+4-amino-3-arylpyrazoles+from+alpha-phthaloylaminoacetophenones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26aulast%3DWilcoxen%26aufirst%3DK.%26aulast%3DMcCarthy%26aufirst%3DJ.%2BR.%26atitle%3DA%2520convenient%2520one-pot%2520synthesis%2520of%25204-amino-3-arylpyrazoles%2520from%2520alpha-phthaloylaminoacetophenones%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D8229%26epage%3D8232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Clay, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collom, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karrick, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wemple, J.</span><span> </span><span class="NLM_article-title">A safe, economical method for the preparation of beta-oxo esters</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1055%2Fs-1993-25849" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADyaK3sXisFCnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&pages=290-292&author=R.+J.+Clayauthor=T.+A.+Collomauthor=G.+L.+Karrickauthor=J.+Wemple&title=A+safe%2C+economical+method+for+the+preparation+of+beta-oxo+esters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A safe, economical method for the preparation of β-oxo esters</span></div><div class="casAuthors">Clay, Ronald J.; Collom, Thomas A.; Karrick, Gregory L.; Wemple, James</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">290-2</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">A high yield, economical method for prepn. of β-oxo esters, e.g., BzCH2CO2Et, has been developed involving the reaction of acid chlorides with potassium Et malonate using a magnesium chloride-triethylamine base system in either acetonitrile or Et acetate solvents.  The method is suitable for the prepn. of high purity β-oxo esters in the lab. and also in large scale prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfDon5BC4otLVg90H21EOLACvtfcHk0lgaGk12wDG6eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXisFCnu7k%253D&md5=f19267f744ed1cc802253f96708a7ada</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1055%2Fs-1993-25849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1993-25849%26sid%3Dliteratum%253Aachs%26aulast%3DClay%26aufirst%3DR.%2BJ.%26aulast%3DCollom%26aufirst%3DT.%2BA.%26aulast%3DKarrick%26aufirst%3DG.%2BL.%26aulast%3DWemple%26aufirst%3DJ.%26atitle%3DA%2520safe%252C%2520economical%2520method%2520for%2520the%2520preparation%2520of%2520beta-oxo%2520esters%26jtitle%3DSynthesis%26date%3D1993%26spage%3D290%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Shioiri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninomiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, S.</span><span> </span><span class="NLM_article-title">Diphenylphosphoryl azide: a new convenient reagent for a modified Curtius reaction and for the peptide synthesis</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">6203</span><span class="NLM_x">–</span> <span class="NLM_lpage">6205</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00772a052" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1972&pages=6203-6205&author=T.+Shioiriauthor=K.+Ninomiyaauthor=S.+Yamada&title=Diphenylphosphoryl+azide%3A+a+new+convenient+reagent+for+a+modified+Curtius+reaction+and+for+the+peptide+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja00772a052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00772a052%26sid%3Dliteratum%253Aachs%26aulast%3DShioiri%26aufirst%3DT.%26aulast%3DNinomiya%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DS.%26atitle%3DDiphenylphosphoryl%2520azide%253A%2520a%2520new%2520convenient%2520reagent%2520for%2520a%2520modified%2520Curtius%2520reaction%2520and%2520for%2520the%2520peptide%2520synthesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1972%26volume%3D94%26spage%3D6203%26epage%3D6205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="note"><p class="first last">Identity of regioisomers definitevely assigned via <sup>1</sup>H NMR nuclear Overhauser effect.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Goikhman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sames, D.</span><span> </span><span class="NLM_article-title">C–H bonds as ubiquitous functionality: a general approach to complex arylated pyrazoles via sequential regioselective <i>C</i>-arylation and <i>N</i>-alkylation enabled by SEM-group transposition</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">3042</span><span class="NLM_x">–</span> <span class="NLM_lpage">3048</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja8096114" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=3042-3048&author=R.+Goikhmanauthor=T.+L.+Jacquesauthor=D.+Sames&title=C%E2%80%93H+bonds+as+ubiquitous+functionality%3A+a+general+approach+to+complex+arylated+pyrazoles+via+sequential+regioselective+C-arylation+and+N-alkylation+enabled+by+SEM-group+transposition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja8096114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja8096114%26sid%3Dliteratum%253Aachs%26aulast%3DGoikhman%26aufirst%3DR.%26aulast%3DJacques%26aufirst%3DT.%2BL.%26aulast%3DSames%26aufirst%3DD.%26atitle%3DC%25E2%2580%2593H%2520bonds%2520as%2520ubiquitous%2520functionality%253A%2520a%2520general%2520approach%2520to%2520complex%2520arylated%2520pyrazoles%2520via%2520sequential%2520regioselective%2520C-arylation%2520and%2520N-alkylation%2520enabled%2520by%2520SEM-group%2520transposition%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D3042%26epage%3D3048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">Invitrogen Selectscreen Kinase Profiling service. Five kinases (DAPK1, Ros, TRKA, TRKB, TRKC) were inhibited greater than 50% by 7a at a compound concentration of 200 nM, a concentration approximately 100-fold higher than the Jak2 <i>K</i><sub>i</sub>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="note"><p class="first last">Mouse pharmacokinetic data is available in tabulated form as <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information, Table S1">Supporting Information, Table S1</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Ritchie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickett, S. D.</span><span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span> <span class="citation_source-journal">Drug. Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1016%2Fj.drudis.2010.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=21129497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=164-171&author=T.+J.+Ritchieauthor=S.+J.+MacDonaldauthor=R.+J.+Youngauthor=S.+D.+Pickett&title=The+impact+of+aromatic+ring+count+on+compound+developability%3A+further+insights+by+examining+carbo-+and+hetero-aromatic+and+-aliphatic+ring+types"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.; Young, Robert J.; Pickett, Stephen D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">164-171</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The impact of carboarom., heteroarom., carboaliph. and heteroaliph. ring counts and fused arom. ring count on several developability measures (soly., lipophilicity, protein binding, P 450 inhibition and hERG binding) is the topic for this review article.  Recent results indicate that increasing ring counts have detrimental effects on developability in the order carboaroms. » heteroaroms. > carboaliphatics > heteroaliphatics, with heteroaliphatics exerting a beneficial effect in many cases.  Increasing arom. ring count exerts effects on several developability parameters that are lipophilicity- and size-independent, and fused arom. systems have a beneficial effect relative to their nonfused counterparts.  Increasing arom. ring count has a detrimental effect on human bioavailability parameters, and heteroarom. ring count (but not other ring counts) has increased over time in marketed oral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYPC7hkoyv7Vg90H21EOLACvtfcHk0lgLXSiWvzNHJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D&md5=8e2d0e4e499d2f07d66ca2f385defb2d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacDonald%26aufirst%3DS.%2BJ.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%253A%2520further%2520insights%2520by%2520examining%2520carbo-%2520and%2520hetero-aromatic%2520and%2520-aliphatic%2520ring%2520types%26jtitle%3DDrug.%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D164%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolian, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guionneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huc, I.</span><span> </span><span class="NLM_article-title">Aromatic δ-peptides: design, synthesis and structural studies of helical, quinoline-derived oligoamide foldamers</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">8365</span><span class="NLM_x">–</span> <span class="NLM_lpage">8374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2003&pages=8365-8374&author=H.+Jiangauthor=J.-M.+Legerauthor=C.+Dolianauthor=P.+Guionneauauthor=I.+Huc&title=Aromatic+%CE%B4-peptides%3A+design%2C+synthesis+and+structural+studies+of+helical%2C+quinoline-derived+oligoamide+foldamers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DLeger%26aufirst%3DJ.-M.%26aulast%3DDolian%26aufirst%3DC.%26aulast%3DGuionneau%26aufirst%3DP.%26aulast%3DHuc%26aufirst%3DI.%26atitle%3DAromatic%2520%25CE%25B4-peptides%253A%2520design%252C%2520synthesis%2520and%2520structural%2520studies%2520of%2520helical%252C%2520quinoline-derived%2520oligoamide%2520foldamers%26jtitle%3DTetrahedron%26date%3D2003%26volume%3D59%26spage%3D8365%26epage%3D8374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pierce, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ter Haar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binch, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span> </span><span class="NLM_article-title">CH···O and CH···N hydrogen bonds in ligand design: a novel quinazolin-4-ylthiazol-2-ylamine protein kinase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1278</span><span class="NLM_x">–</span> <span class="NLM_lpage">1281</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0492249" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1278-1281&author=A.+C.+Pierceauthor=E.+ter+Haarauthor=H.+M.+Binchauthor=D.+P.+Kayauthor=S.+R.+Patelauthor=P.+Li&title=CH%C2%B7%C2%B7%C2%B7O+and+CH%C2%B7%C2%B7%C2%B7N+hydrogen+bonds+in+ligand+design%3A+a+novel+quinazolin-4-ylthiazol-2-ylamine+protein+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1021%2Fjm0492249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0492249%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DA.%2BC.%26aulast%3Dter%2BHaar%26aufirst%3DE.%26aulast%3DBinch%26aufirst%3DH.%2BM.%26aulast%3DKay%26aufirst%3DD.%2BP.%26aulast%3DPatel%26aufirst%3DS.%2BR.%26aulast%3DLi%26aufirst%3DP.%26atitle%3DCH%25C2%25B7%25C2%25B7%25C2%25B7O%2520and%2520CH%25C2%25B7%25C2%25B7%25C2%25B7N%2520hydrogen%2520bonds%2520in%2520ligand%2520design%253A%2520a%2520novel%2520quinazolin-4-ylthiazol-2-ylamine%2520protein%2520kinase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1278%26epage%3D1281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yoshikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haginoya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komoriya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, T.</span><span> </span><span class="NLM_article-title">Design, synthesis, and SAR of <i>cis</i>-1,2-diaminocyclohexane derivatives as potent factor Xa inhibitors. Part II: exploration of 6–6 fused rings as alternative S1 moieties</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">8221</span><span class="NLM_x">–</span> <span class="NLM_lpage">8233</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=8221-8233&author=K.+Yoshikawaauthor=S.+Kobayashiauthor=Y.+Nakamotoauthor=N.+Haginoyaauthor=S.+Komoriyaauthor=T.+Yoshinoauthor=T.+Nagataauthor=A.+Mochizukiauthor=K.+Watanabeauthor=M.+Suzukiauthor=H.+Kannoauthor=T.+Ohta&title=Design%2C+synthesis%2C+and+SAR+of+cis-1%2C2-diaminocyclohexane+derivatives+as+potent+factor+Xa+inhibitors.+Part+II%3A+exploration+of+6%E2%80%936+fused+rings+as+alternative+S1+moieties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshikawa%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DNakamoto%26aufirst%3DY.%26aulast%3DHaginoya%26aufirst%3DN.%26aulast%3DKomoriya%26aufirst%3DS.%26aulast%3DYoshino%26aufirst%3DT.%26aulast%3DNagata%26aufirst%3DT.%26aulast%3DMochizuki%26aufirst%3DA.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DKanno%26aufirst%3DH.%26aulast%3DOhta%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520SAR%2520of%2520cis-1%252C2-diaminocyclohexane%2520derivatives%2520as%2520potent%2520factor%2520Xa%2520inhibitors.%2520Part%2520II%253A%2520exploration%2520of%25206%25E2%2580%25936%2520fused%2520rings%2520as%2520alternative%2520S1%2520moieties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D8221%26epage%3D8233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">A medicinal chemist’s guide to molecular interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5061</span><span class="NLM_x">–</span> <span class="NLM_lpage">5084</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100112j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5061-5084&author=C.+Bissantzauthor=B.+Kuhnauthor=M.+Stahl&title=A+medicinal+chemist%E2%80%99s+guide+to+molecular+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28d&amp;dbid=16384&amp;doi=10.1021%2Fjm100112j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100112j%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DA%2520medicinal%2520chemist%25E2%2580%2599s%2520guide%2520to%2520molecular%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5061%26epage%3D5084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Shimizu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasumatsu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasukochi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iimura, S.</span><span> </span><span class="NLM_article-title">Discovery of imidazo[1,2-<i>b</i>]pyridazine derivatives as IKKβ inhibitors. Part 1: Hit-to-lead study and structure–activity relationship</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5113</span><span class="NLM_x">–</span> <span class="NLM_lpage">5118</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5113-5118&author=H.+Shimizuauthor=S.+Tanakaauthor=T.+Tokiauthor=I.+Yasumatsuauthor=T.+Akimotoauthor=K.+Morishitaauthor=T.+Yamasakiauthor=T.+Yasukochiauthor=S.+Iimura&title=Discovery+of+imidazo%5B1%2C2-b%5Dpyridazine+derivatives+as+IKK%CE%B2+inhibitors.+Part+1%3A+Hit-to-lead+study+and+structure%E2%80%93activity+relationship"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DToki%26aufirst%3DT.%26aulast%3DYasumatsu%26aufirst%3DI.%26aulast%3DAkimoto%26aufirst%3DT.%26aulast%3DMorishita%26aufirst%3DK.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DYasukochi%26aufirst%3DT.%26aulast%3DIimura%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520imidazo%255B1%252C2-b%255Dpyridazine%2520derivatives%2520as%2520IKK%25CE%25B2%2520inhibitors.%2520Part%25201%253A%2520Hit-to-lead%2520study%2520and%2520structure%25E2%2580%2593activity%2520relationship%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5113%26epage%3D5118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Dubey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, D.</span><span> </span><span class="NLM_article-title">Weak interactions: a versatile role in aromatic compounds</span> <span class="citation_source-journal">Curr. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2072</span><span class="NLM_x">–</span> <span class="NLM_lpage">2081</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28f&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.2174%2F138527211795703667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28f&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnslantb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=2072-2081&author=R.+Dubeyauthor=D.+Lim&title=Weak+interactions%3A+a+versatile+role+in+aromatic+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28fR"><div class="casContent"><span class="casTitleNuber">28f</span><div class="casTitle"><span class="NLM_cas:atitle">Weak interactions: a versatile role in aromatic compounds</span></div><div class="casAuthors">Dubey, Rashmi; Lim, Dongyeol</div><div class="citationInfo"><span class="NLM_cas:title">Current Organic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2072-2081</span>CODEN:
                <span class="NLM_cas:coden">CORCFE</span>;
        ISSN:<span class="NLM_cas:issn">1385-2728</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Arom. interactions are essential for stabilizing the conformation and crystal packing of mols.  They also play a vital role in drug chem. by mediating drug-receptor interactions.  In the present review, the various fields in which arom. interactions are important and the role of such interactions are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKiKCvMaqc1rVg90H21EOLACvtfcHk0lhEKXc4DlaEXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnslantb0%253D&md5=8f32f80a4784947e8a19751fcb0905c0</span></div><a href="/servlet/linkout?suffix=cit28f&amp;dbid=16384&amp;doi=10.2174%2F138527211795703667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138527211795703667%26sid%3Dliteratum%253Aachs%26aulast%3DDubey%26aufirst%3DR.%26aulast%3DLim%26aufirst%3DD.%26atitle%3DWeak%2520interactions%253A%2520a%2520versatile%2520role%2520in%2520aromatic%2520compounds%26jtitle%3DCurr.%2520Org.%2520Chem.%26date%3D2011%26volume%3D15%26spage%3D2072%26epage%3D2081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">Amino acid differences between Jak2 and other family members are as follows. Jak3 amino acid:Jak2-Gln832:Ser, Met865:Leu, Tyr934:Ser, Ser936:Cys, Lys943:Arg, Gly993:Arg. Tyk2 amino acid:Jak2-Lys857:Glu, Val911:Ile, Leu932:Val, Tyr934:Leu, Lys943:Arg.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ju, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uetrecht, J. P.</span><span> </span><span class="NLM_article-title">Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.2174%2F1389200023337333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=12093356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlCqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=367-377&author=C.+Juauthor=J.+P.+Uetrecht&title=Mechanism+of+idiosyncratic+drug+reactions%3A+reactive+metabolite+formation%2C+protein+binding+and+the+regulation+of+the+immune+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of idiosyncratic drug reactions: reactive metabolites formation, protein binding and the regulation of the immune system</span></div><div class="casAuthors">Ju, C.; Uetrecht, J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">367-377</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug-induced adverse reactions, esp. type B reactions, represent a major clin. problem.  They also impart a significant degree of uncertainty into drug development because they are often not detected until the drug has been released onto the market.  Type B reactions are also termed idiosyncratic drug reactions by many investigators due to their unpredictable nature and our lack of understanding of the mechanisms involved.  It is currently believed that the majority of these reactions are immune-mediated and are caused by immunogenic conjugates formed from the reaction of a reactive metabolite of a drug with cellular proteins.  It has been shown that most drugs assocd. with idiosyncratic reactions form reactive metabolites to some degree.  Covalent binding of reactive metabolites to cellular proteins has also been shown in many cases.  However, studies to reveal the role of reactive metabolites and their protein-adducts in the mechanism of drug-induced idiosyncratic reactions are lacking.  This review will focus on our current understanding and speculative views on how a reactive metabolite of a drug might ultimately lead to immune-mediated toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpowmI5awuRjLVg90H21EOLACvtfcHk0lhEKXc4DlaEXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlCqtrg%253D&md5=c678c3f4bcf9a775bedb690c6986381e</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.2174%2F1389200023337333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200023337333%26sid%3Dliteratum%253Aachs%26aulast%3DJu%26aufirst%3DC.%26aulast%3DUetrecht%26aufirst%3DJ.%2BP.%26atitle%3DMechanism%2520of%2520idiosyncratic%2520drug%2520reactions%253A%2520reactive%2520metabolite%2520formation%252C%2520protein%2520binding%2520and%2520the%2520regulation%2520of%2520the%2520immune%2520system%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2002%26volume%3D3%26spage%3D367%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Evans, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span> </span><span class="NLM_article-title">Drug–protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx034170b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=3-16&author=D.+C.+Evansauthor=A.+P.+Wattauthor=D.+A.+Nicoll-Griffithauthor=T.+A.+Baillie&title=Drug%E2%80%93protein+adducts%3A+an+industry+perspective+on+minimizing+the+potential+for+drug+bioactivation+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1021%2Ftx034170b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx034170b%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BC.%26aulast%3DWatt%26aufirst%3DA.%2BP.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DDrug%25E2%2580%2593protein%2520adducts%253A%2520an%2520industry%2520perspective%2520on%2520minimizing%2520the%2520potential%2520for%2520drug%2520bioactivation%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2004%26volume%3D17%26spage%3D3%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contillo, L. G.</span><span> </span><span class="NLM_article-title">The development of a higher throughput reactive intermediate screening assay incorporating micro-bore liquid chromatography-micro-electrospray ionization-tandem mass spectrometry and glutathione ethyl ester as an in vitro conjugating agent</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1016%2Fj.jpba.2004.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=15351054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlems7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=105-116&author=J.+R.+Sogliaauthor=S.+P.+Harrimanauthor=S.+Zhaoauthor=J.+Barberiaauthor=M.+J.+Coleauthor=J.+G.+Boydauthor=L.+G.+Contillo&title=The+development+of+a+higher+throughput+reactive+intermediate+screening+assay+incorporating+micro-bore+liquid+chromatography-micro-electrospray+ionization-tandem+mass+spectrometry+and+glutathione+ethyl+ester+as+an+in+vitro+conjugating+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30cR"><div class="casContent"><span class="casTitleNuber">30c</span><div class="casTitle"><span class="NLM_cas:atitle">The development of a higher throughput reactive intermediate screening assay incorporating micro-bore liquid chromatography-micro-electrospray ionization-tandem mass spectrometry and glutathione ethyl ester as an in vitro conjugating agent</span></div><div class="casAuthors">Soglia, John R.; Harriman, Shawn P.; Zhao, Sabrina; Barberia, John; Cole, Mark J.; Boyd, James G.; Contillo, Leonard G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-116</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An in vitro reactive intermediate screening assay, incorporating the use of the close analog of glutathione, glutathione Et ester (GSH-EE) as a conjugating agent, was developed to identify compds. that form reactive intermediates in an in vitro metabolite generating system.  The biol. assay consisted of substrate [s] = 10 μM, human liver microsomes, an NADPH generating system, and glutathione Et ester.  Conjugates were extd. from the biol. matrix using a combination of protein pptn. and a semi-automated 96-well plate solid phase extn. (SPE) procedure.  A micro-bore liq. chromatog.-micro-electrospray ionization-tandem mass spectrometry (μLC-μESI-MS/MS) method detected glutathione Et ester conjugates using selected reaction monitoring (SRM) to simultaneously monitor for multiple MH+ to [MH - 129]+ transitions, where the 129 mass unit (Da) represents the neutral loss of the pyroglutamate moiety from GSH-EE.  The multiple MH+ to [MH - 129]+ transitions (SRM mass table) were generated for potential reactive intermediates of each compd.  Glutathione (GSH) and GSH-EE conjugate stds. were used to evaluate MS detection sensitivity.  Based on direct comparison of std. curve data, an approx. 10-fold increase in sensitivity was obsd. for conjugates contg. GSH-EE moiety vs. GSH.  In vitro expts. were conducted using literature substrates acetaminophen, rosiglitazone, clozapine, diclofenac and either GSH-EE or GSH as a reactive intermediate conjugating agent.  An increase in detection sensitivity was obsd. for each GSH-EE conjugate and in the case of acetaminophen-GSH-EE the peak area increase was approx. 80-fold.  Twelve drug compds., each having known biotransformation mechanisms, were used to further test the detection capabilities of the assay and establish a concordance to literature data.  When GSH was used in the assay, conjugates were detected for 4 out of the 12 test compds. (33%).  When GSH-EE was used in the assay, conjugates were detected for 10 out of the 12 test compds. (83%).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3NwMX6-E_3LVg90H21EOLACvtfcHk0lhEKXc4DlaEXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlems7w%253D&md5=23e4c3df8558019ad3770d748a1f9815</span></div><a href="/servlet/linkout?suffix=cit30c&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2004.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2004.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DBarberia%26aufirst%3DJ.%26aulast%3DCole%26aufirst%3DM.%2BJ.%26aulast%3DBoyd%26aufirst%3DJ.%2BG.%26aulast%3DContillo%26aufirst%3DL.%2BG.%26atitle%3DThe%2520development%2520of%2520a%2520higher%2520throughput%2520reactive%2520intermediate%2520screening%2520assay%2520incorporating%2520micro-bore%2520liquid%2520chromatography-micro-electrospray%2520ionization-tandem%2520mass%2520spectrometry%2520and%2520glutathione%2520ethyl%2520ester%2520as%2520an%2520in%2520vitro%2520conjugating%2520agent%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2004%26volume%3D36%26spage%3D105%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span> </span><span class="NLM_article-title">A comprehensive listing of bioactivation pathways of organic functional groups</span> <span class="citation_source-journal">Curr. Drug. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30d&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.2174%2F1389200054021799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30d&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=15975040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30d&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=161-225&author=A.+S.+Kalgutkarauthor=I.+Gardnerauthor=R.+S.+Obachauthor=C.+L.+Shafferauthor=E.+Callegariauthor=K.+R.+Henneauthor=A.+E.+Mutlibauthor=D.+K.+Dalvieauthor=J.+S.+Leeauthor=Y.+Nakaiauthor=J.+P.+O%E2%80%99Donnellauthor=J.+Boerauthor=S.+P.+Harriman&title=A+comprehensive+listing+of+bioactivation+pathways+of+organic+functional+groups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30dR"><div class="casContent"><span class="casTitleNuber">30d</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive listing of bioactivation pathways of organic functional groups</span></div><div class="casAuthors">Kalgutkar, Amit S.; Gardner, Iain; Obach, R. Scott; Shaffer, Christopher L.; Callegari, Ernesto; Henne, Kirk R.; Mutlib, Abdul E.; Dalvie, Deepak K.; Lee, Jae S.; Nakai, Yasuhiro; O'Donnell, John P.; Boer, Jason; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-225</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of idiosyncratic adverse drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use and even in its withdrawal.  Metabolic activation of relatively inert functional groups to reactive electrophilic intermediates is considered to be an obligatory event in the etiol. of many drug-induced adverse reactions.  Therefore, a thorough examn. of the biochem. reactivity of functional groups/structural motifs in all new drug candidates is essential from a safety standpoint.  A major theme attempted in this review is the comprehensive cataloging of all of the known bioactivation pathways of functional groups or structural motifs commonly utilized in drug design efforts.  Potential strategies in the detection of reactive intermediates in biochem. systems are also discussed.  The intention of this review is not to "black list" functional groups or to immediately discard compds. based on their potential to form reactive metabolites, but rather to serve as a resource describing the structural diversity of these functionalities as well as exptl. approaches that could be taken to evaluate whether a "structural alert" in a new drug candidate undergoes bioactivation to reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVj7cmxfwXrVg90H21EOLACvtfcHk0lhH796ySU_X3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D&md5=b16dfc2de97c40a11218ecc3043bed66</span></div><a href="/servlet/linkout?suffix=cit30d&amp;dbid=16384&amp;doi=10.2174%2F1389200054021799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200054021799%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DA%2520comprehensive%2520listing%2520of%2520bioactivation%2520pathways%2520of%2520organic%2520functional%2520groups%26jtitle%3DCurr.%2520Drug.%2520Metab.%26date%3D2005%26volume%3D6%26spage%3D161%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Blagg, J.</span><span> </span><span class="NLM_article-title">Structure–activity relationships for in vitro and in vivo toxicity</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=353-368&author=J.+Blagg&title=Structure%E2%80%93activity+relationships+for+in+vitro+and+in+vivo+toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520for%2520in%2520vitro%2520and%2520in%2520vivo%2520toxicity%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2006%26volume%3D41%26spage%3D353%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Milletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sforna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruciani, G.</span><span> </span><span class="NLM_article-title">New and original p<i>K</i><sub>a</sub> prediction method using grid molecular interaction fields</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2172</span><span class="NLM_x">–</span> <span class="NLM_lpage">2181</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci700018y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=2172-2181&author=F.+Millettiauthor=L.+Storchiauthor=G.+Sfornaauthor=G.+Cruciani&title=New+and+original+pKa+prediction+method+using+grid+molecular+interaction+fields"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">New and Original pKa Prediction Method Using Grid Molecular Interaction Fields</span></div><div class="casAuthors">Milletti, Francesca; Storchi, Loriano; Sforna, Gianluca; Cruciani, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2172-2181</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One of the most important physicochem. properties of a mol. is pKa.  It is known that two parameters imperative in ADME profiling, soly., and lipophilicity are governed by pKa, and receptor binding can be influenced by pKa.  Because most drugs are ionized in physiol. conditions, pKa is particularly relevant to medicinal chem.  Despite the numerous advances in high-throughput measurements, in silico detn. is still the fastest and cheapest way of obtaining pKa.  This paper presents a new original computational method for pKa prediction of org. compds.  Descriptors were generated using the program GRID, and these descriptors are based on mol. interaction fields precomputed on a set of mol. fragments.  The new method was developed, trained, and cross-validated by using a large and diverse data set of 24 617 pKa values.  This paper presents the results for a class of 421 acidic nitrogen compds. (RMSE = 0.41, r2 = 0.97, q2 = 0.87) and for a class of 947 six-membered N-heterocyclic bases (RMSE = 0.60, r2 = 0.93, q2 = 0.85).  For external validation 28 novel compds. were selected that covered nine different ionizable groups, and 39 pKa values could be exptl. detd. by spectral gradient anal. (SGA).  Comparison of exptl. pKa with calcd. pKa demonstrated that the predictive ability of the method is good (external set, r2 = 0.85, RMSE = 0.90).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzEk0uiS1E6rVg90H21EOLACvtfcHk0lhH796ySU_X3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrF&md5=f2b1dec853ccb0ef1a40540d234232fb</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1021%2Fci700018y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700018y%26sid%3Dliteratum%253Aachs%26aulast%3DMilletti%26aufirst%3DF.%26aulast%3DStorchi%26aufirst%3DL.%26aulast%3DSforna%26aufirst%3DG.%26aulast%3DCruciani%26aufirst%3DG.%26atitle%3DNew%2520and%2520original%2520pKa%2520prediction%2520method%2520using%2520grid%2520molecular%2520interaction%2520fields%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D2172%26epage%3D2181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Milletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goracci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendels, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruciani, G.</span><span> </span><span class="NLM_article-title">Extending p<i>K</i><sub>a</sub> prediction accuracy: high-throughput p<i>K</i><sub>a</sub> measurements to understand p<i>K</i><sub>a</sub> modulation of new chemical series</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4270</span><span class="NLM_x">–</span> <span class="NLM_lpage">4279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1016%2Fj.ejmech.2010.06.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=20633962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvFKhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=4270-4279&author=F.+Millettiauthor=L.+Storchiauthor=L.+Goracciauthor=S.+Bendelsauthor=B.+Wagnerauthor=M.+Kansyauthor=G.+Cruciani&title=Extending+pKa+prediction+accuracy%3A+high-throughput+pKa+measurements+to+understand+pKa+modulation+of+new+chemical+series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Extending pKa prediction accuracy: High-throughput pKa measurements to understand pKa modulation of new chemical series</span></div><div class="casAuthors">Milletti, Francesca; Storchi, Loriano; Goracci, Laura; Bendels, Stefanie; Wagner, Bjoern; Kansy, Manfred; Cruciani, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4270-4279</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">We have recently developed a tool, MoKα, to predict the pKa of org. compds. using a large dataset of over 26,500 literature pKa values as a training set.  However, predicting accurately pKa (<0.5 pH units) remains challenging for novel series, and this can be a drawback in the optimization of activity and ADME properties of lead compds.  To address this issue it is important to expand our knowledge of pKa determinants, therefore we have conducted high-throughput pKa measurements by using Spectral Gradient Anal. (SGA) on novel series of compds. selected from vendor databases.  Here we report our findings on the effect of specific chem. groups and steric constraints on the pKa of common functionalities in medicinal chem., such as amines, sulfonamides, and amides.  Furthermore, we report the pKa of ionizable groups that were not well represented in the database of literature pKa of MoKα, such as hydrazide derivs.  These findings helped us to enhance MoKα, which is here benchmarked on a set of exptl. pKa values from the Roche inhouse library (N = 5581; RMSE = 1.09; R2 = 0.82).  The accuracy of the predictions was greatly improved (RMSE = 0.49, R2 = 0.96) after training the software by using the automated tool Kibitzer with 6226 pK a values taken from a different set of Roche compds. appropriately selected, and this demonstrates the value of using high-throughput pKa measurements to expand the training set of pKa values used by the software MoKα.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxQ9UJOAhB-rVg90H21EOLACvtfcHk0lhH796ySU_X3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvFKhtLo%253D&md5=e4c579032df7fa37ec3551c69a09257a</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DMilletti%26aufirst%3DF.%26aulast%3DStorchi%26aufirst%3DL.%26aulast%3DGoracci%26aufirst%3DL.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DCruciani%26aufirst%3DG.%26atitle%3DExtending%2520pKa%2520prediction%2520accuracy%253A%2520high-throughput%2520pKa%2520measurements%2520to%2520understand%2520pKa%2520modulation%2520of%2520new%2520chemical%2520series%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D4270%26epage%3D4279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">van De Waterbeemd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. K.</span><span> </span><span class="NLM_article-title">Property-based design: optimization of drug absorption and pharmacokinetics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1313</span><span class="NLM_x">–</span> <span class="NLM_lpage">1333</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000407e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD3MXit1Whu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1313-1333&author=H.+van+De+Waterbeemdauthor=D.+A.+Smithauthor=K.+Beaumontauthor=D.+K.+Walker&title=Property-based+design%3A+optimization+of+drug+absorption+and+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Property-based design: optimization of drug absorption and pharmacokinetics</span></div><div class="casAuthors">van de Waterbeemd, Han; Smith, Dennis A.; Beaumont, Kevin; Walker, Don K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1313-1333</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 223 refs.  The authors discuss some aspects of the properties of biol. barriers.  In different sections the estn. of drug absorption via important barriers including gastrointestinal tract, blood-brain barrier, and skin are reviewed.  Various approaches for the measurement and computation of physicochem. and mol. properties currently used in the optimization of absorption as well as the use of physicochem. properties in the design of optimal pharmacokinetic profiles are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaQwsmoX0-mbVg90H21EOLACvtfcHk0lhKvuOTy6P__A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXit1Whu7c%253D&md5=3183baedca70020f4ce27f306ba0997e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm000407e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000407e%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDe%2BWaterbeemd%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DWalker%26aufirst%3DD.%2BK.%26atitle%3DProperty-based%2520design%253A%2520optimization%2520of%2520drug%2520absorption%2520and%2520pharmacokinetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D1313%26epage%3D1333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Laurence, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brameld, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Questel, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, E.</span><span> </span><span class="NLM_article-title">The pK(BHX) database: toward a better understanding of hydrogen-bond basicity for medicinal chemists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4073</span><span class="NLM_x">–</span> <span class="NLM_lpage">4086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801331y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFKns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4073-4086&author=C.+Laurenceauthor=K.+A.+Brameldauthor=J.+Gratonauthor=J.+Y.+Le+Questelauthor=E.+Renault&title=The+pK%28BHX%29+database%3A+toward+a+better+understanding+of+hydrogen-bond+basicity+for+medicinal+chemists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The pKBHX Database: Toward a Better Understanding of Hydrogen-Bond Basicity for Medicinal Chemists</span></div><div class="casAuthors">Laurence, Christian; Brameld, Ken A.; Graton, Jerome; Le Questel, Jean-Yves; Renault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4073-4086</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The pKBHX database is presented, which corresponds to three main fields of data: hydrogen bond donor identification, thermodn. data and spectroscopic data.  The pKBHX scale of hydrogen donor basicity differs considerable from the pKBH+ scale of proton transfer basicity.  The hydrogen bond basicities of functional groups relevant to medicinal chem. and drug design is reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql9OhmMu2VILVg90H21EOLACvtfcHk0lhKvuOTy6P__A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFKns7w%253D&md5=9ce4bea3e810752baba6ea5784b55ea0</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm801331y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801331y%26sid%3Dliteratum%253Aachs%26aulast%3DLaurence%26aufirst%3DC.%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DGraton%26aufirst%3DJ.%26aulast%3DLe%2BQuestel%26aufirst%3DJ.%2BY.%26aulast%3DRenault%26aufirst%3DE.%26atitle%3DThe%2520pK%2528BHX%2529%2520database%253A%2520toward%2520a%2520better%2520understanding%2520of%2520hydrogen-bond%2520basicity%2520for%2520medicinal%2520chemists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4073%26epage%3D4086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Testa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">Inhibitors of Cytochrome P-450s and their mechanism of action</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.3109%2F03602538109011082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=7028434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADyaL3MXkslGru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1981&pages=1-117&author=B.+Testaauthor=P.+Jenner&title=Inhibitors+of+Cytochrome+P-450s+and+their+mechanism+of+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of cytochrome P-450s and their mechanism of action</span></div><div class="casAuthors">Testa, Bernard; Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-117</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    </div><div class="casAbstract">A review with 236 refs., of inhibitors of cytochrome P 450-dependent monooxygenase systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeDqU6i1SMN7Vg90H21EOLACvtfcHk0lhKvuOTy6P__A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXkslGru7g%253D&md5=8b08f336435114f8480cf96cadd0805a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3109%2F03602538109011082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602538109011082%26sid%3Dliteratum%253Aachs%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520Cytochrome%2520P-450s%2520and%2520their%2520mechanism%2520of%2520action%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D1981%26volume%3D12%26spage%3D1%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Iwaoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomoda, S.</span><span> </span><span class="NLM_article-title">Statistical and theoretical investigations on the directionality of nonbonded S···O interactions. Implications for molecular design and protein engineering</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">10613</span><span class="NLM_x">–</span> <span class="NLM_lpage">10620</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja026472q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVCnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=10613-10620&author=M.+Iwaokaauthor=S.+Takemotoauthor=S.+Tomoda&title=Statistical+and+theoretical+investigations+on+the+directionality+of+nonbonded+S%C2%B7%C2%B7%C2%B7O+interactions.+Implications+for+molecular+design+and+protein+engineering"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36aR"><div class="casContent"><span class="casTitleNuber">36a</span><div class="casTitle"><span class="NLM_cas:atitle">Statistical and Theoretical Investigations on the Directionality of Nonbonded S···O Interactions. Implications for Molecular Design and Protein Engineering</span></div><div class="casAuthors">Iwaoka, Michio; Takemoto, Shinya; Tomoda, Shuji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">10613-10620</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Weak nonbonded interactions between a divalent sulfur (S) atom and a main-chain carbonyl oxygen (O) atom have recently been characterized in proteins.  However, they have shown distinctly different directional propensities around the O atom from the S···O interactions in small org. compds., although the linearity of the C-S···O or S-S···O at. alignment was commonly obsd.  To elucidate the obsd. discrepancy, a comprehensive search for nonbonded S···O interactions in the Cambridge Structural Database (CSD) and MP2 calcns. on the model complexes between di-Me disulfide (CH3SSCH3) and various carbonyl compds. were performed.  It was found that the O atom showed a strong intrinsic tendency to approach the S atom from the backside of the S-C or S-S bond (in the σS* direction).  On the other hand, the S atom had both possibilities of approach to the carbonyl O atom within the same plane (in the nO direction) and out of the plane (in the πO direction).  In the case of S···O(amide) interactions, the πO direction was significantly preferred as obsd. in proteins.  Thus, structural features of S···O interactions depend on the type of carbonyl groups involved.  The results suggested that S···O interactions may control protein structures to some extent and that the unique directional properties of S···O interactions could be applied to mol. design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSkXUNoB9lurVg90H21EOLACvtfcHk0lhKvuOTy6P__A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVCnt7k%253D&md5=d018c0b07864ff06c04330100708cb13</span></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1021%2Fja026472q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja026472q%26sid%3Dliteratum%253Aachs%26aulast%3DIwaoka%26aufirst%3DM.%26aulast%3DTakemoto%26aufirst%3DS.%26aulast%3DTomoda%26aufirst%3DS.%26atitle%3DStatistical%2520and%2520theoretical%2520investigations%2520on%2520the%2520directionality%2520of%2520nonbonded%2520S%25C2%25B7%25C2%25B7%25C2%25B7O%2520interactions.%2520Implications%2520for%2520molecular%2520design%2520and%2520protein%2520engineering%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D10613%26epage%3D10620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Haginoya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komoriya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirokawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furugori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagahara, T.</span><span> </span><span class="NLM_article-title">Synthesis and conformational analysis of a non-amidine factor Xa inhibitor that incorporates 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-<i>c</i>]pyridine as S4 binding element</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5167</span><span class="NLM_x">–</span> <span class="NLM_lpage">5182</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049884d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5167-5182&author=N.+Haginoyaauthor=S.+Kobayashiauthor=S.+Komoriyaauthor=T.+Yoshinoauthor=M.+Suzukiauthor=T.+Shimadaauthor=K.+Watanabeauthor=Y.+Hirokawaauthor=T.+Furugoriauthor=T.+Nagahara&title=Synthesis+and+conformational+analysis+of+a+non-amidine+factor+Xa+inhibitor+that+incorporates+5-methyl-4%2C5%2C6%2C7-tetrahydrothiazolo%5B5%2C4-c%5Dpyridine+as+S4+binding+element"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1021%2Fjm049884d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049884d%26sid%3Dliteratum%253Aachs%26aulast%3DHaginoya%26aufirst%3DN.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DKomoriya%26aufirst%3DS.%26aulast%3DYoshino%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DShimada%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DHirokawa%26aufirst%3DY.%26aulast%3DFurugori%26aufirst%3DT.%26aulast%3DNagahara%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520conformational%2520analysis%2520of%2520a%2520non-amidine%2520factor%2520Xa%2520inhibitor%2520that%2520incorporates%25205-methyl-4%252C5%252C6%252C7-tetrahydrothiazolo%255B5%252C4-c%255Dpyridine%2520as%2520S4%2520binding%2520element%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5167%26epage%3D5182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Nettekoven, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neidhart, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattei, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pflieger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span> </span><span class="NLM_article-title">Isomeric thiazole derivatives as ligands for the neuropeptide Y5 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3446</span><span class="NLM_x">–</span> <span class="NLM_lpage">3449</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3446-3449&author=M.+Nettekovenauthor=W.+Gubaauthor=W.+Neidhartauthor=P.+Matteiauthor=P.+Pfliegerauthor=O.+Rocheauthor=S.+Taylor&title=Isomeric+thiazole+derivatives+as+ligands+for+the+neuropeptide+Y5+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNettekoven%26aufirst%3DM.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DNeidhart%26aufirst%3DW.%26aulast%3DMattei%26aufirst%3DP.%26aulast%3DPflieger%26aufirst%3DP.%26aulast%3DRoche%26aufirst%3DO.%26aulast%3DTaylor%26aufirst%3DS.%26atitle%3DIsomeric%2520thiazole%2520derivatives%2520as%2520ligands%2520for%2520the%2520neuropeptide%2520Y5%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3446%26epage%3D3449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sugiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sogabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeura, Y.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity relationship studies of benzothieno[3,2-<i>b</i>]furan derivatives as a novel class of IKKbeta inhibitors</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=613-624&author=H.+Sugiyamaauthor=M.+Yoshidaauthor=K.+Moriauthor=T.+Kawamotoauthor=S.+Sogabeauthor=T.+Takagiauthor=H.+Okiauthor=T.+Tanakaauthor=H.+Kimuraauthor=Y.+Ikeura&title=Synthesis+and+structure%E2%80%93activity+relationship+studies+of+benzothieno%5B3%2C2-b%5Dfuran+derivatives+as+a+novel+class+of+IKKbeta+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSugiyama%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DTakagi%26aufirst%3DT.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DIkeura%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520studies%2520of%2520benzothieno%255B3%252C2-b%255Dfuran%2520derivatives%2520as%2520a%2520novel%2520class%2520of%2520IKKbeta%2520inhibitors%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2007%26volume%3D55%26spage%3D613%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from flatland: increasing saturation as an approach to improving clinical success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+increasing+saturation+as+an+approach+to+improving+clinical+success"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0ljORqn6Wp1H9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="note"><p class="first last">Good agreement was observed between the pSTAT5 SET2 MSD format used for compounds in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and the pSTAT5 TF1+EPO MSD format used for compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Compound <b>7j</b> was assessed in both formats, with IC<sub>50</sub> = 3.9 nM in the SET2 format as compared with IC<sub>50</sub> = 7.4 nM in the TF1+EPO format. See the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for details on both cell assays.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="note"><p class="first last">TDI was observed sporadically in compounds in this chemical series with no clear SAR.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="note"><p class="first last">Invitrogen Selectscreen Kinase Profiling service. IC<sub>50</sub>s: Fyn 4.97 μM, Ros 15.2 μM, TrkA 3.97 μM, TrkB 5.38 μM, TrkC 1.3 μM.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bir Kohli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubhayakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span> </span><span class="NLM_article-title">Development and validation of a novel acute myeloid leukemia xenograft model that is dependent on the JAK2 V617F mutation for growth in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">A20</span><div class="note"><p class="first last">GNE-372 refers to compound <b>7j</b>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=A20&author=L.+Leeauthor=M.+Berryauthor=A.+Zhouauthor=T.+Rawsonauthor=E.+Hananauthor=J.+Liauthor=P.+Bir+Kohliauthor=K.+Barrettauthor=C.+Changauthor=J.+Chenauthor=S.+Ubhayakarauthor=M.+Siuauthor=J.+Kennyauthor=A.+Johnsonauthor=A.+Van+Abbemaauthor=W.+Blairauthor=N.+Ghilardiauthor=D.+Sampath&title=Development+and+validation+of+a+novel+acute+myeloid+leukemia+xenograft+model+that+is+dependent+on+the+JAK2+V617F+mutation+for+growth+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DL.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DA.%26aulast%3DRawson%26aufirst%3DT.%26aulast%3DHanan%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBir%2BKohli%26aufirst%3DP.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DKenny%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DVan%2BAbbema%26aufirst%3DA.%26aulast%3DBlair%26aufirst%3DW.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DSampath%26aufirst%3DD.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520novel%2520acute%2520myeloid%2520leukemia%2520xenograft%2520model%2520that%2520is%2520dependent%2520on%2520the%2520JAK2%2520V617F%2520mutation%2520for%2520growth%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3DA20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Morrison, J. F.</span><span> </span><span class="NLM_article-title">Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1016%2F0005-2744%2869%2990420-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=4980133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADyaF1MXkvVOqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=1969&pages=269-286&author=J.+F.+Morrison&title=Kinetics+of+the+reversible+inhibition+of+enzyme-catalysed+reactions+by+tight-binding+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42aR"><div class="casContent"><span class="casTitleNuber">42a</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of the reversible inhibition of enzyme-catalyzed reactions by tight-binding inhibitors</span></div><div class="casAuthors">Morrison, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Enzymology</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-86</span>CODEN:
                <span class="NLM_cas:coden">BBEZAD</span>;
        ISSN:<span class="NLM_cas:issn">0924-1086</span>.
    </div><div class="casAbstract">A theoretical kinetic study has been undertaken to det. the kinetic characteristics of enzymic reactions that are reversibly inhibited by a substrate analog. at concns. comparable to that of the enzyme.  A general rate equation, that allows for the combination of such a tight-binding inhibitor with one or more enzyme forms of any reaction mechanism, has been derived and shown to be quadratic with sq. and linear terms in υ which represents the true initial steady-state velocity.  From plots of υ against total enzyme concn. at fixed total inhibitor concn., the concn. of enzyme catalytic sites can be detd. irrespective of the nature of the inhibition and the reaction mechanism.  However, plots of υ (or I/υ) against total inhibitor concn. can be used for this purpose only if the dissocn. const. assocd. with the inhibitor is virtually zero.  Particular initial rate equations have been obtained for the cases in which the tight-binding inhibitor gives rise to competitive, noncompetitive, and uncompetitive inhibition with respect to one of the substrates of a bireactant mechanism.  From these equations it has been deduced that, in the presence of inhibitor, plots of I/υ against the reciprocals of the substrate concns. yield families of concave-down, nonrectangular hyperbolas.  The difficulties assocd. with the detn. of inhibition consts. for tight-binding inhibitors are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj4s_N2iV3CLVg90H21EOLACvtfcHk0lhcnXXwplj7cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXkvVOqsbo%253D&md5=74d467477385488dfbb053358534ada6</span></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=10.1016%2F0005-2744%2869%2990420-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2744%252869%252990420-3%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26atitle%3DKinetics%2520of%2520the%2520reversible%2520inhibition%2520of%2520enzyme-catalysed%2520reactions%2520by%2520tight-binding%2520inhibitors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1969%26volume%3D185%26spage%3D269%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit42b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Williams, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, J. F.</span><span> </span><span class="NLM_article-title">The kinetics of reversible tight-binding inhibition</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1016%2F0076-6879%2879%2963019-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=502865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADyaL3cXovF2ntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1979&pages=437-467&author=J.+W.+Williamsauthor=J.+F.+Morrison&title=The+kinetics+of+reversible+tight-binding+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42bR"><div class="casContent"><span class="casTitleNuber">42b</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetics of reversible tight-binding inhibition</span></div><div class="casAuthors">Williams, Jeffrey W.; Morrison, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">Enzyme Kinet. Mech., Part A</span>),
    <span class="NLM_cas:pages">437-67</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    </div><div class="casAbstract">In addn. to a general discussion of the kinetics of reversible tight-binding inhibitors, which exert their effect at a concn. comparable to that of the enzyme, and for which steady-state theory is used, exptl. results are given of the tight-binding inhibition of creatine kinase by Eu3+ (actually Eu-ADP) under steady-state conditions.  The inhibition of creatine kinase by fixed concns. of Eu3+ in the presence of varying concns. of Mg-ADP indicated that the inhibition is competitive, suggesting that Eu-ADP acts as a structural analog of Mg-ADP.  The inhibition was noncompetitive with respect to creatine phosphate.  The dissocn. consts. for binding of Eu-ADP to the free enzyme and the enzyme-phosphocreatine complex were 1.5 and 2.2 nM, resp., as detd. from Ki values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2CwV3voXt27Vg90H21EOLACvtfcHk0lhcnXXwplj7cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXovF2ntw%253D%253D&md5=a770f91b51661c9502d0aca44a24e1c7</span></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1016%2F0076-6879%2879%2963019-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0076-6879%252879%252963019-7%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DJ.%2BW.%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520kinetics%2520of%2520reversible%2520tight-binding%2520inhibition%26jtitle%3DMethods%2520Enzymol.%26date%3D1979%26volume%3D63%26spage%3D437%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Halladay, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinhababu, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh-Bakht, S. C.</span><span> </span><span class="NLM_article-title">Metabolic stability screen for drug discovery using cassette analysis and column switching</span> <span class="citation_source-journal">Drug. Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.2174%2F187231207779814364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=19356021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtleru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2007&pages=67-72&author=J.+S.+Halladayauthor=S.+Wongauthor=S.+M.+Jafferauthor=A.+K.+Sinhababuauthor=S.+C.+Khojasteh-Bakht&title=Metabolic+stability+screen+for+drug+discovery+using+cassette+analysis+and+column+switching"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic stability screen for drug discovery using cassette analysis and column switching</span></div><div class="casAuthors">Halladay, Jason S.; Wong, Susan; Jaffer, Sharmin M.; Sinhababu, Achintya K.; Khojasteh-Bakht, S. Cyrus</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-72</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">In vitro metabolic stability assays are used to screen compds. for stability in the presence of various drug metabolizing enzymes, usually cytochrome P 450 in liver prepns. (e.g., liver microsomes).  High-throughput metabolic stability assays using pooling methods have been developed to keep pace with screening requirements at the lead ADME optimization stage.  In our lab., we have improved the metabolic stability assay using the cassette anal. method, column switching, and incorporated time saving techniques in method development to yield a robust method which reduces data turnaround time, increases compd. throughput, and maximizes mass spectrometer usage.  This method can det. metabolic stability using microsomes or hepatocytes from any species.  We describe our findings following incubation of 40 different compds. with human liver microsomes and anal. by the cassette and discrete anal. methods.  Similar metabolic stability results were obtained using the cassette anal. and discrete anal. method.  An overall 70% time savings was achieved by pooling four new compds. into one sample for method development/MS optimization, cassetting four samples into one sample to minimize the no. of injections on LC/MS/MS anal., and using a column switching system to analyze the samples, which results in a two-fold decrease in the LC/MS/MS anal. time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKzVSm6sBe1bVg90H21EOLACvtfcHk0lhcnXXwplj7cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtleru74%253D&md5=e00c66b3ca6a1eaee107c4eb81e07bf5</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.2174%2F187231207779814364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231207779814364%26sid%3Dliteratum%253Aachs%26aulast%3DHalladay%26aufirst%3DJ.%2BS.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DJaffer%26aufirst%3DS.%2BM.%26aulast%3DSinhababu%26aufirst%3DA.%2BK.%26aulast%3DKhojasteh-Bakht%26aufirst%3DS.%2BC.%26atitle%3DMetabolic%2520stability%2520screen%2520for%2520drug%2520discovery%2520using%2520cassette%2520analysis%2520and%2520column%2520switching%26jtitle%3DDrug.%2520Metab.%2520Lett.%26date%3D2007%26volume%3D1%26spage%3D67%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Irvine, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolan, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selick, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grove, J. R.</span><span> </span><span class="NLM_article-title">MDCK (Madin–Darby canine kidney) cells: A tool for membrane permeability screening</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=28-33&author=J.+D.+Irvineauthor=L.+Takahashiauthor=K.+Lockhartauthor=J.+Cheongauthor=J.+W.+Tolanauthor=H.+E.+Selickauthor=J.+R.+Grove&title=MDCK+%28Madin%E2%80%93Darby+canine+kidney%29+cells%3A+A+tool+for+membrane+permeability+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIrvine%26aufirst%3DJ.%2BD.%26aulast%3DTakahashi%26aufirst%3DL.%26aulast%3DLockhart%26aufirst%3DK.%26aulast%3DCheong%26aufirst%3DJ.%26aulast%3DTolan%26aufirst%3DJ.%2BW.%26aulast%3DSelick%26aufirst%3DH.%2BE.%26aulast%3DGrove%26aufirst%3DJ.%2BR.%26atitle%3DMDCK%2520%2528Madin%25E2%2580%2593Darby%2520canine%2520kidney%2529%2520cells%253A%2520A%2520tool%2520for%2520membrane%2520permeability%2520screening%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D28%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit44b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Plise, E.; Sindelar, E.; Duck, B.; Cheong, J.; Sodhi, J.; Salphati, L.</span><span> </span><span class="NLM_article-title">Fully Automated 24-Well Madlin–Darby Canine Kidney (MDCK) Permeability Assay Utilizing the Hamilton Microlab Star Liquid Handling Platform</span>.  <span class="citation_source-journal">AAPS Annu/ Meet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span>. AAPS Abstract: <a href="http://www.aapsj.org/abstracts/AM_2009/AAPS2009-001769.PDF" class="extLink">http://www.aapsj.org/abstracts/AM_2009/AAPS2009-001769.PDF</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=E.+Plise&author=E.+Sindelar&author=B.+Duck&author=J.+Cheong&author=J.+Sodhi&author=L.+Salphati&title=Fully+Automated+24-Well+Madlin%E2%80%93Darby+Canine+Kidney+%28MDCK%29+Permeability+Assay+Utilizing+the+Hamilton+Microlab+Star+Liquid+Handling+Platform"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlise%26aufirst%3DE.%26atitle%3DFully%2520Automated%252024-Well%2520Madlin%25E2%2580%2593Darby%2520Canine%2520Kidney%2520%2528MDCK%2529%2520Permeability%2520Assay%2520Utilizing%2520the%2520Hamilton%2520Microlab%2520Star%2520Liquid%2520Handling%2520Platform%26jtitle%3DAAPS%2520Annu%252F%2520Meet.%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyke, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohli, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narukulla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubhayakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waszkowycz, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, M.</span><span> </span><span class="NLM_article-title">Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5901</span><span class="NLM_x">–</span> <span class="NLM_lpage">5921</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300438j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVOktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5901-5921&author=J.+J.+Kulagowskiauthor=W.+Blairauthor=R.+J.+Bullauthor=C.+Changauthor=G.+Deshmukhauthor=H.+J.+Dykeauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=T.+K.+Harrisonauthor=P.+R.+Hewittauthor=M.+Liimattaauthor=C.+A.+Hurleyauthor=A.+Johnsonauthor=T.+Johnsonauthor=J.+Kennyauthor=P.+B.+Kohliauthor=R.+J.+Maxeyauthor=R.+Mendoncaauthor=K.+Mortaraauthor=J.+Murrayauthor=R.+Narukullaauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=M.+Ultschauthor=A.+van+Abbemaauthor=S.+I.+Wardauthor=B+Waszkowyczauthor=M.+Zak&title=Identification+of+imidazo-pyrrolopyridines+as+novel+and+potent+JAK1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45aR"><div class="casContent"><span class="casTitleNuber">45a</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors</span></div><div class="casAuthors">Kulagowski, Janusz J.; Blair, Wade; Bull, Richard J.; Chang, Christine; Deshmukh, Gauri; Dyke, Hazel J.; Eigenbrot, Charles; Ghilardi, Nico; Gibbons, Paul; Harrison, Trevor K.; Hewitt, Peter R.; Liimatta, Marya; Hurley, Christopher A.; Johnson, Adam; Johnson, Tony; Kenny, Jane R.; Bir Kohli, Pawan; Maxey, Robert J.; Mendonca, Rohan; Mortara, Kyle; Murray, Jeremy; Narukulla, Raman; Shia, Steven; Steffek, Micah; Ubhayakar, Savita; Ultsch, Mark; van Abbema, Anne; Ward, Stuart I.; Waszkowycz, Bohdan; Zak, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5901-5921</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A therapeutic rationale is proposed for the treatment of inflammatory diseases, such as rheumatoid arthritis (RA), by specific targeting of the JAK1 pathway.  Examn. of the preferred binding conformation of clin. effective, pan-JAK inhibitor 1 led to identification of a novel, tricyclic hinge binding scaffold 3.  Exploration of SAR through a series of cycloamino and cycloalkylamino analogs demonstrated this template to be highly tolerant of substitution, with a predisposition to moderate selectivity for the JAK1 isoform over JAK2.  This study culminated in the identification of subnanomolar JAK1 inhibitors such as 22 and 49, having excellent cell potency, good rat pharmacokinetic characteristics, and excellent kinase selectivity.  Detn. of the binding modes of the series in JAK1 and JAK2 by X-ray crystallog. supported the design of analogs to enhance affinity and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpamrk0bG1MK7Vg90H21EOLACvtfcHk0lgoc8leyqfjig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVOktL0%253D&md5=d91bc0e24abf14adcf44caf61e3e879f</span></div><a href="/servlet/linkout?suffix=cit45a&amp;dbid=16384&amp;doi=10.1021%2Fjm300438j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300438j%26sid%3Dliteratum%253Aachs%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DBlair%26aufirst%3DW.%26aulast%3DBull%26aufirst%3DR.%2BJ.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DDyke%26aufirst%3DH.%2BJ.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DHarrison%26aufirst%3DT.%2BK.%26aulast%3DHewitt%26aufirst%3DP.%2BR.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKenny%26aufirst%3DJ.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DMaxey%26aufirst%3DR.%2BJ.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DMortara%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DNarukulla%26aufirst%3DR.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DS.%2BI.%26aulast%3DWaszkowycz%26aufirst%3DB%26aulast%3DZak%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520imidazo-pyrrolopyridines%2520as%2520novel%2520and%2520potent%2520JAK1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5901%26epage%3D5921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit45b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balazs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVoss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovich, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gradl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harstad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, M. F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohli, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulagowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labadie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupardus, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubhayakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van-Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span> </span><span class="NLM_article-title">Discovery and optimization of C-2 methyl imidazo-pyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6176</span><span class="NLM_x">–</span> <span class="NLM_lpage">6193</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300628c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6176-6193&author=M.+Zakauthor=R.+Mendoncaauthor=M.+Balazsauthor=K.+Barrettauthor=P.+Bergeronauthor=W.+S.+Blairauthor=C.+Changauthor=G.+Deshmukhauthor=J.+DeVossauthor=P.+S.+Dragovichauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=S.+Gradlauthor=C.+Hammanauthor=E.+Hananauthor=E.+Harstadauthor=P.+R.+Hewittauthor=C.+A.+Hurleyauthor=T.+Jinauthor=A.+Johnsonauthor=T.+Johnsonauthor=J.+R.+Kennyauthor=M.+F.+T.+Koehlerauthor=P.+B.+Kohliauthor=J.+Kulagowskiauthor=S.+Labadieauthor=J.+Liaoauthor=M.+Liimattaauthor=Z.+Linauthor=P.+J.+Lupardusauthor=R.+J.+Maxeyauthor=J.+M.+Murrayauthor=R.+Pulkauthor=M.+Rodriguezauthor=S.+Savageauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=M.+Ultschauthor=A.+Van-Abbemaauthor=S.+Wardauthor=L.+Xiaoauthor=Y.+Xiao&title=Discovery+and+optimization+of+C-2+methyl+imidazo-pyrrolopyridines+as+potent+and+orally+bioavailable+JAK1+inhibitors+with+selectivity+over+JAK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45b&amp;dbid=16384&amp;doi=10.1021%2Fjm300628c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300628c%26sid%3Dliteratum%253Aachs%26aulast%3DZak%26aufirst%3DM.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DBalazs%26aufirst%3DM.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DBlair%26aufirst%3DW.%2BS.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DGradl%26aufirst%3DS.%26aulast%3DHamman%26aufirst%3DC.%26aulast%3DHanan%26aufirst%3DE.%26aulast%3DHarstad%26aufirst%3DE.%26aulast%3DHewitt%26aufirst%3DP.%2BR.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DJin%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DKulagowski%26aufirst%3DJ.%26aulast%3DLabadie%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DMaxey%26aufirst%3DR.%2BJ.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DSavage%26aufirst%3DS.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3DVan-Abbema%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DS.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DXiao%26aufirst%3DY.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520C-2%2520methyl%2520imidazo-pyrrolopyridines%2520as%2520potent%2520and%2520orally%2520bioavailable%2520JAK1%2520inhibitors%2520with%2520selectivity%2520over%2520JAK2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6176%26epage%3D6193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b','cit2c','cit2d'],'ref3':['cit3a','cit3b','cit3c','cit3d','cit3e','cit3f'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b','cit13c'],'ref14':[],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':[],'ref24':['cit24'],'ref25':[],'ref26':[],'ref27':['cit27'],'ref28':['cit28a','cit28b','cit28c','cit28d','cit28e','cit28f'],'ref29':[],'ref30':['cit30a','cit30b','cit30c','cit30d'],'ref31':['cit31'],'ref32':['cit32a','cit32b'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36a','cit36b','cit36c','cit36d'],'ref37':['cit37'],'ref38':[],'ref39':[],'ref40':[],'ref41':['cit41'],'ref42':['cit42a','cit42b'],'ref43':['cit43'],'ref44':['cit44a','cit44b'],'ref45':['cit45a','cit45b']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 55 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Malcolm P. Huestis, Matthew R. Durk, Charles Eigenbrot, Paul Gibbons, Thomas L. Hunsaker, Hank La, Dennis H. Leung, Wendy Liu, Shiva Malek, Mark Merchant, John G. Moffat, Christine S. Muli, Christine J. Orr, Brendan T. Parr, Frances Shanahan, Christopher J. Sneeringer, Weiru Wang, Ivana Yen, Jianping Yin, Joachim Rudolph, <span class="NLM_string-name hlFld-ContribAuthor">Michael Siu</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (5)
                                     , 791-797. <a href="https://doi.org/10.1021/acsmedchemlett.1c00063" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.1c00063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.1c00063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.1c00063%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTargeting%252BKRAS%252BMutant%252BCancers%252Bvia%252BCombination%252BTreatment%25253A%252BDiscovery%252Bof%252Ba%252BPyridopyridazinone%252Bpan-RAF%252BKinase%252BInhibitor%26aulast%3DHuestis%26aufirst%3DMalcolm%2BP.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D27012021%26date%3D31032021%26date%3D21042021%26volume%3D12%26issue%3D5%26spage%3D791%26epage%3D797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Malcolm P. Huestis, Darlene Dela Cruz, Antonio G. DiPasquale, Matthew R. Durk, Charles Eigenbrot, Paul Gibbons, Alberto Gobbi, Thomas L. Hunsaker, Hank La, Dennis H. Leung, Wendy Liu, Shiva Malek, Mark Merchant, John G. Moffat, Christine S. Muli, Christine J. Orr, Brendan T. Parr, Frances Shanahan, Christopher J. Sneeringer, Weiru Wang, Ivana Yen, Jianping Yin, Michael Siu, <span class="NLM_string-name hlFld-ContribAuthor">Joachim Rudolph</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3H)-quinazolinone Aryl Urea pan-RAF Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (7)
                                     , 3940-3955. <a href="https://doi.org/10.1021/acs.jmedchem.0c02085" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02085%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BKRAS%252BMutant%252BCancers%252Bvia%252BCombination%252BTreatment%25253A%252BDiscovery%252Bof%252Ba%252B5-Fluoro-4-%2525283H%252529-quinazolinone%252BAryl%252BUrea%252Bpan-RAF%252BKinase%252BInhibitor%26aulast%3DHuestis%26aufirst%3DMalcolm%2BP.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D01122020%26date%3D29032021%26volume%3D64%26issue%3D7%26spage%3D3940%26epage%3D3955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sowmya Ramaswamy Krishnan, Navneet Bung, Gopalakrishnan Bulusu, <span class="NLM_string-name hlFld-ContribAuthor">Arijit Roy</span>. </span><span class="cited-content_cbyCitation_article-title">Accelerating De Novo Drug Design against Novel Proteins Using Deep Learning. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2021,</strong> <em>61 </em>
                                    (2)
                                     , 621-630. <a href="https://doi.org/10.1021/acs.jcim.0c01060" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c01060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c01060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c01060%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DAccelerating%252BDe%252BNovo%252BDrug%252BDesign%252Bagainst%252BNovel%252BProteins%252BUsing%252BDeep%252BLearning%26aulast%3DKrishnan%26aufirst%3DSowmya%2BRamaswamy%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D10092020%26date%3D25012021%26volume%3D61%26issue%3D2%26spage%3D621%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marian C. Bryan, Joy Drobnick, Alberto Gobbi, Aleksandr Kolesnikov, Yongsheng Chen, Naomi Rajapaksa, Chudi Ndubaku, Jianwen Feng, Willy Chang, Ross Francis, Christine Yu, Edna F. Choo, Kevin DeMent, Yingqing Ran, Le An, Claire Emson, Zhiyu Huang, Swathi Sujatha-Bhaskar, Hans Brightbill, Antonio DiPasquale, Jonathan Maher, John Wai, Brent S. McKenzie, Patrick J. Lupardus, Ali A. Zarrin, <span class="NLM_string-name hlFld-ContribAuthor">James R. Kiefer</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Potent and Selective Pyrazolopyrimidine IRAK4 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (13)
                                     , 6223-6240. <a href="https://doi.org/10.1021/acs.jmedchem.9b00439" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00439</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00439%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BPotent%252Band%252BSelective%252BPyrazolopyrimidine%252BIRAK4%252BInhibitors%26aulast%3DBryan%26aufirst%3DMarian%2BC.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26032019%26date%3D24052019%26date%3D13052019%26volume%3D62%26issue%3D13%26spage%3D6223%26epage%3D6240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Cheng-Kun Li, Ze-Kun Tao, Zhi-Hao Zhou, Xiao-Guang Bao, Shao-Fang Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Jian-Ping Zou</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Oxidative sp3-Carbon Radical Cross-Coupling with Trialkylphosphites Leading to α-Phosphonyl 1,3-Dicarbonyl Compounds. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (4)
                                     , 2351-2357. <a href="https://doi.org/10.1021/acs.joc.8b03093" title="DOI URL">https://doi.org/10.1021/acs.joc.8b03093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b03093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b03093%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper-Catalyzed%252BOxidative%252Bsp3-Carbon%252BRadical%252BCross-Coupling%252Bwith%252BTrialkylphosphites%252BLeading%252Bto%252B%2525CE%2525B1-Phosphonyl%252B1%25252C3-Dicarbonyl%252BCompounds%26aulast%3DLi%26aufirst%3DCheng-Kun%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D04122018%26date%3D04022019%26date%3D22012019%26volume%3D84%26issue%3D4%26spage%3D2351%26epage%3D2357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zubaoyi  Yi</span>, <span class="hlFld-ContribAuthor ">Yodit  Aschenaki</span>, <span class="hlFld-ContribAuthor ">Ryan  Daley</span>, <span class="hlFld-ContribAuthor ">Stephen  Davick</span>, <span class="hlFld-ContribAuthor ">Abigail  Schnaith</span>, <span class="hlFld-ContribAuthor ">Rylee  Wander</span>, and <span class="hlFld-ContribAuthor ">Dipannita  Kalyani</span>  . </span><span class="cited-content_cbyCitation_article-title">Palladium Catalyzed Arylation and Benzylation of Nitroarenes Using Aryl Sulfonates and Benzyl Acetates. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (13)
                                     , 6946-6957. <a href="https://doi.org/10.1021/acs.joc.7b00550" title="DOI URL">https://doi.org/10.1021/acs.joc.7b00550</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b00550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b00550%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPalladium%252BCatalyzed%252BArylation%252Band%252BBenzylation%252Bof%252BNitroarenes%252BUsing%252BAryl%252BSulfonates%252Band%252BBenzyl%252BAcetates%26aulast%3DYi%26aufirst%3DZubaoyi%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D07032017%26date%3D15062017%26date%3D07072017%26volume%3D82%26issue%3D13%26spage%3D6946%26epage%3D6957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Su Jin  Han</span>, <span class="hlFld-ContribAuthor ">Hyun Tae  Kim</span>, and <span class="hlFld-ContribAuthor ">Jung Min  Joo</span>  . </span><span class="cited-content_cbyCitation_article-title">Direct C–H Alkenylation of Functionalized Pyrazoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (2)
                                     , 689-698. <a href="https://doi.org/10.1021/acs.joc.5b02398" title="DOI URL">https://doi.org/10.1021/acs.joc.5b02398</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b02398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b02398%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDirect%252BC%2525E2%252580%252593H%252BAlkenylation%252Bof%252BFunctionalized%252BPyrazoles%26aulast%3DHan%26aufirst%3DSu%2BJin%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D15102015%26date%3D23122015%26date%3D15012016%26volume%3D81%26issue%3D2%26spage%3D689%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">W F.  Rodhan</span>, <span class="hlFld-ContribAuthor ">S S.  Kadhium</span>, <span class="hlFld-ContribAuthor ">Z Z M  Ali</span>, <span class="hlFld-ContribAuthor ">A G  Eleiwi</span>, <span class="hlFld-ContribAuthor ">R F  Abbas</span>, <span class="hlFld-ContribAuthor ">I R  Mohamed</span>, <span class="hlFld-ContribAuthor ">Z A  Hussein</span>. </span><span class="cited-content_cbyCitation_article-title">Chemistry and synthesis of Bis Pyrazole derivatives and their biological activity: a review. </span><span class="cited-content_cbyCitation_journal-name">Journal of Physics: Conference Series</span><span> <strong>2021,</strong> <em>1853 </em>
                                    (1)
                                     , 012059. <a href="https://doi.org/10.1088/1742-6596/1853/1/012059" title="DOI URL">https://doi.org/10.1088/1742-6596/1853/1/012059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1088/1742-6596/1853/1/012059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1088%2F1742-6596%2F1853%2F1%2F012059%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Physics%253A%2520Conference%2520Series%26atitle%3DChemistry%252Band%252Bsynthesis%252Bof%252BBis%252BPyrazole%252Bderivatives%252Band%252Btheir%252Bbiological%252Bactivity%25253A%252Ba%252Breview%26aulast%3DRodhan%26aufirst%3DW%2BF.%26date%3D2021%26volume%3D1853%26issue%3D1%26spage%3D012059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samir  Bondock</span>, <span class="hlFld-ContribAuthor ">Salwa  Alqahtani</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  Fouda</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anticancer evaluation of some new pyrazolo[3,4‐
              d
              ][1,2,3]triazin‐4‐ones, pyrazolo[1,5‐
              a
              ]pyrimidines, and imidazo[1,2‐
              b
              ]pyrazoles clubbed with carbazole. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2021,</strong> <em>58 </em>
                                    (1)
                                     , 56-73. <a href="https://doi.org/10.1002/jhet.4148" title="DOI URL">https://doi.org/10.1002/jhet.4148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.4148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.4148%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Band%252Banticancer%252Bevaluation%252Bof%252Bsome%252Bnew%252Bpyrazolo%25255B3%25252C4%2525E2%252580%252590%252Bd%252B%25255D%25255B1%25252C2%25252C3%25255Dtriazin%2525E2%252580%2525904%2525E2%252580%252590ones%25252C%252Bpyrazolo%25255B1%25252C5%2525E2%252580%252590%252Ba%252B%25255Dpyrimidines%25252C%252Band%252Bimidazo%25255B1%25252C2%2525E2%252580%252590%252Bb%252B%25255Dpyrazoles%252Bclubbed%252Bwith%252Bcarbazole%26aulast%3DBondock%26aufirst%3DSamir%26date%3D2021%26date%3D2020%26volume%3D58%26issue%3D1%26spage%3D56%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dmitrii L.  Obydennov</span>, <span class="hlFld-ContribAuthor ">Elena V.  Chernyshova</span>, <span class="hlFld-ContribAuthor ">Vyacheslav Ya.  Sosnovskikh</span>. </span><span class="cited-content_cbyCitation_article-title">Acyclic Enaminodiones in the Synthesis of Heterocyclic Compounds. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2020,</strong> <em>56 </em>
                                    (10)
                                     , 1241-1253. <a href="https://doi.org/10.1007/s10593-020-02807-0" title="DOI URL">https://doi.org/10.1007/s10593-020-02807-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-020-02807-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-020-02807-0%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DAcyclic%252BEnaminodiones%252Bin%252Bthe%252BSynthesis%252Bof%252BHeterocyclic%252BCompounds%26aulast%3DObydennov%26aufirst%3DDmitrii%2BL.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D10%26spage%3D1241%26epage%3D1253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eunsu  Kang</span>, <span class="hlFld-ContribAuthor ">Hyun Tae  Kim</span>, <span class="hlFld-ContribAuthor ">Jung Min  Joo</span>. </span><span class="cited-content_cbyCitation_article-title">Transition-metal-catalyzed C–H functionalization of pyrazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (32)
                                     , 6192-6210. <a href="https://doi.org/10.1039/D0OB01265C" title="DOI URL">https://doi.org/10.1039/D0OB01265C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB01265C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB01265C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DTransition-metal-catalyzed%252BC%2525E2%252580%252593H%252Bfunctionalization%252Bof%252Bpyrazoles%26aulast%3DKang%26aufirst%3DEunsu%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D32%26spage%3D6192%26epage%3D6210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R. Nishanth  Rao</span>, <span class="hlFld-ContribAuthor ">Kaushik  Chanda</span>. </span><span class="cited-content_cbyCitation_article-title">An assessment study of known pyrazolopyrimidines: Chemical methodology and cellular activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103801. <a href="https://doi.org/10.1016/j.bioorg.2020.103801" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103801</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103801%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DAn%252Bassessment%252Bstudy%252Bof%252Bknown%252Bpyrazolopyrimidines%25253A%252BChemical%252Bmethodology%252Band%252Bcellular%252Bactivity%26aulast%3DRao%26aufirst%3DR.%2BNishanth%26date%3D2020%26volume%3D99%26spage%3D103801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy E  Defnet</span>, <span class="hlFld-ContribAuthor ">Jeffery D  Hasday</span>, <span class="hlFld-ContribAuthor ">Paul  Shapiro</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase inhibitors in the treatment of obstructive pulmonary diseases. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2020,</strong> <em>51 </em>, 11-18. <a href="https://doi.org/10.1016/j.coph.2020.03.005" title="DOI URL">https://doi.org/10.1016/j.coph.2020.03.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2020.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2020.03.005%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3DKinase%252Binhibitors%252Bin%252Bthe%252Btreatment%252Bof%252Bobstructive%252Bpulmonary%252Bdiseases%26aulast%3DDefnet%26aufirst%3DAmy%2BE%26date%3D2020%26volume%3D51%26spage%3D11%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Xu</span>, <span class="hlFld-ContribAuthor ">Pei  Shen</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Xi  Xu</span>, <span class="hlFld-ContribAuthor ">Raoling  Ge</span>, <span class="hlFld-ContribAuthor ">Xinying  Cheng</span>, <span class="hlFld-ContribAuthor ">Qiuyu  Chen</span>, <span class="hlFld-ContribAuthor ">Jinlei  Bian</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Li</span>, <span class="hlFld-ContribAuthor ">JuBo  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>192 </em>, 112155. <a href="https://doi.org/10.1016/j.ejmech.2020.112155" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112155</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112155%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DJanus%252Bkinases%252B%252528JAKs%252529%25253A%252BThe%252Befficient%252Btherapeutic%252Btargets%252Bfor%252Bautoimmune%252Bdiseases%252Band%252Bmyeloproliferative%252Bdisorders%26aulast%3DXu%26aufirst%3DPengfei%26date%3D2020%26volume%3D192%26spage%3D112155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sathya  Babu</span>, <span class="hlFld-ContribAuthor ">Santhosh Kumar  Nagarajan</span>, <span class="hlFld-ContribAuthor ">Thirumurthy  Madhavan</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding the structural features of JAK2 inhibitors: a combined 3D-QSAR, DFT and molecular dynamics study. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2019,</strong> <em>23 </em>
                                    (4)
                                     , 845-874. <a href="https://doi.org/10.1007/s11030-018-09913-4" title="DOI URL">https://doi.org/10.1007/s11030-018-09913-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-018-09913-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-018-09913-4%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DUnderstanding%252Bthe%252Bstructural%252Bfeatures%252Bof%252BJAK2%252Binhibitors%25253A%252Ba%252Bcombined%252B3D-QSAR%25252C%252BDFT%252Band%252Bmolecular%252Bdynamics%252Bstudy%26aulast%3DBabu%26aufirst%3DSathya%26date%3D2019%26date%3D2019%26volume%3D23%26issue%3D4%26spage%3D845%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alsaedi</span>, <span class="hlFld-ContribAuthor ">Farghaly</span>, <span class="hlFld-ContribAuthor ">Shaaban</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antimicrobial Evaluation of Novel Pyrazolopyrimidines Incorporated with Mono- and Diphenylsulfonyl Groups. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (21)
                                     , 4009. <a href="https://doi.org/10.3390/molecules24214009" title="DOI URL">https://doi.org/10.3390/molecules24214009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24214009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24214009%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BAntimicrobial%252BEvaluation%252Bof%252BNovel%252BPyrazolopyrimidines%252BIncorporated%252Bwith%252BMono-%252Band%252BDiphenylsulfonyl%252BGroups%26aulast%3DAlsaedi%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D21%26spage%3D4009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed E. M.  Mekky</span>, <span class="hlFld-ContribAuthor ">Sherif M. H.  Sanad</span>, <span class="hlFld-ContribAuthor ">Ahmed A. M.  Ahmed</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave Assisted Three Component One‐pot Synthesis of Bis(aminoazolo[1,5‐
              a
              ]pyrimidines) and Bis(aminoazino[1,2‐
              a
              ]benzimidazoles) Bearing Thiazole Moiety. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (33)
                                     , 9710-9715. <a href="https://doi.org/10.1002/slct.201902828" title="DOI URL">https://doi.org/10.1002/slct.201902828</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201902828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201902828%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DMicrowave%252BAssisted%252BThree%252BComponent%252BOne%2525E2%252580%252590pot%252BSynthesis%252Bof%252BBis%252528aminoazolo%25255B1%25252C5%2525E2%252580%252590%252Ba%252B%25255Dpyrimidines%252529%252Band%252BBis%252528aminoazino%25255B1%25252C2%2525E2%252580%252590%252Ba%252B%25255Dbenzimidazoles%252529%252BBearing%252BThiazole%252BMoiety%26aulast%3DMekky%26aufirst%3DAhmed%2BE.%2BM.%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D33%26spage%3D9710%26epage%3D9715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amal  Al-Azmi</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazolo[1,5-a]pyrimidines: A Close Look into their Synthesis and Applications. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Chemistry</span><span> <strong>2019,</strong> <em>23 </em>
                                    (6)
                                     , 721-743. <a href="https://doi.org/10.2174/1385272823666190410145238" title="DOI URL">https://doi.org/10.2174/1385272823666190410145238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1385272823666190410145238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1385272823666190410145238%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Chemistry%26atitle%3DPyrazolo%25255B1%25252C5-a%25255Dpyrimidines%25253A%252BA%252BClose%252BLook%252Binto%252Btheir%252BSynthesis%252Band%252BApplications%26aulast%3DAl-Azmi%26aufirst%3DAmal%26date%3D2019%26volume%3D23%26issue%3D6%26spage%3D721%26epage%3D743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nadia Hanafy  Metwally</span>, <span class="hlFld-ContribAuthor ">Mona Said  Mohamed</span>, <span class="hlFld-ContribAuthor ">Eman Ali  Ragb</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, anticancer evaluation, molecular docking and cell cycle analysis of 3-methyl-4,7-dihydropyrazolo[1,5-a]pyrimidine derivatives as potent histone lysine demethylases (KDM) inhibitors and apoptosis inducers. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>88 </em>, 102929. <a href="https://doi.org/10.1016/j.bioorg.2019.102929" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.102929</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.102929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.102929%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Banticancer%252Bevaluation%25252C%252Bmolecular%252Bdocking%252Band%252Bcell%252Bcycle%252Banalysis%252Bof%252B3-methyl-4%25252C7-dihydropyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bderivatives%252Bas%252Bpotent%252Bhistone%252Blysine%252Bdemethylases%252B%252528KDM%252529%252Binhibitors%252Band%252Bapoptosis%252Binducers%26aulast%3DMetwally%26aufirst%3DNadia%2BHanafy%26date%3D2019%26volume%3D88%26spage%3D102929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Palmi  Modi</span>, <span class="hlFld-ContribAuthor ">Shivani  Patel</span>, <span class="hlFld-ContribAuthor ">Mahesh  Chhabria</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>87 </em>, 240-251. <a href="https://doi.org/10.1016/j.bioorg.2019.02.044" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.02.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.02.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.02.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DStructure-based%252Bdesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Ba%252Bnewer%252Bseries%252Bof%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Banalogues%252Bas%252Bpotential%252Banti-tubercular%252Bagents%26aulast%3DModi%26aufirst%3DPalmi%26date%3D2019%26volume%3D87%26spage%3D240%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Emily J.  Hanan</span>, <span class="hlFld-ContribAuthor ">Patrick  Lupardus</span>, <span class="hlFld-ContribAuthor ">David G.  Brown</span>, <span class="hlFld-ContribAuthor ">Colin  Robinson</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>, <span class="hlFld-ContribAuthor ">F. Anthony  Romero</span>, <span class="hlFld-ContribAuthor ">Guiling  Zhao</span>, <span class="hlFld-ContribAuthor ">Terry  Kellar</span>, <span class="hlFld-ContribAuthor ">Rohan  Mendonca</span>, <span class="hlFld-ContribAuthor ">Nicholas C.  Ray</span>, <span class="hlFld-ContribAuthor ">Simon C.  Goodacre</span>, <span class="hlFld-ContribAuthor ">Peter H.  Crackett</span>, <span class="hlFld-ContribAuthor ">Neville  McLean</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Hurley</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Yun-Xing  Cheng</span>, <span class="hlFld-ContribAuthor ">Xiongcai  Liu</span>, <span class="hlFld-ContribAuthor ">Marya  Liimatta</span>, <span class="hlFld-ContribAuthor ">Pawan Bir  Kohli</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Gary  Salmon</span>, <span class="hlFld-ContribAuthor ">Gerry  Buckley</span>, <span class="hlFld-ContribAuthor ">Julia  Lloyd</span>, <span class="hlFld-ContribAuthor ">Paul  Gibbons</span>, <span class="hlFld-ContribAuthor ">Nico  Ghilardi</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">Adam  Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (12)
                                     , 1522-1531. <a href="https://doi.org/10.1016/j.bmcl.2019.04.008" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.04.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.04.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bclass%252Bof%252Bhighly%252Bpotent%252BJanus%252BKinase%252B1%25252F2%252B%252528JAK1%25252F2%252529%252Binhibitors%252Bdemonstrating%252Beffective%252Bcell-based%252Bblockade%252Bof%252BIL-13%252Bsignaling%26aulast%3DZak%26aufirst%3DMark%26date%3D2019%26volume%3D29%26issue%3D12%26spage%3D1522%26epage%3D1531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nejc  Petek</span>, <span class="hlFld-ContribAuthor ">Bogdan  Štefane</span>, <span class="hlFld-ContribAuthor ">Marko  Novinec</span>, <span class="hlFld-ContribAuthor ">Jurij  Svete</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 7-(aminoalkyl)pyrazolo[1,5-a]pyrimidine derivatives as cathepsin K inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>, 226-238. <a href="https://doi.org/10.1016/j.bioorg.2018.11.029" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.11.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.11.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.11.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B7-%252528aminoalkyl%252529pyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bderivatives%252Bas%252Bcathepsin%252BK%252Binhibitors%26aulast%3DPetek%26aufirst%3DNejc%26date%3D2019%26volume%3D84%26spage%3D226%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hart S.  Dengler</span>, <span class="hlFld-ContribAuthor ">Xiumin  Wu</span>, <span class="hlFld-ContribAuthor ">Ivan  Peng</span>, <span class="hlFld-ContribAuthor ">Cornelia H.  Rinderknecht</span>, <span class="hlFld-ContribAuthor ">Youngsu  Kwon</span>, <span class="hlFld-ContribAuthor ">Eric  Suto</span>, <span class="hlFld-ContribAuthor ">Pawan Bir  Kohli</span>, <span class="hlFld-ContribAuthor ">Marya  Liimatta</span>, <span class="hlFld-ContribAuthor ">Kathy  Barrett</span>, <span class="hlFld-ContribAuthor ">Julia  Lloyd</span>, <span class="hlFld-ContribAuthor ">Gary  Cain</span>, <span class="hlFld-ContribAuthor ">Mike  Briggs</span>, <span class="hlFld-ContribAuthor ">Stephanie  Addo</span>, <span class="hlFld-ContribAuthor ">Gary  Salmon</span>, <span class="hlFld-ContribAuthor ">Savita  Ubhayakar</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Sheerin K.  Shahidi-Latham</span>, <span class="hlFld-ContribAuthor ">Cristine M.  Quiason-Huynh</span>, <span class="hlFld-ContribAuthor ">Janet  Jackman</span>, <span class="hlFld-ContribAuthor ">John  Liu</span>, <span class="hlFld-ContribAuthor ">Nicholas C.  Ray</span>, <span class="hlFld-ContribAuthor ">Simon C.  Goodacre</span>, <span class="hlFld-ContribAuthor ">Adam  Johnson</span>, <span class="hlFld-ContribAuthor ">Brent S.  McKenzie</span>, <span class="hlFld-ContribAuthor ">Wyne P.  Lee</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">Nico  Ghilardi</span>. </span><span class="cited-content_cbyCitation_article-title">Lung-restricted inhibition of Janus kinase 1 is effective in rodent models of asthma. </span><span class="cited-content_cbyCitation_journal-name">Science Translational Medicine</span><span> <strong>2018,</strong> <em>10 </em>
                                    (468)
                                     , eaao2151. <a href="https://doi.org/10.1126/scitranslmed.aao2151" title="DOI URL">https://doi.org/10.1126/scitranslmed.aao2151</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scitranslmed.aao2151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscitranslmed.aao2151%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Translational%2520Medicine%26atitle%3DLung-restricted%252Binhibition%252Bof%252BJanus%252Bkinase%252B1%252Bis%252Beffective%252Bin%252Brodent%252Bmodels%252Bof%252Basthma%26aulast%3DDengler%26aufirst%3DHart%2BS.%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D468%26spage%3Deaao2151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yifan  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiao  Liu</span>, <span class="hlFld-ContribAuthor ">Youzhi  Zhang</span>, <span class="hlFld-ContribAuthor ">Long  Peng</span>, <span class="hlFld-ContribAuthor ">John Z. H.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Residue-specific free energy analysis in ligand bindings to JAK2. </span><span class="cited-content_cbyCitation_journal-name">Molecular Physics</span><span> <strong>2018,</strong> <em>116 </em>
                                    (19-20)
                                     , 2633-2641. <a href="https://doi.org/10.1080/00268976.2018.1442596" title="DOI URL">https://doi.org/10.1080/00268976.2018.1442596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00268976.2018.1442596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00268976.2018.1442596%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Physics%26atitle%3DResidue-specific%252Bfree%252Benergy%252Banalysis%252Bin%252Bligand%252Bbindings%252Bto%252BJAK2%26aulast%3DZhou%26aufirst%3DYifan%26date%3D2018%26date%3D2018%26volume%3D116%26issue%3D19-20%26spage%3D2633%26epage%3D2641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">András  Demjén</span>, <span class="hlFld-ContribAuthor ">Róbert  Alföldi</span>, <span class="hlFld-ContribAuthor ">Anikó  Angyal</span>, <span class="hlFld-ContribAuthor ">Márió  Gyuris</span>, <span class="hlFld-ContribAuthor ">László  Hackler</span>, <span class="hlFld-ContribAuthor ">Gábor J.  Szebeni</span>, <span class="hlFld-ContribAuthor ">János  Wölfling</span>, <span class="hlFld-ContribAuthor ">László G.  Puskás</span>, <span class="hlFld-ContribAuthor ">Iván  Kanizsai</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, cytotoxic characterization, and SAR study of imidazo[1,2-
              b
              ]pyrazole-7-carboxamides. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2018,</strong> <em>351 </em>
                                    (7)
                                     , 1800062. <a href="https://doi.org/10.1002/ardp.201800062" title="DOI URL">https://doi.org/10.1002/ardp.201800062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201800062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201800062%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%25252C%252Bcytotoxic%252Bcharacterization%25252C%252Band%252BSAR%252Bstudy%252Bof%252Bimidazo%25255B1%25252C2-%252Bb%252B%25255Dpyrazole-7-carboxamides%26aulast%3DDemj%25C3%25A9n%26aufirst%3DAndr%25C3%25A1s%26date%3D2018%26date%3D2018%26volume%3D351%26issue%3D7%26spage%3D1800062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyeri  Ha</span>, <span class="hlFld-ContribAuthor ">Changhoon  Shin</span>, <span class="hlFld-ContribAuthor ">Seri  Bae</span>, <span class="hlFld-ContribAuthor ">Jung Min  Joo</span>. </span><span class="cited-content_cbyCitation_article-title">Divergent Palladium-Catalyzed Cross-Coupling of Nitropyrazoles with Terminal Alkynes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (20-21)
                                     , 2645-2650. <a href="https://doi.org/10.1002/ejoc.201800166" title="DOI URL">https://doi.org/10.1002/ejoc.201800166</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201800166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201800166%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDivergent%252BPalladium-Catalyzed%252BCross-Coupling%252Bof%252BNitropyrazoles%252Bwith%252BTerminal%252BAlkynes%26aulast%3DHa%26aufirst%3DHyeri%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D20-21%26spage%3D2645%26epage%3D2650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linhong  He</span>, <span class="hlFld-ContribAuthor ">Mingfeng  Shao</span>, <span class="hlFld-ContribAuthor ">Taijin  Wang</span>, <span class="hlFld-ContribAuthor ">Tingxuan  Lan</span>, <span class="hlFld-ContribAuthor ">Chufeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Lijuan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and SAR study of highly potent, selective, irreversible covalent JAK3 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2018,</strong> <em>22 </em>
                                    (2)
                                     , 343-358. <a href="https://doi.org/10.1007/s11030-017-9803-2" title="DOI URL">https://doi.org/10.1007/s11030-017-9803-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-017-9803-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-017-9803-2%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252BSAR%252Bstudy%252Bof%252Bhighly%252Bpotent%25252C%252Bselective%25252C%252Birreversible%252Bcovalent%252BJAK3%252Binhibitors%26aulast%3DHe%26aufirst%3DLinhong%26date%3D2018%26date%3D2018%26volume%3D22%26issue%3D2%26spage%3D343%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khalid  Karrouchi</span>, <span class="hlFld-ContribAuthor ">Smaail  Radi</span>, <span class="hlFld-ContribAuthor ">Youssef  Ramli</span>, <span class="hlFld-ContribAuthor ">Jamal  Taoufik</span>, <span class="hlFld-ContribAuthor ">Yahia  Mabkhot</span>, <span class="hlFld-ContribAuthor ">Faiz  Al-aizari</span>, <span class="hlFld-ContribAuthor ">M’hammed  Ansar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (1)
                                     , 134. <a href="https://doi.org/10.3390/molecules23010134" title="DOI URL">https://doi.org/10.3390/molecules23010134</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23010134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23010134%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BPharmacological%252BActivities%252Bof%252BPyrazole%252BDerivatives%25253A%252BA%252BReview%26aulast%3DKarrouchi%26aufirst%3DKhalid%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D1%26spage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Badr  Jismy</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>, <span class="hlFld-ContribAuthor ">Hassan  Allouchi</span>, <span class="hlFld-ContribAuthor ">Mohamed  Akssira</span>, <span class="hlFld-ContribAuthor ">Mohamed  Abarbri</span>. </span><span class="cited-content_cbyCitation_article-title">Concise and Efficient Access to 5,7-Disubstituted Pyrazolo[1,5-
              a
              ]pyrimidines by Pd-Catalyzed Sequential Arylation, Alkynylation and SN
              Ar
              Reaction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (41)
                                     , 6168-6178. <a href="https://doi.org/10.1002/ejoc.201701024" title="DOI URL">https://doi.org/10.1002/ejoc.201701024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701024%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DConcise%252Band%252BEfficient%252BAccess%252Bto%252B5%25252C7-Disubstituted%252BPyrazolo%25255B1%25252C5-%252Ba%252B%25255Dpyrimidines%252Bby%252BPd-Catalyzed%252BSequential%252BArylation%25252C%252BAlkynylation%252Band%252BSN%252BAr%252BReaction%26aulast%3DJismy%26aufirst%3DBadr%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D41%26spage%3D6168%26epage%3D6178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Porta</span>, <span class="hlFld-ContribAuthor ">Arianna  Gelain</span>, <span class="hlFld-ContribAuthor ">Daniela  Barlocco</span>, <span class="hlFld-ContribAuthor ">Nicola  Ferri</span>, <span class="hlFld-ContribAuthor ">Silvia  Marchianò</span>, <span class="hlFld-ContribAuthor ">Valentina  Cappello</span>, <span class="hlFld-ContribAuthor ">Livia  Basile</span>, <span class="hlFld-ContribAuthor ">Salvatore  Guccione</span>, <span class="hlFld-ContribAuthor ">Fiorella  Meneghetti</span>, <span class="hlFld-ContribAuthor ">Stefania  Villa</span>. </span><span class="cited-content_cbyCitation_article-title">A field-based disparity analysis of new 1,2,5-oxadiazole derivatives endowed with antiproliferative activity. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2017,</strong> <em>90 </em>
                                    (5)
                                     , 820-839. <a href="https://doi.org/10.1111/cbdd.13003" title="DOI URL">https://doi.org/10.1111/cbdd.13003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13003%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DA%252Bfield-based%252Bdisparity%252Banalysis%252Bof%252Bnew%252B1%25252C2%25252C5-oxadiazole%252Bderivatives%252Bendowed%252Bwith%252Bantiproliferative%252Bactivity%26aulast%3DPorta%26aufirst%3DFederica%26date%3D2017%26date%3D2017%26volume%3D90%26issue%3D5%26spage%3D820%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyoung Bin  Yoon</span>, <span class="hlFld-ContribAuthor ">Sung Yun  Cho</span>, <span class="hlFld-ContribAuthor ">Su Jin  An</span>, <span class="hlFld-ContribAuthor ">Kyeong Ryang  Park</span>, <span class="hlFld-ContribAuthor ">Hyo Jeong  Lee</span>, <span class="hlFld-ContribAuthor ">Hae Sung  Yoon</span>, <span class="hlFld-ContribAuthor ">Sun-Mi  Lee</span>, <span class="hlFld-ContribAuthor ">Yong-Chul  Kim</span>, <span class="hlFld-ContribAuthor ">Sun-Young  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of the aminopyridine derivative KRC-180 as a JAK2 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Oncology Letters</span><span> <strong>2017,</strong> <em>14 </em>
                                    (2)
                                     , 1347-1354. <a href="https://doi.org/10.3892/ol.2017.6353" title="DOI URL">https://doi.org/10.3892/ol.2017.6353</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ol.2017.6353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fol.2017.6353%26sid%3Dliteratum%253Aachs%26jtitle%3DOncology%2520Letters%26atitle%3DCharacterization%252Bof%252Bthe%252Baminopyridine%252Bderivative%252BKRC-180%252Bas%252Ba%252BJAK2%252Binhibitor%26aulast%3DYoon%26aufirst%3DKyoung%2BBin%26date%3D2017%26date%3D2017%26volume%3D14%26issue%3D2%26spage%3D1347%26epage%3D1354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yazhou  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Minhang  Xin</span>, <span class="hlFld-ContribAuthor ">Pan  Chen</span>, <span class="hlFld-ContribAuthor ">Li  Gui</span>, <span class="hlFld-ContribAuthor ">Xinge  Zhao</span>, <span class="hlFld-ContribAuthor ">Feng  Tang</span>, <span class="hlFld-ContribAuthor ">Jia  Wang</span>, <span class="hlFld-ContribAuthor ">Fei  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 4-(2-furanyl)pyrimidin-2-amines as Janus kinase 2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (1)
                                     , 75-83. <a href="https://doi.org/10.1016/j.bmc.2016.10.011" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.10.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.10.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252B4-%2525282-furanyl%252529pyrimidin-2-amines%252Bas%252BJanus%252Bkinase%252B2%252Binhibitors%26aulast%3DWang%26aufirst%3DYazhou%26date%3D2017%26volume%3D25%26issue%3D1%26spage%3D75%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srinivasulu  Cherukupalli</span>, <span class="hlFld-ContribAuthor ">Rajshekhar  Karpoormath</span>, <span class="hlFld-ContribAuthor ">Balakumar  Chandrasekaran</span>, <span class="hlFld-ContribAuthor ">Girish. A.  Hampannavar</span>, <span class="hlFld-ContribAuthor ">Neeta  Thapliyal</span>, <span class="hlFld-ContribAuthor ">Venkata Narayana  Palakollu</span>. </span><span class="cited-content_cbyCitation_article-title">An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>126 </em>, 298-352. <a href="https://doi.org/10.1016/j.ejmech.2016.11.019" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.11.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.11.019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Binsight%252Bon%252Bsynthetic%252Band%252Bmedicinal%252Baspects%252Bof%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bscaffold%26aulast%3DCherukupalli%26aufirst%3DSrinivasulu%26date%3D2017%26volume%3D126%26spage%3D298%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohemmed Faraz  Khan</span>, <span class="hlFld-ContribAuthor ">Mohammad Mumtaz  Alam</span>, <span class="hlFld-ContribAuthor ">Garima  Verma</span>, <span class="hlFld-ContribAuthor ">Wasim  Akhtar</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>, <span class="hlFld-ContribAuthor ">Mohammad  Shaquiquzzaman</span>. </span><span class="cited-content_cbyCitation_article-title">The therapeutic voyage of pyrazole and its analogs: A review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>120 </em>, 170-201. <a href="https://doi.org/10.1016/j.ejmech.2016.04.077" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.04.077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.04.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.04.077%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Btherapeutic%252Bvoyage%252Bof%252Bpyrazole%252Band%252Bits%252Banalogs%25253A%252BA%252Breview%26aulast%3DKhan%26aufirst%3DMohemmed%2BFaraz%26date%3D2016%26volume%3D120%26spage%3D170%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carina  Michl</span>, <span class="hlFld-ContribAuthor ">Fabio  Vivarelli</span>, <span class="hlFld-ContribAuthor ">Julia  Weigl</span>, <span class="hlFld-ContribAuthor ">Gina Rosalinda  De Nicola</span>, <span class="hlFld-ContribAuthor ">Donatella  Canistro</span>, <span class="hlFld-ContribAuthor ">Moreno  Paolini</span>, <span class="hlFld-ContribAuthor ">Renato  Iori</span>, <span class="hlFld-ContribAuthor ">Anne  Rascle</span>, . </span><span class="cited-content_cbyCitation_article-title">The Chemopreventive Phytochemical Moringin Isolated from Moringa oleifera Seeds Inhibits JAK/STAT Signaling. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2016,</strong> <em>11 </em>
                                    (6)
                                     , e0157430. <a href="https://doi.org/10.1371/journal.pone.0157430" title="DOI URL">https://doi.org/10.1371/journal.pone.0157430</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0157430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0157430%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DThe%252BChemopreventive%252BPhytochemical%252BMoringin%252BIsolated%252Bfrom%252BMoringa%252Boleifera%252BSeeds%252BInhibits%252BJAK%25252FSTAT%252BSignaling%26aulast%3DMichl%26aufirst%3DCarina%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D6%26spage%3De0157430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tingfang  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaofei  Liu</span>, <span class="hlFld-ContribAuthor ">Meixi  Hao</span>, <span class="hlFld-ContribAuthor ">Jianan  Qiao</span>, <span class="hlFld-ContribAuthor ">Caoyun  Ju</span>, <span class="hlFld-ContribAuthor ">Lingjing  Xue</span>, <span class="hlFld-ContribAuthor ">Can  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of pyrrolo[2,3- d ]pyrimidine-phenylamide hybrids as potent Janus kinase 2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (12)
                                     , 2936-2941. <a href="https://doi.org/10.1016/j.bmcl.2016.04.027" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.04.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.04.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.04.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bpyrrolo%25255B2%25252C3-%252Bd%252B%25255Dpyrimidine-phenylamide%252Bhybrids%252Bas%252Bpotent%252BJanus%252Bkinase%252B2%252Binhibitors%26aulast%3DWang%26aufirst%3DTingfang%26date%3D2016%26volume%3D26%26issue%3D12%26spage%3D2936%26epage%3D2941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lukáš  Jedinák</span>, <span class="hlFld-ContribAuthor ">Petr  Cankař</span>. </span><span class="cited-content_cbyCitation_article-title">4-Arylation of
              N
              -Acylamino- and Aminopyrazoles by the Suzuki-Miyaura Cross-Coupling Reaction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (11)
                                     , 2013-2023. <a href="https://doi.org/10.1002/ejoc.201600072" title="DOI URL">https://doi.org/10.1002/ejoc.201600072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600072%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D4-Arylation%252Bof%252BN%252B-Acylamino-%252Band%252BAminopyrazoles%252Bby%252Bthe%252BSuzuki-Miyaura%252BCross-Coupling%252BReaction%26aulast%3DJedin%25C3%25A1k%26aufirst%3DLuk%25C3%25A1%25C5%25A1%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D11%26spage%3D2013%26epage%3D2023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kurt  Zimmermann</span>, <span class="hlFld-ContribAuthor ">Xiaopeng  Sang</span>, <span class="hlFld-ContribAuthor ">Harold A.  Mastalerz</span>, <span class="hlFld-ContribAuthor ">Walter L.  Johnson</span>, <span class="hlFld-ContribAuthor ">Guifen  Zhang</span>, <span class="hlFld-ContribAuthor ">Qingjie  Liu</span>, <span class="hlFld-ContribAuthor ">Douglas  Batt</span>, <span class="hlFld-ContribAuthor ">Louis J.  Lombardo</span>, <span class="hlFld-ContribAuthor ">Dinesh  Vyas</span>, <span class="hlFld-ContribAuthor ">George L.  Trainor</span>, <span class="hlFld-ContribAuthor ">John S.  Tokarski</span>, <span class="hlFld-ContribAuthor ">Matthew V.  Lorenzi</span>, <span class="hlFld-ContribAuthor ">Dan  You</span>, <span class="hlFld-ContribAuthor ">Marco M.  Gottardis</span>, <span class="hlFld-ContribAuthor ">Jonathan  Lippy</span>, <span class="hlFld-ContribAuthor ">Javed  Khan</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">Ashok V.  Purandare</span>. </span><span class="cited-content_cbyCitation_article-title">9H-Carbazole-1-carboxamides as potent and selective JAK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (14)
                                     , 2809-2812. <a href="https://doi.org/10.1016/j.bmcl.2015.04.101" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.04.101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.04.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.04.101%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D9H-Carbazole-1-carboxamides%252Bas%252Bpotent%252Band%252Bselective%252BJAK2%252Binhibitors%26aulast%3DZimmermann%26aufirst%3DKurt%26date%3D2015%26volume%3D25%26issue%3D14%26spage%3D2809%26epage%3D2812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stella  Vukelić</span>, <span class="hlFld-ContribAuthor ">Dmitry B.  Ushakov</span>, <span class="hlFld-ContribAuthor ">Kerry  Gilmore</span>, <span class="hlFld-ContribAuthor ">Beate  Koksch</span>, <span class="hlFld-ContribAuthor ">Peter H.  Seeberger</span>. </span><span class="cited-content_cbyCitation_article-title">Flow Synthesis of Fluorinated α-Amino Acids. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>2015 </em>
                                    (14)
                                     , 3036-3039. <a href="https://doi.org/10.1002/ejoc.201500300" title="DOI URL">https://doi.org/10.1002/ejoc.201500300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201500300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201500300%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFlow%252BSynthesis%252Bof%252BFluorinated%252B%2525CE%2525B1-Amino%252BAcids%26aulast%3DVukeli%25C4%2587%26aufirst%3DStella%26date%3D2015%26date%3D2015%26volume%3D2015%26issue%3D14%26spage%3D3036%26epage%3D3039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A V  Galenko</span>, <span class="hlFld-ContribAuthor ">A F  Khlebnikov</span>, <span class="hlFld-ContribAuthor ">M S  Novikov</span>, <span class="hlFld-ContribAuthor ">V V  Pakalnis</span>, <span class="hlFld-ContribAuthor ">N V  Rostovskii</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in isoxazole chemistry. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Reviews</span><span> <strong>2015,</strong> <em>84 </em>
                                    (4)
                                     , 335-377. <a href="https://doi.org/10.1070/RCR4503" title="DOI URL">https://doi.org/10.1070/RCR4503</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1070/RCR4503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1070%2FRCR4503%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Reviews%26atitle%3DRecent%252Badvances%252Bin%252Bisoxazole%252Bchemistry%26aulast%3DGalenko%26aufirst%3DA%2BV%26date%3D2015%26date%3D2015%26volume%3D84%26issue%3D4%26spage%3D335%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Shen  Liu</span>, <span class="hlFld-ContribAuthor ">Binhui  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao  Guo</span>, <span class="hlFld-ContribAuthor ">Yongping  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of polysubstituted 4-aminopyrazoles and 4-hydroxypyrazoles from vinyl azides and hydrazines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (41)
                                     , 32740-32743. <a href="https://doi.org/10.1039/C5RA04371A" title="DOI URL">https://doi.org/10.1039/C5RA04371A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA04371A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA04371A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Bof%252Bpolysubstituted%252B4-aminopyrazoles%252Band%252B4-hydroxypyrazoles%252Bfrom%252Bvinyl%252Bazides%252Band%252Bhydrazines%26aulast%3DHuang%26aufirst%3DWei%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D41%26spage%3D32740%26epage%3D32743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miha  Drev</span>, <span class="hlFld-ContribAuthor ">Uroš  Grošelj</span>, <span class="hlFld-ContribAuthor ">Špela  Mevec</span>, <span class="hlFld-ContribAuthor ">Eva  Pušavec</span>, <span class="hlFld-ContribAuthor ">Janja  Štrekelj</span>, <span class="hlFld-ContribAuthor ">Amalija  Golobič</span>, <span class="hlFld-ContribAuthor ">Georg  Dahmann</span>, <span class="hlFld-ContribAuthor ">Branko  Stanovnik</span>, <span class="hlFld-ContribAuthor ">Jurij  Svete</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective synthesis of 1- and 4-substituted 7-oxopyrazolo[1,5-a]pyrimidine-3-carboxamides. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (44)
                                     , 8267-8279. <a href="https://doi.org/10.1016/j.tet.2014.09.020" title="DOI URL">https://doi.org/10.1016/j.tet.2014.09.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.09.020%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DRegioselective%252Bsynthesis%252Bof%252B1-%252Band%252B4-substituted%252B7-oxopyrazolo%25255B1%25252C5-a%25255Dpyrimidine-3-carboxamides%26aulast%3DDrev%26aufirst%3DMiha%26date%3D2014%26volume%3D70%26issue%3D44%26spage%3D8267%26epage%3D8279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haeun  Jung</span>, <span class="hlFld-ContribAuthor ">Seri  Bae</span>, <span class="hlFld-ContribAuthor ">Ha-Lim  Jang</span>, <span class="hlFld-ContribAuthor ">Jung Min  Joo</span>. </span><span class="cited-content_cbyCitation_article-title">C-H Arylation of Nitroimidazoles and Nitropyrazoles Guided by the Electronic Effect of the Nitro Group. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2014,</strong> <em>35 </em>
                                    (10)
                                     , 3009-3014. <a href="https://doi.org/10.5012/bkcs.2014.35.10.3009" title="DOI URL">https://doi.org/10.5012/bkcs.2014.35.10.3009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5012/bkcs.2014.35.10.3009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5012%2Fbkcs.2014.35.10.3009%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DC-H%252BArylation%252Bof%252BNitroimidazoles%252Band%252BNitropyrazoles%252BGuided%252Bby%252Bthe%252BElectronic%252BEffect%252Bof%252Bthe%252BNitro%252BGroup%26aulast%3DJung%26aufirst%3DHaeun%26date%3D2014%26volume%3D35%26issue%3D10%26spage%3D3009%26epage%3D3014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Li</span>, <span class="hlFld-ContribAuthor ">Bao-Xiang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Progress of the synthesis of condensed pyrazole derivatives (from 2010 to mid-2013). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>85 </em>, 311-340. <a href="https://doi.org/10.1016/j.ejmech.2014.07.102" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.07.102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.07.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.07.102%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bof%252Bthe%252Bsynthesis%252Bof%252Bcondensed%252Bpyrazole%252Bderivatives%252B%252528from%252B2010%252Bto%252Bmid-2013%252529%26aulast%3DLi%26aufirst%3DMeng%26date%3D2014%26volume%3D85%26spage%3D311%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian W  Dymock</span>, <span class="hlFld-ContribAuthor ">Eugene Guorong  Yang</span>, <span class="hlFld-ContribAuthor ">Yuyi  Chu-Farseeva</span>, <span class="hlFld-ContribAuthor ">Lianbin  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Selective JAK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (12)
                                     , 1439-1471. <a href="https://doi.org/10.4155/fmc.14.92" title="DOI URL">https://doi.org/10.4155/fmc.14.92</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.92%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSelective%252BJAK%252Binhibitors%26aulast%3DDymock%26aufirst%3DBrian%2BW%26date%3D2014%26volume%3D6%26issue%3D12%26spage%3D1439%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christel J  Menet</span>. </span><span class="cited-content_cbyCitation_article-title">Toward selective TYK2 inhibitors as therapeutic agents for the treatment of inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2014,</strong> <em>3 </em>
                                    (4)
                                     , 449-466. <a href="https://doi.org/10.4155/ppa.14.23" title="DOI URL">https://doi.org/10.4155/ppa.14.23</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa.14.23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa.14.23%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DToward%252Bselective%252BTYK2%252Binhibitors%252Bas%252Btherapeutic%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252Binflammatory%252Bdiseases%26aulast%3DMenet%26aufirst%3DChristel%2BJ%26date%3D2014%26volume%3D3%26issue%3D4%26spage%3D449%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sophia  Pinz</span>, <span class="hlFld-ContribAuthor ">Samy  Unser</span>, <span class="hlFld-ContribAuthor ">Anne  Rascle</span>, . </span><span class="cited-content_cbyCitation_article-title">The Natural Chemopreventive Agent Sulforaphane Inhibits STAT5 Activity. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (6)
                                     , e99391. <a href="https://doi.org/10.1371/journal.pone.0099391" title="DOI URL">https://doi.org/10.1371/journal.pone.0099391</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0099391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0099391%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DThe%252BNatural%252BChemopreventive%252BAgent%252BSulforaphane%252BInhibits%252BSTAT5%252BActivity%26aulast%3DPinz%26aufirst%3DSophia%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D6%26spage%3De99391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J  Adam</span>, <span class="hlFld-ContribAuthor ">M  Yang</span>, <span class="hlFld-ContribAuthor ">T  Soga</span>, <span class="hlFld-ContribAuthor ">P J  Pollard</span>. </span><span class="cited-content_cbyCitation_article-title">Rare insights into cancer biology. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2014,</strong> <em>33 </em>
                                    (20)
                                     , 2547-2556. <a href="https://doi.org/10.1038/onc.2013.222" title="DOI URL">https://doi.org/10.1038/onc.2013.222</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/onc.2013.222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fonc.2013.222%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DRare%252Binsights%252Binto%252Bcancer%252Bbiology%26aulast%3DAdam%26aufirst%3DJ%26date%3D2014%26date%3D2013%26volume%3D33%26issue%3D20%26spage%3D2547%26epage%3D2556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sophia  Pinz</span>, <span class="hlFld-ContribAuthor ">Samy  Unser</span>, <span class="hlFld-ContribAuthor ">Susanne  Brueggemann</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Besl</span>, <span class="hlFld-ContribAuthor ">Nafisah  Al-Rifai</span>, <span class="hlFld-ContribAuthor ">Hermina  Petkes</span>, <span class="hlFld-ContribAuthor ">Sabine  Amslinger</span>, <span class="hlFld-ContribAuthor ">Anne  Rascle</span>, . </span><span class="cited-content_cbyCitation_article-title">The Synthetic α-Bromo-2′,3,4,4′-Tetramethoxychalcone (α-Br-TMC) Inhibits the JAK/STAT Signaling Pathway. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (3)
                                     , e90275. <a href="https://doi.org/10.1371/journal.pone.0090275" title="DOI URL">https://doi.org/10.1371/journal.pone.0090275</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0090275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0090275%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DThe%252BSynthetic%252B%2525CE%2525B1-Bromo-2%2525E2%252580%2525B2%25252C3%25252C4%25252C4%2525E2%252580%2525B2-Tetramethoxychalcone%252B%252528%2525CE%2525B1-Br-TMC%252529%252BInhibits%252Bthe%252BJAK%25252FSTAT%252BSignaling%252BPathway%26aulast%3DPinz%26aufirst%3DSophia%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D3%26spage%3De90275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jake R.  Zimmerman</span>, <span class="hlFld-ContribAuthor ">Brian J.  Myers</span>, <span class="hlFld-ContribAuthor ">Samantha  Bouhall</span>, <span class="hlFld-ContribAuthor ">Allison  McCarthy</span>, <span class="hlFld-ContribAuthor ">Olivia  Johntony</span>, <span class="hlFld-ContribAuthor ">Madhuri  Manpadi</span>. </span><span class="cited-content_cbyCitation_article-title">A two-step, single pot procedure for the synthesis of substituted dihydropyrazolo-pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (4)
                                     , 936-940. <a href="https://doi.org/10.1016/j.tetlet.2013.12.057" title="DOI URL">https://doi.org/10.1016/j.tetlet.2013.12.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2013.12.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2013.12.057%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Btwo-step%25252C%252Bsingle%252Bpot%252Bprocedure%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bsubstituted%252Bdihydropyrazolo-pyrimidines%26aulast%3DZimmerman%26aufirst%3DJake%2BR.%26date%3D2014%26volume%3D55%26issue%3D4%26spage%3D936%26epage%3D940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petr  Cankař</span>, <span class="hlFld-ContribAuthor ">Lukáš  Jedinák</span>, <span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>, <span class="hlFld-ContribAuthor ">Zdeněk  Trávníček</span>. </span><span class="cited-content_cbyCitation_article-title">Multicomponent and Regioselective Synthesis of Dihydropyrazolo[1,5-a]pyrimidines from Aromatic Aldehydes, Meldrum’s Acid, and Aminopyrazole CAN508. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2014,</strong> <em>89 </em>
                                    (8)
                                     , 1892. <a href="https://doi.org/10.3987/COM-14-13026" title="DOI URL">https://doi.org/10.3987/COM-14-13026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-14-13026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-14-13026%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DMulticomponent%252Band%252BRegioselective%252BSynthesis%252Bof%252BDihydropyrazolo%25255B1%25252C5-a%25255Dpyrimidines%252Bfrom%252BAromatic%252BAldehydes%25252C%252BMeldrum%2525E2%252580%252599s%252BAcid%25252C%252Band%252BAminopyrazole%252BCAN508%26aulast%3DCanka%25C5%2599%26aufirst%3DPetr%26date%3D2014%26volume%3D89%26issue%3D8%26spage%3D1892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sizana  Ahmetaj</span>, <span class="hlFld-ContribAuthor ">Nina  Velikanje</span>, <span class="hlFld-ContribAuthor ">Uroš  Grošelj</span>, <span class="hlFld-ContribAuthor ">Ines  Šterbal</span>, <span class="hlFld-ContribAuthor ">Benjamin  Prek</span>, <span class="hlFld-ContribAuthor ">Amalija  Golobič</span>, <span class="hlFld-ContribAuthor ">Drago  Kočar</span>, <span class="hlFld-ContribAuthor ">Georg  Dahmann</span>, <span class="hlFld-ContribAuthor ">Branko  Stanovnik</span>, <span class="hlFld-ContribAuthor ">Jurij  Svete</span>. </span><span class="cited-content_cbyCitation_article-title">Parallel synthesis of 7-heteroaryl-pyrazolo[1,5-a]pyrimidine-3-carboxamides. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2013,</strong> <em>17 </em>
                                    (4)
                                     , 731-743. <a href="https://doi.org/10.1007/s11030-013-9469-3" title="DOI URL">https://doi.org/10.1007/s11030-013-9469-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-013-9469-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-013-9469-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DParallel%252Bsynthesis%252Bof%252B7-heteroaryl-pyrazolo%25255B1%25252C5-a%25255Dpyrimidine-3-carboxamides%26aulast%3DAhmetaj%26aufirst%3DSizana%26date%3D2013%26date%3D2013%26volume%3D17%26issue%3D4%26spage%3D731%26epage%3D743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sharada  Labadie</span>, <span class="hlFld-ContribAuthor ">Kathy  Barrett</span>, <span class="hlFld-ContribAuthor ">Wade S.  Blair</span>, <span class="hlFld-ContribAuthor ">Christine  Chang</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Paul  Gibbons</span>, <span class="hlFld-ContribAuthor ">Adam  Johnson</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">Pawan Bir  Kohli</span>, <span class="hlFld-ContribAuthor ">Marya  Liimatta</span>, <span class="hlFld-ContribAuthor ">Patrick J.  Lupardus</span>, <span class="hlFld-ContribAuthor ">Steven  Shia</span>, <span class="hlFld-ContribAuthor ">Micah  Steffek</span>, <span class="hlFld-ContribAuthor ">Savita  Ubhayakar</span>, <span class="hlFld-ContribAuthor ">Anne van  Abbema</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>. </span><span class="cited-content_cbyCitation_article-title">Design and evaluation of novel 8-oxo-pyridopyrimidine Jak1/2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (21)
                                     , 5923-5930. <a href="https://doi.org/10.1016/j.bmcl.2013.08.082" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.08.082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.08.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.08.082%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bevaluation%252Bof%252Bnovel%252B8-oxo-pyridopyrimidine%252BJak1%25252F2%252Binhibitors%26aulast%3DLabadie%26aufirst%3DSharada%26date%3D2013%26volume%3D23%26issue%3D21%26spage%3D5923%26epage%3D5930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian W  Dymock</span>, <span class="hlFld-ContribAuthor ">Cheng Shang  See</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 – 2012. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (4)
                                     , 449-501. <a href="https://doi.org/10.1517/13543776.2013.765862" title="DOI URL">https://doi.org/10.1517/13543776.2013.765862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.765862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.765862%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DInhibitors%252Bof%252BJAK2%252Band%252BJAK3%25253A%252Ban%252Bupdate%252Bon%252Bthe%252Bpatent%252Bliterature%252B2010%252B%2525E2%252580%252593%252B2012%26aulast%3DDymock%26aufirst%3DBrian%2BW%26date%3D2013%26date%3D2013%26volume%3D23%26issue%3D4%26spage%3D449%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anton M.  Prokhorov</span>, <span class="hlFld-ContribAuthor ">Dmitry N.  Kozhevnikov</span>. </span><span class="cited-content_cbyCitation_article-title">Triazines, Tetrazines, and Fused Ring Polyaza Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 391-408. <a href="https://doi.org/10.1016/B978-0-08-099406-2.00015-7" title="DOI URL">https://doi.org/10.1016/B978-0-08-099406-2.00015-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-099406-2.00015-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-099406-2.00015-7%26sid%3Dliteratum%253Aachs%26atitle%3DTriazines%25252C%252BTetrazines%25252C%252Band%252BFused%252BRing%252BPolyaza%252BSystems%26aulast%3DProkhorov%26aufirst%3DAnton%2BM.%26date%3D2013%26spage%3D391%26epage%3D408%26pub%3DElsevier%26date%3D2013%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of Jak2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Procedure for 5-Amino-pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) 21% EtONa, EtOH, 95%; (b) HOAc, H<sub>2</sub>O, 85%; (c) <i>N</i>-iodosuccinimide, DMF, 86%; (d) CO (1 atm), Pd(OAc)<sub>2</sub>, Et<sub>3</sub>N, MeOH; (e) 5% aq LiOH, 68% (2 steps); (f) POCl<sub>3</sub>, DIPEA, 87%; (g) H<sub>2</sub>NR, DIPEA, DCM, 52–92%; (h) NH<sub>3</sub>, iPrOH, DIPEA, μW 120 °C, 15 min, 9–80%; (i) H<sub>2</sub>NCH<sub>3</sub>, H<sub>2</sub>O, μW 100 °C, 15 min, 62%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Procedure for Compounds <b>8</b>–<b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) RNH<sub>2</sub>, HATU or PyAOP, DIPEA, DMAP, 20–90%; (b) (COCl)<sub>2</sub>, DCM; (c) 2-bromopyridin-3-amine or 3-bromopyridin-4-amine or <b>17</b>, Et<sub>3</sub>N, DCM, 21–56%; (d) 3-chlorophenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, H<sub>2</sub>O, μW, 120 °C, 42–59%; (e) 3-chlorophenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, diglyme, 100 °C, 7%; (f) R<sup>3</sup>-X, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 5–61%; (g) subsituted oxirane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 46%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Aminopyridine <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) mCPBA, DCM, 99%; (b) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, 90%; (c) SnCl<sub>2</sub>, HCl, 56%.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. 2-Bromo-1-phenylethanone-Based Synthesis of 1-Methyl-3-phenyl-1<i>H</i>-pyrazol-4-amines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) potassium phthalimide, 88%; (b) HN(Boc)<sub>2</sub>, NaH, 34–77%; (c) DMFDMA, 38–80%; (d) methylhydrazine, EtOH, 38–53%; (e) hydrazine, EtOH, 80%.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0010.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Benzoic Acid Based Synthesis of 3-(5-Chloro-2-methylphenyl)-1-methyl-1<i>H</i>-pyrazol-4-amine<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) potassium ethyl malonate, CDI, MgCl<sub>2</sub>, THF, 50 °C; (b) potassium ethyl malonate, Et<sub>3</sub>N, MgCl<sub>2</sub>, CH<sub>3</sub>CN; (c) DMFDMA, 34–70% (2 steps); (d) hydrazine, EtOH, 70 °C, quant; (e) CH<sub>3</sub>I, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 40 °C, 81%; (f) methylhydrazine, AcOH, 45%; (g) NaOH, EtOH/H<sub>2</sub>O; (h) (PhO)<sub>2</sub>P(O)N<sub>3</sub>, Et<sub>3</sub>N, 1,4-dioxane, tBuOH; (i) HCl, 1,4-dioxane, 37–46% (3 steps).</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0011.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. 4-Nitropyrazole CH-arylation Synthesis of <b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) SEM-Cl, NaH, THF, 99%; (b) 2-bromo-4-chloro-1-methoxybenzene, Pd(OAc)<sub>2</sub>, (Ad)<sub>2</sub>BuP, K<sub>2</sub>CO<sub>3</sub>, tBuCO<sub>2</sub>H, DMF, 120 °C, 89%; (c) Fe, NH<sub>4</sub>Cl, EtOH, H<sub>2</sub>O, 70 °C, quant.</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0012.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Aminoisoxazole <b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) diethyl carbonate, NaH, toluene, rt to reflux, 51%; (b) DMFDMA, DMF, reflux; (c) NH<sub>2</sub>OH-HCl, MeOH, reflux, 79% (2 steps); (d) HCl, AcOH, reflux; (e) SOCl<sub>2</sub>, reflux, NaN<sub>3</sub>, acetone, 0 °C to rt, tBuOH, 85 °C, 55% (2 steps); (f) 4 M HCl in 1,4-dioxane, 40 °C, quant.</p></p></figure><figure data-id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0013.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Aminoisoxazole <b>42</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) NH<sub>2</sub>OH-HCl, pyridine, EtOH, quant; (b) NCS, DMF, quant; (c) ethyl propiolate, toluene, 94%; (d) Et<sub>3</sub>N, Et<sub>2</sub>O, 57%; (e) HCl, AcOH, reflux, 99%; (f) (PhO)<sub>2</sub>P(O)N<sub>3</sub>, Et<sub>3</sub>N, tBuOH, 85 °C, 77%; (g) 4 M HCl in 1,4-dioxane, 97%.</p></p></figure><figure data-id="sch9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0014.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Aminothiazole <b>43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) powdered sulfur, EtOH, 0 °C; (b) acetaldehyde, Et<sub>3</sub>N, EtOH, 60 °C, 73% (2 steps).</p></p></figure><figure data-id="fig2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0003.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Co-crystal structure (2.3 Å) of compound <b>8</b> in the active site of the Jak2 kinase domain with the P-loop removed to allow a better view of the key active site interactions. Dashed lines indicate close contacts between ligand and protein with distances labeled in Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0004.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Potential reactive metabolites of the 3-methyl-<i>N</i>-aryl-methylpyrazole scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/medium/jm-2012-012239_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0005.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. PK/PD study of <b>7j</b> at an oral dose of 100 mg/kg in a SET2 xenograft model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3012239/production/images/large/jm-2012-012239_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3012239&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i85">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17672" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17672" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 45 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Yamaoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saharinen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, V. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvennoinen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">The Janus kinases (Jaks)</span> <span class="citation_source-journal">Genome Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=253&author=K.+Yamaokaauthor=P.+Saharinenauthor=M.+Pesuauthor=V.+E.+Holtauthor=O.+Silvennoinenauthor=J.+J.+O%E2%80%99Shea&title=The+Janus+kinases+%28Jaks%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamaoka%26aufirst%3DK.%26aulast%3DSaharinen%26aufirst%3DP.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DHolt%26aufirst%3DV.%2BE.%26aulast%3DSilvennoinen%26aufirst%3DO.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520Janus%2520kinases%2520%2528Jaks%2529%26jtitle%3DGenome%2520Biol.%26date%3D2004%26volume%3D5%26spage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Aaronson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, C. M.</span><span> </span><span class="NLM_article-title">A road map for those who don’t know JAK-STAT</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">1653</span><span class="NLM_x">–</span> <span class="NLM_lpage">1655</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=1653-1655&author=D.+S.+Aaronsonauthor=C.+M.+Horvath&title=A+road+map+for+those+who+don%E2%80%99t+know+JAK-STAT"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAaronson%26aufirst%3DD.%2BS.%26aulast%3DHorvath%26aufirst%3DC.%2BM.%26atitle%3DA%2520road%2520map%2520for%2520those%2520who%2520don%25E2%2580%2599t%2520know%2520JAK-STAT%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D1653%26epage%3D1655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kisseleva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braunstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, C. W.</span><span> </span><span class="NLM_article-title">Signaling through the JAK/STAT pathway, recent advances and future challenges</span> <span class="citation_source-journal">Gene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2002&pages=1-24&author=T.+Kisselevaauthor=S.+Bhattacharyaauthor=J.+Braunsteinauthor=C.+W.+Schindler&title=Signaling+through+the+JAK%2FSTAT+pathway%2C+recent+advances+and+future+challenges"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKisseleva%26aufirst%3DT.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DBraunstein%26aufirst%3DJ.%26aulast%3DSchindler%26aufirst%3DC.%2BW.%26atitle%3DSignaling%2520through%2520the%2520JAK%252FSTAT%2520pathway%252C%2520recent%2520advances%2520and%2520future%2520challenges%26jtitle%3DGene%26date%3D2002%26volume%3D285%26spage%3D1%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, R. D.</span><span> </span><span class="NLM_article-title">Cytokine signaling in 2002: new surprises in the Jak/Stat pathway</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl</span><span class="NLM_x">) </span> <span class="NLM_fpage">S121</span><span class="NLM_x">–</span> <span class="NLM_lpage">S131</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=S121-S131&issue=Suppl&author=J.+J.+O%E2%80%99Sheaauthor=M.+Gadinaauthor=R.+D.+Schreiber&title=Cytokine+signaling+in+2002%3A+new+surprises+in+the+Jak%2FStat+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DGadina%26aufirst%3DM.%26aulast%3DSchreiber%26aufirst%3DR.%2BD.%26atitle%3DCytokine%2520signaling%2520in%25202002%253A%2520new%2520surprises%2520in%2520the%2520Jak%252FStat%2520pathway%26jtitle%3DCell%26date%3D2002%26volume%3D109%26issue%3DSuppl%26spage%3DS121%26epage%3DS131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Heinrich, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrmann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermanns, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller-Newen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaper, F.</span><span> </span><span class="NLM_article-title">Principles of interleukin (IL)-6-type cytokine signalling and its regulation</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2003&pages=1-20&author=P.+C.+Heinrichauthor=I.+Behrmannauthor=S.+Haanauthor=H.+M.+Hermannsauthor=G.+Muller-Newenauthor=F.+Schaper&title=Principles+of+interleukin+%28IL%29-6-type+cytokine+signalling+and+its+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DP.%2BC.%26aulast%3DBehrmann%26aufirst%3DI.%26aulast%3DHaan%26aufirst%3DS.%26aulast%3DHermanns%26aufirst%3DH.%2BM.%26aulast%3DMuller-Newen%26aufirst%3DG.%26aulast%3DSchaper%26aufirst%3DF.%26atitle%3DPrinciples%2520of%2520interleukin%2520%2528IL%2529-6-type%2520cytokine%2520signalling%2520and%2520its%2520regulation%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D374%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Baxter, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">East, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fourouclas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassiliou, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bench, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erber, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. R.</span><span> </span><span class="NLM_article-title">Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">1054</span><span class="NLM_x">–</span> <span class="NLM_lpage">1061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1016%2FS0140-6736%2805%2971142-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=15781101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFGrs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2005&pages=1054-1061&author=E.+J.+Baxterauthor=L.+M.+Scottauthor=P.+J.+Campbellauthor=C.+Eastauthor=N.+Fourouclasauthor=S.+Swantonauthor=G.+S.+Vassiliouauthor=A.+J.+Benchauthor=E.+M.+Boydauthor=N.+Curtinauthor=M.+A.+Scottauthor=W.+N.+Erberauthor=A.+R.+Green&title=Acquired+mutation+of+the+tyrosine+kinase+JAK2+in+human+myeloproliferative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders</span></div><div class="casAuthors">Baxter, E. Joanna; Scott, Linda M.; Campbell, Peter J.; East, Clare; Fourouclas, Nasios; Swanton, Soheila; Vassiliou, George S.; Bench, Anthony J.; Boyd, Elaine M.; Curtin, Natasha; Scott, Mike A.; Erber, Wendy N.; Green, Anthony R.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">9464</span>),
    <span class="NLM_cas:pages">1054-1061</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Background: Human myeloproliferative disorders form a range of clonal haematol. malignant diseases, the main members of which are polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis.  The mol. pathogenesis of these disorders is unknown, but tyrosine kinases have been implicated in several related disorders.  We investigated the role of the cytoplasmic tyrosine kinase JAK2 in patients with a myeloproliferative disorder.  Methods: We obtained DNA samples from patients with polycythemia vera, essential thrombocythemia, or idiopathic myelofibrosis.  The coding exons of JAK2 were bidirectionally sequenced from peripheral-blood granulocytes, T cells, or both.  Allele-specific PCR, mol. cytogenetic studies, microsatellite PCR, Affymetrix single nucleotide polymorphism array analyses, and colony assays were undertaken on subgroups of patients.  Findings: A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythemia vera, 29 (57%) of 51 with essential thrombocythemia, and eight (50%) of 16 with idiopathic myelofibrosis.  The mutation is acquired, is present in a variable proportion of granulocytes, alters a highly conserved valine present in the neg. regulatory JH2 domain, and is predicted to dysregulate kinase activity.  It was heterozygous in most patients, homozygous in a subset as a result of mitotic recombination, and arose in a multipotent progenitor capable of giving rise to erythroid and myeloid cells.  The mutation was present in all erythropoietin-independent erythroid colonies.  Interpretation: A single acquired mutation of JAK2 was noted in more than half of patients with a myeloproliferative disorder.  Its presence in all erythropoietin-independent erythroid colonies demonstrates a link with growth factor hypersensitivity, a key biol. feature of these disorders.  Relevance to practice: Identification of the Val617Phe JAK2 mutation lays the foundation for new approaches to the diagnosis, classification, and treatment of myeloproliferative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8cc-kg2leZrVg90H21EOLACvtfcHk0ljcPif_drztZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFGrs7g%253D&md5=3c9dc565a1986a47d12e4bccd8c8cc1a</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2971142-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252971142-9%26sid%3Dliteratum%253Aachs%26aulast%3DBaxter%26aufirst%3DE.%2BJ.%26aulast%3DScott%26aufirst%3DL.%2BM.%26aulast%3DCampbell%26aufirst%3DP.%2BJ.%26aulast%3DEast%26aufirst%3DC.%26aulast%3DFourouclas%26aufirst%3DN.%26aulast%3DSwanton%26aufirst%3DS.%26aulast%3DVassiliou%26aufirst%3DG.%2BS.%26aulast%3DBench%26aufirst%3DA.%2BJ.%26aulast%3DBoyd%26aufirst%3DE.%2BM.%26aulast%3DCurtin%26aufirst%3DN.%26aulast%3DScott%26aufirst%3DM.%2BA.%26aulast%3DErber%26aufirst%3DW.%2BN.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26atitle%3DAcquired%2520mutation%2520of%2520the%2520tyrosine%2520kinase%2520JAK2%2520in%2520human%2520myeloproliferative%2520disorders%26jtitle%3DLancet%26date%3D2005%26volume%3D365%26spage%3D1054%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">James, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Couedic, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staerk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delhommeau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacout, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raslova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennaceur-Griscelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villeval, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constantinescu, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadevall, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vainchenker, W.</span><span> </span><span class="NLM_article-title">A unique clonal JAK2 mutation leading to constitutive signaling causes polycythaemia vera</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=1144-1148&author=C.+Jamesauthor=V.+Ugoauthor=J.-P.+Le+Couedicauthor=J.+Staerkauthor=F.+Delhommeauauthor=C.+Lacoutauthor=L.+Garconauthor=H.+Raslovaauthor=R.+Bergerauthor=A.+Bennaceur-Griscelliauthor=J.+L.+Villevalauthor=S.+N.+Constantinescuauthor=N.+Casadevallauthor=W.+Vainchenker&title=A+unique+clonal+JAK2+mutation+leading+to+constitutive+signaling+causes+polycythaemia+vera"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DC.%26aulast%3DUgo%26aufirst%3DV.%26aulast%3DLe%2BCouedic%26aufirst%3DJ.-P.%26aulast%3DStaerk%26aufirst%3DJ.%26aulast%3DDelhommeau%26aufirst%3DF.%26aulast%3DLacout%26aufirst%3DC.%26aulast%3DGarcon%26aufirst%3DL.%26aulast%3DRaslova%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DBennaceur-Griscelli%26aufirst%3DA.%26aulast%3DVilleval%26aufirst%3DJ.%2BL.%26aulast%3DConstantinescu%26aufirst%3DS.%2BN.%26aulast%3DCasadevall%26aufirst%3DN.%26aulast%3DVainchenker%26aufirst%3DW.%26atitle%3DA%2520unique%2520clonal%2520JAK2%2520mutation%2520leading%2520to%2520constitutive%2520signaling%2520causes%2520polycythaemia%2520vera%26jtitle%3DNature%26date%3D2005%26volume%3D434%26spage%3D1144%26epage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kralovics, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passamonti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teo, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiedt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passweg, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tichelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazzola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skoda, R. C.</span><span> </span><span class="NLM_article-title">A gain-of-function mutation of JAK2 in myeloproliferative disorders</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">1779</span><span class="NLM_x">–</span> <span class="NLM_lpage">1790</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1056%2FNEJMoa051113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=15858187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsFyhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=1779-1790&author=R.+Kralovicsauthor=F.+Passamontiauthor=A.+S.+Buserauthor=S.-S.+Teoauthor=R.+Tiedtauthor=J.+R.+Passwegauthor=A.+Tichelliauthor=M.+Cazzolaauthor=R.+C.+Skoda&title=A+gain-of-function+mutation+of+JAK2+in+myeloproliferative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">A gain-of-function mutation of JAK2 in myeloproliferative disorders</span></div><div class="casAuthors">Kralovics, Robert; Passamonti, Francesco; Buser, Andreas S.; Teo, Soon-Siong; Tiedt, Ralph; Passweg, Jakob R.; Tichelli, Andre; Cazzola, Mario; Skoda, Radek C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1779-1790</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are clonal myeloproliferative disorders arising from a multi-potent progenitor.  The loss of heterozygosity (LOH) on the short arm of chromosome 9 (9pLOH) in myeloproliferative disorders suggests that 9p harbors a mutation that contributes to the cause of clonal expansion of hematopoietic cells in these diseases.  METHODS We performed microsatellite mapping of the 9pLOH region and DNA sequencing in 244 patients with myeloproliferative disorders (128 with polycythemia vera, 93 with essential thrombocythemia, and 23 with idiopathic myelofibrosis).  RESULTS Microsatellite mapping identified a 9pLOH region that included the Janus kinase 2 (JAK2) gene.  In patients with 9pLOH, JAK2 had a homozygous G→T transversion, causing phenylalanine to be substituted for valine at position 617 of JAK2 (V617F).  All 51 patients with 9pLOH had the V617F mutation.  Of 193 patients without 9pLOH, 66 were heterozygous for V617F and 127 did not have the mutation.  The frequency of V617F was 65 % among patients with polycythemia vera (83 of 128), 57 % among patients with idiopathic myelofibrosis (13 of 23), and 23 % among patients with essential thrombocythemia (21 of 93).  V617F is a somatic mutation present in hematopoietic cells.  Mitotic recombination probably causes both 9pLOH and the transition from heterozygosity to homozygosity for V617F.  Genetic evidence and in vitro functional studies indicate that V617F gives hematopoietic precursors proliferative and survival advantages.  Patients with the V617F mutation had a significantly longer duration of disease and a higher rate of complications (fibrosis, hemorrhage, and thrombosis) and treatment with cytoreductive therapy than patients with wild-type JAK2.  CONCLUSIONS A high proportion of patients with myeloproliferative disorders carry a dominant gain-of-function mutation of JAK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqTe7EsB_527Vg90H21EOLACvtfcHk0lj7m3qWTIBP7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsFyhsLw%253D&md5=5dd4bc090ded1c812b61923cad36e77e</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa051113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa051113%26sid%3Dliteratum%253Aachs%26aulast%3DKralovics%26aufirst%3DR.%26aulast%3DPassamonti%26aufirst%3DF.%26aulast%3DBuser%26aufirst%3DA.%2BS.%26aulast%3DTeo%26aufirst%3DS.-S.%26aulast%3DTiedt%26aufirst%3DR.%26aulast%3DPassweg%26aufirst%3DJ.%2BR.%26aulast%3DTichelli%26aufirst%3DA.%26aulast%3DCazzola%26aufirst%3DM.%26aulast%3DSkoda%26aufirst%3DR.%2BC.%26atitle%3DA%2520gain-of-function%2520mutation%2520of%2520JAK2%2520in%2520myeloproliferative%2520disorders%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D1779%26epage%3D1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadleigh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cools, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wlodarska, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelsperger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercher, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frohling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marynen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberghe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesa, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span> </span><span class="NLM_article-title">Activating mutation in the tyrosine kinase JAK2 in polycythemia vera essential thrombocythemia, and myeloid metaplasia with myelofibrosis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=387-397&author=R.+L.+Levineauthor=M.+Wadleighauthor=J.+Coolsauthor=B.+L.+Ebertauthor=G.+Wernigauthor=B.+J.+Huntlyauthor=T.+J.+Boggonauthor=I.+Wlodarskaauthor=J.+J.+Clarkauthor=S.+Mooreauthor=J.+Adelspergerauthor=S.+Kooauthor=J.+C.+Leeauthor=S.+Gabrielauthor=T.+Mercherauthor=A.+D%E2%80%99Andreaauthor=S.+Frohlingauthor=K.+Dohnerauthor=P.+Marynenauthor=P.+Vandenbergheauthor=R.+A.+Mesaauthor=A.+Tefferiauthor=J.+D.+Griffinauthor=M.+J.+Eckauthor=W.+R.+Sellersauthor=M.+Meyersonauthor=T.+R.+Golubauthor=S.+J.+Leeauthor=D.+G.+Gilliland&title=Activating+mutation+in+the+tyrosine+kinase+JAK2+in+polycythemia+vera+essential+thrombocythemia%2C+and+myeloid+metaplasia+with+myelofibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DWadleigh%26aufirst%3DM.%26aulast%3DCools%26aufirst%3DJ.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DWernig%26aufirst%3DG.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DWlodarska%26aufirst%3DI.%26aulast%3DClark%26aufirst%3DJ.%2BJ.%26aulast%3DMoore%26aufirst%3DS.%26aulast%3DAdelsperger%26aufirst%3DJ.%26aulast%3DKoo%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DMercher%26aufirst%3DT.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%26aulast%3DFrohling%26aufirst%3DS.%26aulast%3DDohner%26aufirst%3DK.%26aulast%3DMarynen%26aufirst%3DP.%26aulast%3DVandenberghe%26aufirst%3DP.%26aulast%3DMesa%26aufirst%3DR.%2BA.%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26atitle%3DActivating%2520mutation%2520in%2520the%2520tyrosine%2520kinase%2520JAK2%2520in%2520polycythemia%2520vera%2520essential%2520thrombocythemia%252C%2520and%2520myeloid%2520metaplasia%2520with%2520myelofibrosis%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D387%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krantz, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z. J.</span><span> </span><span class="NLM_article-title">Identification of an acquired JAK2 mutation in polycythemia vera</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">22788</span><span class="NLM_x">–</span> <span class="NLM_lpage">22792</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=22788-22792&author=R.+Zhaoauthor=S.+Xingauthor=Z.+Liauthor=X.+Fuauthor=Q.+Liauthor=S.+B.+Krantzauthor=Z.+J.+Zhao&title=Identification+of+an+acquired+JAK2+mutation+in+polycythemia+vera"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DXing%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DKrantz%26aufirst%3DS.%2BB.%26aulast%3DZhao%26aufirst%3DZ.%2BJ.%26atitle%3DIdentification%2520of%2520an%2520acquired%2520JAK2%2520mutation%2520in%2520polycythemia%2520vera%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D22788%26epage%3D22792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardanani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span> </span><span class="NLM_article-title">Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1038%2Fnrc2210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=17721432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFSjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=673-683&author=R.+L.+Levineauthor=A.+Pardananiauthor=A.+Tefferiauthor=D.+G.+Gilliland&title=Role+of+JAK2+in+the+pathogenesis+and+therapy+of+myeloproliferative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3fR"><div class="casContent"><span class="casTitleNuber">3f</span><div class="casTitle"><span class="NLM_cas:atitle">Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders</span></div><div class="casAuthors">Levine, Ross L.; Pardanani, Animesh; Tefferi, Ayalew; Gilliland, D. Gary</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">673-683</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The myeloproliferative disorders polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) are clonal disorders of multipotent hematopoietic progenitors.  The genetic cause of these diseases was not known until 2005, when several independent groups demonstrated that most patients with PV, ET and PMF acquire a single point mutation in the cytoplasmic tyrosine kinase JAK2 (JAK2V617F).  These discoveries have changed the landscape for diagnosis and classification of PV, ET and PMF, and show the ability of genomic technologies to identify new mol. targets in human malignancies with pathogenetic, diagnostic and therapeutic significance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ5nfhX3BsOrVg90H21EOLACvtfcHk0ljsnDBDF0Vfmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFSjsbg%253D&md5=89429b6786f421d06163a48540c03dcb</span></div><a href="/servlet/linkout?suffix=cit3f&amp;dbid=16384&amp;doi=10.1038%2Fnrc2210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2210%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DPardanani%26aufirst%3DA.%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26atitle%3DRole%2520of%2520JAK2%2520in%2520the%2520pathogenesis%2520and%2520therapy%2520of%2520myeloproliferative%2520disorders%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D673%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Campbell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. R.</span><span> </span><span class="NLM_article-title">The Myeloproliferative Disorders</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">2452</span><span class="NLM_x">–</span> <span class="NLM_lpage">2466</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1056%2FNEJMra063728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=17151367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12nt7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=2452-2466&author=P.+J.+Campbellauthor=A.+R.+Green&title=The+Myeloproliferative+Disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The myeloproliferative disorders</span></div><div class="casAuthors">Campbell, Peter J.; Green, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2452-2466</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The three main Philadelphia chromosome-neg. myeloproliferative disorders - polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis - are the focus of this article.  The altered genetics and pathogenesis of myeloproliferative disorders are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBxI0YeB02JrVg90H21EOLACvtfcHk0ljsnDBDF0Vfmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12nt7vN&md5=a3437f87672e934689348b7d0cf6935d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMra063728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra063728%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DP.%2BJ.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26atitle%3DThe%2520Myeloproliferative%2520Disorders%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D2452%26epage%3D2466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">James, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadevall, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constantinescu, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vainchenker, W.</span><span> </span><span class="NLM_article-title">A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospect</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">546</span><span class="NLM_x">–</span> <span class="NLM_lpage">554</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=546-554&author=C.+Jamesauthor=V.+Ugoauthor=N.+Casadevallauthor=S.+N.+Constantinescuauthor=W.+Vainchenker&title=A+JAK2+mutation+in+myeloproliferative+disorders%3A+pathogenesis+and+therapeutic+and+scientific+prospect"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DC.%26aulast%3DUgo%26aufirst%3DV.%26aulast%3DCasadevall%26aufirst%3DN.%26aulast%3DConstantinescu%26aufirst%3DS.%2BN.%26aulast%3DVainchenker%26aufirst%3DW.%26atitle%3DA%2520JAK2%2520mutation%2520in%2520myeloproliferative%2520disorders%253A%2520pathogenesis%2520and%2520therapeutic%2520and%2520scientific%2520prospect%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D546%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Wernig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharas, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okabe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullen, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doukas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noronha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span> </span><span class="NLM_article-title">Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1016%2Fj.ccr.2008.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=18394554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslSjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=311-320&author=G.+Wernigauthor=M.+G.+Kharasauthor=R.+Okabeauthor=S.+A.+Mooreauthor=D.+S.+Leemanauthor=D.+E.+Cullenauthor=M.+Gozoauthor=E.+P.+McDowellauthor=R.+L.+Levineauthor=J.+Doukasauthor=C.+C.+Makauthor=G.+Noronhaauthor=M.+Martinauthor=Y.+D.+Koauthor=B.+H.+Leeauthor=R.+M.+Sollauthor=A.+Tefferiauthor=J.+D.+Hoodauthor=D.+G.+Gilliland&title=Efficacy+of+TG101348%2C+a+selective+JAK2+inhibitor%2C+in+treatment+of+a+murine+model+of+JAK2V617F-induced+polycythemia+vera"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera</span></div><div class="casAuthors">Wernig, Gerlinde; Kharas, Michael G.; Okabe, Rachel; Moore, Sandra A.; Leeman, Dena S.; Cullen, Dana E.; Gozo, Maricel; McDowell, Elizabeth P.; Levine, Ross L.; Doukas, John; Mak, Chi Ching; Noronha, Glenn; Martin, Michael; Ko, Yon D.; Lee, Benjamin H.; Soll, Richard M.; Tefferi, Ayalew; Hood, John D.; Gilliland, D. Gary</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-320</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We report that TG101348, a selective small-mol. inhibitor of JAK2 with an in vitro IC50 of ∼3 nM, shows therapeutic efficacy in a murine model of myeloproliferative disease induced by the JAK2V617F mutation.  In treated animals, there was a statistically significant redn. in hematocrit and leukocyte count, a dose-dependent redn./elimination of extramedullary hematopoiesis, and, at least in some instances, evidence for attenuation of myelofibrosis.  There were no apparent toxicities and no effect on T cell no.  In vivo responses were correlated with surrogate endpoints, including redn./elimination of JAK2V617F disease burden assessed by quant. genomic PCR, suppression of endogenous erythroid colony formation, and in vivo inhibition of JAK-STAT signal transduction as assessed by flow cytometric measurement of phosphorylated Stat5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSJOc4cS_lO7Vg90H21EOLACvtfcHk0ljsnDBDF0Vfmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslSjtrs%253D&md5=3dd923595cafebb6439dd67f026735be</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2008.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2008.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DWernig%26aufirst%3DG.%26aulast%3DKharas%26aufirst%3DM.%2BG.%26aulast%3DOkabe%26aufirst%3DR.%26aulast%3DMoore%26aufirst%3DS.%2BA.%26aulast%3DLeeman%26aufirst%3DD.%2BS.%26aulast%3DCullen%26aufirst%3DD.%2BE.%26aulast%3DGozo%26aufirst%3DM.%26aulast%3DMcDowell%26aufirst%3DE.%2BP.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DDoukas%26aufirst%3DJ.%26aulast%3DMak%26aufirst%3DC.%2BC.%26aulast%3DNoronha%26aufirst%3DG.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DKo%26aufirst%3DY.%2BD.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DHood%26aufirst%3DJ.%2BD.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26atitle%3DEfficacy%2520of%2520TG101348%252C%2520a%2520selective%2520JAK2%2520inhibitor%252C%2520in%2520treatment%2520of%2520a%2520murine%2520model%2520of%2520JAK2V617F-induced%2520polycythemia%2520vera%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D13%26spage%3D311%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Hart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotny-Diermayr, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentze, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amalini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">William, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaraman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethirajulu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. W.</span><span> </span><span class="NLM_article-title">SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1751</span><span class="NLM_x">–</span> <span class="NLM_lpage">1759</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1751-1759&author=S.+Hartauthor=K.+C.+Gohauthor=V.+Novotny-Diermayrauthor=C.+Y.+Huauthor=H.+Hentzeauthor=Y.+C.+Tanauthor=B.+Madanauthor=C.+Amaliniauthor=Y.+K.+Lohauthor=L.+C.+Ongauthor=A.+D.+Williamauthor=A.+Leeauthor=A.+Poulsenauthor=R.+Jayaramanauthor=K.+H.+Ongauthor=K.+Ethirajuluauthor=B.+W.+Dymockauthor=J.+W.+Wood&title=SB1518%2C+a+novel+macrocyclic+pyrimidine-based+JAK2+inhibitor+for+the+treatment+of+myeloid+and+lymphoid+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DS.%26aulast%3DGoh%26aufirst%3DK.%2BC.%26aulast%3DNovotny-Diermayr%26aufirst%3DV.%26aulast%3DHu%26aufirst%3DC.%2BY.%26aulast%3DHentze%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DY.%2BC.%26aulast%3DMadan%26aufirst%3DB.%26aulast%3DAmalini%26aufirst%3DC.%26aulast%3DLoh%26aufirst%3DY.%2BK.%26aulast%3DOng%26aufirst%3DL.%2BC.%26aulast%3DWilliam%26aufirst%3DA.%2BD.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DJayaraman%26aufirst%3DR.%26aulast%3DOng%26aufirst%3DK.%2BH.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DWood%26aufirst%3DJ.%2BW.%26atitle%3DSB1518%252C%2520a%2520novel%2520macrocyclic%2520pyrimidine-based%2520JAK2%2520inhibitor%2520for%2520the%2520treatment%2520of%2520myeloid%2520and%2520lymphoid%2520malignancies%26jtitle%3DLeukemia%26date%3D2011%26volume%3D25%26spage%3D1751%26epage%3D1759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ionnidis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alimzhanov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M.</span><span> </span><span class="NLM_article-title">Discovery of 5-Chloro-<i>N</i>2-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i>4-(5-methyl-1<i>H</i>-pyrazol-3-yl)-pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat Pathway</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=262-276&author=S.+Ionnidisauthor=M.+L.+Lambauthor=T.+Wangauthor=L.+Almeidaauthor=M.+H.+Blockauthor=A.+M.+Daviesauthor=B.+Pengauthor=M.+Suauthor=H.-J.+Zhangauthor=E.+Hoffmanauthor=C.+Rivardauthor=I.+Greenauthor=T.+Howardauthor=H.+Pollardauthor=J.+Readauthor=M.+Alimzhanovauthor=G.+Bebernitzauthor=K.+Bellauthor=M.+Yeauthor=D.+Huszarauthor=M.+Zinda&title=Discovery+of+5-Chloro-N2-%5B%281S%29-1-%285-fluoropyrimidin-2-yl%29ethyl%5D-N4-%285-methyl-1H-pyrazol-3-yl%29-pyrimidine-2%2C4-diamine+%28AZD1480%29+as+a+Novel+Inhibitor+of+the+Jak%2FStat+Pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIonnidis%26aufirst%3DS.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DBlock%26aufirst%3DM.%2BH.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.-J.%26aulast%3DHoffman%26aufirst%3DE.%26aulast%3DRivard%26aufirst%3DC.%26aulast%3DGreen%26aufirst%3DI.%26aulast%3DHoward%26aufirst%3DT.%26aulast%3DPollard%26aufirst%3DH.%26aulast%3DRead%26aufirst%3DJ.%26aulast%3DAlimzhanov%26aufirst%3DM.%26aulast%3DBebernitz%26aufirst%3DG.%26aulast%3DBell%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DHuszar%26aufirst%3DD.%26aulast%3DZinda%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25205-Chloro-N2-%255B%25281S%2529-1-%25285-fluoropyrimidin-2-yl%2529ethyl%255D-N4-%25285-methyl-1H-pyrazol-3-yl%2529-pyrimidine-2%252C4-diamine%2520%2528AZD1480%2529%2520as%2520a%2520Novel%2520Inhibitor%2520of%2520the%2520Jak%252FStat%2520Pathway%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D262%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Burkholder, T. P.; Clayton, J. R.; Ma, L.</span><span> </span><span class="NLM_article-title">Amino pyrazole compound</span>. U.S. Pat. Appl. Publ. US 20100152181 A1 20100617; CAN 153:97762, AN 2010:753991.201,<span class="NLM_x"> </span><span class="NLM_year">2010</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+P.+Burkholder&author=J.+R.+Clayton&author=L.+Ma&title=Amino+pyrazole+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurkholder%26aufirst%3DT.%2BP.%26atitle%3DAmino%2520pyrazole%2520compound%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Burns, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourke, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donohue, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrugia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feutrill, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joffe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nero, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikanyik, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Styles, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treutlein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilks, A. F.</span><span> </span><span class="NLM_article-title">Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5887</span><span class="NLM_x">–</span> <span class="NLM_lpage">5882</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5887-5882&author=C.+J.+Burnsauthor=D.+G.+Bourkeauthor=L.+Andrauauthor=X.+Buauthor=S.+A.+Charmanauthor=A.+C.+Donohueauthor=E.+Fantinoauthor=M.+Farrugiaauthor=J.+T.+Feutrillauthor=M.+Joffeauthor=M.+R.+Klingauthor=M.+Kurekauthor=T.+L.+Neroauthor=T.+Nguyenauthor=J.+T.+Palmerauthor=I.+Phillipsauthor=D.+M.+Shaklefordauthor=H.+Sikanyikauthor=M.+Stylesauthor=S.+Suauthor=H.+Treutleinauthor=J.+Zengauthor=A.+F.+Wilks&title=Phenylaminopyrimidines+as+inhibitors+of+Janus+kinases+%28JAKs%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26aulast%3DBourke%26aufirst%3DD.%2BG.%26aulast%3DAndrau%26aufirst%3DL.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DDonohue%26aufirst%3DA.%2BC.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DFarrugia%26aufirst%3DM.%26aulast%3DFeutrill%26aufirst%3DJ.%2BT.%26aulast%3DJoffe%26aufirst%3DM.%26aulast%3DKling%26aufirst%3DM.%2BR.%26aulast%3DKurek%26aufirst%3DM.%26aulast%3DNero%26aufirst%3DT.%2BL.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPhillips%26aufirst%3DI.%26aulast%3DShakleford%26aufirst%3DD.%2BM.%26aulast%3DSikanyik%26aufirst%3DH.%26aulast%3DStyles%26aufirst%3DM.%26aulast%3DSu%26aufirst%3DS.%26aulast%3DTreutlein%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26atitle%3DPhenylaminopyrimidines%2520as%2520inhibitors%2520of%2520Janus%2520kinases%2520%2528JAKs%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5887%26epage%3D5882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tyner, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bumm, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aichberger, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriaux, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, M. W.</span><span> </span><span class="NLM_article-title">CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">5232</span><span class="NLM_x">–</span> <span class="NLM_lpage">5240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=5232-5240&author=J.+W.+Tynerauthor=T.+G.+Bummauthor=J.+Deiningerauthor=L.+Woodauthor=K.+J.+Aichbergerauthor=M.+M.+Loriauxauthor=B.+J.+Drukerauthor=C.+J.+Burnsauthor=E.+Fantinoauthor=M.+W.+Deininger&title=CYT387%2C+a+novel+JAK2+inhibitor%2C+induces+hematologic+responses+and+normalizes+inflammatory+cytokines+in+murine+myeloproliferative+neoplasms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DBumm%26aufirst%3DT.%2BG.%26aulast%3DDeininger%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DL.%26aulast%3DAichberger%26aufirst%3DK.%2BJ.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DDeininger%26aufirst%3DM.%2BW.%26atitle%3DCYT387%252C%2520a%2520novel%2520JAK2%2520inhibitor%252C%2520induces%2520hematologic%2520responses%2520and%2520normalizes%2520inflammatory%2520cytokines%2520in%2520murine%2520myeloproliferative%2520neoplasms%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D5232%26epage%3D5240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Verstovsek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesa, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardanani, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Franco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrov, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson-Viitanen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span> </span><span class="NLM_article-title">Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1056%2FNEJMoa1002028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=20843246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOltrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1117-1127&author=S.+Verstovsekauthor=H.+Kantarjianauthor=R.+A.+Mesaauthor=A.+D.+Pardananiauthor=J.+Cortes-Francoauthor=D.+A.+Thomasauthor=Z.+Estrovauthor=J.+S.+Fridmanauthor=E.+C.+Bradleyauthor=S.+Erickson-Viitanenauthor=K.+Vaddiauthor=R.+Levyauthor=A.+Tefferi&title=Safety+and+efficacy+of+INCB018424%2C+a+JAK1+and+JAK2+inhibitor%2C+in+myelofibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis</span></div><div class="casAuthors">Verstovsek, Srdan; Kantarjian, Hagop; Mesa, Ruben A.; Pardanani, Animesh D.; Cortes-Franco, Jorge; Thomas, Deborah A.; Estrov, Zeev; Fridman, Jordan S.; Bradley, Edward C.; Erickson-Viitanen, Susan; Vaddi, Kris; Levy, Richard; Tefferi, Ayalew</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1117-1127</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Myelofibrosis is a Philadelphia chromosome-neg. myeloproliferative neoplasm assocd. with cytopenias, splenomegaly, poor quality of life, and shortened survival.  About half of patients with myelofibrosis carry a gain-of-function mutation in the Janus kinase 2 gene (JAK2 V617F) that contributes to the pathophysiol. of the disease.  INCB018424 is a potent and selective Janus kinase 1 (JAK1) and JAK2 inhibitor.  Methods: We conducted a phase 1-2 trial of INCB018424 in patients with JAK2 V617F-pos. or JAK2 V617F-neg. primary myelofibrosis, post-essential thrombocythemia myelofibrosis, or post-polycythemia vera myelofibrosis.  Results: A total of 153 patients received INCB018424 for a median duration of more than 14.7 mo.  The initial dose-escalation phase established 25 mg twice daily or 100 mg once daily as max. tolerated doses, on the basis of reversible thrombocytopenia.  A dose-dependent suppression of phosphorylated signal transducer and activator of transcription 3 (STAT3), a marker of JAK signaling, was demonstrated in patients with wild-type JAK2 and in patients with the JAK2 V617F mutation.  We studied addnl. doses and established that a 15-mg twice-daily starting dose, followed by individualized dose titrn., was the most effective and safest dosing regimen.  At this dose, 17 of 33 patients (52%) had a rapid objective response (>50% redn. of splenomegaly) lasting for 12 mo or more, and this therapy was assocd. with grade 3 or grade 4 adverse events (mainly myelosuppression) in less than 10% of patients.  Patients with debilitating symptoms, including wt. loss, fatigue, night sweats, and pruritus, had rapid improvement.  Clin. benefits were assocd. with a marked diminution of levels of circulating inflammatory cytokines that are commonly elevated in myelofibrosis.  Conclusions: INCB018424 was assocd. with marked and durable clin. benefits in patients with myelofibrosis for whom no approved therapies existed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUi05ApP1FLrVg90H21EOLACvtfcHk0ljOqS3U6fUFXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOltrjJ&md5=ba6fe766323a10a1508c686fdb3720b1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1002028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1002028%26sid%3Dliteratum%253Aachs%26aulast%3DVerstovsek%26aufirst%3DS.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DMesa%26aufirst%3DR.%2BA.%26aulast%3DPardanani%26aufirst%3DA.%2BD.%26aulast%3DCortes-Franco%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DD.%2BA.%26aulast%3DEstrov%26aufirst%3DZ.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DBradley%26aufirst%3DE.%2BC.%26aulast%3DErickson-Viitanen%26aufirst%3DS.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DLevy%26aufirst%3DR.%26aulast%3DTefferi%26aufirst%3DA.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520INCB018424%252C%2520a%2520JAK1%2520and%2520JAK2%2520inhibitor%252C%2520in%2520myelofibrosis%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D1117%26epage%3D1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Quintas-Cardama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manshouri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caulder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waeltz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">3109</span><span class="NLM_x">–</span> <span class="NLM_lpage">3117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1182%2Fblood-2009-04-214957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=20130243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltlWqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=3109-3117&author=A.+Quintas-Cardamaauthor=K.+Vaddiauthor=P.+Liuauthor=T.+Manshouriauthor=J.+Liauthor=P.+A.+Scherleauthor=E.+Caulderauthor=X.+Wenauthor=Y.+Liauthor=P.+Waeltzauthor=M.+Ruparauthor=T.+Burnauthor=Y.+Loauthor=J.+Kelleyauthor=M.+Covingtonauthor=S.+Shepardauthor=J.+D.+Rodgersauthor=P.+Haleyauthor=J.+Kantarjianauthor=J.+S.+Fridmanauthor=S.+Verstovsek&title=Preclinical+characterization+of+the+selective+JAK1%2F2+inhibitor+INCB018424%3A+therapeutic+implications+for+the+treatment+of+myeloproliferative+neoplasms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms</span></div><div class="casAuthors">Quintas-Cardama, Alfonso; Vaddi, Kris; Liu, Phillip; Manshouri, Taghi; Li, Jun; Scherle, Peggy A.; Caulder, Eian; Wen, Xiaoming; Li, Yanlong; Waeltz, Paul; Rupar, Mark; Burn, Timothy; Lo, Yvonne; Kelley, Jennifer; Covington, Maryanne; Shepard, Stacey; Rodgers, James D.; Haley, Patrick; Kantarjian, Hagop; Fridman, Jordan S.; Verstovsek, Srdan</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3109-3117</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Constitutive JAK2 activation in hematopoietic cells by the JAK2V617F mutation recapitulates myeloproliferative neoplasm (MPN) phenotypes in mice, establishing JAK2 inhibition as a potential therapeutic strategy.  Although most polycythemia vera patients carry the JAK2V617F mutation, half of those with essential thrombocythemia or primary myelofibrosis do not, suggesting alternative mechanisms for constitutive JAK-STAT signaling in MPNs.  Most patients with primary myelofibrosis have elevated levels of JAK-dependent proinflammatory cytokines (eg, interleukin-6) consistent with our observation of JAK1 hyperactivation.  Accordingly, we evaluated the effectiveness of selective JAK1/2 inhibition in exptl. models relevant to MPNs and report on the effects of INCB018424, the first potent, selective, oral JAK1/JAK2 inhibitor to enter the clinic.  INCB018424 inhibited interleukin-6 signaling (50% inhibitory concn. [IC50] = 281nM), and proliferation of JAK2V617F+ Ba/F3 cells (IC50 = 127nM).  In primary cultures, INCB018424 preferentially suppressed erythroid progenitor colony formation from JAK2V617F+ polycythemia vera patients (IC50 = 67nM) vs. healthy donors (IC50 > 400nM).  In a mouse model of JAK2V617F+ MPN, oral INCB018424 markedly reduced splenomegaly and circulating levels of inflammatory cytokines, and preferentially eliminated neoplastic cells, resulting in significantly prolonged survival without myelosuppressive or immunosuppressive effects.  Preliminary clin. results support these preclin. data and establish INCB018424 as a promising oral agent for the treatment of MPNs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvKGz1l6Y-CbVg90H21EOLACvtfcHk0ljOqS3U6fUFXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltlWqsr8%253D&md5=cd52b7013d76ed00ca2df22444c45160</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-04-214957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-04-214957%26sid%3Dliteratum%253Aachs%26aulast%3DQuintas-Cardama%26aufirst%3DA.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DManshouri%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26aulast%3DCaulder%26aufirst%3DE.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWaeltz%26aufirst%3DP.%26aulast%3DRupar%26aufirst%3DM.%26aulast%3DBurn%26aufirst%3DT.%26aulast%3DLo%26aufirst%3DY.%26aulast%3DKelley%26aufirst%3DJ.%26aulast%3DCovington%26aufirst%3DM.%26aulast%3DShepard%26aufirst%3DS.%26aulast%3DRodgers%26aufirst%3DJ.%2BD.%26aulast%3DHaley%26aufirst%3DP.%26aulast%3DKantarjian%26aufirst%3DJ.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DPreclinical%2520characterization%2520of%2520the%2520selective%2520JAK1%252F2%2520inhibitor%2520INCB018424%253A%2520therapeutic%2520implications%2520for%2520the%2520treatment%2520of%2520myeloproliferative%2520neoplasms%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D3109%26epage%3D3117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Macchi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacco, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frattini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugazio, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candotti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vezzoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Notarangelo, L. D.</span><span> </span><span class="NLM_article-title">Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1038%2F377065a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=7659163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADyaK2MXnvFektb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=1995&pages=65-68&author=P.+Macchiauthor=A.+Villaauthor=S.+Gilianiauthor=M.+G.+Saccoauthor=A.+Frattiniauthor=F.+Portaauthor=A.+G.+Ugazioauthor=J.+A.+Johnstonauthor=F.+Candottiauthor=J.+J.+O%E2%80%99Sheaauthor=P.+Vezzoniauthor=L.+D.+Notarangelo&title=Mutations+of+Jak-3+gene+in+patients+with+autosomal+severe+combined+immune+deficiency+%28SCID%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)</span></div><div class="casAuthors">Macchi, Paolo; Villa, Anna; Giliani, Silvia; Sacco, Maria G.; Frattini, Annalisa; Porta, Fulvio; Ugazio, Alberto G.; Johnston, James A.; Candotti, Fabio; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">6544</span>),
    <span class="NLM_cas:pages">65-8</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Severe combined immune deficiency (SCID) represents a heterogeneous group of hereditary diseases.  Mutations in the common γ-chain (γc), which is part of several cytokine receptors including those for interleukin (IL)-2, IL-4, IL-7, IL-9 and IL-15, are responsible for X-linked SCID, which is usually assocd. with a lack of circulating T cells and the presence of B lymphocytes (T- B+ SCID).  The gene(s) responsible for autosomal recessive T- B+ SCID is still unknown.  The Jak-3 protein kinase has been found to assoc. with the γc-chain-contg. cytokine receptors.  Therefore Jak-3 or other STAT proteins with which it interacts are candidate genes for autosomal recessive T- B+ SCID.  Here the authors investigate two unrelated T- B+ SCID patients (both from consanguineous parents) who have homozygous mutations in the gene for Jak-3.  One patient carries a mutation (Tyr100→Cys) in a conserved tyrosine residue in the JH7 domain of Jak-3 which is absent in more than 150 investigated chromosomes.  The other patient carries a homozygous 151-base-pair deletion in the kinase-like domain, leading to a frameshift and premature termination.  Both mutations resulted in markedly reduced levels of Jak-3.  These findings show that abnormalities in the Jak/STAT signaling pathway can account for SCID in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJWFs-Wbegq7Vg90H21EOLACvtfcHk0lhl4023rs94Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvFektb4%253D&md5=ac5a7064e6c3361c8906813770e1b6d9</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1038%2F377065a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F377065a0%26sid%3Dliteratum%253Aachs%26aulast%3DMacchi%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DA.%26aulast%3DGiliani%26aufirst%3DS.%26aulast%3DSacco%26aufirst%3DM.%2BG.%26aulast%3DFrattini%26aufirst%3DA.%26aulast%3DPorta%26aufirst%3DF.%26aulast%3DUgazio%26aufirst%3DA.%2BG.%26aulast%3DJohnston%26aufirst%3DJ.%2BA.%26aulast%3DCandotti%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DVezzoni%26aufirst%3DP.%26aulast%3DNotarangelo%26aufirst%3DL.%2BD.%26atitle%3DMutations%2520of%2520Jak-3%2520gene%2520in%2520patients%2520with%2520autosomal%2520severe%2520combined%2520immune%2520deficiency%2520%2528SCID%2529%26jtitle%3DNature%26date%3D1995%26volume%3D377%26spage%3D65%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Russell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tayebi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedy, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migone, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markert, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, W. J.</span><span> </span><span class="NLM_article-title">Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=797-800&author=S.+M.+Russellauthor=N.+Tayebiauthor=H.+Nakajimaauthor=M.+C.+Riedyauthor=J.+L.+Robertsauthor=M.+J.+Amanauthor=T.+S.+Migoneauthor=M.+Noguchiauthor=M.+L.+Markertauthor=R.+H.+Buckleyauthor=J.+J.+O%E2%80%99Sheaauthor=W.+J.+Leonard&title=Mutation+of+Jak3+in+a+patient+with+SCID%3A+essential+role+of+Jak3+in+lymphoid+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DS.%2BM.%26aulast%3DTayebi%26aufirst%3DN.%26aulast%3DNakajima%26aufirst%3DH.%26aulast%3DRiedy%26aufirst%3DM.%2BC.%26aulast%3DRoberts%26aufirst%3DJ.%2BL.%26aulast%3DAman%26aufirst%3DM.%2BJ.%26aulast%3DMigone%26aufirst%3DT.%2BS.%26aulast%3DNoguchi%26aufirst%3DM.%26aulast%3DMarkert%26aufirst%3DM.%2BL.%26aulast%3DBuckley%26aufirst%3DR.%2BH.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26atitle%3DMutation%2520of%2520Jak3%2520in%2520a%2520patient%2520with%2520SCID%253A%2520essential%2520role%2520of%2520Jak3%2520in%2520lymphoid%2520development%26jtitle%3DScience%26date%3D1995%26volume%3D270%26spage%3D797%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meraz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, R. D.</span><span> </span><span class="NLM_article-title">Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1998&pages=373-383&author=S.+J.+Rodigauthor=M.+A.+Merazauthor=J.+M.+Whiteauthor=P.+A.+Lampeauthor=J.+K.+Rileyauthor=C.+D.+Arthurauthor=K.+L.+Kingauthor=K.+C.+Sheehanauthor=L.+Yinauthor=D.+Pennicaauthor=E.+M.+Johnsonauthor=R.+D.+Schreiber&title=Disruption+of+the+Jak1+gene+demonstrates+obligatory+and+nonredundant+roles+of+the+Jaks+in+cytokine-induced+biologic+responses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DMeraz%26aufirst%3DM.%2BA.%26aulast%3DWhite%26aufirst%3DJ.%2BM.%26aulast%3DLampe%26aufirst%3DP.%2BA.%26aulast%3DRiley%26aufirst%3DJ.%2BK.%26aulast%3DArthur%26aufirst%3DC.%2BD.%26aulast%3DKing%26aufirst%3DK.%2BL.%26aulast%3DSheehan%26aufirst%3DK.%2BC.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DPennica%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DE.%2BM.%26aulast%3DSchreiber%26aufirst%3DR.%2BD.%26atitle%3DDisruption%2520of%2520the%2520Jak1%2520gene%2520demonstrates%2520obligatory%2520and%2520nonredundant%2520roles%2520of%2520the%2520Jaks%2520in%2520cytokine-induced%2520biologic%2520responses%26jtitle%3DCell%26date%3D1998%26volume%3D93%26spage%3D373%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="note"><p class="first last">The prescribing information for ruxolitinib (Jakafi) includes: “Active serious infections should have resolved before starting therapy with Jakafi. Physicians should carefully observe patients receiving Jakafi for signs and symptoms of infection and initiate appropriate treatment promptly.”</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eYRoKSwPyzrCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Keseru, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makara, G. M.</span><span> </span><span class="NLM_article-title">The influence of lead discovery strategies on the properties of drug candidates</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=203-212&author=G.+M.+Keseruauthor=G.+M.+Makara&title=The+influence+of+lead+discovery+strategies+on+the+properties+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DThe%2520influence%2520of%2520lead%2520discovery%2520strategies%2520on%2520the%2520properties%2520of%2520drug%2520candidates%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D203%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Cruciani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crivori, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Molecular fields in quantitative structure-permeation relationships: the VolSurf approach</span> <span class="citation_source-journal">J. Mol. Struct. (THEOCHEM)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">503</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2000&pages=17-30&author=G.+Crucianiauthor=P.+Crivoriauthor=P.-A.+Carruptauthor=B.+Testa&title=Molecular+fields+in+quantitative+structure-permeation+relationships%3A+the+VolSurf+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DCrivori%26aufirst%3DP.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DMolecular%2520fields%2520in%2520quantitative%2520structure-permeation%2520relationships%253A%2520the%2520VolSurf%2520approach%26jtitle%3DJ.%2520Mol.%2520Struct.%2520%2528THEOCHEM%2529%26date%3D2000%26volume%3D503%26spage%3D17%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Gavrin, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Provencher, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massefski, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huhn, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciszewski, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKew, J. C.</span><span> </span><span class="NLM_article-title">Synthesis of pyrazolo[1,5-alpha]pyrimidinone regioisomers</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1043</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo062120g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=1043-1046&author=L.+K.+Gavrinauthor=A.+Leeauthor=B.+A.+Provencherauthor=W.+W.+Massefskiauthor=S.+D.+Huhnauthor=G.+M.+Ciszewskiauthor=D.+C.+Coleauthor=J.+C.+McKew&title=Synthesis+of+pyrazolo%5B1%2C5-alpha%5Dpyrimidinone+regioisomers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjo062120g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo062120g%26sid%3Dliteratum%253Aachs%26aulast%3DGavrin%26aufirst%3DL.%2BK.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DProvencher%26aufirst%3DB.%2BA.%26aulast%3DMassefski%26aufirst%3DW.%2BW.%26aulast%3DHuhn%26aufirst%3DS.%2BD.%26aulast%3DCiszewski%26aufirst%3DG.%2BM.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DMcKew%26aufirst%3DJ.%2BC.%26atitle%3DSynthesis%2520of%2520pyrazolo%255B1%252C5-alpha%255Dpyrimidinone%2520regioisomers%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26spage%3D1043%26epage%3D1046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Miyaura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2457</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00039a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2457-2483&author=N.+Miyauraauthor=A.+Suzuki&title=Palladium-Catalyzed+Cross-Coupling+Reactions+of+Organoboron+Compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span></div><div class="casAuthors">Miyaura, Norio; Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2457-83</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with >250 refs. including title reactions and their mechanisms, prepn. of organoboron reagents, alkoxycarbonylation and dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwupBJT1UCbVg90H21EOLACvtfcHk0litlx4YUgi4dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D&md5=d127b414a75161652876eebc3ed0c486</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcr00039a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00039a007%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DPalladium-Catalyzed%2520Cross-Coupling%2520Reactions%2520of%2520Organoboron%2520Compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26spage%3D2457%26epage%3D2483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcoxen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, J. R.</span><span> </span><span class="NLM_article-title">A convenient one-pot synthesis of 4-amino-3-arylpyrazoles from alpha-phthaloylaminoacetophenones</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">8229</span><span class="NLM_x">–</span> <span class="NLM_lpage">8232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=8229-8232&author=C.+Chenauthor=K.+Wilcoxenauthor=J.+R.+McCarthy&title=A+convenient+one-pot+synthesis+of+4-amino-3-arylpyrazoles+from+alpha-phthaloylaminoacetophenones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26aulast%3DWilcoxen%26aufirst%3DK.%26aulast%3DMcCarthy%26aufirst%3DJ.%2BR.%26atitle%3DA%2520convenient%2520one-pot%2520synthesis%2520of%25204-amino-3-arylpyrazoles%2520from%2520alpha-phthaloylaminoacetophenones%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D8229%26epage%3D8232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Clay, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collom, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karrick, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wemple, J.</span><span> </span><span class="NLM_article-title">A safe, economical method for the preparation of beta-oxo esters</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1055%2Fs-1993-25849" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADyaK3sXisFCnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&pages=290-292&author=R.+J.+Clayauthor=T.+A.+Collomauthor=G.+L.+Karrickauthor=J.+Wemple&title=A+safe%2C+economical+method+for+the+preparation+of+beta-oxo+esters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A safe, economical method for the preparation of β-oxo esters</span></div><div class="casAuthors">Clay, Ronald J.; Collom, Thomas A.; Karrick, Gregory L.; Wemple, James</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">290-2</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">A high yield, economical method for prepn. of β-oxo esters, e.g., BzCH2CO2Et, has been developed involving the reaction of acid chlorides with potassium Et malonate using a magnesium chloride-triethylamine base system in either acetonitrile or Et acetate solvents.  The method is suitable for the prepn. of high purity β-oxo esters in the lab. and also in large scale prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfDon5BC4otLVg90H21EOLACvtfcHk0litlx4YUgi4dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXisFCnu7k%253D&md5=f19267f744ed1cc802253f96708a7ada</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1055%2Fs-1993-25849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1993-25849%26sid%3Dliteratum%253Aachs%26aulast%3DClay%26aufirst%3DR.%2BJ.%26aulast%3DCollom%26aufirst%3DT.%2BA.%26aulast%3DKarrick%26aufirst%3DG.%2BL.%26aulast%3DWemple%26aufirst%3DJ.%26atitle%3DA%2520safe%252C%2520economical%2520method%2520for%2520the%2520preparation%2520of%2520beta-oxo%2520esters%26jtitle%3DSynthesis%26date%3D1993%26spage%3D290%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Shioiri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninomiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, S.</span><span> </span><span class="NLM_article-title">Diphenylphosphoryl azide: a new convenient reagent for a modified Curtius reaction and for the peptide synthesis</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">6203</span><span class="NLM_x">–</span> <span class="NLM_lpage">6205</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00772a052" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1972&pages=6203-6205&author=T.+Shioiriauthor=K.+Ninomiyaauthor=S.+Yamada&title=Diphenylphosphoryl+azide%3A+a+new+convenient+reagent+for+a+modified+Curtius+reaction+and+for+the+peptide+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja00772a052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00772a052%26sid%3Dliteratum%253Aachs%26aulast%3DShioiri%26aufirst%3DT.%26aulast%3DNinomiya%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DS.%26atitle%3DDiphenylphosphoryl%2520azide%253A%2520a%2520new%2520convenient%2520reagent%2520for%2520a%2520modified%2520Curtius%2520reaction%2520and%2520for%2520the%2520peptide%2520synthesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1972%26volume%3D94%26spage%3D6203%26epage%3D6205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="note"><p class="first last">Identity of regioisomers definitevely assigned via <sup>1</sup>H NMR nuclear Overhauser effect.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Goikhman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sames, D.</span><span> </span><span class="NLM_article-title">C–H bonds as ubiquitous functionality: a general approach to complex arylated pyrazoles via sequential regioselective <i>C</i>-arylation and <i>N</i>-alkylation enabled by SEM-group transposition</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">3042</span><span class="NLM_x">–</span> <span class="NLM_lpage">3048</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja8096114" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=3042-3048&author=R.+Goikhmanauthor=T.+L.+Jacquesauthor=D.+Sames&title=C%E2%80%93H+bonds+as+ubiquitous+functionality%3A+a+general+approach+to+complex+arylated+pyrazoles+via+sequential+regioselective+C-arylation+and+N-alkylation+enabled+by+SEM-group+transposition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja8096114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja8096114%26sid%3Dliteratum%253Aachs%26aulast%3DGoikhman%26aufirst%3DR.%26aulast%3DJacques%26aufirst%3DT.%2BL.%26aulast%3DSames%26aufirst%3DD.%26atitle%3DC%25E2%2580%2593H%2520bonds%2520as%2520ubiquitous%2520functionality%253A%2520a%2520general%2520approach%2520to%2520complex%2520arylated%2520pyrazoles%2520via%2520sequential%2520regioselective%2520C-arylation%2520and%2520N-alkylation%2520enabled%2520by%2520SEM-group%2520transposition%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D3042%26epage%3D3048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">Invitrogen Selectscreen Kinase Profiling service. Five kinases (DAPK1, Ros, TRKA, TRKB, TRKC) were inhibited greater than 50% by 7a at a compound concentration of 200 nM, a concentration approximately 100-fold higher than the Jak2 <i>K</i><sub>i</sub>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="note"><p class="first last">Mouse pharmacokinetic data is available in tabulated form as <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information, Table S1">Supporting Information, Table S1</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Ritchie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickett, S. D.</span><span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span> <span class="citation_source-journal">Drug. Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1016%2Fj.drudis.2010.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=21129497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=164-171&author=T.+J.+Ritchieauthor=S.+J.+MacDonaldauthor=R.+J.+Youngauthor=S.+D.+Pickett&title=The+impact+of+aromatic+ring+count+on+compound+developability%3A+further+insights+by+examining+carbo-+and+hetero-aromatic+and+-aliphatic+ring+types"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.; Young, Robert J.; Pickett, Stephen D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">164-171</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The impact of carboarom., heteroarom., carboaliph. and heteroaliph. ring counts and fused arom. ring count on several developability measures (soly., lipophilicity, protein binding, P 450 inhibition and hERG binding) is the topic for this review article.  Recent results indicate that increasing ring counts have detrimental effects on developability in the order carboaroms. » heteroaroms. > carboaliphatics > heteroaliphatics, with heteroaliphatics exerting a beneficial effect in many cases.  Increasing arom. ring count exerts effects on several developability parameters that are lipophilicity- and size-independent, and fused arom. systems have a beneficial effect relative to their nonfused counterparts.  Increasing arom. ring count has a detrimental effect on human bioavailability parameters, and heteroarom. ring count (but not other ring counts) has increased over time in marketed oral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYPC7hkoyv7Vg90H21EOLACvtfcHk0ljiG1fwE7-vZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D&md5=8e2d0e4e499d2f07d66ca2f385defb2d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacDonald%26aufirst%3DS.%2BJ.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%253A%2520further%2520insights%2520by%2520examining%2520carbo-%2520and%2520hetero-aromatic%2520and%2520-aliphatic%2520ring%2520types%26jtitle%3DDrug.%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D164%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolian, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guionneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huc, I.</span><span> </span><span class="NLM_article-title">Aromatic δ-peptides: design, synthesis and structural studies of helical, quinoline-derived oligoamide foldamers</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">8365</span><span class="NLM_x">–</span> <span class="NLM_lpage">8374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2003&pages=8365-8374&author=H.+Jiangauthor=J.-M.+Legerauthor=C.+Dolianauthor=P.+Guionneauauthor=I.+Huc&title=Aromatic+%CE%B4-peptides%3A+design%2C+synthesis+and+structural+studies+of+helical%2C+quinoline-derived+oligoamide+foldamers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DLeger%26aufirst%3DJ.-M.%26aulast%3DDolian%26aufirst%3DC.%26aulast%3DGuionneau%26aufirst%3DP.%26aulast%3DHuc%26aufirst%3DI.%26atitle%3DAromatic%2520%25CE%25B4-peptides%253A%2520design%252C%2520synthesis%2520and%2520structural%2520studies%2520of%2520helical%252C%2520quinoline-derived%2520oligoamide%2520foldamers%26jtitle%3DTetrahedron%26date%3D2003%26volume%3D59%26spage%3D8365%26epage%3D8374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pierce, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ter Haar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binch, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span> </span><span class="NLM_article-title">CH···O and CH···N hydrogen bonds in ligand design: a novel quinazolin-4-ylthiazol-2-ylamine protein kinase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1278</span><span class="NLM_x">–</span> <span class="NLM_lpage">1281</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0492249" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1278-1281&author=A.+C.+Pierceauthor=E.+ter+Haarauthor=H.+M.+Binchauthor=D.+P.+Kayauthor=S.+R.+Patelauthor=P.+Li&title=CH%C2%B7%C2%B7%C2%B7O+and+CH%C2%B7%C2%B7%C2%B7N+hydrogen+bonds+in+ligand+design%3A+a+novel+quinazolin-4-ylthiazol-2-ylamine+protein+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1021%2Fjm0492249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0492249%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DA.%2BC.%26aulast%3Dter%2BHaar%26aufirst%3DE.%26aulast%3DBinch%26aufirst%3DH.%2BM.%26aulast%3DKay%26aufirst%3DD.%2BP.%26aulast%3DPatel%26aufirst%3DS.%2BR.%26aulast%3DLi%26aufirst%3DP.%26atitle%3DCH%25C2%25B7%25C2%25B7%25C2%25B7O%2520and%2520CH%25C2%25B7%25C2%25B7%25C2%25B7N%2520hydrogen%2520bonds%2520in%2520ligand%2520design%253A%2520a%2520novel%2520quinazolin-4-ylthiazol-2-ylamine%2520protein%2520kinase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1278%26epage%3D1281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yoshikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haginoya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komoriya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, T.</span><span> </span><span class="NLM_article-title">Design, synthesis, and SAR of <i>cis</i>-1,2-diaminocyclohexane derivatives as potent factor Xa inhibitors. Part II: exploration of 6–6 fused rings as alternative S1 moieties</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">8221</span><span class="NLM_x">–</span> <span class="NLM_lpage">8233</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=8221-8233&author=K.+Yoshikawaauthor=S.+Kobayashiauthor=Y.+Nakamotoauthor=N.+Haginoyaauthor=S.+Komoriyaauthor=T.+Yoshinoauthor=T.+Nagataauthor=A.+Mochizukiauthor=K.+Watanabeauthor=M.+Suzukiauthor=H.+Kannoauthor=T.+Ohta&title=Design%2C+synthesis%2C+and+SAR+of+cis-1%2C2-diaminocyclohexane+derivatives+as+potent+factor+Xa+inhibitors.+Part+II%3A+exploration+of+6%E2%80%936+fused+rings+as+alternative+S1+moieties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshikawa%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DNakamoto%26aufirst%3DY.%26aulast%3DHaginoya%26aufirst%3DN.%26aulast%3DKomoriya%26aufirst%3DS.%26aulast%3DYoshino%26aufirst%3DT.%26aulast%3DNagata%26aufirst%3DT.%26aulast%3DMochizuki%26aufirst%3DA.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DKanno%26aufirst%3DH.%26aulast%3DOhta%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520SAR%2520of%2520cis-1%252C2-diaminocyclohexane%2520derivatives%2520as%2520potent%2520factor%2520Xa%2520inhibitors.%2520Part%2520II%253A%2520exploration%2520of%25206%25E2%2580%25936%2520fused%2520rings%2520as%2520alternative%2520S1%2520moieties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D8221%26epage%3D8233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">A medicinal chemist’s guide to molecular interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5061</span><span class="NLM_x">–</span> <span class="NLM_lpage">5084</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100112j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5061-5084&author=C.+Bissantzauthor=B.+Kuhnauthor=M.+Stahl&title=A+medicinal+chemist%E2%80%99s+guide+to+molecular+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28d&amp;dbid=16384&amp;doi=10.1021%2Fjm100112j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100112j%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DA%2520medicinal%2520chemist%25E2%2580%2599s%2520guide%2520to%2520molecular%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5061%26epage%3D5084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Shimizu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasumatsu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasukochi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iimura, S.</span><span> </span><span class="NLM_article-title">Discovery of imidazo[1,2-<i>b</i>]pyridazine derivatives as IKKβ inhibitors. Part 1: Hit-to-lead study and structure–activity relationship</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5113</span><span class="NLM_x">–</span> <span class="NLM_lpage">5118</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5113-5118&author=H.+Shimizuauthor=S.+Tanakaauthor=T.+Tokiauthor=I.+Yasumatsuauthor=T.+Akimotoauthor=K.+Morishitaauthor=T.+Yamasakiauthor=T.+Yasukochiauthor=S.+Iimura&title=Discovery+of+imidazo%5B1%2C2-b%5Dpyridazine+derivatives+as+IKK%CE%B2+inhibitors.+Part+1%3A+Hit-to-lead+study+and+structure%E2%80%93activity+relationship"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DToki%26aufirst%3DT.%26aulast%3DYasumatsu%26aufirst%3DI.%26aulast%3DAkimoto%26aufirst%3DT.%26aulast%3DMorishita%26aufirst%3DK.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DYasukochi%26aufirst%3DT.%26aulast%3DIimura%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520imidazo%255B1%252C2-b%255Dpyridazine%2520derivatives%2520as%2520IKK%25CE%25B2%2520inhibitors.%2520Part%25201%253A%2520Hit-to-lead%2520study%2520and%2520structure%25E2%2580%2593activity%2520relationship%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5113%26epage%3D5118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Dubey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, D.</span><span> </span><span class="NLM_article-title">Weak interactions: a versatile role in aromatic compounds</span> <span class="citation_source-journal">Curr. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2072</span><span class="NLM_x">–</span> <span class="NLM_lpage">2081</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28f&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.2174%2F138527211795703667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28f&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnslantb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=2072-2081&author=R.+Dubeyauthor=D.+Lim&title=Weak+interactions%3A+a+versatile+role+in+aromatic+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28fR"><div class="casContent"><span class="casTitleNuber">28f</span><div class="casTitle"><span class="NLM_cas:atitle">Weak interactions: a versatile role in aromatic compounds</span></div><div class="casAuthors">Dubey, Rashmi; Lim, Dongyeol</div><div class="citationInfo"><span class="NLM_cas:title">Current Organic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2072-2081</span>CODEN:
                <span class="NLM_cas:coden">CORCFE</span>;
        ISSN:<span class="NLM_cas:issn">1385-2728</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Arom. interactions are essential for stabilizing the conformation and crystal packing of mols.  They also play a vital role in drug chem. by mediating drug-receptor interactions.  In the present review, the various fields in which arom. interactions are important and the role of such interactions are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKiKCvMaqc1rVg90H21EOLACvtfcHk0liXrZLRc7XjCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnslantb0%253D&md5=8f32f80a4784947e8a19751fcb0905c0</span></div><a href="/servlet/linkout?suffix=cit28f&amp;dbid=16384&amp;doi=10.2174%2F138527211795703667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138527211795703667%26sid%3Dliteratum%253Aachs%26aulast%3DDubey%26aufirst%3DR.%26aulast%3DLim%26aufirst%3DD.%26atitle%3DWeak%2520interactions%253A%2520a%2520versatile%2520role%2520in%2520aromatic%2520compounds%26jtitle%3DCurr.%2520Org.%2520Chem.%26date%3D2011%26volume%3D15%26spage%3D2072%26epage%3D2081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">Amino acid differences between Jak2 and other family members are as follows. Jak3 amino acid:Jak2-Gln832:Ser, Met865:Leu, Tyr934:Ser, Ser936:Cys, Lys943:Arg, Gly993:Arg. Tyk2 amino acid:Jak2-Lys857:Glu, Val911:Ile, Leu932:Val, Tyr934:Leu, Lys943:Arg.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ju, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uetrecht, J. P.</span><span> </span><span class="NLM_article-title">Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.2174%2F1389200023337333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=12093356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlCqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=367-377&author=C.+Juauthor=J.+P.+Uetrecht&title=Mechanism+of+idiosyncratic+drug+reactions%3A+reactive+metabolite+formation%2C+protein+binding+and+the+regulation+of+the+immune+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of idiosyncratic drug reactions: reactive metabolites formation, protein binding and the regulation of the immune system</span></div><div class="casAuthors">Ju, C.; Uetrecht, J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">367-377</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug-induced adverse reactions, esp. type B reactions, represent a major clin. problem.  They also impart a significant degree of uncertainty into drug development because they are often not detected until the drug has been released onto the market.  Type B reactions are also termed idiosyncratic drug reactions by many investigators due to their unpredictable nature and our lack of understanding of the mechanisms involved.  It is currently believed that the majority of these reactions are immune-mediated and are caused by immunogenic conjugates formed from the reaction of a reactive metabolite of a drug with cellular proteins.  It has been shown that most drugs assocd. with idiosyncratic reactions form reactive metabolites to some degree.  Covalent binding of reactive metabolites to cellular proteins has also been shown in many cases.  However, studies to reveal the role of reactive metabolites and their protein-adducts in the mechanism of drug-induced idiosyncratic reactions are lacking.  This review will focus on our current understanding and speculative views on how a reactive metabolite of a drug might ultimately lead to immune-mediated toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpowmI5awuRjLVg90H21EOLACvtfcHk0liXrZLRc7XjCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlCqtrg%253D&md5=c678c3f4bcf9a775bedb690c6986381e</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.2174%2F1389200023337333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200023337333%26sid%3Dliteratum%253Aachs%26aulast%3DJu%26aufirst%3DC.%26aulast%3DUetrecht%26aufirst%3DJ.%2BP.%26atitle%3DMechanism%2520of%2520idiosyncratic%2520drug%2520reactions%253A%2520reactive%2520metabolite%2520formation%252C%2520protein%2520binding%2520and%2520the%2520regulation%2520of%2520the%2520immune%2520system%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2002%26volume%3D3%26spage%3D367%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Evans, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span> </span><span class="NLM_article-title">Drug–protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx034170b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=3-16&author=D.+C.+Evansauthor=A.+P.+Wattauthor=D.+A.+Nicoll-Griffithauthor=T.+A.+Baillie&title=Drug%E2%80%93protein+adducts%3A+an+industry+perspective+on+minimizing+the+potential+for+drug+bioactivation+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1021%2Ftx034170b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx034170b%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BC.%26aulast%3DWatt%26aufirst%3DA.%2BP.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DDrug%25E2%2580%2593protein%2520adducts%253A%2520an%2520industry%2520perspective%2520on%2520minimizing%2520the%2520potential%2520for%2520drug%2520bioactivation%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2004%26volume%3D17%26spage%3D3%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contillo, L. G.</span><span> </span><span class="NLM_article-title">The development of a higher throughput reactive intermediate screening assay incorporating micro-bore liquid chromatography-micro-electrospray ionization-tandem mass spectrometry and glutathione ethyl ester as an in vitro conjugating agent</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1016%2Fj.jpba.2004.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=15351054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlems7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=105-116&author=J.+R.+Sogliaauthor=S.+P.+Harrimanauthor=S.+Zhaoauthor=J.+Barberiaauthor=M.+J.+Coleauthor=J.+G.+Boydauthor=L.+G.+Contillo&title=The+development+of+a+higher+throughput+reactive+intermediate+screening+assay+incorporating+micro-bore+liquid+chromatography-micro-electrospray+ionization-tandem+mass+spectrometry+and+glutathione+ethyl+ester+as+an+in+vitro+conjugating+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30cR"><div class="casContent"><span class="casTitleNuber">30c</span><div class="casTitle"><span class="NLM_cas:atitle">The development of a higher throughput reactive intermediate screening assay incorporating micro-bore liquid chromatography-micro-electrospray ionization-tandem mass spectrometry and glutathione ethyl ester as an in vitro conjugating agent</span></div><div class="casAuthors">Soglia, John R.; Harriman, Shawn P.; Zhao, Sabrina; Barberia, John; Cole, Mark J.; Boyd, James G.; Contillo, Leonard G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-116</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An in vitro reactive intermediate screening assay, incorporating the use of the close analog of glutathione, glutathione Et ester (GSH-EE) as a conjugating agent, was developed to identify compds. that form reactive intermediates in an in vitro metabolite generating system.  The biol. assay consisted of substrate [s] = 10 μM, human liver microsomes, an NADPH generating system, and glutathione Et ester.  Conjugates were extd. from the biol. matrix using a combination of protein pptn. and a semi-automated 96-well plate solid phase extn. (SPE) procedure.  A micro-bore liq. chromatog.-micro-electrospray ionization-tandem mass spectrometry (μLC-μESI-MS/MS) method detected glutathione Et ester conjugates using selected reaction monitoring (SRM) to simultaneously monitor for multiple MH+ to [MH - 129]+ transitions, where the 129 mass unit (Da) represents the neutral loss of the pyroglutamate moiety from GSH-EE.  The multiple MH+ to [MH - 129]+ transitions (SRM mass table) were generated for potential reactive intermediates of each compd.  Glutathione (GSH) and GSH-EE conjugate stds. were used to evaluate MS detection sensitivity.  Based on direct comparison of std. curve data, an approx. 10-fold increase in sensitivity was obsd. for conjugates contg. GSH-EE moiety vs. GSH.  In vitro expts. were conducted using literature substrates acetaminophen, rosiglitazone, clozapine, diclofenac and either GSH-EE or GSH as a reactive intermediate conjugating agent.  An increase in detection sensitivity was obsd. for each GSH-EE conjugate and in the case of acetaminophen-GSH-EE the peak area increase was approx. 80-fold.  Twelve drug compds., each having known biotransformation mechanisms, were used to further test the detection capabilities of the assay and establish a concordance to literature data.  When GSH was used in the assay, conjugates were detected for 4 out of the 12 test compds. (33%).  When GSH-EE was used in the assay, conjugates were detected for 10 out of the 12 test compds. (83%).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3NwMX6-E_3LVg90H21EOLACvtfcHk0lhQisH1X3eq8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlems7w%253D&md5=23e4c3df8558019ad3770d748a1f9815</span></div><a href="/servlet/linkout?suffix=cit30c&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2004.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2004.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DBarberia%26aufirst%3DJ.%26aulast%3DCole%26aufirst%3DM.%2BJ.%26aulast%3DBoyd%26aufirst%3DJ.%2BG.%26aulast%3DContillo%26aufirst%3DL.%2BG.%26atitle%3DThe%2520development%2520of%2520a%2520higher%2520throughput%2520reactive%2520intermediate%2520screening%2520assay%2520incorporating%2520micro-bore%2520liquid%2520chromatography-micro-electrospray%2520ionization-tandem%2520mass%2520spectrometry%2520and%2520glutathione%2520ethyl%2520ester%2520as%2520an%2520in%2520vitro%2520conjugating%2520agent%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2004%26volume%3D36%26spage%3D105%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span> </span><span class="NLM_article-title">A comprehensive listing of bioactivation pathways of organic functional groups</span> <span class="citation_source-journal">Curr. Drug. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30d&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.2174%2F1389200054021799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30d&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=15975040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30d&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=161-225&author=A.+S.+Kalgutkarauthor=I.+Gardnerauthor=R.+S.+Obachauthor=C.+L.+Shafferauthor=E.+Callegariauthor=K.+R.+Henneauthor=A.+E.+Mutlibauthor=D.+K.+Dalvieauthor=J.+S.+Leeauthor=Y.+Nakaiauthor=J.+P.+O%E2%80%99Donnellauthor=J.+Boerauthor=S.+P.+Harriman&title=A+comprehensive+listing+of+bioactivation+pathways+of+organic+functional+groups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30dR"><div class="casContent"><span class="casTitleNuber">30d</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive listing of bioactivation pathways of organic functional groups</span></div><div class="casAuthors">Kalgutkar, Amit S.; Gardner, Iain; Obach, R. Scott; Shaffer, Christopher L.; Callegari, Ernesto; Henne, Kirk R.; Mutlib, Abdul E.; Dalvie, Deepak K.; Lee, Jae S.; Nakai, Yasuhiro; O'Donnell, John P.; Boer, Jason; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-225</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of idiosyncratic adverse drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use and even in its withdrawal.  Metabolic activation of relatively inert functional groups to reactive electrophilic intermediates is considered to be an obligatory event in the etiol. of many drug-induced adverse reactions.  Therefore, a thorough examn. of the biochem. reactivity of functional groups/structural motifs in all new drug candidates is essential from a safety standpoint.  A major theme attempted in this review is the comprehensive cataloging of all of the known bioactivation pathways of functional groups or structural motifs commonly utilized in drug design efforts.  Potential strategies in the detection of reactive intermediates in biochem. systems are also discussed.  The intention of this review is not to "black list" functional groups or to immediately discard compds. based on their potential to form reactive metabolites, but rather to serve as a resource describing the structural diversity of these functionalities as well as exptl. approaches that could be taken to evaluate whether a "structural alert" in a new drug candidate undergoes bioactivation to reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVj7cmxfwXrVg90H21EOLACvtfcHk0lhQisH1X3eq8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D&md5=b16dfc2de97c40a11218ecc3043bed66</span></div><a href="/servlet/linkout?suffix=cit30d&amp;dbid=16384&amp;doi=10.2174%2F1389200054021799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200054021799%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DA%2520comprehensive%2520listing%2520of%2520bioactivation%2520pathways%2520of%2520organic%2520functional%2520groups%26jtitle%3DCurr.%2520Drug.%2520Metab.%26date%3D2005%26volume%3D6%26spage%3D161%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Blagg, J.</span><span> </span><span class="NLM_article-title">Structure–activity relationships for in vitro and in vivo toxicity</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=353-368&author=J.+Blagg&title=Structure%E2%80%93activity+relationships+for+in+vitro+and+in+vivo+toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520for%2520in%2520vitro%2520and%2520in%2520vivo%2520toxicity%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2006%26volume%3D41%26spage%3D353%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Milletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sforna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruciani, G.</span><span> </span><span class="NLM_article-title">New and original p<i>K</i><sub>a</sub> prediction method using grid molecular interaction fields</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2172</span><span class="NLM_x">–</span> <span class="NLM_lpage">2181</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci700018y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=2172-2181&author=F.+Millettiauthor=L.+Storchiauthor=G.+Sfornaauthor=G.+Cruciani&title=New+and+original+pKa+prediction+method+using+grid+molecular+interaction+fields"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">New and Original pKa Prediction Method Using Grid Molecular Interaction Fields</span></div><div class="casAuthors">Milletti, Francesca; Storchi, Loriano; Sforna, Gianluca; Cruciani, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2172-2181</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One of the most important physicochem. properties of a mol. is pKa.  It is known that two parameters imperative in ADME profiling, soly., and lipophilicity are governed by pKa, and receptor binding can be influenced by pKa.  Because most drugs are ionized in physiol. conditions, pKa is particularly relevant to medicinal chem.  Despite the numerous advances in high-throughput measurements, in silico detn. is still the fastest and cheapest way of obtaining pKa.  This paper presents a new original computational method for pKa prediction of org. compds.  Descriptors were generated using the program GRID, and these descriptors are based on mol. interaction fields precomputed on a set of mol. fragments.  The new method was developed, trained, and cross-validated by using a large and diverse data set of 24 617 pKa values.  This paper presents the results for a class of 421 acidic nitrogen compds. (RMSE = 0.41, r2 = 0.97, q2 = 0.87) and for a class of 947 six-membered N-heterocyclic bases (RMSE = 0.60, r2 = 0.93, q2 = 0.85).  For external validation 28 novel compds. were selected that covered nine different ionizable groups, and 39 pKa values could be exptl. detd. by spectral gradient anal. (SGA).  Comparison of exptl. pKa with calcd. pKa demonstrated that the predictive ability of the method is good (external set, r2 = 0.85, RMSE = 0.90).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzEk0uiS1E6rVg90H21EOLACvtfcHk0lhQisH1X3eq8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrF&md5=f2b1dec853ccb0ef1a40540d234232fb</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1021%2Fci700018y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700018y%26sid%3Dliteratum%253Aachs%26aulast%3DMilletti%26aufirst%3DF.%26aulast%3DStorchi%26aufirst%3DL.%26aulast%3DSforna%26aufirst%3DG.%26aulast%3DCruciani%26aufirst%3DG.%26atitle%3DNew%2520and%2520original%2520pKa%2520prediction%2520method%2520using%2520grid%2520molecular%2520interaction%2520fields%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D2172%26epage%3D2181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Milletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goracci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendels, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruciani, G.</span><span> </span><span class="NLM_article-title">Extending p<i>K</i><sub>a</sub> prediction accuracy: high-throughput p<i>K</i><sub>a</sub> measurements to understand p<i>K</i><sub>a</sub> modulation of new chemical series</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4270</span><span class="NLM_x">–</span> <span class="NLM_lpage">4279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1016%2Fj.ejmech.2010.06.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=20633962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvFKhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=4270-4279&author=F.+Millettiauthor=L.+Storchiauthor=L.+Goracciauthor=S.+Bendelsauthor=B.+Wagnerauthor=M.+Kansyauthor=G.+Cruciani&title=Extending+pKa+prediction+accuracy%3A+high-throughput+pKa+measurements+to+understand+pKa+modulation+of+new+chemical+series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Extending pKa prediction accuracy: High-throughput pKa measurements to understand pKa modulation of new chemical series</span></div><div class="casAuthors">Milletti, Francesca; Storchi, Loriano; Goracci, Laura; Bendels, Stefanie; Wagner, Bjoern; Kansy, Manfred; Cruciani, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4270-4279</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">We have recently developed a tool, MoKα, to predict the pKa of org. compds. using a large dataset of over 26,500 literature pKa values as a training set.  However, predicting accurately pKa (<0.5 pH units) remains challenging for novel series, and this can be a drawback in the optimization of activity and ADME properties of lead compds.  To address this issue it is important to expand our knowledge of pKa determinants, therefore we have conducted high-throughput pKa measurements by using Spectral Gradient Anal. (SGA) on novel series of compds. selected from vendor databases.  Here we report our findings on the effect of specific chem. groups and steric constraints on the pKa of common functionalities in medicinal chem., such as amines, sulfonamides, and amides.  Furthermore, we report the pKa of ionizable groups that were not well represented in the database of literature pKa of MoKα, such as hydrazide derivs.  These findings helped us to enhance MoKα, which is here benchmarked on a set of exptl. pKa values from the Roche inhouse library (N = 5581; RMSE = 1.09; R2 = 0.82).  The accuracy of the predictions was greatly improved (RMSE = 0.49, R2 = 0.96) after training the software by using the automated tool Kibitzer with 6226 pK a values taken from a different set of Roche compds. appropriately selected, and this demonstrates the value of using high-throughput pKa measurements to expand the training set of pKa values used by the software MoKα.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxQ9UJOAhB-rVg90H21EOLACvtfcHk0liJP5wF6UI57w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvFKhtLo%253D&md5=e4c579032df7fa37ec3551c69a09257a</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DMilletti%26aufirst%3DF.%26aulast%3DStorchi%26aufirst%3DL.%26aulast%3DGoracci%26aufirst%3DL.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DCruciani%26aufirst%3DG.%26atitle%3DExtending%2520pKa%2520prediction%2520accuracy%253A%2520high-throughput%2520pKa%2520measurements%2520to%2520understand%2520pKa%2520modulation%2520of%2520new%2520chemical%2520series%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D4270%26epage%3D4279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">van De Waterbeemd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. K.</span><span> </span><span class="NLM_article-title">Property-based design: optimization of drug absorption and pharmacokinetics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1313</span><span class="NLM_x">–</span> <span class="NLM_lpage">1333</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000407e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD3MXit1Whu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1313-1333&author=H.+van+De+Waterbeemdauthor=D.+A.+Smithauthor=K.+Beaumontauthor=D.+K.+Walker&title=Property-based+design%3A+optimization+of+drug+absorption+and+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Property-based design: optimization of drug absorption and pharmacokinetics</span></div><div class="casAuthors">van de Waterbeemd, Han; Smith, Dennis A.; Beaumont, Kevin; Walker, Don K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1313-1333</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 223 refs.  The authors discuss some aspects of the properties of biol. barriers.  In different sections the estn. of drug absorption via important barriers including gastrointestinal tract, blood-brain barrier, and skin are reviewed.  Various approaches for the measurement and computation of physicochem. and mol. properties currently used in the optimization of absorption as well as the use of physicochem. properties in the design of optimal pharmacokinetic profiles are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaQwsmoX0-mbVg90H21EOLACvtfcHk0liJP5wF6UI57w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXit1Whu7c%253D&md5=3183baedca70020f4ce27f306ba0997e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm000407e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000407e%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDe%2BWaterbeemd%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DWalker%26aufirst%3DD.%2BK.%26atitle%3DProperty-based%2520design%253A%2520optimization%2520of%2520drug%2520absorption%2520and%2520pharmacokinetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D1313%26epage%3D1333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Laurence, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brameld, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Questel, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, E.</span><span> </span><span class="NLM_article-title">The pK(BHX) database: toward a better understanding of hydrogen-bond basicity for medicinal chemists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4073</span><span class="NLM_x">–</span> <span class="NLM_lpage">4086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801331y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFKns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4073-4086&author=C.+Laurenceauthor=K.+A.+Brameldauthor=J.+Gratonauthor=J.+Y.+Le+Questelauthor=E.+Renault&title=The+pK%28BHX%29+database%3A+toward+a+better+understanding+of+hydrogen-bond+basicity+for+medicinal+chemists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The pKBHX Database: Toward a Better Understanding of Hydrogen-Bond Basicity for Medicinal Chemists</span></div><div class="casAuthors">Laurence, Christian; Brameld, Ken A.; Graton, Jerome; Le Questel, Jean-Yves; Renault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4073-4086</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The pKBHX database is presented, which corresponds to three main fields of data: hydrogen bond donor identification, thermodn. data and spectroscopic data.  The pKBHX scale of hydrogen donor basicity differs considerable from the pKBH+ scale of proton transfer basicity.  The hydrogen bond basicities of functional groups relevant to medicinal chem. and drug design is reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql9OhmMu2VILVg90H21EOLACvtfcHk0liJP5wF6UI57w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFKns7w%253D&md5=9ce4bea3e810752baba6ea5784b55ea0</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm801331y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801331y%26sid%3Dliteratum%253Aachs%26aulast%3DLaurence%26aufirst%3DC.%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DGraton%26aufirst%3DJ.%26aulast%3DLe%2BQuestel%26aufirst%3DJ.%2BY.%26aulast%3DRenault%26aufirst%3DE.%26atitle%3DThe%2520pK%2528BHX%2529%2520database%253A%2520toward%2520a%2520better%2520understanding%2520of%2520hydrogen-bond%2520basicity%2520for%2520medicinal%2520chemists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4073%26epage%3D4086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Testa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">Inhibitors of Cytochrome P-450s and their mechanism of action</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.3109%2F03602538109011082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=7028434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADyaL3MXkslGru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1981&pages=1-117&author=B.+Testaauthor=P.+Jenner&title=Inhibitors+of+Cytochrome+P-450s+and+their+mechanism+of+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of cytochrome P-450s and their mechanism of action</span></div><div class="casAuthors">Testa, Bernard; Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-117</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    </div><div class="casAbstract">A review with 236 refs., of inhibitors of cytochrome P 450-dependent monooxygenase systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeDqU6i1SMN7Vg90H21EOLACvtfcHk0ljKDFIkRG7W-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXkslGru7g%253D&md5=8b08f336435114f8480cf96cadd0805a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3109%2F03602538109011082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602538109011082%26sid%3Dliteratum%253Aachs%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520Cytochrome%2520P-450s%2520and%2520their%2520mechanism%2520of%2520action%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D1981%26volume%3D12%26spage%3D1%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Iwaoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomoda, S.</span><span> </span><span class="NLM_article-title">Statistical and theoretical investigations on the directionality of nonbonded S···O interactions. Implications for molecular design and protein engineering</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">10613</span><span class="NLM_x">–</span> <span class="NLM_lpage">10620</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja026472q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVCnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=10613-10620&author=M.+Iwaokaauthor=S.+Takemotoauthor=S.+Tomoda&title=Statistical+and+theoretical+investigations+on+the+directionality+of+nonbonded+S%C2%B7%C2%B7%C2%B7O+interactions.+Implications+for+molecular+design+and+protein+engineering"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36aR"><div class="casContent"><span class="casTitleNuber">36a</span><div class="casTitle"><span class="NLM_cas:atitle">Statistical and Theoretical Investigations on the Directionality of Nonbonded S···O Interactions. Implications for Molecular Design and Protein Engineering</span></div><div class="casAuthors">Iwaoka, Michio; Takemoto, Shinya; Tomoda, Shuji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">10613-10620</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Weak nonbonded interactions between a divalent sulfur (S) atom and a main-chain carbonyl oxygen (O) atom have recently been characterized in proteins.  However, they have shown distinctly different directional propensities around the O atom from the S···O interactions in small org. compds., although the linearity of the C-S···O or S-S···O at. alignment was commonly obsd.  To elucidate the obsd. discrepancy, a comprehensive search for nonbonded S···O interactions in the Cambridge Structural Database (CSD) and MP2 calcns. on the model complexes between di-Me disulfide (CH3SSCH3) and various carbonyl compds. were performed.  It was found that the O atom showed a strong intrinsic tendency to approach the S atom from the backside of the S-C or S-S bond (in the σS* direction).  On the other hand, the S atom had both possibilities of approach to the carbonyl O atom within the same plane (in the nO direction) and out of the plane (in the πO direction).  In the case of S···O(amide) interactions, the πO direction was significantly preferred as obsd. in proteins.  Thus, structural features of S···O interactions depend on the type of carbonyl groups involved.  The results suggested that S···O interactions may control protein structures to some extent and that the unique directional properties of S···O interactions could be applied to mol. design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSkXUNoB9lurVg90H21EOLACvtfcHk0ljKDFIkRG7W-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVCnt7k%253D&md5=d018c0b07864ff06c04330100708cb13</span></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1021%2Fja026472q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja026472q%26sid%3Dliteratum%253Aachs%26aulast%3DIwaoka%26aufirst%3DM.%26aulast%3DTakemoto%26aufirst%3DS.%26aulast%3DTomoda%26aufirst%3DS.%26atitle%3DStatistical%2520and%2520theoretical%2520investigations%2520on%2520the%2520directionality%2520of%2520nonbonded%2520S%25C2%25B7%25C2%25B7%25C2%25B7O%2520interactions.%2520Implications%2520for%2520molecular%2520design%2520and%2520protein%2520engineering%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D10613%26epage%3D10620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Haginoya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komoriya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirokawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furugori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagahara, T.</span><span> </span><span class="NLM_article-title">Synthesis and conformational analysis of a non-amidine factor Xa inhibitor that incorporates 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-<i>c</i>]pyridine as S4 binding element</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5167</span><span class="NLM_x">–</span> <span class="NLM_lpage">5182</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049884d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5167-5182&author=N.+Haginoyaauthor=S.+Kobayashiauthor=S.+Komoriyaauthor=T.+Yoshinoauthor=M.+Suzukiauthor=T.+Shimadaauthor=K.+Watanabeauthor=Y.+Hirokawaauthor=T.+Furugoriauthor=T.+Nagahara&title=Synthesis+and+conformational+analysis+of+a+non-amidine+factor+Xa+inhibitor+that+incorporates+5-methyl-4%2C5%2C6%2C7-tetrahydrothiazolo%5B5%2C4-c%5Dpyridine+as+S4+binding+element"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1021%2Fjm049884d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049884d%26sid%3Dliteratum%253Aachs%26aulast%3DHaginoya%26aufirst%3DN.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DKomoriya%26aufirst%3DS.%26aulast%3DYoshino%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DShimada%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DHirokawa%26aufirst%3DY.%26aulast%3DFurugori%26aufirst%3DT.%26aulast%3DNagahara%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520conformational%2520analysis%2520of%2520a%2520non-amidine%2520factor%2520Xa%2520inhibitor%2520that%2520incorporates%25205-methyl-4%252C5%252C6%252C7-tetrahydrothiazolo%255B5%252C4-c%255Dpyridine%2520as%2520S4%2520binding%2520element%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5167%26epage%3D5182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Nettekoven, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neidhart, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattei, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pflieger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span> </span><span class="NLM_article-title">Isomeric thiazole derivatives as ligands for the neuropeptide Y5 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3446</span><span class="NLM_x">–</span> <span class="NLM_lpage">3449</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3446-3449&author=M.+Nettekovenauthor=W.+Gubaauthor=W.+Neidhartauthor=P.+Matteiauthor=P.+Pfliegerauthor=O.+Rocheauthor=S.+Taylor&title=Isomeric+thiazole+derivatives+as+ligands+for+the+neuropeptide+Y5+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNettekoven%26aufirst%3DM.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DNeidhart%26aufirst%3DW.%26aulast%3DMattei%26aufirst%3DP.%26aulast%3DPflieger%26aufirst%3DP.%26aulast%3DRoche%26aufirst%3DO.%26aulast%3DTaylor%26aufirst%3DS.%26atitle%3DIsomeric%2520thiazole%2520derivatives%2520as%2520ligands%2520for%2520the%2520neuropeptide%2520Y5%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3446%26epage%3D3449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sugiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sogabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeura, Y.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity relationship studies of benzothieno[3,2-<i>b</i>]furan derivatives as a novel class of IKKbeta inhibitors</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=613-624&author=H.+Sugiyamaauthor=M.+Yoshidaauthor=K.+Moriauthor=T.+Kawamotoauthor=S.+Sogabeauthor=T.+Takagiauthor=H.+Okiauthor=T.+Tanakaauthor=H.+Kimuraauthor=Y.+Ikeura&title=Synthesis+and+structure%E2%80%93activity+relationship+studies+of+benzothieno%5B3%2C2-b%5Dfuran+derivatives+as+a+novel+class+of+IKKbeta+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSugiyama%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DTakagi%26aufirst%3DT.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DIkeura%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520studies%2520of%2520benzothieno%255B3%252C2-b%255Dfuran%2520derivatives%2520as%2520a%2520novel%2520class%2520of%2520IKKbeta%2520inhibitors%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2007%26volume%3D55%26spage%3D613%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from flatland: increasing saturation as an approach to improving clinical success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+increasing+saturation+as+an+approach+to+improving+clinical+success"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0ljzHWSPuOCcXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="note"><p class="first last">Good agreement was observed between the pSTAT5 SET2 MSD format used for compounds in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and the pSTAT5 TF1+EPO MSD format used for compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Compound <b>7j</b> was assessed in both formats, with IC<sub>50</sub> = 3.9 nM in the SET2 format as compared with IC<sub>50</sub> = 7.4 nM in the TF1+EPO format. See the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for details on both cell assays.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="note"><p class="first last">TDI was observed sporadically in compounds in this chemical series with no clear SAR.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="note"><p class="first last">Invitrogen Selectscreen Kinase Profiling service. IC<sub>50</sub>s: Fyn 4.97 μM, Ros 15.2 μM, TrkA 3.97 μM, TrkB 5.38 μM, TrkC 1.3 μM.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bir Kohli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubhayakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span> </span><span class="NLM_article-title">Development and validation of a novel acute myeloid leukemia xenograft model that is dependent on the JAK2 V617F mutation for growth in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">A20</span><div class="note"><p class="first last">GNE-372 refers to compound <b>7j</b>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=A20&author=L.+Leeauthor=M.+Berryauthor=A.+Zhouauthor=T.+Rawsonauthor=E.+Hananauthor=J.+Liauthor=P.+Bir+Kohliauthor=K.+Barrettauthor=C.+Changauthor=J.+Chenauthor=S.+Ubhayakarauthor=M.+Siuauthor=J.+Kennyauthor=A.+Johnsonauthor=A.+Van+Abbemaauthor=W.+Blairauthor=N.+Ghilardiauthor=D.+Sampath&title=Development+and+validation+of+a+novel+acute+myeloid+leukemia+xenograft+model+that+is+dependent+on+the+JAK2+V617F+mutation+for+growth+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DL.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DA.%26aulast%3DRawson%26aufirst%3DT.%26aulast%3DHanan%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBir%2BKohli%26aufirst%3DP.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DKenny%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DVan%2BAbbema%26aufirst%3DA.%26aulast%3DBlair%26aufirst%3DW.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DSampath%26aufirst%3DD.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520novel%2520acute%2520myeloid%2520leukemia%2520xenograft%2520model%2520that%2520is%2520dependent%2520on%2520the%2520JAK2%2520V617F%2520mutation%2520for%2520growth%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3DA20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Morrison, J. F.</span><span> </span><span class="NLM_article-title">Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1016%2F0005-2744%2869%2990420-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=4980133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADyaF1MXkvVOqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=1969&pages=269-286&author=J.+F.+Morrison&title=Kinetics+of+the+reversible+inhibition+of+enzyme-catalysed+reactions+by+tight-binding+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42aR"><div class="casContent"><span class="casTitleNuber">42a</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of the reversible inhibition of enzyme-catalyzed reactions by tight-binding inhibitors</span></div><div class="casAuthors">Morrison, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Enzymology</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-86</span>CODEN:
                <span class="NLM_cas:coden">BBEZAD</span>;
        ISSN:<span class="NLM_cas:issn">0924-1086</span>.
    </div><div class="casAbstract">A theoretical kinetic study has been undertaken to det. the kinetic characteristics of enzymic reactions that are reversibly inhibited by a substrate analog. at concns. comparable to that of the enzyme.  A general rate equation, that allows for the combination of such a tight-binding inhibitor with one or more enzyme forms of any reaction mechanism, has been derived and shown to be quadratic with sq. and linear terms in υ which represents the true initial steady-state velocity.  From plots of υ against total enzyme concn. at fixed total inhibitor concn., the concn. of enzyme catalytic sites can be detd. irrespective of the nature of the inhibition and the reaction mechanism.  However, plots of υ (or I/υ) against total inhibitor concn. can be used for this purpose only if the dissocn. const. assocd. with the inhibitor is virtually zero.  Particular initial rate equations have been obtained for the cases in which the tight-binding inhibitor gives rise to competitive, noncompetitive, and uncompetitive inhibition with respect to one of the substrates of a bireactant mechanism.  From these equations it has been deduced that, in the presence of inhibitor, plots of I/υ against the reciprocals of the substrate concns. yield families of concave-down, nonrectangular hyperbolas.  The difficulties assocd. with the detn. of inhibition consts. for tight-binding inhibitors are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj4s_N2iV3CLVg90H21EOLACvtfcHk0ljzHWSPuOCcXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXkvVOqsbo%253D&md5=74d467477385488dfbb053358534ada6</span></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=10.1016%2F0005-2744%2869%2990420-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2744%252869%252990420-3%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26atitle%3DKinetics%2520of%2520the%2520reversible%2520inhibition%2520of%2520enzyme-catalysed%2520reactions%2520by%2520tight-binding%2520inhibitors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1969%26volume%3D185%26spage%3D269%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit42b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Williams, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, J. F.</span><span> </span><span class="NLM_article-title">The kinetics of reversible tight-binding inhibition</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.1016%2F0076-6879%2879%2963019-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=502865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADyaL3cXovF2ntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1979&pages=437-467&author=J.+W.+Williamsauthor=J.+F.+Morrison&title=The+kinetics+of+reversible+tight-binding+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42bR"><div class="casContent"><span class="casTitleNuber">42b</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetics of reversible tight-binding inhibition</span></div><div class="casAuthors">Williams, Jeffrey W.; Morrison, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">Enzyme Kinet. Mech., Part A</span>),
    <span class="NLM_cas:pages">437-67</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    </div><div class="casAbstract">In addn. to a general discussion of the kinetics of reversible tight-binding inhibitors, which exert their effect at a concn. comparable to that of the enzyme, and for which steady-state theory is used, exptl. results are given of the tight-binding inhibition of creatine kinase by Eu3+ (actually Eu-ADP) under steady-state conditions.  The inhibition of creatine kinase by fixed concns. of Eu3+ in the presence of varying concns. of Mg-ADP indicated that the inhibition is competitive, suggesting that Eu-ADP acts as a structural analog of Mg-ADP.  The inhibition was noncompetitive with respect to creatine phosphate.  The dissocn. consts. for binding of Eu-ADP to the free enzyme and the enzyme-phosphocreatine complex were 1.5 and 2.2 nM, resp., as detd. from Ki values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2CwV3voXt27Vg90H21EOLACvtfcHk0ljzHWSPuOCcXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXovF2ntw%253D%253D&md5=a770f91b51661c9502d0aca44a24e1c7</span></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1016%2F0076-6879%2879%2963019-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0076-6879%252879%252963019-7%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DJ.%2BW.%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520kinetics%2520of%2520reversible%2520tight-binding%2520inhibition%26jtitle%3DMethods%2520Enzymol.%26date%3D1979%26volume%3D63%26spage%3D437%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Halladay, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinhababu, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh-Bakht, S. C.</span><span> </span><span class="NLM_article-title">Metabolic stability screen for drug discovery using cassette analysis and column switching</span> <span class="citation_source-journal">Drug. Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm3012239&amp;key=10.2174%2F187231207779814364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm3012239&amp;key=19356021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtleru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2007&pages=67-72&author=J.+S.+Halladayauthor=S.+Wongauthor=S.+M.+Jafferauthor=A.+K.+Sinhababuauthor=S.+C.+Khojasteh-Bakht&title=Metabolic+stability+screen+for+drug+discovery+using+cassette+analysis+and+column+switching"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic stability screen for drug discovery using cassette analysis and column switching</span></div><div class="casAuthors">Halladay, Jason S.; Wong, Susan; Jaffer, Sharmin M.; Sinhababu, Achintya K.; Khojasteh-Bakht, S. Cyrus</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-72</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">In vitro metabolic stability assays are used to screen compds. for stability in the presence of various drug metabolizing enzymes, usually cytochrome P 450 in liver prepns. (e.g., liver microsomes).  High-throughput metabolic stability assays using pooling methods have been developed to keep pace with screening requirements at the lead ADME optimization stage.  In our lab., we have improved the metabolic stability assay using the cassette anal. method, column switching, and incorporated time saving techniques in method development to yield a robust method which reduces data turnaround time, increases compd. throughput, and maximizes mass spectrometer usage.  This method can det. metabolic stability using microsomes or hepatocytes from any species.  We describe our findings following incubation of 40 different compds. with human liver microsomes and anal. by the cassette and discrete anal. methods.  Similar metabolic stability results were obtained using the cassette anal. and discrete anal. method.  An overall 70% time savings was achieved by pooling four new compds. into one sample for method development/MS optimization, cassetting four samples into one sample to minimize the no. of injections on LC/MS/MS anal., and using a column switching system to analyze the samples, which results in a two-fold decrease in the LC/MS/MS anal. time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKzVSm6sBe1bVg90H21EOLACvtfcHk0lhgXFXXj2kzFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtleru74%253D&md5=e00c66b3ca6a1eaee107c4eb81e07bf5</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.2174%2F187231207779814364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231207779814364%26sid%3Dliteratum%253Aachs%26aulast%3DHalladay%26aufirst%3DJ.%2BS.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DJaffer%26aufirst%3DS.%2BM.%26aulast%3DSinhababu%26aufirst%3DA.%2BK.%26aulast%3DKhojasteh-Bakht%26aufirst%3DS.%2BC.%26atitle%3DMetabolic%2520stability%2520screen%2520for%2520drug%2520discovery%2520using%2520cassette%2520analysis%2520and%2520column%2520switching%26jtitle%3DDrug.%2520Metab.%2520Lett.%26date%3D2007%26volume%3D1%26spage%3D67%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Irvine, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolan, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selick, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grove, J. R.</span><span> </span><span class="NLM_article-title">MDCK (Madin–Darby canine kidney) cells: A tool for membrane permeability screening</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=28-33&author=J.+D.+Irvineauthor=L.+Takahashiauthor=K.+Lockhartauthor=J.+Cheongauthor=J.+W.+Tolanauthor=H.+E.+Selickauthor=J.+R.+Grove&title=MDCK+%28Madin%E2%80%93Darby+canine+kidney%29+cells%3A+A+tool+for+membrane+permeability+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIrvine%26aufirst%3DJ.%2BD.%26aulast%3DTakahashi%26aufirst%3DL.%26aulast%3DLockhart%26aufirst%3DK.%26aulast%3DCheong%26aufirst%3DJ.%26aulast%3DTolan%26aufirst%3DJ.%2BW.%26aulast%3DSelick%26aufirst%3DH.%2BE.%26aulast%3DGrove%26aufirst%3DJ.%2BR.%26atitle%3DMDCK%2520%2528Madin%25E2%2580%2593Darby%2520canine%2520kidney%2529%2520cells%253A%2520A%2520tool%2520for%2520membrane%2520permeability%2520screening%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D28%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit44b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Plise, E.; Sindelar, E.; Duck, B.; Cheong, J.; Sodhi, J.; Salphati, L.</span><span> </span><span class="NLM_article-title">Fully Automated 24-Well Madlin–Darby Canine Kidney (MDCK) Permeability Assay Utilizing the Hamilton Microlab Star Liquid Handling Platform</span>.  <span class="citation_source-journal">AAPS Annu/ Meet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span>. AAPS Abstract: <a href="http://www.aapsj.org/abstracts/AM_2009/AAPS2009-001769.PDF" class="extLink">http://www.aapsj.org/abstracts/AM_2009/AAPS2009-001769.PDF</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=E.+Plise&author=E.+Sindelar&author=B.+Duck&author=J.+Cheong&author=J.+Sodhi&author=L.+Salphati&title=Fully+Automated+24-Well+Madlin%E2%80%93Darby+Canine+Kidney+%28MDCK%29+Permeability+Assay+Utilizing+the+Hamilton+Microlab+Star+Liquid+Handling+Platform"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlise%26aufirst%3DE.%26atitle%3DFully%2520Automated%252024-Well%2520Madlin%25E2%2580%2593Darby%2520Canine%2520Kidney%2520%2528MDCK%2529%2520Permeability%2520Assay%2520Utilizing%2520the%2520Hamilton%2520Microlab%2520Star%2520Liquid%2520Handling%2520Platform%26jtitle%3DAAPS%2520Annu%252F%2520Meet.%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyke, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohli, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narukulla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubhayakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waszkowycz, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, M.</span><span> </span><span class="NLM_article-title">Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5901</span><span class="NLM_x">–</span> <span class="NLM_lpage">5921</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300438j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=32&amp;doi=10.1021%2Fjm3012239&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVOktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5901-5921&author=J.+J.+Kulagowskiauthor=W.+Blairauthor=R.+J.+Bullauthor=C.+Changauthor=G.+Deshmukhauthor=H.+J.+Dykeauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=T.+K.+Harrisonauthor=P.+R.+Hewittauthor=M.+Liimattaauthor=C.+A.+Hurleyauthor=A.+Johnsonauthor=T.+Johnsonauthor=J.+Kennyauthor=P.+B.+Kohliauthor=R.+J.+Maxeyauthor=R.+Mendoncaauthor=K.+Mortaraauthor=J.+Murrayauthor=R.+Narukullaauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=M.+Ultschauthor=A.+van+Abbemaauthor=S.+I.+Wardauthor=B+Waszkowyczauthor=M.+Zak&title=Identification+of+imidazo-pyrrolopyridines+as+novel+and+potent+JAK1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45aR"><div class="casContent"><span class="casTitleNuber">45a</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors</span></div><div class="casAuthors">Kulagowski, Janusz J.; Blair, Wade; Bull, Richard J.; Chang, Christine; Deshmukh, Gauri; Dyke, Hazel J.; Eigenbrot, Charles; Ghilardi, Nico; Gibbons, Paul; Harrison, Trevor K.; Hewitt, Peter R.; Liimatta, Marya; Hurley, Christopher A.; Johnson, Adam; Johnson, Tony; Kenny, Jane R.; Bir Kohli, Pawan; Maxey, Robert J.; Mendonca, Rohan; Mortara, Kyle; Murray, Jeremy; Narukulla, Raman; Shia, Steven; Steffek, Micah; Ubhayakar, Savita; Ultsch, Mark; van Abbema, Anne; Ward, Stuart I.; Waszkowycz, Bohdan; Zak, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5901-5921</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A therapeutic rationale is proposed for the treatment of inflammatory diseases, such as rheumatoid arthritis (RA), by specific targeting of the JAK1 pathway.  Examn. of the preferred binding conformation of clin. effective, pan-JAK inhibitor 1 led to identification of a novel, tricyclic hinge binding scaffold 3.  Exploration of SAR through a series of cycloamino and cycloalkylamino analogs demonstrated this template to be highly tolerant of substitution, with a predisposition to moderate selectivity for the JAK1 isoform over JAK2.  This study culminated in the identification of subnanomolar JAK1 inhibitors such as 22 and 49, having excellent cell potency, good rat pharmacokinetic characteristics, and excellent kinase selectivity.  Detn. of the binding modes of the series in JAK1 and JAK2 by X-ray crystallog. supported the design of analogs to enhance affinity and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpamrk0bG1MK7Vg90H21EOLACvtfcHk0lhgXFXXj2kzFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVOktL0%253D&md5=d91bc0e24abf14adcf44caf61e3e879f</span></div><a href="/servlet/linkout?suffix=cit45a&amp;dbid=16384&amp;doi=10.1021%2Fjm300438j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300438j%26sid%3Dliteratum%253Aachs%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DBlair%26aufirst%3DW.%26aulast%3DBull%26aufirst%3DR.%2BJ.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DDyke%26aufirst%3DH.%2BJ.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DHarrison%26aufirst%3DT.%2BK.%26aulast%3DHewitt%26aufirst%3DP.%2BR.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKenny%26aufirst%3DJ.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DMaxey%26aufirst%3DR.%2BJ.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DMortara%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DNarukulla%26aufirst%3DR.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DS.%2BI.%26aulast%3DWaszkowycz%26aufirst%3DB%26aulast%3DZak%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520imidazo-pyrrolopyridines%2520as%2520novel%2520and%2520potent%2520JAK1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5901%26epage%3D5921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit45b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balazs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVoss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovich, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gradl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harstad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, M. F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohli, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulagowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labadie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupardus, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubhayakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van-Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span> </span><span class="NLM_article-title">Discovery and optimization of C-2 methyl imidazo-pyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6176</span><span class="NLM_x">–</span> <span class="NLM_lpage">6193</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300628c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6176-6193&author=M.+Zakauthor=R.+Mendoncaauthor=M.+Balazsauthor=K.+Barrettauthor=P.+Bergeronauthor=W.+S.+Blairauthor=C.+Changauthor=G.+Deshmukhauthor=J.+DeVossauthor=P.+S.+Dragovichauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=S.+Gradlauthor=C.+Hammanauthor=E.+Hananauthor=E.+Harstadauthor=P.+R.+Hewittauthor=C.+A.+Hurleyauthor=T.+Jinauthor=A.+Johnsonauthor=T.+Johnsonauthor=J.+R.+Kennyauthor=M.+F.+T.+Koehlerauthor=P.+B.+Kohliauthor=J.+Kulagowskiauthor=S.+Labadieauthor=J.+Liaoauthor=M.+Liimattaauthor=Z.+Linauthor=P.+J.+Lupardusauthor=R.+J.+Maxeyauthor=J.+M.+Murrayauthor=R.+Pulkauthor=M.+Rodriguezauthor=S.+Savageauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=M.+Ultschauthor=A.+Van-Abbemaauthor=S.+Wardauthor=L.+Xiaoauthor=Y.+Xiao&title=Discovery+and+optimization+of+C-2+methyl+imidazo-pyrrolopyridines+as+potent+and+orally+bioavailable+JAK1+inhibitors+with+selectivity+over+JAK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45b&amp;dbid=16384&amp;doi=10.1021%2Fjm300628c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300628c%26sid%3Dliteratum%253Aachs%26aulast%3DZak%26aufirst%3DM.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DBalazs%26aufirst%3DM.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DBlair%26aufirst%3DW.%2BS.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DGradl%26aufirst%3DS.%26aulast%3DHamman%26aufirst%3DC.%26aulast%3DHanan%26aufirst%3DE.%26aulast%3DHarstad%26aufirst%3DE.%26aulast%3DHewitt%26aufirst%3DP.%2BR.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DJin%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DKulagowski%26aufirst%3DJ.%26aulast%3DLabadie%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DMaxey%26aufirst%3DR.%2BJ.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DSavage%26aufirst%3DS.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3DVan-Abbema%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DS.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DXiao%26aufirst%3DY.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520C-2%2520methyl%2520imidazo-pyrrolopyridines%2520as%2520potent%2520and%2520orally%2520bioavailable%2520JAK1%2520inhibitors%2520with%2520selectivity%2520over%2520JAK2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6176%26epage%3D6193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HGE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HGE','PDB','4HGE'); return false;">PDB: 4HGE</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i81"><a href="/doi/suppl/10.1021/jm3012239">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_00472"></div></div></div></div></div><hr /></hr><p class="last">Mouse pharmacokinetic parameters for selected compounds, X-ray data collection and refinement details, cocrystal structure (2.3 Å) of compound <b>8</b> in the active site of the Jak2 kinase with protein surface displayed, and preparation and characterization of compounds <b>6b</b>–<b>j</b>, <b>7d</b>–<b>k</b>, <b>9b</b>–<b>c</b>, <b>10b</b>–<b>c</b>, <b>13b</b>–<b>g</b>, <b>14b</b>–<b>e</b>, <b>14g</b>–<b>j</b>, <b>18c</b>–<b>d</b>, <b>19b</b>–<b>d</b>, <b>20b</b>–<b>e</b>, <b>22b</b>, and <b>26b</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3012239/suppl_file/jm3012239_si_001.pdf">jm3012239_si_001.pdf (324.6 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3012239&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm3012239" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3012239" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6679794b48782440","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
